Register Login

ABBOTT LABORATORIES (ABT)

SymbolABT
NameABBOTT LABORATORIES
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address100 ABBOTT PARK ROAD, ABBOTT PARK, Illinois, 60064-6400, United States
Telephone+1 224 667-6100
Fax—
Email—
Websitehttps://www.abbottinvestor.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0000001800
Description

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Additional info from NASDAQ:
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

2026-07-16 11:36

(93% Neutral) ABBOTT LABORATORIES (ABT) Reports Q3 2026 Financial Results

Read more
2026-07-16 11:30

Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance

Read more
2026-06-29 21:34

Cushman Elizabeth C. 🔴 sold 560 shares of ABBOTT LABORATORIES (ABT) at $94.12 Transaction Date: Jun 27, 2026 | Filing ID: 000009

Read more
2026-06-25 13:00

Abbott hosts conference call for second-quarter earnings

Read more
2026-06-12 18:29

Abbott declares 410th consecutive quarterly dividend

Read more
2026-06-08 13:00

New research shows even stronger health outcomes for participants in a Food is Medicine program when paired with support from community health workers

Read more
2026-06-06 13:00

New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis

Read more
2026-05-27 17:48

New Form SD - ABBOTT LABORATORIES <b>Filed:</b> 2026-05-27 <b>AccNo:</b> 0001104659-26-066986 <b>Size:</b> 52 KB

Read more
2026-05-27 13:00

Abbott secures CE Mark for worlds first dual glucose-ketone sensing technology for people with diabetes

Read more
2026-05-27 11:01

ACS guideline reaffirms Abbott leadership in noninvasive colorectal cancer screening

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00000644 A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Diss… Phase2 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00002275 A Comparison of Two Types of Injected Nutritional Supplements in Patients With … Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002366 The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kapos… Phase2 Sarcoma, Kaposi Completed — — ClinicalTrials.gov
NCT00004580 A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Take… Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00004581 A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who … Phase3 HIV Infections Completed — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT06321705 Safety and Efficacy of Continued CS1 Treatment of Patients With Pulmonary Arter… — Pulmonary Arterial Hypertension Available — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT01078610 Safety and Effectiveness and Effect on Quality of Life and Work Productivity of… — Psoriatic Arthritis Withdrawn — — ClinicalTrials.gov
NCT01144156 Small Bowel Mucosal Healing Induced by Adalimumab in Crohn's Disease Patients a… Na Crohn's Disease Unknown — — ClinicalTrials.gov
NCT00121017 A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Susti… Phase2 HIV Infection Withdrawn — — ClinicalTrials.gov
NCT00583401 PFO ACCESS Registry — Patent Foramen Ovale No_Longer_Available — — ClinicalTrials.gov
NCT00583505 Emergency/Compassionate Use - Membranous VSD Occluder — Membranous No_Longer_Available — — ClinicalTrials.gov
NCT00584064 Emergency/Compassionate Use PFO Occluder — Patent Foramen Ovale Approved_For_Marketing — — ClinicalTrials.gov
NCT00590382 Emergency/Compassionate Use - Muscular VSD Occluder — Muscular Approved_For_Marketing — — ClinicalTrials.gov
NCT00002036 Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human) Phase1 HIV Infections Completed — — ClinicalTrials.gov
NCT00002029 Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Sy… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00650026 Early Access Program of the Safety of Human Anti-TNF Monoclonal Antibody Adalim… — Rheumatoid Arthritis Approved_For_Marketing — — ClinicalTrials.gov
NCT00002201 A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patien… Na HIV Infections Completed — — ClinicalTrials.gov
NCT00002223 A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients Na HIV Infections Completed — — ClinicalTrials.gov
NCT00000971 The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosin… Phase1 Mycobacterium Avium-intracellulare Infection Completed — — ClinicalTrials.gov
NCT00000961 The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin… Phase2 HIV Infections Terminated — — ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07696182 Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Usi… Na Severe Native Calcific Aortic Stenosis Not_Yet_Recruiting 2026-11-30 2038-12-30 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07666581 Influence of the Use of Specific Nutritional Formulas on Time in Range in Patie… Na Type 2 Diabetes Not_Yet_Recruiting 2026-08-01 2028-12-01 ClinicalTrials.gov
NCT07270562 ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threat… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2031-12-01 ClinicalTrials.gov
NCT07270575 REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapoplitea… — Chronic Limb Threatening Ischemia Not_Yet_Recruiting 2026-08-01 2032-12-01 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07626658 Food-i-Sense Analytics: Integrating AI Into Continuous Glucose Monitoring Data … — Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) Not_Yet_Recruiting 2026-07-01 2028-12-01 ClinicalTrials.gov
NCT07621003 PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Interve… Na Atrial Fibrillation Not_Yet_Recruiting 2026-07-01 2031-03-31 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07211802 CKM For Safe Use of SGLT2i in Type 1 Diabetes Phase3 Type 1 Diabetes (T1D) Not_Yet_Recruiting 2026-07-01 2030-12-31 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07586995 A Post-Market Assessment of the Safety and Performance of the TriClip™ System — Tricuspid Regurgitation (TR) Recruiting 2026-06-01 2033-08-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07524907 Stunting and Targeting Reduction of Impaired Growth in Kids Effectively — Malnutrition (Calorie) Not_Yet_Recruiting 2026-06-01 2028-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07599982 Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabe… Na Type 1 Diabetes (T1D) Recruiting 2026-05-25 2027-01-01 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07638995 Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction — Atrial Fibrillation Recruiting 2026-05-18 2029-12-31 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07604844 Comparative Efficacy of Intralesional Tranexamic Acid Versus Mandelic Acid Peel… Na Melasma Not_Yet_Recruiting 2026-05-01 2026-10-01 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07421076 Grid eXplore Mapping Study Na Paroxysmal Atrial Fibrillation (PAF) Recruiting 2026-04-02 2027-10-31 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07045298 CGM Use in Heart Failure Na Heart Failure Not_Yet_Recruiting 2026-04-01 2027-04-01 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07423637 The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Contro… Na Type 1 Diabetes Not_Yet_Recruiting 2026-04-01 2028-12-31 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07523620 Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration Na Atrial Fibrillation (AF) Recruiting 2026-03-31 2028-02-28 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT07441382 Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients Wi… Na Atrial Fibrillation (AF) Recruiting 2026-03-24 2028-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT04823299 Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillati… Na Atrial Fibrillation Recruiting 2026-03-23 2030-03-01 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07426406 Oral Nutritional Supplement in Adults With or at Risk of Malnutrition Na Gastrointestinal Tolerance Completed 2026-03-22 2026-06-30 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07509658 TriClip Japan Post-Approval Study — Tricuspid Regurgitation Recruiting 2026-03-02 2029-12-15 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07135531 Continuous Glucose Monitoring (CGM) in an Underserved Population Na Diabetes Not_Yet_Recruiting 2026-03-01 2027-07-01 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07361445 Agilis RF TSP Early Feasibility Study Na Cardiac Arrythmias Recruiting 2026-02-16 2026-08-03 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07331792 Comparative Efficacy of Topical 1% Clotrimazole vs Oral Itraconazole in the Tre… Phase1 Pityriasis Versicolor Not_Yet_Recruiting 2026-02-02 2026-05-31 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07256925 Malnutrition Screening Study — Malnutrition, Calorie Recruiting 2026-01-12 2026-07-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07271043 Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Ty… Na Type 2 Diabetes Recruiting 2026-01-01 2026-12-01 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07373353 A Clinical Evaluation of AMJ-401 Na Ischemic Heart Disease (IHD) Recruiting 2025-12-17 2031-10-31 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07250828 Efficacy and Feasibility of BurstDR SCS in Painful Diabetic Neuropathy Na Painful Diabetic Neuropathy (PDN) Enrolling_By_Invitation 2025-12-15 2027-05-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07287423 LEAP 2 Chronic EFS Na Cardiac Pacemaker Recruiting 2025-12-13 2028-12-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07181590 BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF Na Paroxysmal AF Recruiting 2025-12-11 2027-08-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07240012 Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and D… Na Diabete Type 1 Recruiting 2025-12-01 2028-10-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07422688 Optical Coherence Tomography in Acute Vessel Evaluation Na Ischemic Heart Disease Enrolling_By_Invitation 2025-11-23 2039-09-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07193888 Navitor Japan Study — Severe Aortic Stenosis Recruiting 2025-10-30 2028-08-01 ClinicalTrials.gov
NCT07116551 Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System f… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2025-10-30 2031-06-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07359898 International Multicenter Study of the Navitor/Navitor Vision Transcatheter Aor… — Severe Native Aortic Stenosis Recruiting 2025-10-11 2031-10-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07215104 A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) … Na Chronic Low Back Pain (CLBP) Recruiting 2025-10-07 2027-01-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07203183 Dengue - Sample Collection Study Pakistan — Dengue Not_Yet_Recruiting 2025-10-01 2026-04-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07198529 OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in S… Na Stable Angina Recruiting 2025-09-30 2029-09-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT07287618 Evaluation of Potassium (K) and Ionized Calcium (iCa) Tests Using Capillary Spe… Na Hematologic Tests Recruiting 2025-09-17 2026-12-01 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06014242 Peripheral Microvascular Resistance as a Predictor for Limb Salvage Na Peripheral Arterial Disease Withdrawn 2025-09-15 2026-09-15 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT06743204 The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic C… Na Gonorrhea Female Recruiting 2025-09-08 2029-01-31 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07157384 REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose … Na Type 2 Diabetes Not_Yet_Recruiting 2025-09-01 2027-06-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07069673 Abbott Cephea Mitral Valve Disease Registry — Mitral Regurgitation Recruiting 2025-08-13 2028-12-01 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT07217392 Left Bundle Branch Area Pacing (LBBAP) PMCF Study Na Bradycardia Recruiting 2025-07-24 2027-04-30 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06920745 TriClip CED RWE Study — Tricuspid Regurgitation Recruiting 2025-07-08 2032-07-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT06928129 Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern He… Na Influenza Type A Not_Yet_Recruiting 2025-06-30 2025-11-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT07244939 Cephea South America Feasibility Study Na Mitral Regurgitation Recruiting 2025-06-17 2028-09-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06736665 Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified… Na Coronary Arterial Disease (CAD) Recruiting 2025-06-12 2027-12-01 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06733324 RCT of SCERTS (Social Communication, Emotional Regulation, Transactional Suppor… Na Autism Spectrum Disorder (ASD Active_Not_Recruiting 2025-06-01 2026-12-15 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06932588 Biomarker Role in Assessing Imaging Needs for Mild Cranial Trauma Na Brain Injuries Recruiting 2025-05-31 2026-06-01 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06795035 Assessment of Coronary Microvascular Dysfunction After STEMI Using Continuous S… — ST Elevation Myocardial Infarction Recruiting 2025-05-29 2027-12-31 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT06957028 CGM for the Early Detection and Management of Hyperglycemia in Pregnancy Na Gestational Diabetes Mellitus in Pregnancy Recruiting 2025-05-27 2027-11-27 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT07106788 Aveir Leadless Pacemaker Japan PMS — Leadless Pacemaker Recruiting 2025-05-26 2029-11-01 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06888687 Comparison of Dietetics Support With and Without Continuous Glucose Monitoring … Na Type 2 Diabetes Mellitus (T2DM) Active_Not_Recruiting 2025-05-12 2026-11-28 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06959797 Insulin Pump Versus Full Closed-loop for Type 2 Diabetes Na Type 2 Diabetes Recruiting 2025-05-05 2028-12-31 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06815536 Master Protocol for Evaluating Multiple Infection Diagnostics for Ciprofloxacin… — Neisseria Gonorrheae Infection Recruiting 2025-04-16 2026-07-01 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06931821 Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ab… Na Sustained Monomorphic VT (MMVT) Not_Yet_Recruiting 2025-04-15 2029-04-30 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06830746 ASCEND CSP IDE Study Na Heart Failure Active_Not_Recruiting 2025-04-11 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06883864 Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgi… Na Atrial Fibrillation (AF) Recruiting 2025-04-08 2028-05-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06885177 TECTONIC CAD IVL IDE Study Na Coronary Artery Calcification Active_Not_Recruiting 2025-04-01 2028-06-01 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT06952296 Study of the Effectiveness of Dydrogesterone in the Treatment of Endometriosis-… — Endometriosis Not_Yet_Recruiting 2025-04-01 2026-06-30 ClinicalTrials.gov
NCT07114393 Optimization of Complex Percutaneous Coronary Intervention With Liberal Use of … — Coronary Artery Disease Recruiting 2025-04-01 2027-05-01 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT04977310 TARGET-LOAD Pilot Study Comparing Hemodynamics-guided LVAD Unloading Vs. Standa… Na Heart Failure Withdrawn 2025-03-31 2026-09-01 ClinicalTrials.gov
NCT06902922 Impact of Severe Tricuspid Regurgitation Correction on Gut Microbiota and Gastr… — Tricuspid Regurgitation (TR) Not_Yet_Recruiting 2025-03-31 2027-09-30 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06921902 Glycemic Metrics and Patterns in People With and Without Prediabetes — Pre Diabetes Recruiting 2025-02-28 2026-12-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06779552 CardioMEMS HF System Coverage With Evidence Development Study — Heart Failure Recruiting 2025-02-07 2032-03-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06766435 Evaluation of the Abbott i-STAT TBI Biomarker Test Na Traumatic Brain Injury Recruiting 2025-01-30 2025-10-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06632002 Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes… Na Diabetes Active_Not_Recruiting 2025-01-02 2026-05-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06241430 The CardioClip Study Na Heart Failure With Reduced Ejection Fraction Recruiting 2024-12-18 2030-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06772493 ViewFlex X ICE First-in-Human Study — Cardiac Arrhythmias Recruiting 2024-12-16 2026-06-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06526195 Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in… Na Heart Failure Recruiting 2024-12-13 2032-09-01 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06709001 An Observational Study to Assess Malnutrition Risk — Malnutrition Completed 2024-12-09 2025-07-25 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06492018 Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population — Hepatitis C Not_Yet_Recruiting 2024-12-01 2025-03-30 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06676072 A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PA… Na Atrial Fibrillation (AF) Completed 2024-11-22 2026-04-13 ClinicalTrials.gov
NCT06669637 Amplify EP Registry — Atrial Fibrillation Not_Yet_Recruiting 2024-11-22 2026-12-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT07082426 Early System Experience With the Abbott Balloon-expandable TAVI System: First-I… Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2024-11-21 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06707688 Abbott Medical - VERITAS Study Na Atrial Fibrillation (AF) Active_Not_Recruiting 2024-11-07 2027-09-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06668935 Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring — Diabetes Mellitus Recruiting 2024-10-24 2027-01-01 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06656364 Esprit BTK Post-Approval Study Na Chronic Limb-Threatening Ischemia Active_Not_Recruiting 2024-10-21 2029-05-30 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06605573 Lay User Evaluation of the Panbio™ HCV Self-Test Na HEPATITIS C (HCV) Not_Yet_Recruiting 2024-10-01 2025-03-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06456541 Infant Formula in Infants and Children With Cow's Milk Allergy Na Cow's Milk Allergy Recruiting 2024-10-01 2029-01-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06423430 Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND) Na Treatment Resistant Depression Recruiting 2024-09-11 2029-04-01 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06790472 Metabolic Wellness and CGM — Cardiometabolic Risk Factors Enrolling_By_Invitation 2024-09-05 2025-10-11 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06584214 Evaluation of the Diagnostic Sensitivity and Specificity of the Determine™ Syph… Na Syphilis Infection Not_Yet_Recruiting 2024-09-01 2024-12-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06590467 Abbott Structural Heart Device Registry — Heart Diseases Recruiting 2024-08-21 2039-11-01 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06271967 FOCALFLEX (CE Mark) Study Na Atrial Fibrillation Paroxysmal Completed 2024-08-15 2026-01-19 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06340763 JETi Hong Kong Post Market Study (PMS) — Peripheral Venous Thrombosis Completed 2024-08-07 2025-02-15 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06395675 Clinical Evaluation of the ID NOW™ CT/NG Test Na Chlamydia Trachomatis Infection Unknown 2024-07-09 2025-01-09 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06368765 Oral Rehydration Solution and Dehydration Recovery Na Dehydration Terminated 2024-07-08 2024-10-17 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06434779 Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP an… Na Peripheral Arterial Disease Not_Yet_Recruiting 2024-07-01 2026-05-01 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06542133 AVEIR Remote Care System Non-Significant Risk Study — Cardiac Pacemaker Completed 2024-06-10 2024-08-30 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06295835 Method Comparison Study for Measuring Potassium (K) and Ionized Calcium (iCa) i… Na Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood Completed 2024-05-31 2025-01-29 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06205537 Muscle Health and Recovery in Older Adults Na Exercise Induced Muscle Damage Completed 2024-05-20 2025-08-19 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06436053 Acute Response to Left Bundle Branch Area Pacing With SyncAV — Heart Failure Recruiting 2024-05-15 2027-07-15 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06375590 NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International E… — Bicuspid Aortic Valve Not_Yet_Recruiting 2024-05-01 2026-05-01 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT06268821 Effect on HbA1c of the Initiation of CGM in Adults With Type 2 Diabetes Treated… Na Type 2 Diabetes Treated With Insulin Terminated 2024-04-02 2024-07-12 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT06266702 Evaluation of a Nutritional Technology for Vitamin D Absorption Na Nutrition, Healthy Completed 2024-03-15 2024-05-02 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT05932615 ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic… Na Aortic Valve Stenosis Enrolling_By_Invitation 2024-03-15 2036-04-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06393478 Southeastern Europe Microcirculation Registry — Angina, Microvascular Recruiting 2024-03-01 2034-03-01 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06217393 Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patie… Phase3 Functional Dyspepsia Completed 2024-02-28 2025-02-28 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06262295 A Safety and Effectiveness Monitoring in France for AVEIR VR LP and AVEIR AR LP… — Pacemaker Recruiting 2024-02-14 2029-09-01 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT06189365 Amplatzer Amulet China Post Market Study (PMS) — Non-Valvular Atrial Fibrillation Terminated 2024-01-30 2025-12-05 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT07271433 Continuous Glucose Monitoring for Post-kidney Transplantation in Pre-existing T… — Kidney Transplant Completed 2024-01-29 2026-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT06100770 Aveir AR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2024-01-18 2031-01-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT05758805 Esophageal Injury of a Tip CF Sensing Ablation Catheter for HP-SD of Paroxysmal… Na Atrial Fibrillation Recruiting 2024-01-08 2025-10-01 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06356727 Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse Remode… Na Heart Failure Recruiting 2024-01-03 2030-01-31 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT06172699 Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study — Atrial Fibrillation Paroxysmal Completed 2024-01-01 2025-11-10 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT05913193 Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Maln… — Malnutrition Completed 2023-12-15 2025-06-17 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT07382076 Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population — Activated Clotting Time Active_Not_Recruiting 2023-12-15 2026-03-30 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT06124638 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use Na COVID-19 Completed 2023-12-04 2024-04-03 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT05981547 Patterns and Glycaemic Endpoints for Diagnosing Gestational Diabetes — Gestational Diabetes Active_Not_Recruiting 2023-11-22 2026-06-21 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT06127108 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel Na COVID-19 Completed 2023-11-14 2024-02-02 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05935007 Aveir DR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-12-31 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT05932602 AVEIR DR Coverage With Evidence Development (CED) Study — Cardiac Pacemaker Recruiting 2023-10-31 2030-05-01 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06039176 Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future — LVAD Recruiting 2023-10-27 2026-12-30 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06106594 VOLT CE Mark Study Na Atrial Arrhythmia Recruiting 2023-10-24 2026-12-01 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06025994 Standardizing the Management of Patients With Coronary Microvascular Dysfunction Na Coronary Artery Disease Active_Not_Recruiting 2023-10-10 2029-02-10 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT06008080 Post-Market Clinical Follow Up Study With Navitor Valve — Aortic Stenosis Recruiting 2023-09-29 2032-06-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05877612 Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex R… — Complex Regional Pain Syndrome Type I Unknown 2023-09-12 2025-09-01 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05572034 Cardiac Autonomic Denervation for Cardio-inhibitory Syncope Na Bradycardia; Syncope Unknown 2023-09-01 2024-03-30 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05705427 The COMBAT HBV Feasibility Trial Phase4 Hepatitis B Completed 2023-08-17 2025-11-25 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05839873 Abbott Ventricular Tachycardia PAS — Ventricular Tachycardia Active_Not_Recruiting 2023-07-24 2026-11-01 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05944432 CGM Use in Adults With Type 2 Diabetes on Basal Insulin Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2023-07-14 2027-11-30 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05387954 PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated S… Phase3 Cryptogenic Ischemic Stroke Recruiting 2023-07-07 2031-07-07 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05802927 Diabetes-specific Formula (DSF) in Individuals With Type 2 Diabetes Na Diabetes Mellitus, Type 2 Completed 2023-07-05 2023-10-26 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05847283 DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Res… Na Diminished Ovarian Reserve Recruiting 2023-06-22 2027-12-31 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05537662 External Sensing and Neuromodulation to Assess Diabetic Pain Outcomes (XANADO) Na Chronic Pain Recruiting 2023-06-06 2025-04-01 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05754775 Remission of Type 2 Diabetes Via Calorie Restriction Na Type 2 Diabetes Completed 2023-06-01 2024-04-30 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT05324683 ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) — Myocardial Ischemia Active_Not_Recruiting 2023-05-04 2026-04-01 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06159231 FAME II-10-year Follow-Up — Coronary Artery Disease Completed 2023-04-25 2024-05-15 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT06030284 The True Efficacy of Burst Spinal Cord Stimulation in the Management of Intract… Na Chronic Intractable Pain Withdrawn 2023-04-20 2023-06-01 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05695716 CSI Percutaneous Ventricular Assist Device (pVAD) Second in Human Study Na Coronary Artery Disease Withdrawn 2023-04-05 2023-07-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05833581 Consistently Assess Signs and Symptom of Heart Failure Na Heart Failure Unknown 2023-03-17 2024-06-17 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05284955 Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (… Phase4 Advanced Heart Failure Unknown 2023-03-02 2025-12-31 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05715684 Patient-Centered Surgical Prehabilitation Na Bladder Cancer Recruiting 2023-03-01 2027-12-25 ClinicalTrials.gov
NCT05709795 CTI Ablation Guided by Omnipolar Wave Speed and Voltage Maps to Diminish RF and… Na Flutter Recruiting 2023-03-01 2025-01-31 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT05547165 Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low … Na Ductus Arteriosus, Patent Recruiting 2023-02-21 2026-02-28 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT04818645 Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Ri… Na Atrial Fibrillation Active_Not_Recruiting 2023-01-31 2028-07-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05599061 Treatment of Functionally Non-significant Vulnerable Plaques in Patients With M… Na Coronary Artery Disease Active_Not_Recruiting 2023-01-30 2028-12-01 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05962710 FreeStyle Libre 3 Continuous Glucose Monitoring System — Diabetes Mellitus Terminated 2023-01-27 2023-01-31 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05455489 GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation With the… — Mitral Valve Regurgitation Recruiting 2023-01-25 2029-08-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05525039 RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myo… Na Sarcopenia Recruiting 2023-01-12 2025-09-01 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05843461 PIMR and Pulmonary Vascular Disease — Pulmonary Hypertension Completed 2023-01-10 2024-07-31 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT05529472 Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy Na Peripheral Artery Disease Completed 2023-01-10 2024-10-10 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT05630365 Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Us… Na COVID-19 Completed 2022-12-15 2023-03-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT06306573 CardioMEMS HF System Real-World Evidence Post-Approval Study — Heart Failure NYHA Class II Enrolling_By_Invitation 2022-12-15 2029-12-31 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05072730 ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2 Na Calcified Coronary Artery Disease Unknown 2022-12-01 2024-09-01 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05569044 Oral Rehydration Solutions in Healthy Adult Athletes Na Hydration Terminated 2022-11-21 2024-06-18 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05437068 Nutritional Supplementation in Children at Risk of Undernutrition Na Malnutrition, Child Withdrawn 2022-11-11 2022-11-11 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05236153 Electroanatomic Interactions Between Transcatheter Pulmonary Valve Prostheses a… Na Tetralogy of Fallot Recruiting 2022-11-04 2024-01-01 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05629572 Abbott i-STAT High Sensitivity Troponin I Study — Myocardial Infarction Completed 2022-11-02 2024-03-11 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05897112 Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in … Phase1 Molluscum Contagiosum Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05493904 PREcise Percutaneous Coronary Intervention for Stent OptimizatION in Treatment … Na Coronary Artery Disease Active_Not_Recruiting 2022-11-01 2027-12-31 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05580978 CGM Plus GEM in Prediabetes Na PreDiabetes Completed 2022-11-01 2025-01-15 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05884151 Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Tr… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05887219 Comparison of Azelaic Acid 20 % Cream Versus Hydroquinone 4% Cream as an Adjuva… Phase1 Melasma Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05895071 Comparison of Topical 5%Potassium Hydroxide vs Liquid Nitrogen in the Treatment… Phase1 Plan Warts Completed 2022-11-01 2023-04-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05434650 Abbott Atrial Fibrillation Post Approval Study — Atrial Arrhythmia Active_Not_Recruiting 2022-10-21 2026-11-30 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05687591 Left Atrial Appendage Occlusion With The Amplatzer Amulet Device: The Southeast… — Atrial Fibrillation Completed 2022-10-01 2024-12-01 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05483140 Digitally-Enabled Weight Management Program on T2DM — Weight Change, Body Completed 2022-09-30 2024-09-30 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05544864 Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent … Na Coronary Artery Disease Recruiting 2022-09-28 2026-09-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05261906 The FreeStyle Libre Enabled Reduction of A1c Through Effective Eating and Exerc… Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2022-09-26 2025-10-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05655910 Enhanced Nutritional Optimization in LVAD Trial Na Heart Failure Recruiting 2022-09-22 2027-01-01 ClinicalTrials.gov
NCT05516797 IGNITE (Impact of Glucose moNitoring and nutrItion on Time in rangE) Na Type 2 Diabetes Completed 2022-09-22 2024-03-01 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05423379 XIENCE Skypoint Large Vessel Post Approval Study — Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2027-08-30 ClinicalTrials.gov
NCT05288361 The DISCOVER INOCA Prospective Multi-center Registry — Ischemia and No Obstructive Coronary Artery Disease Active_Not_Recruiting 2022-09-14 2032-12-31 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05428384 Validation of CardioMEMS HF System Cardiac Output Algorithm IDE — Heart Failure Completed 2022-08-31 2024-01-30 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05822232 FreeStyle Libre 2 Discharge Trial Na Diabetes Mellitus, Type 2 Unknown 2022-08-17 2024-04-30 ClinicalTrials.gov
NCT05389631 Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes — Aortic Valve Disease Completed 2022-08-17 2023-12-21 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT07059598 Relationship of Nutritional Status to Chemotherapy Treatment Completion and Out… — Cancer-related Malnutrition Completed 2022-08-12 2025-03-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05073419 Arrhythmia Detection After MI Na Acute Myocardial Infarction Recruiting 2022-08-09 2026-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05708131 Outcomes of Functional Substrate Mapping of Ventricular Tachycardia — Ventricular Tachycardia Unknown 2022-07-13 2024-12-01 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05752435 Comparison of Therapeutic Efficacy Between Intralesional Bleomycin and Cryother… Na Viral Wart Completed 2022-07-01 2022-12-31 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05301556 Food for Special Medical Purpose in Patients With Digestive Tract Tumor Na Gastrointestinal Cancer Completed 2022-06-24 2024-01-09 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05336877 Aveir VR Coverage With Evidence Development Post-Approval Study — Cardiac Pacemaker Recruiting 2022-06-21 2028-01-01 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05270499 Aveir VR Real-World Evidence Post-Approval Study — Cardiac Pacemaker Active_Not_Recruiting 2022-06-21 2034-09-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05712837 Efficacy of 25% Trichloroacetic Acid Peel Versus 30% Salicylic Acid Peel in Mil… Na Acne Vulgaris Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05712811 Comparison of Cryotherapy and Peeling Agent in the Treatment of Common Warts Na Warts Completed 2022-06-01 2022-11-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05344313 Oral Nutritional Supplementation With HMB Enhance Muscle Quality in Sarcopenic … Na Sarcopenia Completed 2022-06-01 2024-06-30 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05368454 Evaluation of a Digital Diabetes Self-Management Education and Support Program Na Type 2 Diabetes Completed 2022-05-31 2024-01-24 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05326828 Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINO… — MINOCA Recruiting 2022-05-24 2031-05-15 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05286359 Performance Evaluation of Malaria Plus Rapid Diagnostic Tests (RDTs) for the De… Na Malaria Completed 2022-05-24 2022-11-17 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05739786 Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts Phase1 Cutaneous Warts Completed 2022-05-11 2022-11-11 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05369494 Infants Fed a Hydrolyzed Infant Formula Na Gastrointestinal Tolerance Completed 2022-05-07 2023-11-18 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05061004 Cephea Early Feasibility Study Na Mitral Regurgitation Recruiting 2022-04-28 2031-03-01 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05370703 A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and … — Dyslipidemia Completed 2022-04-26 2022-11-18 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05154045 Postprandial Glycemic Response in Adults With Type 2 Diabetes Na Glycemic Control Completed 2022-04-09 2022-07-12 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05330468 Regent China Post-Market Clinical Follow-up Study — Valvular Heart Disease Completed 2022-03-29 2024-10-10 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05327101 Patient Preferences for Leadless Pacemakers — Cardiac Rhythm Disorder Completed 2022-03-28 2023-06-13 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05269862 Remote Optimization, Adjustment and Measurement for Deep Brain Stimulation Na Parkinson Disease Active_Not_Recruiting 2022-03-24 2024-12-01 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05333068 COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVE… Na Multivessel Coronary Artery Disease Active_Not_Recruiting 2022-03-16 2026-12-31 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05315544 Cardiovascular Systems Inc. (CSI) pVAD First in Human Study Na Coronary Artery Disease Completed 2022-03-14 2022-03-16 ClinicalTrials.gov
NCT05354115 Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel. Na COVID-19 Completed 2022-03-14 2022-08-22 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05057637 The Impact of Optical Coherence Tomography on the Endovascular Treatment Planni… — Femoropopliteal Stenosis Active_Not_Recruiting 2022-03-09 2027-04-01 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05578950 Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuou… Phase1 Onychomycosis Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05588999 Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy P… Phase1 Plantar Wart Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05634460 Comparison of 5% Potassium Hydroxide With 10% Potassium Hydroxide Solution in T… Phase1 Molluscum Contagiosum Completed 2022-03-01 2022-08-31 ClinicalTrials.gov
NCT05862714 Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Pati… Phase1 Tinea Versicolor Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05862701 Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of … Phase1 Scabies Completed 2022-03-01 2022-09-30 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05165693 Evaluation of Glycemic Response in Individuals With Type 2 Diabetes Na Glycemic Control Completed 2022-02-23 2022-06-16 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05734157 CVT-SFA First in Human Trial for Treatment of Superficial Femoral Artery or Pro… Na Femoral Artery Stenosis Completed 2022-02-17 2025-08-27 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05272618 Coronary Microvascular Dysfunction Assessments in Myocardial Infarction With No… — Myocardial Infarction Recruiting 2022-02-14 2030-12-31 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT05208905 LIFE-BTK PK Sub-study Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2022-02-10 2028-02-22 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT04354077 Deep Brain Stimulation Effects In Patients With Opioid Use Disorder Na Opioid-use Disorder Recruiting 2022-02-07 2030-01-01 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05198791 Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and … Phase2 Myocardial Infarction, Acute Recruiting 2022-02-04 2026-07-31 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05252702 Aveir DR i2i Study Na Cardiac Pacemaker, Artificial Completed 2022-02-02 2026-02-03 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05239208 Effects of Oral Nutritional Supplementation in Children at Risk of Undernutriti… Na Undernutrition Completed 2022-01-14 2022-12-18 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05242250 Real-World Evidence Registry to Assess Outcomes of Catheter Ablation for Atrial… — Atrial Fibrillation Terminated 2022-01-10 2023-12-31 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05103527 Dorsal Root Ganglion Stimulation for the Treatment of Arthritic Knee Pain Na Knee Osteoarthritis Active_Not_Recruiting 2022-01-01 2026-05-01 ClinicalTrials.gov
NCT05433831 Application of Nutritional Ultrasound in the Diagnosis and Follow-up of Patient… — Nutrition Disorders Unknown 2022-01-01 2022-12-01 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05189938 HbA1c Variation Study — Diabetes Mellitus Completed 2021-12-20 2023-12-30 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT05301218 CAlcified Lesion Intervention Planning Steered by OCT. Na Coronary Artery Calcification Unknown 2021-12-15 2023-12-15 ClinicalTrials.gov
NCT05186779 Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy — Early Pregnancy Bleeding Terminated 2021-12-15 2023-07-14 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT04865978 Evaluation of the Hemocompatibility of the Direct Oral Anti-Coagulant Apixaban … Phase2 Heart Failure Completed 2021-12-14 2023-11-07 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT05322395 Pragmatic Randomised Trial of the ESC 0/1 Versus 0/3 Hour Troponin Pathway Na Acute Coronary Syndrome Unknown 2021-12-10 2024-11-10 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT04259411 MitraClip China PMS Na Mitral Regurgitation Completed 2021-12-06 2025-03-07 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT05168306 T2 FSL2 Weight Loss — Diabetes Mellitus, Type 2 Terminated 2021-12-05 2023-07-19 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT04997512 Freestyle Libre and Hospital Admissions in Type 2 Diabetes Na Type 2 Diabetes Unknown 2021-11-01 2025-08-01 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05002088 Portico Valve-in-Valve Retrospective Registry — Aortic Valve Stenosis Completed 2021-10-21 2023-12-29 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05000840 Integrating Abbott Point-of-Care Technologies and the Community Scientist Model… — Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-10-20 2025-03-31 ClinicalTrials.gov
NCT05731700 CVT-ISR First in Human Trial for Coronary In-Stent Restenosis Na In-stent Restenosis Completed 2021-10-20 2025-05-08 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05405335 Effect of Prone Positioning on the Severity of COVID-19 Pneumonia and Acute Res… Na COVID-19 Acute Respiratory Distress Syndrome Completed 2021-10-15 2022-02-28 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT05731466 Exercise Right Ventricular Coupling in HFpEF Na Heart Failure With Preserved Ejection Fraction Unknown 2021-10-13 2025-12-31 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT06444386 ECGi of SyncAV With MultiPoint Pacing — Cardiac Resynchronization Therapy Completed 2021-09-29 2024-04-01 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT04904809 Perclose Multi-Access Duplex Ultrasound (DUS) Study Na Arrhythmia Completed 2021-09-01 2022-05-27 ClinicalTrials.gov
NCT05040087 Changing the Natural History of Type 2 Diabetes ("CHANGE" Study) Na Type 2 Diabetes Active_Not_Recruiting 2021-09-01 2027-03-31 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04748965 Imaging-Guided Vessel Sizing in the Tibial Arteries — Peripheral Artery Disease Completed 2021-08-16 2024-06-09 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04710563 SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs — Peripheral Arterial Disease Active_Not_Recruiting 2021-08-11 2028-09-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04996277 A Prospective Evaluation of Clinical Impact of Physiology Versus Optical Cohere… Na ST Elevation Myocardial Infarction Unknown 2021-07-31 2024-03-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04780971 Use of Physiology to Evaluate Procedural Result After PCI CTO Na Percutaneous Coronary Revascularisation Recruiting 2021-07-21 2026-06-01 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04703855 Hong Kong and Taiwan HM3 PMS Na Advanced Heart Failure Terminated 2021-07-14 2022-06-30 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04788888 Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2021-07-13 2036-02-28 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT04915937 Formula Tolerance of Term Infants Na Gastro-Intestinal Tolerance Completed 2021-07-13 2022-11-22 ClinicalTrials.gov
NCT04754217 Valved Graft PMCF Study — Aortic Valve Disease Recruiting 2021-07-13 2029-09-01 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT05519514 Bio-Equivalence Study of Budesonide Prolonged-release Tablets 9 Mg In Healthy H… Phase1 Healthy Subjects Completed 2021-07-12 2021-11-15 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04934397 Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula Na Gastro-Intestinal Tolerance Terminated 2021-07-08 2022-02-18 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04942756 GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Gluc… Na Palliative Care Unknown 2021-06-30 2022-06-30 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT04873817 Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation — Pain Completed 2021-06-29 2023-03-08 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT05554822 Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy A… Phase3 Left Atrial Appendage Occlusion Unknown 2021-06-14 2023-12-31 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04729985 Diabetes Discharge Transitional CGM Study (DDT-CGM) Na Diabetes Mellitus, Type 2 Active_Not_Recruiting 2021-06-01 2024-12-01 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT05362500 Comparison of Chemical Peeling Agent With Transamine for Treatment of Melasma Phase1 Melasma Completed 2021-06-01 2021-11-30 ClinicalTrials.gov
NCT04320849 Human Use Condition Study- Evaluation of Implanted Leads in Humans — Pacemaker Malfunction Completed 2021-06-01 2022-05-23 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT04959552 FSL2 Post Approval Study for Pediatric and Young Adults Patients — Diabete Mellitus Active_Not_Recruiting 2021-06-01 2026-12-30 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT05659836 Spinal Cord Stimulation Trial to Permanent Prediction — Chronic Pain Completed 2021-05-27 2023-06-15 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT04818502 Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitat… — Mitral Valve Regurgitation Active_Not_Recruiting 2021-05-04 2028-05-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT05577637 Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for t… Phase1 Vitiligo Completed 2021-05-01 2021-11-30 ClinicalTrials.gov
NCT05567484 Comparative Study Between Pulsed and Continuous Itraconazole for the Treatment … Phase1 Onychomychosis Completed 2021-05-01 2021-12-31 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04843527 Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in Pe… Na Diabetes Mellitus, Type 2 Unknown 2021-04-02 2025-06-01 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04809701 Non-vascular ICD Electrode Configuration Feasibility Study Na Ventricular Arrythmia Completed 2021-03-22 2022-03-24 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04104815 GI Tolerance and Acceptability of a New Thickener Na Gastro-intestinal Tolerance Withdrawn 2021-02-05 2021-02-05 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04761120 Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study — Mitral Regurgitation Recruiting 2021-02-01 2031-03-01 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04431661 CAOCT: Intra CoronAry Optical Computerized Tomography in out-of Hospital Cardia… — Out of Hospital Cardiac Arrest Terminated 2021-01-29 2023-01-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04784208 A Study to Determine the Validity and Sensitivity of 'Questionnaire to Screen f… — Hypothyroidism Unknown 2021-01-18 2022-12-31 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04945083 Evaluation of a High Protein, High Calorie Pudding in Adults With/or at Risk fo… Na Gastrointestinal Tolerance Completed 2021-01-13 2021-12-09 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04419480 Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Tr… Na Cardiogenic Shock Recruiting 2020-12-31 2028-12-31 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04464785 CentriMag Failure-to-Wean Post Approval Study — Heart Failure Completed 2020-12-30 2024-10-25 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04683133 The FAST OCT Study Na Tomography, Optical Coherence Unknown 2020-12-01 2021-12-31 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT04489823 PARADIGM: Amplatzer Valvular Plug for PVL Closure Na Paravalvular Aortic Regurgitation Active_Not_Recruiting 2020-12-01 2026-12-13 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT05175131 Efficacy and Safety of Mebeverine + Simethicone in Patients With Functional Bow… Phase3 Functional Bowel Disorder Completed 2020-11-27 2021-05-18 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04548128 Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical S… — Advanced Refractory Left Ventricular Heart Failure Completed 2020-11-17 2022-12-20 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04559945 The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System Na Cardiac Rhythm Disorder Completed 2020-11-13 2023-09-15 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04915924 Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in K… Na Advanced Heart Failure Completed 2020-10-30 2024-06-02 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04650152 Study to Assess Tricor Therapy Effectiveness in Patients With Metabolic Syndrom… — Hypertriglyceridemia Completed 2020-10-27 2021-11-12 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04604093 Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemi… — Diabetes Mellitus Completed 2020-10-20 2023-03-30 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04942353 Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in Hear… Na Heart Failure Completed 2020-10-19 2023-04-17 ClinicalTrials.gov
NCT04029454 Neovac 2 Burkina Faso: Impact of the Integration of Hepatitis B Birth Dose Vacc… Na Hepatitis B Completed 2020-10-19 2023-12-15 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04304963 Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS — Diabetes Mellitus, Type 1 Completed 2020-10-01 2022-10-31 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04577976 FreeStyle Libre 2 Flash Glucose Monitoring System Control Phase Study for Pedia… — Diabetes Mellitus Terminated 2020-09-23 2022-07-14 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04529759 Healthy Term Infants Fed Milk-Based Infant Formula Na Tolerance Completed 2020-09-12 2021-06-18 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04562714 Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Ins… Na Diabetes Mellitus, Type 2 Completed 2020-09-08 2022-09-06 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04851418 Pre-hOspital Evaluation of Chest Pain Patients With sUspected Non ST-segment eL… — Coronary Artery Disease Unknown 2020-09-01 2022-02-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04483089 An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Pat… — Tricuspid Valve Regurgitation Active_Not_Recruiting 2020-08-27 2028-01-01 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04345497 Diabetes-Specific Formula on Long Term Glycemic Control Na Diabetes Mellitus, Type 2 Completed 2020-08-26 2022-12-06 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04227899 LIFE-BTK Randomized Controlled Trial Na Critical Limb Ischemia (CLI) Active_Not_Recruiting 2020-08-18 2027-07-01 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04495738 Infant Formula and Toddler Drink Feeding Intervention Na Respiratory Infections in Children Terminated 2020-08-10 2021-04-12 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04427124 The CLI-AMP Registry — Critical Limb Ischemia Unknown 2020-08-01 2023-12-31 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04171960 Clinical Evaluation of the i-STAT TBI Test — Traumatic Brain Injury Completed 2020-07-31 2023-11-29 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT04479787 Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT) Na Chronic Low-Back Pain Completed 2020-07-31 2024-02-26 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT05313919 Coronary Microcirculatory Disease and Inflammation in Patients With Chronic Cor… — Coronary Artery Disease Unknown 2020-07-24 2023-06-30 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04198870 MitraClip REPAIR MR Study Na Mitral Valve Regurgitation Active_Not_Recruiting 2020-07-21 2035-12-01 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04464772 FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2020-07-10 2020-09-22 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04641416 Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levita… — End-stage Heart Failure Unknown 2020-07-09 2025-12-30 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04226547 Amplatzer Amulet LAAO vs. NOAC Na Atrial Fibrillation Active_Not_Recruiting 2020-07-07 2031-04-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356040 TactiFlex Paroxysmal Atrial Fibrillation IDE Trial Na Paroxysmal Atrial Fibrillation Completed 2020-06-29 2022-07-01 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04356027 FUnctional diagnoSIs of corONary Stenosis (FUSION) — Coronary Artery Disease Completed 2020-06-26 2021-10-15 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04900831 Validation of Beat-to-beat Wavefront Direction Using Omnipolar Mapping — Atrial Flutter Typical Unknown 2020-06-18 2022-08-01 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04282148 Abbott Next Generation Drug Eluting Stent 48mm Study Na Coronary Artery Disease Completed 2020-06-17 2023-09-17 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04434586 Contribution of Optical Coherence Tomography in the Endovascular Treatment of F… Na Superficial Femoral Artery Stenosis Recruiting 2020-06-16 2026-06-01 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04460209 EP Device Registry — Cardiac Rhythm Disorder Completed 2020-06-12 2026-01-31 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04657783 French National Cohort of People With Type 1 Diabetes — Diabetes Mellitus, Type 1 Recruiting 2020-06-10 2035-06-10 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04313920 Study of a Carbohydrate Drink in Adults Na Glycemic Response Completed 2020-04-07 2020-08-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04235062 NATriuretic Response to Expansion and dIUretics in huMans With Heart Failure Na Heart Failure Completed 2020-04-01 2021-04-26 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04328272 Effectiveness of Hydroxychloroquine in Covid-19 Patients Phase3 COVID19 Unknown 2020-03-28 2020-06-28 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04041908 Use of a Medical Food in Adults Undergoing Surgery Na Compliance, Patient Terminated 2020-03-13 2020-04-10 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04259437 Gastrointestinal Tolerance of a Nutritional Supplement in Adult Patients With o… Na Gastro-Intestinal Tolerance Completed 2020-03-10 2021-05-11 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04370691 JETi Lower Extremity Arterial Thrombosis — Arterial Thrombosis Completed 2020-03-06 2024-10-09 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04249297 Predictors of Pregnancy Rate in Assisted Reproductive Technology According to A… — Infertility Unknown 2020-03-03 2022-12-01 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04350372 MitraClip Russia Trial Na Functional Mitral Regurgitation Completed 2020-02-18 2020-10-02 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04253171 Balloon Lithoplasty for Preparation of Severely Calcified Coronary Lesions Na Percutaneous Coronary Intervention Completed 2020-01-29 2025-11-01 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04180540 Comparison of Percutaneous Closure to Manual Compression for Hemostasis Na Atrial Fibrillation Completed 2020-01-22 2021-01-13 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04177394 MitraClip EXPAND G4 Study — Mitral Valve Regurgitation Active_Not_Recruiting 2020-01-17 2028-03-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04180605 Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure Na Atrial Fibrillation Unknown 2020-01-06 2022-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04205877 The U.S. PDA Registry — Ductus Arteriosus, Patent Not_Yet_Recruiting 2020-01-01 2031-12-01 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04127656 Infants Fed an Amino Acid-based Formula Na Food Allergy Terminated 2019-12-16 2021-12-16 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04268875 Morphological Parameters of In-stent RESTenosis Assessed and Identified by OCT Na In-stent Restenosis Completed 2019-12-11 2022-12-06 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04597489 Fractional FLOw Reserve In Cardiovascular DiseAses — Coronary Artery Disease Completed 2019-12-01 2020-03-02 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT04071847 Abbott DBS Post-Market Study of Outcomes for Indications Over Time — Movement Disorders Recruiting 2019-11-26 2030-09-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03924661 SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacemen… — Aortic Valve Disease Active_Not_Recruiting 2019-10-24 2028-10-01 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT03991949 Evaluation of Preterm Infants Fed Post-Discharge Preterm Infant Formula Na Infant Development Completed 2019-10-04 2022-11-16 ClinicalTrials.gov
NCT03786640 Abbott Brady 3T MRI PMCF — Syncope Completed 2019-10-04 2021-12-18 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04100148 SyncAV Post-Market Trial Na Congestive Heart Failure Active_Not_Recruiting 2019-10-03 2026-06-30 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04349995 Amplatzer PFO Occluder Post-marketing Surveillance Study — PFO - Patent Foramen Ovale Completed 2019-10-01 2025-05-28 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04105686 Growth and Tolerance of Young Infants Fed Infant Formula Na Growth and Tolerance Completed 2019-09-30 2020-12-04 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04011722 Portico Next Generation Approval Study Na Symptomatic Severe Aortic Stenosis Active_Not_Recruiting 2019-09-17 2033-01-01 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04595305 Septal Mapping And Resynchronisation Therapy- (SMART) Study Na Cardiac Resynchronization Therapy Completed 2019-09-16 2022-08-23 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT04022954 HD Mapping of Atrial Fibrillation in Asia Pacific — Paroxysmal Atrial Fibrillation Completed 2019-09-11 2021-08-13 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03940651 Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase4 Renal Injury Terminated 2019-09-04 2020-09-23 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03363087 High Density Scar Guided Atrial Fibrillation Mapping Na Atrial Fibrillation Completed 2019-08-27 2023-03-01 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT03882021 High-Density (HD) Wave Mapping in Subjects With Atrial Fibrillation as a Predic… Na Paroxysmal Atrial Fibrillation Completed 2019-08-26 2022-01-13 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04006236 Infants Fed Extensively Hydrolyzed Casein-Based Infant Formulas Na Infant Development Completed 2019-08-05 2021-09-20 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT04272411 SCS Stimulation Clamp to Assess Impact of Stimulation on Glucose Metabolism Na Spinal Cord Stimulation (SCS) Completed 2019-07-11 2020-06-01 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03802942 Prevention of Hypoglycemia Among Diabetes Patients Admitted to Internal Medicin… Phase3 Hypoglycemia Unknown 2019-07-01 2023-12-01 ClinicalTrials.gov
NCT04001452 2nd International Survey on Interventional Strategies — Coronary Artery Disease Unknown 2019-07-01 2020-01-31 ClinicalTrials.gov
NCT03989726 Efficacy of High Density Voltage and Fractionation Map Guided Ablation in Patie… Na Atrial Fibrillation Unknown 2019-07-01 2021-05-31 ClinicalTrials.gov
NCT02997670 Quartet Lead With Defibrillator Multisite Algorithmic Cardiac Resynchronisation… Na Heart Failure, Systolic Withdrawn 2019-07-01 2019-07-01 ClinicalTrials.gov
NCT03682991 Reversal of Atrial Substrate to Prevent Atrial Na Atrial Fibrillation Active_Not_Recruiting 2019-07-01 2027-12-31 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03941314 A Superiority Trial of the SUPERA Peripheral Stent System in Patients With Femo… Na Peripheral Arterial Disease Completed 2019-06-25 2026-03-19 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03943160 Radial accEss for nAvigation to Your CHosen Lesion for Peripheral Vascular Inte… — Peripheral Artery Disease Completed 2019-06-11 2019-12-11 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03967132 Growth and Tolerance of Infants Fed Milk-Based Infant Formula Na Gastro-Intestinal Tolerance Completed 2019-06-08 2020-05-29 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03958604 Burst Neurostimulation for Discogenic Low Back Pain Na Discogenic Pain Completed 2019-05-28 2021-12-31 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03906461 LSI (Lesion Index) Workflow Observational Study — Paroxysmal Atrial Fibrillation Completed 2019-05-17 2021-04-27 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03951727 Stella Supera Siberia Na Atherosclerosis Unknown 2019-05-13 2022-05-13 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03677336 Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Lutea… Phase4 Infertility, Female Completed 2019-05-01 2020-08-24 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03908476 PROLONG Prospective, Multi-center, Open-label, Post-market Study Na Chronic Pain Completed 2019-04-16 2021-11-15 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT03884231 A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Condit… — Movement Disorders Completed 2019-04-10 2021-08-20 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03828357 China (CN)_Magnetic Resonance Imaging (MRI)_Implantable Cardiac Defibrillator (… — Tachycardia Completed 2019-03-27 2020-12-01 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT05307614 Bioequivalence Study of Moksi® 400mg Tablet and Avelox® 400mg Tablet (Moxifloxa… Phase1 Bioequivalence Completed 2019-03-27 2019-04-27 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03884309 Evaluation of Infants Fed an Extensively Hydrolyzed Infant Formula Na Protein Intolerance Completed 2019-03-25 2020-01-07 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03679832 A Nutrition-Focused Quality Improvement Program in Hospitalized Malnourished Pa… — Malnutrition Completed 2019-03-21 2019-10-11 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03803995 Mapping and Pacing of the His Bundle for Heart Failure Patients With Left Bundl… Na Heart Failure Completed 2019-03-20 2024-04-26 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03690999 The RAMP Study - Rejuvenation of the Aging Microbiota With Prebiotics Na Microbiome Completed 2019-03-14 2020-12-14 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03876054 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator — Chronic Pain Recruiting 2019-03-13 2029-12-01 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03891823 Transcatheter Mitral Valve Repair for the Treatment of Mitral Valve Regurgitati… Na Ventricular Remodeling, Left Terminated 2019-03-08 2024-05-15 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03585387 Cardiac Positioning System in Peripheral Angioplasty Procedure. — Peripheral Arterial Disease Completed 2019-02-27 2020-06-09 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03724812 FlexNav EU CE Mark Study Na Symptomatic Severe Aortic Stenosis Completed 2019-02-26 2021-02-10 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03815175 XIENCE 28 USA Study Na Bleeding Disorder Completed 2019-02-25 2021-02-04 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03705312 MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE… Na Mitral Regurgitation Unknown 2019-02-22 2022-01-01 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03820050 FreeStyle LIbre Flash Glucose Monitoring System Pediatric Accuracy Study — Diabetes Mellitus Completed 2019-01-29 2019-06-14 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03825419 Detection of Muscle Loss in Acute Stroke Patients Who Need Enteral Nutrition (M… — Acute Ischemic Stroke Completed 2019-01-23 2021-11-30 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT03733392 Advisor HD Grid Observational Study — Persistent Atrial Fibrillation Completed 2019-01-11 2021-05-27 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT05746416 Xience Registry In Complex Lesion of Acute Coronary Syndrome Patients witH Tica… — Coronary Artery Disease Completed 2019-01-02 2021-12-31 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT03447834 EUROpean Intracoronary Cooling Evaluation in Patients With ST-elevation Myocard… Na Acute Myocardial Infarction Unknown 2019-01-01 2023-06-30 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT00613418 Comparative Study Of Safety And Efficacy Of The SUPERA® Nitinol Stent - Iliac A… Na With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries Withdrawn 2019-01-01 2019-01-01 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03781258 Anti-thrombotic Monotherapy in HeartMate 3 Left Ventricular Assist System (LVAS) Na Heart Failure Unknown 2018-11-23 2021-12-31 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03701867 Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women Na Energy Metabolism Completed 2018-11-14 2019-07-22 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03803969 ConfirmRxTM: Posture and Activity Na Syncope Completed 2018-10-30 2020-07-30 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03785418 Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LI… Na Atrial Fibrillation Unknown 2018-10-29 2020-07-01 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03752866 CONFIDENCE Registry to Assess Safety and Performance of Portico System to Treat… Na Symptomatic Degenerative Aortic Stenosis Completed 2018-10-25 2022-07-28 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03561051 The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study — Chest Pain Active_Not_Recruiting 2018-10-16 2025-01-01 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03539458 Feasibility Study of the Tendyne Mitral Valve System in Mitral Annular Calcific… Na Mitral Regurgitation Completed 2018-10-10 2024-06-18 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03567096 LV Only MPP With SyncAV Na Heart Failure Completed 2018-10-09 2023-09-30 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03165526 The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption… — Post-Infarction Ventricular Septal Defect Completed 2018-10-01 2021-11-29 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03650556 Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCat… Na Persistent Atrial Fibrillation Completed 2018-09-28 2021-01-11 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03690765 Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone … — Endometriosis Completed 2018-09-27 2020-05-29 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT03628196 A Nutrition-Focused QIP in Outpatient Clinics — Malnutrition Completed 2018-09-26 2020-03-18 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT04475380 Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xien… — Acute Coronary Syndrome Completed 2018-09-21 2025-12-31 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03628183 Tolerance of Infants Fed a Hydrolysate Formula Na Gastrointestinal Tolerance Completed 2018-08-28 2018-11-23 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03473561 Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to… Phase3 Diarrhea, Infantile Completed 2018-08-25 2020-01-08 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03775759 Treatment of Tricuspid Valve Regurgitation in Patients Undergoing Left Ventricu… Na Tricuspid Valve Insufficiency Completed 2018-08-22 2023-02-15 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT03704220 Anti-thrombotic Monotherapy With the HeartMate 3 LVAS Na Heart Failure Unknown 2018-08-16 2021-12-01 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT04397224 Reduction or Extension of COnduction Time With Ventricular Electromechanical Re… — Heart Failure Unknown 2018-07-20 2024-07-20 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03564860 HBP Device EGM Data Collection — Sick Sinus Syndrome Completed 2018-07-17 2020-09-30 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03630302 Intraoperative Investigation of a Directional Lead and Local Field Potentials f… — Parkinson Completed 2018-07-12 2020-01-31 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03433274 Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Tr… Na Mitral Regurgitation Active_Not_Recruiting 2018-06-15 2028-06-01 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03459001 Evaluation of a High Calorie, High Protein Tube Feeding Product in an Adult Pop… — Malnutrition Completed 2018-06-08 2019-02-07 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03632057 Shock Efficacy Study Comparing Fixed Tilt and Fixed Pulse Width in a General Im… Na Ventricular Arrythmia Completed 2018-06-06 2025-04-18 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03720639 Confirm Rx™ Versus Reveal LINQ™ - Which is More Reliable in Data Transmission? … Na Cardiac Arrythmias Completed 2018-05-18 2020-03-09 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03507777 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI) Na Coronary Artery Disease Completed 2018-05-17 2023-02-28 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03508154 Evaluation of Carbohydrates - Glycemic Index Na Glycemic Index Completed 2018-05-07 2018-05-22 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03458013 Psychosocial Outcomes in Hand Therapy Na Hand Injuries Completed 2018-05-01 2020-01-22 ClinicalTrials.gov
NCT03503851 Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips i… Na Mitral Regurgitation Functional Withdrawn 2018-05-01 2020-12-01 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03502811 The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices — Mitral Valve Regurgitation Completed 2018-04-26 2020-12-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03505801 Confirm Rx Insertable Cardiac Monitor SMART Registry — Cardiac Arrhythmias Active_Not_Recruiting 2018-04-24 2026-03-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03548506 Subthalamic Steering for Therapy Optimization in Parkinson's Disease Na Parkinson Disease Completed 2018-04-19 2023-12-31 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03502174 FreeStyle Libre Glucose Monitoring System in Pediatric Populations — Diabetes Mellitus Completed 2018-04-05 2018-07-03 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03744000 Deferred Stenting in Patients With Anterior Wall STEMI Na Acute Myocardial Infarction With ST Elevation Active_Not_Recruiting 2018-04-03 2025-11-30 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03500692 MitraClip NT System Post-marketing Surveillance Study - Japan — Mitral Regurgitation Completed 2018-04-02 2022-03-23 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03463512 Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants… Phase3 Diarrhea Completed 2018-03-29 2018-09-10 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03387813 Hemodynamic-GUIDEd Management of Heart Failure Na Heart Failure Completed 2018-03-15 2023-05-17 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03271762 Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients W… Na Mitral Regurgitation Active_Not_Recruiting 2018-03-02 2028-01-01 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03448367 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatr… — Diabetes Mellitus Terminated 2018-02-27 2020-10-13 ClinicalTrials.gov
NCT03448380 FreeStyle Libre Flash Glucose Monitoring System Post Approval Study — Diabetes Mellitus Completed 2018-02-27 2021-03-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03355742 XIENCE 28 Global Study Na Bleeding Disorder Completed 2018-02-09 2020-04-30 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03309332 AMPLATZER PFO Occluder Post Approval Study Na Stroke Active_Not_Recruiting 2018-01-31 2030-02-05 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03597113 Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Form… — Gastrointestinal Tolerance Completed 2018-01-31 2020-03-27 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03415152 A Prospective Observational Program Using Digital Technology Tools to Enhance P… — History of Myocardial Infarction Completed 2018-01-24 2019-07-01 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03667196 Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of … — Chronic Total Occlusion of Coronary Artery Recruiting 2018-01-11 2032-12-31 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03549143 Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrom… — Irritable Bowel Syndrome Completed 2017-12-25 2019-04-19 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03354663 TactiSense IDE Trial of TactiCath SE for Paroxysmal Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2017-12-11 2019-10-30 ClinicalTrials.gov
NCT03369899 FreeStyle Libre Flash Glucose Monitoring System in Pediatric Populations — Diabete Mellitus Completed 2017-12-11 2018-05-23 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT04682483 Cardiogenic Shock Working Group Registry — Cardiogenic Shock Recruiting 2017-12-04 2026-06-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT03315884 Pilot Randomized Clinical Study of the Iliac Arteries and Common Femoral Artery… Na Atherosclerosis of the Peripheral Arteries Unknown 2017-12-01 2020-12-01 ClinicalTrials.gov
NCT01643746 Evaluation of Luminal Expansion Following Stenting of Femoro-popliteal Occlusiv… Na Femoropopliteal Stenosis Withdrawn 2017-12-01 2017-12-01 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03338374 Cardiac Resynchronisation Therapy Versus Rate-responsive Pacing in Heart Failur… Na Diastolic Heart Failure Completed 2017-11-27 2022-05-30 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT03214029 COmparisoN of High-sensitivity Cardiac TRoponin I and T ASsays Trial — Acute Myocardial Infarction Active_Not_Recruiting 2017-11-06 2025-12-31 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT02924285 Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contra… Phase3 Heart Diseases Completed 2017-11-01 2021-03-04 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03350256 BurstDR™ micrOdosing stimuLation in De-novo Patients Na Pain, Intractable Completed 2017-10-30 2019-07-02 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03153397 Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome i… Na Enteral Nutrition Completed 2017-10-23 2021-05-31 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03489603 Clinical and Economic Outcomes of High Sensitivity Troponin for no ST Elevation… — NSTEMI - Non-ST Segment Elevation MI Completed 2017-10-11 2019-06-15 ClinicalTrials.gov
NCT03276884 Growth and Tolerance of Young Infants Na Growth Completed 2017-10-11 2018-11-08 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03451617 Alpine vs. Xpedition: Evaluation of Stent Delivery System Na Percutaneous Coronary Intervention Unknown 2017-10-05 2020-10-05 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03277378 Evaluating Anatomic Versus Targeted Lead Placement for Burst Stimulation Therap… Na Chronic, Intractable Pain of the Trunk and/or Lower Limbs Completed 2017-09-22 2018-10-12 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03293706 Evaluation of Carbohydrates Part 2 Na Gastro-Intestinal Tolerance Completed 2017-09-21 2017-11-15 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03213340 Effects of Phytonutrients Upon Muscle Perfusion in Response to Feeding Na Biological Aging Completed 2017-09-14 2019-10-02 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03450772 Equivalence Study to Compare Two Strengths of Creon in China Phase3 Pancreatic Insufficiency Unknown 2017-08-31 2022-04-30 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03240952 The Nutritional Health for the Elderly Reference Centre Study (NHERC Study) — Malnutrition Completed 2017-08-30 2018-07-26 ClinicalTrials.gov
NCT03245047 The Nutritional Health for the Elderly Reference Centre Study (The NHERC Study) Na Malnutrition Completed 2017-08-30 2020-03-10 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03244683 A Study of the Efficacy of ONS to Reduce Postoperative Complications Associated… Na Pancreatic Cancer Terminated 2017-08-28 2018-08-01 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03247829 Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Dev… — Heart Failure Completed 2017-08-24 2020-06-30 ClinicalTrials.gov
NCT03811938 Ablation of Low Voltage Regions in Persistent Atrial Fibrillation Na Persistent Atrial Fibrillation Unknown 2017-08-24 2020-06-01 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03257501 FreeStyle Libre Flash Accuracy Study — Diabetes Mellitus Completed 2017-08-22 2018-01-08 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03455374 Diamondback in Peripheral Vascular Disease Na Peripheral Vascular Diseases Terminated 2017-08-08 2019-05-13 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT03227757 TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With… Na Tricuspid Valve Insufficiency Completed 2017-08-01 2024-05-30 ClinicalTrials.gov
NCT02943616 ABSORB Post-Approval Clinical Study Na Ischemic Heart Disease Withdrawn 2017-08-01 2021-01-01 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT02814578 Assessment of Coronary Artery Lesion Using Optical Coherence Tomography Versus … Na Coronary Artery Disease Terminated 2017-07-31 2017-07-31 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03218787 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HB… Na Coronary Artery Lesions Completed 2017-07-19 2020-09-04 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03242122 Evaluation of Carbohydrates Na Glycemic Index Completed 2017-07-17 2017-08-18 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03171311 The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bi… Na Ischaemic Heart Disease Active_Not_Recruiting 2017-07-05 2029-05-01 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03055858 AMPLATZER Duct Occluder II Additional Sizes Na Patent Ductus Arteriosus Completed 2017-06-05 2022-04-05 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03001141 Study Protocol/ Registry of MultiPoint™ Pacing in Brazil — Heart Failure, Unspecified Terminated 2017-05-18 2019-02-08 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03084991 OPTical Coherence Tomography IMAging in Patients With Acute myocardiaL Infarcti… — Acute Myocardial Infarction Unknown 2017-05-17 2022-12-01 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03159546 FreeStyle Libre Flash Glucose Monitoring System Accuracy — Diabete Mellitus Completed 2017-05-13 2017-08-24 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT03073447 WAMIF : Young Women Presenting Acute Myocardial Infarction in France Na Acute Myocardial Infarction Completed 2017-05-04 2020-10-06 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT02830152 Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Pa… Na Atrial Fibrillation Active_Not_Recruiting 2017-05-03 2028-12-01 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03175315 Evaluation of a Treatment and Education Program for Diabetic Patients Who Use F… Na Diabetes Mellitus Completed 2017-05-02 2018-03-09 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03141892 FreeStyle Libre Flash Glucose Monitoring System Accuracy Study — Diabetes Mellitus Completed 2017-04-13 2017-05-30 ClinicalTrials.gov
NCT03041233 ABLATOR Brazil - Ablation Observational Study (Registry) — Atrial Fibrillation Completed 2017-04-13 2020-04-27 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT02963259 IPG Replacement Study (PREFERENCE-H) — Parkinson Disease Completed 2017-03-29 2020-01-31 ClinicalTrials.gov
NCT03056573 Assessment of the St Jude Medical Portico Resheathable Aortic Valve System-Alte… Na Aortic Valve Stenosis Completed 2017-03-29 2019-07-05 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03108456 Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbit… Na Coronary Artery Disease Unknown 2017-03-27 2025-06-12 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03061929 Human Milk Composition in Indian Mothers — Breast Feeding Completed 2017-03-24 2019-06-30 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03016169 Trifecta™ GT Post Market Clinical Follow-up Na Aortic Valve Disease Completed 2017-03-09 2023-08-31 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03082261 Multi-center Prospective Study Determining the Sustainability of Pain Relief an… Na Chronic Pain Completed 2017-03-03 2020-08-26 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03048890 VascTrac Peripheral Arterial Disease (PAD) Study — Peripheral Artery Disease Unknown 2017-03-01 2023-12-01 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03055910 Fractional Flow Reserve Fax Registry — Coronary Artery Disease Unknown 2017-03-01 2018-01-31 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT03082599 Symfony Toric Intraocular Lens Visual Outcomes Na Cataract Bilateral Completed 2017-02-17 2018-04-03 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT04230889 Evaluation of Glucose Control in Patients With Diabetes Na Glycemic Control Completed 2017-02-06 2018-02-15 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03052803 Comparison of Devices Evaluating Fractional Flow Reserve in Coronary Arteries — Coronary Artery Disease Completed 2017-02-01 2017-12-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03078374 MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGE… Na Heart Failure Unknown 2017-01-11 2022-10-01 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03117426 A Randomised Evaluation of Visual Function After Bilateral Implantation of Two … Na Cataract Completed 2017-01-01 2017-10-30 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03036956 The Prevalence of Sub Clinical Hypothyroidism During Early Pregnancy in Pakistan — Subclinical Hypothyroidism Completed 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT02471729 Effect at 6 Months of Renal Denervation in Chronic Heart Failure d'Insuffisance… Phase1 Chronic Heart Failure Unknown 2017-01-01 2018-01-01 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT03409731 Absorb GT1 Japan PMS Na Ischemic Heart Disease Completed 2016-12-13 2023-02-06 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02964208 AMPLATZER™ LAA Occluder Post Approval Study (PAS) — Atrial Fibrillation Completed 2016-12-08 2022-08-10 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02931435 Radiofrequency For Chronic Knee Pain Post-Arthroplasty Na Chronic Knee Pain Completed 2016-12-01 2018-11-30 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT03020290 Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents — Atherosclerosis Obliterans Completed 2016-12-01 2018-04-10 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT02943954 FLOW Evaluation to Guide Revascularization in Multi-vessel ST-elevation Myocard… Na Acute ST Segment Elevation Myocardial Infarction Unknown 2016-12-01 2022-01-01 ClinicalTrials.gov
NCT02903940 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-12-01 2022-12-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02698540 A Study of an Oral Nutritional Supplement in a Malnourished Population With GI … — Malnutrition Completed 2016-11-28 2018-05-01 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT02954237 AMPLATZER™ Cardiac Plug Observational Post-Approval Study — Non-valvular Atrial Fibrillation (NVAF) Completed 2016-11-14 2021-01-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT03012568 Clinical Study to Confirm MRI Safety and Effectiveness Using St. Jude Medical (… — Bradycardia Completed 2016-11-10 2018-03-29 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02858245 A Feasibility Registry of Actigraphy Monitoring in Degenerative Mitral Regurgit… — Mitral Regurgitation Terminated 2016-11-01 2017-12-01 ClinicalTrials.gov
NCT02844127 Effect of Right Ventricular Lead Position on Defibrillation Threshold Na Ventricular Tachycardia Withdrawn 2016-11-01 2017-04-04 ClinicalTrials.gov
NCT02836652 Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients With… Phase4 Heart Failure Completed 2016-11-01 2019-07-18 ClinicalTrials.gov
NCT02986074 CompaRison of Paresthesia Mapping to anatomIc Midline-based burSt Programming S… Na Chronic Pain Completed 2016-11-01 2019-08-19 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT03237169 Performance of a New REsting Pressure Index During Invasive Angiography Compare… — Fractional Flow Reserve, Myocardial Unknown 2016-10-28 2018-09-01 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02738840 A Post-Market Study Evaluating the Prodigy MRI and Proclaim Elite MR Conditiona… Na Chronic Pain Completed 2016-10-21 2020-12-02 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02935088 PRESSUREwire Study — Coronary Artery Disease Completed 2016-10-12 2019-03-22 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02877693 A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD Syste… Na ICD Completed 2016-10-10 2020-03-23 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02360722 Improving Nutritional Status With Oral Nutritional Supplement in Chinese Elderly Phase4 Malnutrition Withdrawn 2016-10-01 2017-12-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT04756180 An Efficacy and Safety Study of Omega-3-acid Ethyl Ester in Chinese Subjects Wi… Phase3 Hypertriglyceridemia Completed 2016-10-01 2019-04-01 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02830360 Antiarrhythmics or Ablation for Ventricular Tachycardia 2 Phase4 Ventricular Tachycardia (VT) Completed 2016-10-01 2024-06-30 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02923960 Effect of Nutritional Products in Subjects With Type 2 Diabetes Na Diabetes Completed 2016-10-01 2017-01-01 ClinicalTrials.gov
NCT02950831 Objective Assessment of Activity and Sleep Quality In Burst Spinal Cord Stimula… Na Chronic Pain Completed 2016-10-01 2018-03-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02913638 A Post Breastfeeding Follow-Up Study — Breast Feeding Completed 2016-09-01 2016-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02910362 Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Ver… Na Cataract Surgery Completed 2016-09-01 2017-01-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT02806765 Effect of Dietary Supplementation on Dynamic Stability Na Aging Withdrawn 2016-09-01 2017-12-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT03098368 Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quant… Phase4 Nocturnal Hypokinesia Unknown 2016-09-01 2018-05-01 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02879448 AMPLATZER™ Amulet™ LAA Occluder Trial Na Stroke Completed 2016-08-24 2024-05-24 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02800863 TARGET Post-Approval Study — Complex Regional Pain Syndrome (CRPS) Completed 2016-08-23 2021-09-23 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02862119 Ffr-gUidance for compLete Non-cuLprit REVASCularization Na Coronary Artery Disease Completed 2016-08-08 2023-07-17 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02892955 MOMENTUM 3 Continued Access Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2016-08-01 2021-03-01 ClinicalTrials.gov
NCT02750787 Use of a Peptide-based Formula in an Adult Population Na Malabsorption Completed 2016-08-01 2017-07-01 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02776007 Patients Perceptions of Using the "Libre" System Compared With Conventional SMB… Na Type 1 Diabetes Completed 2016-07-01 2020-04-30 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02832622 MultiPoint Pacing™ Post Market Study — Heart Failure Completed 2016-07-01 2019-07-15 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02896361 Burst Optimized Stimulation Study Na Chronic Pain Completed 2016-07-01 2017-08-01 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02954341 CardioMEMS HF System OUS Post Market Study — Heart Failure Completed 2016-07-01 2023-12-08 ClinicalTrials.gov
NCT02173860 Strategies for Revascularization in Patients Undergoing Heart Valve Surgery Wit… Na Coronary Artery Disease Unknown 2016-07-01 2021-08-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02825134 Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe … Na Aortic Valve Stenosis Active_Not_Recruiting 2016-06-30 2029-06-01 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02821117 FreeStyle Libre Glucose Monitoring System Paediatric Study Na Diabetes Mellitus Completed 2016-06-30 2017-02-22 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02728739 Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients Na Acute Heart Failure Completed 2016-06-06 2018-02-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02782598 The Application of Negative Atrioventricular Hysteresis in Cardiac Resynchroniz… — Heart Failure Completed 2016-06-01 2020-05-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02814214 Device-based QRS Evaluation — Heart Failure Completed 2016-06-01 2017-09-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02807948 SJM MRI Diagnostic Imaging Registry (IDE) Na Cardiac Arrhythmia Completed 2016-06-01 2018-01-31 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02799043 Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation With F… Na Persistent Atrial Fibrillation Completed 2016-06-01 2020-07-01 ClinicalTrials.gov
NCT02928198 Bifurcation ABSORB OCT Trial Na Myocardial Ischemia Unknown 2016-06-01 2020-03-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT02787291 A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse … Na Implantable Defibrillator User Completed 2016-05-01 2018-04-11 ClinicalTrials.gov
NCT02706574 Brain Injury Assessment Study at Hennepin County Medical Center — Traumatic Brain Injury Unknown 2016-05-01 2022-07-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT03047603 Evaluation of Diagnostic Efficiency of PIVKA-II and Other Tumor Markers in HCC — Hepatocellular Carcinoma Completed 2016-05-01 2019-03-20 ClinicalTrials.gov
NCT03167424 Restenosis Intrastent: Treatment of Bioresorbable Vascular Scaffolds Restenosis — Coronary In-stnent Restenosis Unknown 2016-05-01 2021-12-01 ClinicalTrials.gov
NCT02693691 CardioMEMS European Monitoring Study for Heart Failure Na Heart Failure Completed 2016-05-01 2020-03-01 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02676466 The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Stu… Phase2 Inflammation Completed 2016-04-26 2018-06-22 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02732158 Novel Laboratory Methods in Nutrition Studies Na Healthy Completed 2016-04-01 2016-09-01 ClinicalTrials.gov
NCT02746016 Effect of Formula on Infant Behavior Na Gastrointestinal Tolerance Completed 2016-04-01 2016-10-01 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02649842 Post-Approval Study of the TECNIS® Toric Extended Cylinder Range Intraocular Le… Na Cataract Completed 2016-03-21 2019-01-28 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02698150 Remote Monitoring of Patients With Functional Mitral Regurgitation Undergoing M… — Mitral Regurgitation Unknown 2016-03-01 2018-10-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02722577 EGM Analysis in Idiopathic Outflow Tract Ventricular Arrhythmia — Ventricular Outflow Tract Tachycardia Completed 2016-03-01 2017-05-01 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02675751 Prospective S&E Study of Wavefront-guided PRK for Myopia With iDesign Advanced … Na Stable Myopic Refractive Error, With or Without Astigmatism Completed 2016-02-03 2018-07-27 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02703454 FIRM Ablation Versus Pulmonary Vein Isolation for the Treatment of Paroxysmal A… Na Paroxysmal Atrial Fibrillation Terminated 2016-02-01 2018-02-01 ClinicalTrials.gov
NCT02699060 Experimental Study to Determine the Effects of Human Refluxate on Macrophage Ph… Na Gastroesophageal Reflux Disease (GERD) Completed 2016-02-01 2019-01-01 ClinicalTrials.gov
NCT02476201 Quartet Lead and Resynchronization Therapy Options III (QUARTO_III) Na Heart Failure Completed 2016-02-01 2019-07-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT02758002 Inhibition of Atrial Fibrillation by Elimination of Transitional Mechanisms Na Atrial Fibrillation Withdrawn 2016-01-28 2018-12-01 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT03058510 Feasibility of Orbital Atherectomy System in Calcified Bifurcation Lesion — Coronary Artery Disease Completed 2016-01-17 2017-10-13 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02168829 Optimal Anticoagulation for Higher Risk Patients Post-Catheter Ablation for Atr… Phase4 Atrial Fibrillation Completed 2016-01-01 2025-08-14 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02613780 Refractive Treatment of Early Keratoconus Phase3 Keratoconus Unknown 2016-01-01 2019-01-01 ClinicalTrials.gov
NCT02665455 FreeStyle Libre in Pregnancy Study Na Diabetes Mellitus Completed 2016-01-01 2016-09-01 ClinicalTrials.gov
NCT02779621 The Potential for HPV Self-testing to Promote Participation in Cervical Screeni… Na Cervix Diseases Withdrawn 2016-01-01 2017-01-25 ClinicalTrials.gov
NCT02847572 Assessment of Visual Performance Combining a Symfony IOL and a +3.25 Tecnis Mul… Na Cataract Completed 2016-01-01 2016-12-01 ClinicalTrials.gov
NCT03069066 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring … Phase4 Coronary In-stent Restenosis Unknown 2016-01-01 2021-12-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02634398 A Post Market Study on DRG Stimulation in FBSS (SYMPATHY) — Failed Back Surgery Syndrome Withdrawn 2015-12-01 2016-11-01 ClinicalTrials.gov
NCT02648230 PrEssure wiRe Compared to Microcatheter-based Sensing Technology For the Evalua… Na Ischemia Completed 2015-12-01 2016-12-08 ClinicalTrials.gov
NCT02377947 A Retrospective, Open-label, Uncontrolled Cohort Study to Assess the Effectiven… — Hepatic Encephalopathy Completed 2015-12-01 2016-03-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Ch… Na Chronic Kidney Diseases Completed 2015-11-01 2018-08-01 ClinicalTrials.gov
NCT02613858 Minimal HePatic Encephalopathy Among CiRrhotics. A Cross SEctional, Clinico-Epi… — Hepatic Encephalopathy Completed 2015-11-01 2017-05-01 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT02548455 Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE)… Na Heart Failure Completed 2015-10-27 2017-03-21 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT03085316 Laryngeal Pacing Study Na Bilateral Vocal Fold Paralysis (BVFP) Terminated 2015-10-26 2023-11-07 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02566083 Post-Approval Study of the Tecnis® Toric IOL Na Cataract Completed 2015-10-21 2019-05-23 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02789904 Evaluation of hsTnI in the Management of Patients With Chest Pain in the Emerge… — Chest Pain Completed 2015-10-05 2017-11-01 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02587637 Study to Evaluate the Effectiveness of DRG Stimulation for Discogenic Low Back … Na Chronic Pain Completed 2015-10-01 2018-01-30 ClinicalTrials.gov
NCT02596321 A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of… Phase3 Allergy Completed 2015-10-01 2016-06-01 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT02520310 AVJ-514 Japan Trial Na Mitral Stenosis With Insufficiency Completed 2015-09-07 2021-05-31 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT06306066 Coronary Thermo-dilution Derived Flow-indices in Chronic Coronary Syndrome — Coronary Artery Disease Completed 2015-09-02 2022-12-28 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02584595 Evaluation of Inducible Monomorphic Ventricular Tachycardia (MMVT) in Patients … — Monomorphic Ventricular Tachycardia Withdrawn 2015-09-01 2022-02-01 ClinicalTrials.gov
NCT02561299 Orbital Vessel PreparaTIon to MaximIZe Dcb Efficacy in Calcified Below the Knee… Na PAD Completed 2015-09-01 2019-07-02 ClinicalTrials.gov
NCT02553408 Patients and Care Providers Perspectives and Experience With Decision Aid Tool … Na Type 2 Diabetes Completed 2015-09-01 2016-06-01 ClinicalTrials.gov
NCT02592889 (MitraClip in Non-Responders to Cardiac Resynchronization Therapy) Phase4 MITRAL REGURGITATION Unknown 2015-09-01 2018-10-01 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02470312 MediGuide Registry — Heart Failure Terminated 2015-08-18 2018-02-28 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02863159 A Clinical Assessment of the Full Range of Functional Vision With Three Tecnis … Na Cataract Unknown 2015-08-01 2017-07-01 ClinicalTrials.gov
NCT02468778 SHIELD II Clinical Investigation Na Coronary Artery Disease Terminated 2015-08-01 2021-05-17 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02656537 EnSite™ HD Grid Catheter AF/AT Mapping Study Na Non-paroxysmal Atrial Fibrillation Completed 2015-08-01 2018-08-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02845804 Effect and Efficacy of Xpedition™/Alpine™, Everolimus-eluting Stent for Coronar… — Coronary Artery Disease Unknown 2015-07-01 2021-07-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02492386 Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Ar… Phase2 Impotence, Arteriogenic Unknown 2015-07-01 2017-03-01 ClinicalTrials.gov
NCT02491437 A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone … Phase3 Female Infertility Completed 2015-07-01 2017-05-01 ClinicalTrials.gov
NCT02489331 Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patient… — Dyslipidemias Completed 2015-07-01 2020-11-10 ClinicalTrials.gov
NCT02571218 AF Substrate Mapping and Guided Ablation Na Persistent Atrial Fibrillation Completed 2015-07-01 2017-02-01 ClinicalTrials.gov
NCT02577887 Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II — Standard Bradycardia Pacing Indication Completed 2015-07-01 2017-12-15 ClinicalTrials.gov
NCT02260154 Effectiveness of Duspatalin® in Patients With Post-cholecystectomy Gastrointest… — Post-cholecystectomy Gastrointestinal Spasms Completed 2015-07-01 2016-10-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02097420 HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotat… Na Mitral Valve Disease Completed 2015-05-07 2023-07-01 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02471586 OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiogra… Na Coronary Artery Disease Completed 2015-05-01 2017-04-25 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02475460 HeartMate 3™ LIS Study Na Heart Failure Completed 2015-05-01 2016-07-01 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02407249 Topera C-FIRM Registry — Atrial Fibrillation Completed 2015-04-01 2018-07-31 ClinicalTrials.gov
NCT02401217 Tolerance of Healthy Infants Fed Infant Formulas Na Gastrointestinal Tolerance Completed 2015-04-01 2015-09-01 ClinicalTrials.gov
NCT02434315 FreeStyle Libre Pro Use in Primary & Secondary Care Na Diabetes Mellitus Completed 2015-04-01 2016-09-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02415959 Efficacy and Safety Study of Creon IR in Subjects With Pancreatic Exocrine Insu… Phase2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis Completed 2015-03-01 2015-07-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02381418 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2015-03-01 2015-03-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02339545 Coronary Flow Reserve Following Orbital Atherectomy — Coronary Artery Disease Completed 2015-02-01 2016-05-01 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02310100 TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post A… Na Paroxysmal Atrial Fibrillation Completed 2015-01-21 2021-09-17 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02353351 ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Atrial Septal Defect Secundum Terminated 2015-01-19 2017-02-24 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02337699 Dorsal Root Ganglion Stimulation as Treatment for Post-surgical Groin Pain — Post Surgical Groin Pain Terminated 2015-01-01 2015-09-01 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02322138 Gastrointestinal Tolerance of Infant Formula Na Gastrointestinal Tolerance Completed 2015-01-01 2015-06-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02336945 Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring … — Type 2 Diabetes Mellitus Completed 2015-01-01 2015-07-01 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02279888 CardioMEMS HF System Post Approval Study — Heart Failure Completed 2015-01-01 2019-10-11 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02367716 Post-market Study of Multi-Vector Left Ventricular Lead Performance in Chinese … — Chronic Heart Failure Completed 2014-12-01 2017-03-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02307760 Evaluation of Human Milk Fortifiers in Preterm Infants Na Infant Growth Completed 2014-12-01 2017-02-01 ClinicalTrials.gov
NCT02421549 Remote Interrogation in Rural Emergency Departments Phase4 Heart Disease Withdrawn 2014-12-01 2016-01-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02344173 ABLATOR Ablation Observational Registry — Atrial Fibrillation Completed 2014-11-01 2017-08-18 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02130765 Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for… Na Monomorphic Ventricular Tachycardia Terminated 2014-11-01 2016-07-25 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02321514 Expanded Clinical Study of the Tendyne Mitral Valve System Na Mitral Valve Regurgitation Completed 2014-11-01 2025-04-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT01989299 Ventricular Tachyarrhythmia Detection by Implantable Loop Recording in Patients… — Heart Failure With Preserved Ejection Fraction (HFpEF) Completed 2014-11-01 2020-06-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT02305342 Sensitivity of Antibiotics for Urinary Tract Infections Patients Attending Fami… — Urinary Tract Infections (UTIs) Completed 2014-11-01 2015-02-01 ClinicalTrials.gov
NCT02283411 Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Sy… Na Diabetes Mellitus, Type 1 Completed 2014-11-01 2015-03-01 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT01722942 Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention … Na Chagas Cardiomyopathy Unknown 2014-10-06 2022-07-31 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02150473 The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Car… Phase3 Rheumatoid Arthritis Terminated 2014-10-01 2017-09-14 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02298556 An Observational Study to Describe the Effectiveness of Angiotensin Converting … — Hypertension Completed 2014-10-01 2016-03-08 ClinicalTrials.gov
NCT02279979 Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial Na Cardiogenic Shock Terminated 2014-10-01 2017-01-01 ClinicalTrials.gov
NCT02245360 Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Im… Phase3 Seasonal Allergic Rhinitis Completed 2014-10-01 2015-03-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02989090 Electronic Patient Notification of Remote ICD Data: Impact of Patient Engagemen… Na Implantable Cardioverter-Defibrillator Completed 2014-10-01 2015-11-01 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT02224755 MOMENTUM 3 IDE Clinical Study Protocol Na Advanced Refractory Left Ventricular Heart Failure Completed 2014-09-02 2019-03-26 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02158403 PREVENtion of HeartMate II Pump Thrombosis Na HeartMate II Pump Thrombosis Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02203721 Clinical Investigation of a New Intraocular Lens Na Cataract Completed 2014-09-01 2015-06-01 ClinicalTrials.gov
NCT01911078 Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study) Na Metabolic Syndrome Completed 2014-09-01 2016-06-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02250469 A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthes… Na Chronic Pain Terminated 2014-09-01 2016-12-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02262286 MIND (Management of Traumatic Brain Injury Diagnosis) — Brain Injury Completed 2014-09-01 2016-09-01 ClinicalTrials.gov
NCT02232698 An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Di… Na Type 1 Diabetes Mellitus Completed 2014-09-01 2015-10-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02100722 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Interventi… Na Coronary Disease Completed 2014-08-25 2024-12-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02213120 To Study the Characteristics of Different Types of Vertigo in Patients Attendin… — Vertigo Completed 2014-08-01 2015-03-01 ClinicalTrials.gov
NCT02060630 Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Isch… Na Critical Limb Ischemia Completed 2014-08-01 2022-03-01 ClinicalTrials.gov
NCT02195843 Quadripolar Leads for the Management of Heart Failure Patients in the Middle Ea… Phase4 Heart Failure Unknown 2014-08-01 2016-08-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT01614717 Triple Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy (HOCM) Patient… Na Hypertrophic Cardiomyopathy With Obstruction Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02513732 XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveil… — Ischemic Heart Disease Completed 2014-07-01 2020-09-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02193971 Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - … Phase4 Acute Coronary Syndrome Completed 2014-07-01 2024-01-01 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02173379 Absorb IV Randomized Controlled Trial Na Coronary Artery Disease Completed 2014-07-01 2022-04-06 ClinicalTrials.gov
NCT02184117 CONTRAST (Can cONTrast Injection Better Approximate FFR compAred to Pure reSTin… — Coronary Artery Disease Completed 2014-07-01 2015-05-01 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02041702 Accent Cardiac MRI Study Na Bradycardia Completed 2014-06-09 2016-03-17 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02404987 An Oral Nutritional Supplement Study in Older Malnourished Spanish Population — Malnutrition Unknown 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02132611 Coronary Orbital Atherectomy System Study Na CAD Completed 2014-06-01 2017-06-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02143791 Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of th… Na Chronic Pain Completed 2014-06-01 2016-10-01 ClinicalTrials.gov
NCT02171065 PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomi… Na Acute Coronary Syndrome (ACS) Completed 2014-06-01 2020-05-01 ClinicalTrials.gov
NCT02115269 IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine an… — Headache Disorders, Primary Completed 2014-06-01 2015-11-01 ClinicalTrials.gov
NCT02200029 Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption Phase3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease Completed 2014-06-01 2015-02-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02000115 Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial Na Aortic Valve Stenosis Active_Not_Recruiting 2014-05-01 2026-12-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02146599 Patient Perception of Visual Quality and Function — Cataract Completed 2014-05-01 2014-07-01 ClinicalTrials.gov
NCT02189096 Validation of Early Warning Score & Lactate in Prehospital Screening — Sepsis Completed 2014-05-01 2015-07-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02229864 Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery L… Na Coronary Artery Disease Completed 2014-05-01 2019-10-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02073071 Effects of Infant Formula on the Growth and Tolerance in Preterm/Low Birth Weig… — Other Preterm Infants Completed 2014-05-01 2015-11-01 ClinicalTrials.gov
NCT02042300 XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice — Percutaneous Transluminal Coronary Angioplasty Completed 2014-05-01 2024-08-30 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT01907828 A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and… Na Persistent Atrial Fibrillation Completed 2014-04-15 2018-10-15 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02672878 Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment (RIBS VI) Phase4 Coronary In-stent Restenosis Unknown 2014-04-01 2020-12-01 ClinicalTrials.gov
NCT02125123 Oral Nutritional Supplementation in Children Na Children Terminated 2014-04-01 2015-07-01 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT01993862 Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Imp… Na Heart Failure Completed 2014-03-17 2016-08-12 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT03249610 Randomized Control Trial for Overweight Employees in Worksites Na Diabetes Mellitus, Type 2 Completed 2014-03-11 2017-06-15 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02090387 Evaluation of an Oral Nutritional Supplement on Lean Body Mass in Healthy Older… Na Healthy Completed 2014-03-01 2016-04-01 ClinicalTrials.gov
NCT02089971 Muscle Mass and Function in Chinese Adults — Sarcopenia Completed 2014-03-01 2014-12-01 ClinicalTrials.gov
NCT02089906 Health and Nutrition Status of Chinese Elderly — Malnutrition Completed 2014-03-01 2015-07-01 ClinicalTrials.gov
NCT02086526 Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET) Phase1 Polycystic Ovary Syndrome Completed 2014-03-01 2016-11-20 ClinicalTrials.gov
NCT02082184 An Evaluation of a Novel Glucose Sensing Technology in Type 2 Diabetes Na Type 2 Diabetes Mellitus Completed 2014-03-01 2015-12-01 ClinicalTrials.gov
NCT02064751 MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics Na Heart Failure Completed 2014-03-01 2016-06-01 ClinicalTrials.gov
NCT02052232 Study of Protein Metabolism in Healthy Older Subjects Na Malnutrition Completed 2014-03-01 2015-04-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02052453 ICD-ON Registry: Periop Management of Cardiac Devices — Oversensing Cardiac Pacemaker Completed 2014-02-01 2015-12-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02030418 The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker Na Bradycardia Completed 2014-02-01 2022-07-15 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02057588 Enhanced Diagnosis of Ventricular Activation Pattern Using Intracardiac Electro… Na Arrythmia Completed 2014-02-01 2016-06-01 ClinicalTrials.gov
NCT02073058 Evaluation of the Accuracy of the Abbott Sensor Based Interstitial Glucose Moni… — Type 1 Diabetes Completed 2014-02-01 2014-05-01 ClinicalTrials.gov
NCT02069522 Healthy Term Infants Fed Milk-Based Formulas Na Infants Terminated 2014-02-01 2015-02-01 ClinicalTrials.gov
NCT02060760 Use of Abbott High Sensitivity Troponin I Assay In Acute Coronary Syndromes — Acute Coronary Syndrome Completed 2014-02-01 2021-12-01 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT01986803 ABSORB STEMI: the TROFI II Study Na Acute ST Segment Elevation Myocardial Infarction Completed 2014-01-06 2017-09-21 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02043197 Fevarin® Effectiveness in Treatment of Depression in Patients With Neurological… — Depression Completed 2014-01-01 2015-11-01 ClinicalTrials.gov
NCT02028156 Feeding Intolerance in Formula-Fed Infants Na Feeding Intolerance Terminated 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02208700 Efficacy of Oxepa Enteral Feeding in LTAC (Long Term Acute Care Hospital) Patie… Na Acute Lung Injury Unknown 2014-01-01 — ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02137382 A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect… Phase3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis Completed 2014-01-01 2014-08-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02006069 MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing Na Heart Failure Terminated 2013-12-01 2021-05-30 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02011893 SUNBURST (Success Using Neuromodulation With BURST) Study Na Chronic Pain Completed 2013-12-01 2017-01-01 ClinicalTrials.gov
NCT02570776 UBT as a Diagnostic Tool for HP Prevalance — Dyspepsia Unknown 2013-12-01 2016-02-01 ClinicalTrials.gov
NCT02004730 Italian Diffuse/Multivessel Disease ABSORB Prospective Registry: IT-Disappears Phase4 Coronary Artery Disease Unknown 2013-12-01 2015-06-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02016261 Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment… Phase4 Recurrent Depressive Disorder Completed 2013-12-01 2015-07-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02029144 Observational Study of Dydrogesterone in Cycle Regularization — Observational Study Completed 2013-12-01 2015-02-01 ClinicalTrials.gov
NCT02051972 The LEADLESS Observational Study — Indications for VVI(R) Pacemaker Completed 2013-12-01 2021-12-22 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT02066623 Observational Study to Evaluate Short and Long-term Safety of the ABSORB Scaffo… — Coronary Artery Stenosis Completed 2013-11-08 2021-07-06 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02187757 Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than… Phase3 Hyperlipidemia Completed 2013-11-01 2014-11-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT02046746 The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status Na Chronic Kidney Disease Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT02016586 Breastfeeding Intervention Study Na Breast Feeding Completed 2013-11-01 2015-05-01 ClinicalTrials.gov
NCT02009410 A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in … Phase4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 Withdrawn 2013-11-01 2014-08-01 ClinicalTrials.gov
NCT02006758 Observational Study of the EnligHTN Renal Denervation System in Europe — Uncontrolled Hypertension Completed 2013-11-01 2017-05-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT01988415 New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction f… Na Myopia Completed 2013-11-01 2014-07-01 ClinicalTrials.gov
NCT01990287 SENSE (Subcutaneous and Epidural Neuromodulation System Evaluation) Study Na Failed Back Surgery Syndrome Terminated 2013-11-01 2016-02-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01218919 Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study — Parkinson Disease Withdrawn 2013-10-01 2013-12-01 ClinicalTrials.gov
NCT01903187 EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hy… Na Hypertension Terminated 2013-10-01 2016-11-01 ClinicalTrials.gov
NCT01962051 AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational — Atrial Fibrillation Withdrawn 2013-10-01 2014-01-01 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01891643 PH III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Tr… Phase3 Newly Diagnosed, Previously Untreated Multiple Myeloma Terminated 2013-09-30 2020-06-25 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01930214 Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely… — Coronary Artery Disease Completed 2013-09-26 2017-06-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT01913080 The Health Log: A Randomized Clinical Trial Na Rheumatoid Arthritis Completed 2013-09-01 2016-09-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01477320 Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. Na Gastrointestinal Hemorrhage Completed 2013-09-01 2016-07-01 ClinicalTrials.gov
NCT02346383 Optimal Stimulation Programming for Spinal Peripheral Neuromodulation Na Chronic Pain Completed 2013-09-01 2016-06-01 ClinicalTrials.gov
NCT01871090 Remote Device Interrogation In The Emergency Department Na Heart Disease Completed 2013-09-01 2015-07-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT01963286 Reduction of Inappropriate Shocks of Implantable Cardioverter Defibrillators (I… Na Tachycardia Completed 2013-08-01 2016-10-01 ClinicalTrials.gov
NCT01850030 A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dyd… Phase3 Female Infertility Completed 2013-08-01 2016-03-01 ClinicalTrials.gov
NCT02056275 A Study of an Oral Nutrition Supplement (ONS) in Children. Na Growth Completed 2013-08-01 2014-04-01 ClinicalTrials.gov
NCT01932944 Accuracy Characterization Study — Type2 Diabetes Completed 2013-08-01 2014-03-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01974986 Rehydration Following Exercise-Induced Dehydration Na Dehydration Related to Exercise Completed 2013-07-01 2016-05-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01917266 Evaluation of Left Ventricular (LV) Lead Positioning Using MediGuide — Heart Failure Completed 2013-07-01 2017-07-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT02234804 The Does Optical Coherence Tomography Optimize Revascularization (DOCTOR) Recro… Na Coronary Disease Unknown 2013-07-01 2017-02-01 ClinicalTrials.gov
NCT01497717 Efficacy of Humira in Behcet Patients With Arthritis Phase3 Arthritis; Behcet Completed 2013-07-01 2016-10-01 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01894152 XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm … — Angioplasty Completed 2013-07-01 2019-10-09 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01923740 A Clinical Evaluation of Absorb™ Bioresorbable Vascular Scaffold (Absorb™ BVS) … Na Coronary Artery Disease Completed 2013-07-01 2019-03-07 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01852123 High-Sensitivity Troponin in the Evaluation of Patients With Acute Coronary Syn… Na Acute Coronary Syndrome Completed 2013-06-10 2017-03-03 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT01850134 Evaluation of a Nutritional Supplement for People With Type 2 Diabetes. Na Diabetes Withdrawn 2013-06-01 2013-07-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT01716039 Pharmacokinetics of Adalimumab With Methotrexate for Treatment of Patients With… Phase2 Ulcerative Colitis Terminated 2013-06-01 2016-07-18 ClinicalTrials.gov
NCT02325973 Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STE… Na Multi Vessel Coronary Artery Disease Completed 2013-06-01 2018-02-01 ClinicalTrials.gov
NCT01847105 Assessing Patient Comfort With Two Different Multi-Purpose Disinfecting Solutio… Na Contact Lens Solution Toxicity Unknown 2013-06-01 2014-05-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT02335229 A Post Market Study to Assess the Spinal Modulation Dorsal Root Ganglion Stimul… — Chronic Post Surgical Pain Terminated 2013-06-01 2017-02-01 ClinicalTrials.gov
NCT02166216 The North Sea Race Endurance Exercise Study — Healthy Active_Not_Recruiting 2013-06-01 2034-06-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT01902212 Evaluation of an Oral Nutrition Supplement Na Gastrointestinal Tolerance Completed 2013-06-01 2013-09-01 ClinicalTrials.gov
NCT01850251 Effects of a Supplement Enriched in Hydroxymethylbutyrate and Vitamin D on Musc… Phase4 Hip Fractures Terminated 2013-06-01 2015-03-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT02513719 XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveill… — Ischemic Heart Disease Completed 2013-05-13 2019-09-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01858636 Post-Market Study of the St. Jude Medical Angio-Seal™ V-Twist Integrated Platfo… — Vascular Closure Completed 2013-05-01 2013-10-01 ClinicalTrials.gov
NCT01856725 MPP Programming Study Na Heart Failure Completed 2013-05-01 2015-02-01 ClinicalTrials.gov
NCT01855412 Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes — Peripheral Arterial Occlusive Disease Completed 2013-05-01 2019-04-11 ClinicalTrials.gov
NCT01850810 Evaluation of a Nutritional Product for People With Type 2 Diabetes Na Diabetes Completed 2013-05-01 2013-08-01 ClinicalTrials.gov
NCT01842568 Vascular Events In Surgery patIents cOhort evaluatioN - Cardiac Surgery — Vascular Death Completed 2013-05-01 2025-07-01 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT02349646 A Post Market Cohort With the Spinal Modulation Neurostimulator System in Perip… — Peripheral Neuropathy Terminated 2013-04-25 2016-10-24 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01802788 5 Year Observation of Patients With PORTICO Valves — Aortic Valve Stenosis Completed 2013-04-16 2022-10-19 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT01844284 AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japan… Na Coronary Artery Disease Completed 2013-04-01 2019-01-16 ClinicalTrials.gov
NCT02346643 A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG st… — Chronic Pain Terminated 2013-04-01 2015-12-01 ClinicalTrials.gov
NCT01772108 A Randomized Study of the MitraClip Device in Heart Failure Patients With Clini… Na Cardiovascular Diseases Terminated 2013-04-01 2015-01-01 ClinicalTrials.gov
NCT01836146 International First-in-Human Study of the EnligHTN Generation 2 System in Patie… Na Hypertension Completed 2013-04-01 2015-09-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT01782456 Tolerance of an Oral Nutritional Supplement(ONS) Na Gastro-Intestinal Tolerance Completed 2013-03-01 2013-04-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT02335489 A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurost… — Chronic Neuropathic Pain Terminated 2013-03-01 2015-11-01 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01522898 Cardiac Resynchronisation Therapy and AV Nodal Ablation Trial in Atrial Fibrill… Na Heart Failure Completed 2013-03-01 2020-08-31 ClinicalTrials.gov
NCT01820130 Trial of Autonomic neuroModulation for trEatment of Chronic Heart Failure Na Heart Failure Withdrawn 2013-03-01 2016-09-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT02819401 The Effects of a High-fiber Formula in Children With Failure to Thrive — GI Tolerance Completed 2013-02-01 2015-06-01 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01705080 IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTens… — Hypertension Terminated 2013-01-17 2019-11-27 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01798043 Impact of Septal Vs Apical Pacing on Right and Left Ventricular Performance Na Heart Block Terminated 2013-01-01 2016-01-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01805154 Advance Cardiac Resynchronization Therapy (CRT) Registry — Heart Failure Completed 2013-01-01 2017-09-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01650298 Safety Study on Stopping Anticoagulation Medication in Patients With a History … Na Atrial Fibrillation Terminated 2013-01-01 2017-08-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT01759251 Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vesti… — Vertigo Completed 2013-01-01 2014-05-01 ClinicalTrials.gov
NCT01769287 EP Study of Patients Who Have Received Left Atrial Ablation Using High Intensit… — Atrial Fibrillation Completed 2013-01-01 2013-09-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT02257801 Effects of Lutein on Learning and Memory in Chronically Stressed Subjects and i… Phase2 Healthy But Chronically Stressed Completed 2013-01-01 2014-12-01 ClinicalTrials.gov
NCT02786173 Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry" — Peripheral Arterial Disease Completed 2013-01-01 2021-11-05 ClinicalTrials.gov
NCT01938391 Tissue Removal Assessment With Ultrasound of THe SFA and Popliteal Na Peripheral Artery Disease Completed 2013-01-01 2015-02-01 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT01675479 Safety and Effectiveness of Wavefront-Guided LASIK Correction of Hyperopic Refr… Na Hyperopia Completed 2012-12-31 2016-10-31 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT02234830 Randomized Comparison of ExoSeal® and Angio-Seal Vascular Closure Devices: The … Na Coronary Disease Completed 2012-12-21 2017-05-14 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01663896 Observational Study of OCT in a Patients Undergoing FFR — Coronary Artery Disease Completed 2012-12-11 2015-10-01 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01675492 Safety and Effectiveness of Wavefront-guided LASIK for the Correction of Mixed … Na Astigmatism Completed 2012-12-06 2016-11-22 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01703611 Diabetes in India Nutrition Guidelines Study (DINGS) Na Type 2 Diabetes Mellitus Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01685047 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular A… — Coronary Artery Disease Completed 2012-12-01 2016-04-01 ClinicalTrials.gov
NCT01694394 Prevalence of Sub-Clinical Atrial Fibrillation Using an Implantable Cardiac Mon… — Atrial Fibrillation Completed 2012-12-01 2016-10-01 ClinicalTrials.gov
NCT01754714 Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine … Phase3 Non Alcoholic Fatty Liver Disease Completed 2012-12-01 2014-09-01 ClinicalTrials.gov
NCT01746407 Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis — Infection Completed 2012-12-01 2014-12-01 ClinicalTrials.gov
NCT01751906 ABSORB III Randomized Controlled Trial (RCT) Na Coronary Artery Disease Completed 2012-12-01 2020-10-01 ClinicalTrials.gov
NCT02146612 Amino Acid Usage Patterns in Daily Practice — Wounds Completed 2012-12-01 2014-03-01 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01418040 PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) — Prostate Cancer Completed 2012-11-28 2017-07-20 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01731405 Consumer Understanding and Use of Medication Guides — Revised Medication Guide Formats Completed 2012-11-01 2014-02-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01722214 Trial on the Effect of Adalimumab on Vascular Inflammation in Patients With Pso… Phase4 Psoriasis Completed 2012-11-01 2016-01-01 ClinicalTrials.gov
NCT01714635 Clinical Investigation of Expanded Designs of a Multifocal IOL Phase1 Cataract Completed 2012-11-01 2014-07-01 ClinicalTrials.gov
NCT01713660 Corneal Incisions With the IntraLase iFS Femtosecond Laser System Na Cataract Completed 2012-11-01 2013-01-01 ClinicalTrials.gov
NCT01690598 Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BR… Phase1 Ovarian Cancer Completed 2012-11-01 2015-02-01 ClinicalTrials.gov
NCT02169401 A Multi-centre Observational Study of the Axium Neurostimulator as a Treatment … — Chronic Pain Completed 2012-11-01 2017-01-25 ClinicalTrials.gov
NCT01749618 Closing the Gap in Care in Seronegative Inflammatory Arthritis Na SpA Completed 2012-11-01 2016-11-01 ClinicalTrials.gov
NCT01747668 Lactation Fortification Study Phase3 Lactation Completed 2012-11-01 2013-04-01 ClinicalTrials.gov
NCT01733368 QUARTO-II Study to Evaluate the Management of Patients Resynchronized With the … — Heart Failure Completed 2012-11-01 2016-08-01 ClinicalTrials.gov
NCT01730898 Lutein Absorption in Healthy Adults Phase3 Healthy Subjects Completed 2012-11-01 2013-03-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01609205 Doppler Evaluation in RA Patients After Adalimumab. Phase4 Rheumatoid Arthritis Completed 2012-10-01 2017-09-01 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01713348 Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes Phase4 Diabetes Mellitus Completed 2012-10-01 2013-07-01 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01720368 OPERA Database - Crohn's Protocol — Inflammatory Bowel Disease Completed 2012-10-01 2015-06-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT02981004 PAR I - Patient-to-Annulus Relation I — Aortic Valve Disease Completed 2012-10-01 2017-12-18 ClinicalTrials.gov
NCT01626404 Screening for Advanced Heart Failure Treatment (SEE-HF) — Advanced Heart Failure Completed 2012-10-01 2016-02-01 ClinicalTrials.gov
NCT01781624 Evaluation of an Oral Nutritional Supplement Na Gastro-intestinal Tolerance Completed 2012-10-01 2012-11-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01562951 Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn'… Phase3 Crohn's Disease Terminated 2012-10-01 2014-03-01 ClinicalTrials.gov
NCT01721096 XIENCE PRIME Japan Post-Marketing Surveillance (PMS) — Angina Completed 2012-10-01 2018-11-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT01673256 DEtermining Accuracy and TrEnding CharacTerization of AF — Atrial Fibrillation Completed 2012-09-01 2013-12-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT01464502 Pressure Wire Guided Cardiac Resynchronisation Therapy Phase2 Heart Failure Unknown 2012-09-01 2018-04-01 ClinicalTrials.gov
NCT02227758 Peripheral Nerve Stimulation Registry for Intractable Migraine Headache — Intractable Chronic Migraine Completed 2012-09-01 2015-12-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01705873 Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated… — HIV Unknown 2012-09-01 2013-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01711216 Treatment Regimen in Menstrual Cycle Regularization and Persistence in Routine … — Irregular Menstrual Cycle Completed 2012-08-01 2014-08-01 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide… Phase2 Fibrolamellar Carcinoma Completed 2012-07-12 2021-07-16 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01593917 Trifecta™ Long Term Follow-Up (LTFU) Study — Aortic Valve Insufficiency Completed 2012-07-02 2019-09-26 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01436747 Efficacy and Safety of Paricalcitol for Reduction of Proteinuria in Kidney Tran… Phase3 Disorder of Transplanted Kidney Completed 2012-07-01 2015-07-01 ClinicalTrials.gov
NCT01629160 Ventricular Wall Motion Characterization — Atrial Fibrillation Completed 2012-07-01 — ClinicalTrials.gov
NCT01629628 Adalimumab for the Management of Post-operative Crohn's Disease (CD) Phase3 Crohn Disease Unknown 2012-07-01 2016-07-01 ClinicalTrials.gov
NCT01678781 Open International Study on Quality of Life in Irritable Bowel Syndrome (IBS) P… — Irritable Bowel Syndrome Completed 2012-07-01 2013-08-01 ClinicalTrials.gov
NCT01776567 Apposition Assessed Using Optical Coherence Tomography of Chromium Stents Eluti… Phase4 Coronary Artery Disease Unknown 2012-07-01 2015-06-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01633749 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Prophylaxis of Influenza Completed 2012-07-01 2012-07-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT02630667 The Acute Effects Fortified Nutritional Supplementation on Childhood Cognition Na Cognitive Ability, General Completed 2012-06-01 — ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01564173 Dependence of LV Hemodynamics on Pacing Site — Heart Failure Completed 2012-06-01 2016-03-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01674712 A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fen… Phase3 Dyslipidemia Completed 2012-06-01 2013-10-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01669655 Plasma Profile of Exclusively Breastfed Infants — Breast Fed Infants Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01647360 Severity of Bleeding as a Predictor of Quality of Life (QoL) in Women With Heav… — Menorrhagia Completed 2012-06-01 2013-05-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01631227 Comparison of the Effect of Eprosartan and Eprosartan Mesylate on Blood Pressur… Phase3 Essential Hypertension Completed 2012-06-01 2013-04-01 ClinicalTrials.gov
NCT01747330 Evaluation of Safety and Tolerability of Creon Micro in Children Younger Than F… Phase3 Pancreatic Exocrine Insufficiency Completed 2012-06-01 2012-12-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01614405 Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis Na Primary Biliary Cirrhosis Terminated 2012-06-01 2015-08-01 ClinicalTrials.gov
NCT01608100 Evaluation of a New Cardiac Biomarker Assay Phase3 Acute Coronary Syndrome Completed 2012-06-01 2014-09-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01582139 Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Mo… Na Type 1 Diabetes Mellitus Completed 2012-05-01 2012-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01485666 Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Manageme… — Left Ventricular Assist Device Completed 2012-05-01 2013-08-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01667068 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 7.5 Years Fol… — Coronary Heart Disease Completed 2012-04-01 2014-10-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01525563 Duphaston in Cycle Regularization: A Post-marketing, Prospective, Multicenter, … — Irregular Menstrual Cycle Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT01583608 ABSORB: Postmarketing Surveillance Registry to Monitor the Everolimus-eluting B… — Cardiovascular Diseases Completed 2012-04-01 2016-06-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01564186 Characterization of Cardiac Hemodynamics During MultiSite Pacing — Heart Failure Completed 2012-04-01 2013-12-01 ClinicalTrials.gov
NCT02335502 A Post Market Study to Assess the Spinal Modulation Neurostimulator System for … — Chronic Pain Completed 2012-04-01 2015-07-01 ClinicalTrials.gov
NCT01556672 Adalimumab-psoriasis and Small Bowel Lesions Phase4 Plaque Psoriasis Completed 2012-04-01 2016-04-01 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01576016 Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker a… Na Adverse Effect of MRI on an Implanted Pacemaker Lead Completed 2012-03-30 2018-02-02 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01562613 A Blood Pressure Regulation and Stroke Risk Evaluation Study in Hypertensive Pa… — Hypertension Completed 2012-03-01 2013-03-01 ClinicalTrials.gov
NCT01656278 An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients Wit… Na Arthritis Completed 2012-03-01 2017-05-01 ClinicalTrials.gov
NCT01648777 Catheter Outcomes With Sternotomy Cardiac Operated Phase3 Pneumonia Completed 2012-03-01 2015-01-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01835808 Portuguese Study on The Evaluation of FFR Guided Treatment of Coronary Disease — Coronary Artery Disease Completed 2012-03-01 2014-11-01 ClinicalTrials.gov
NCT01522352 Comparison Between Three Types of Stented Pericardial Aortic Valves Na Aortic Valve Replacement Unknown 2012-03-01 2013-12-01 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01555619 Quadripolar Pacing Post Approval Study — Heart Failure Completed 2012-02-15 2019-02-28 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01468285 The CBF Study Evaluating the Effect of Betahistine on the Cerebral Blood Flow Phase4 Gait or Balance Disorder Problems Completed 2012-02-01 2013-04-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01602822 Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following … Phase4 HIV Terminated 2012-02-01 2012-05-01 ClinicalTrials.gov
NCT01550835 Impact of Aspiration Thrombectomy During Carotid Stenting Na Carotid Artery Stenosis Unknown 2012-02-01 — ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01528150 Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing … — Bradycardia Completed 2012-02-01 2015-03-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01573871 Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula Phase3 Infant Completed 2012-02-01 2012-09-01 ClinicalTrials.gov
NCT01842243 Effect of Septal Versus Apical Pacing- a Comparative Study Using Cardiac MRI Na Ventricular Dysfunction Completed 2012-02-01 2015-12-31 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01489761 LONG-DES VI (Drug Eluting Stent for Long Lesions in Coronary Artery) Phase4 Coronary Artery Disease Terminated 2012-01-01 2017-02-14 ClinicalTrials.gov
NCT01519466 Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Stu… Na Type 1 Diabetes Completed 2012-01-01 2012-10-01 ClinicalTrials.gov
NCT01519739 Clinical Evaluation of Mediguide System in Cardiac Resynchronization Therapy (C… Na Heart Failure Completed 2012-01-01 2012-11-01 ClinicalTrials.gov
NCT01535404 Right Versus Left Apical Transvenous Pacing for Patients With Preserved Left Ve… Na Bradyarrhythmia Terminated 2012-01-01 2016-05-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01500148 St. Jude Medical Percutaneous Mitral Valve Repair Study Phase1 Mitral Valve Prolapse Completed 2011-12-01 2012-08-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT01716884 China STEMI-PCI Program — ST Segment Elevation Myocardial Infarction Unknown 2011-12-01 2016-06-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT02377596 Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children… — Feeding Difficulties Withdrawn 2011-12-01 2014-08-01 ClinicalTrials.gov
NCT01599065 Comparison of a MAGNET Protocol Versus "off-on" Protocol for Patients With Impl… — Sudden Cardiac Death Completed 2011-12-01 2013-10-01 ClinicalTrials.gov
NCT01663168 EARNEST Rifabutin Pharmacokinetics (PK) Substudy Phase2 HIV Unknown 2011-12-01 2014-01-01 ClinicalTrials.gov
NCT01588691 Traumatic Brain Injury Peripheral Nerve Study Phase1 Traumatic Brain Injury Completed 2011-12-01 2014-11-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01468974 ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbabl… Na Atherosclerosis Completed 2011-11-01 2015-12-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01472783 Veliparib Monotherapy for Relapsed Ovarian Cancer With BRCA Mutation Phase1 Recurrent, Epithelial Ovarian Cancer Completed 2011-11-01 2016-08-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01425281 ABSORB II Randomized Controlled Trial Na Coronary Artery Disease Completed 2011-11-01 2018-05-23 ClinicalTrials.gov
NCT01341340 The ABSORB BTK (Below The Knee) Clinical Investigation Na Atherosclerosis Terminated 2011-11-01 2012-11-01 ClinicalTrials.gov
NCT01408485 Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter Na Typical Atrial Flutter Completed 2011-11-01 2012-10-01 ClinicalTrials.gov
NCT01510652 More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions t… Na Postoperative Cardiac Complication Completed 2011-11-01 2014-05-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01464320 A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Ki… Phase1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine Completed 2011-11-01 2012-04-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01484613 Selected Site Pacing to Avoid Phrenic Nerve Stimulation in Cardiac Resynchroniz… — Heart Failure Completed 2011-11-01 2014-06-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01301625 MitraClip System in Australia and New Zealand — Mitral Regurgitation Terminated 2011-11-01 2014-09-01 ClinicalTrials.gov
NCT01482845 A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in … Phase1 Alzheimer's Disease Completed 2011-11-01 2012-03-01 ClinicalTrials.gov
NCT01477528 Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the He… — Anticoagulation Completed 2011-11-01 2015-08-01 ClinicalTrials.gov
NCT01476020 Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogr… — Restenosis Unknown 2011-11-01 2015-07-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01658267 Compliance With Dietary Recommendations in Children at Risk for Undernutrition Phase3 Children Completed 2011-10-01 2012-10-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT00969865 Individualized Comprehensive Atherosclerosis Risk-reduction Evaluation Program — Atherosclerosis Completed 2011-10-01 2016-12-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01448135 Tolerance and Efficacy of a Predigested, High Protein, High Omega 3 Fat Enteral… Na Critical Illness Completed 2011-10-01 2014-11-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01462877 A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients Wit… Phase4 Dyslipidemias Completed 2011-10-01 2014-03-01 ClinicalTrials.gov
NCT01464385 Nutrition Beverage Tolerance Study Phase2 Human Volunteers Completed 2011-10-01 2011-12-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01476956 Assess Structural Damage in Rheumatoid Arthritis Using Biomarkers and Radiograp… — Rheumatoid Arthritis Completed 2011-10-01 2019-12-31 ClinicalTrials.gov
NCT01444378 Absolute Pro® MOMENTUM™ Na Peripheral Artery Disease Completed 2011-10-01 2015-05-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01483976 Comparison of Medical Nutritional Supplements Phase3 Elderly Completed 2011-10-01 2012-05-01 ClinicalTrials.gov
NCT01495351 Study of ABT-888 in Combination With Bortezomib and Dexamethasone in Patients W… Phase1 Multiple Myeloma Completed 2011-10-01 2015-02-10 ClinicalTrials.gov
NCT01438229 Safety and Efficacy Study of Renal Artery Ablation in Resistant Hypertension Pa… Na Hypertension Completed 2011-10-01 2014-07-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01401361 Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along Wi… Phase3 Typical Atrial Flutter Completed 2011-10-01 2012-09-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01764334 Fractional Flow Reserve Versus Angiographically Guided Management to Optimise O… Phase4 NonST Elevation Myocardial Infarction Unknown 2011-10-01 2020-06-01 ClinicalTrials.gov
NCT01477723 Evaluation of an Oral Nutritional Supplement in Older Hospitalized Patients Phase3 Pneumonia Terminated 2011-10-01 2012-11-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01506934 A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Foo… Phase1 Advanced or Metastatic Solid Tumors Terminated 2011-10-01 2012-01-01 ClinicalTrials.gov
NCT01536236 Spinal Cord Stimulation for Diabetic Polyneuropathy Na Diabetic Polyneuropathy Withdrawn 2011-10-01 2014-10-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01435031 EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Elut… Na Coronary Artery Disease (CAD) Completed 2011-09-01 2017-12-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01432275 Ease of Use of New Blood Glucose Meter With In-built Insulin Calculator at Home… Na Diabetes Mellitus Completed 2011-09-01 2012-04-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01573884 Ex Vivo Exploratory Analysis in Healthy Full-term Infants — Healthy Infant and Mother Pairs Completed 2011-09-01 2012-02-01 ClinicalTrials.gov
NCT01393808 Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2011-09-01 2015-07-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01286974 A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in… Phase1 Advanced Solid Tumors Terminated 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01482507 Examination of the Effectiveness of Diffusion Weighted Magnetic Resonance Imagi… — Rheumatoid Arthritis Completed 2011-08-01 2014-12-01 ClinicalTrials.gov
NCT01527344 Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography — Cardiac Allograft Vasculopathy Completed 2011-08-01 2013-08-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01421680 The Effects of Preoperative and Postoperative Oral Nutritional Supplements in M… Na Malnourished Completed 2011-08-01 2013-12-01 ClinicalTrials.gov
NCT01406236 SAFE-PCI for Women Na Percutaneous Coronary Intervention Terminated 2011-08-01 2013-09-01 ClinicalTrials.gov
NCT01373073 Evaluation of a Novel Human Milk Fortifier in Preterm Infants Phase3 Preterm Infants Completed 2011-08-01 2012-12-01 ClinicalTrials.gov
NCT01299207 PITT PCI Xience Registry — Coronary Artery Disease Completed 2011-08-01 2015-12-01 ClinicalTrials.gov
NCT01487330 First in Human Experience of the St. Jude Medical TAVI Valve and Delivery System Na Symptomatic Aortic Stenosis Completed 2011-08-01 2012-09-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01377103 Testosterone Therapy in Heart Failure Na Heart Failure Withdrawn 2011-07-01 2012-12-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01276093 Pulmonary Vein Ablation Versus Amiodarone in the Elderly Na Atrial Fibrillation Terminated 2011-07-01 2016-03-01 ClinicalTrials.gov
NCT01288352 Early Treatment of Atrial Fibrillation for Stroke Prevention Trial Phase4 Atrial Fibrillation Completed 2011-07-01 2020-05-31 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01385826 Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthri… Phase2 Uveitis Completed 2011-06-29 2015-08-27 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01366144 Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors T… Phase1 Breast Carcinoma Active_Not_Recruiting 2011-06-20 2027-03-03 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01801319 A Clinical Evaluation of Subcallosal Cingulate Gyrus Deep Brain Stimulation for… Na Treatment Resistant Depression Unknown 2011-06-01 2017-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT04154852 ADalimumab in Persistent Early Oligoarthrits Study (ADEOS) Phase2 Oligoarthritis Completed 2011-06-01 2017-01-16 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01393041 St. Jude Medical Angio-Seal VIP Vascular Closure Device Na Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01390610 Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matri… — Diabetes Mellitus, Type 2 Completed 2011-06-01 2013-01-01 ClinicalTrials.gov
NCT01387009 Acquisition of Normative Data for Musculoskeletal Ultrasound in Children — Normative Data Study of Joints of Healthy Children Completed 2011-06-01 2018-12-01 ClinicalTrials.gov
NCT01380886 Growth and Tolerance of Young Infants Fed Infant Formulas Phase3 Infant Newborn Completed 2011-06-01 2011-12-01 ClinicalTrials.gov
NCT01366404 Study of the Natural History of FFR Guided Percutaneous Coronary Intervention — Coronary Artery Disease Recruiting 2011-06-01 2037-04-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01401933 Effect of Rifampin on the Pharmacokinetics of Linifanib in Subjects With Advanc… Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-10-01 ClinicalTrials.gov
NCT01405326 REstore Working Ability in RheumatoiD Arthritis Phase4 Rheumatoid Arthritis Unknown 2011-05-01 2013-03-01 ClinicalTrials.gov
NCT01381341 To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. Phase1 Advanced Solid Tumors Completed 2011-05-01 2011-12-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01545310 A Positron Emission Tomography Study of SLV354 in Healthy Subjects and Subjects… Phase1 Schizophrenia Completed 2011-05-01 2012-07-01 ClinicalTrials.gov
NCT01354938 Outcome Study to Evaluate Klaricid XL® (Clarithromycin Modified Release) in Pat… — Bronchitis Completed 2011-05-01 2012-01-01 ClinicalTrials.gov
NCT01352819 Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Dis… — Parkinson's Disease Completed 2011-05-01 2013-12-01 ClinicalTrials.gov
NCT01348854 Safety and Effectiveness of Arcuate Incisions Performed With the iFS Femtosecon… Phase2 Corneal Astigmatism Completed 2011-05-01 2013-04-01 ClinicalTrials.gov
NCT01331330 European Deep Brain Stimulation (DBS) Depression Study Na Depressive Disorder, Major Completed 2011-05-01 2015-01-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01192035 PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial Phase4 HIV-1 Completed 2011-05-01 2014-09-01 ClinicalTrials.gov
NCT01605721 Efficacy and Safety of Xience in Coronary arEry Disease aLL-comers After stENTi… Phase4 Coronary Artery Disease Unknown 2011-05-01 2015-04-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01338740 Switching From Adalimumab to Infliximab — Crohn's Disease Completed 2011-04-01 2014-02-17 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01348399 Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME) — Coronary Artery Disease Completed 2011-04-01 2017-09-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01362725 Spinal Cord Stimulation For Heart Failure Phase2 Systolic Heart Failure Completed 2011-04-01 2016-01-01 ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01260844 Open Label, Single Dose, Non-randomized Study to Assess the Drug to Drug Intera… Phase1 Moderate to Severe Plaque Psoriasis Withdrawn 2011-04-01 — ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01346319 Study of the Safety, Tolerability and Pharmacokinetics of Testosterone Undecano… Phase1 Hypogonadal Males Completed 2011-04-01 2011-09-01 ClinicalTrials.gov
NCT01282086 Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevoran… — Anesthesia, General Completed 2011-04-01 2011-12-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01294228 Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in th… — Acute Kidney Injury Completed 2011-03-01 2014-12-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01295814 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Phase3 Interstitial Cystitis Completed 2011-03-01 2013-07-01 ClinicalTrials.gov
NCT01617889 Healthy Term Infants Fed Milk-Based Formulas Phase3 Healthy Term Infant Completed 2011-03-01 2012-08-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01214408 Effect of Digene Total (Buffered Pantoprazole) on 24 Hour Gastric Potential Hyd… Phase4 Acid Peptic Disorder Completed 2011-03-01 2011-07-01 ClinicalTrials.gov
NCT01604902 miRNAs and mRNAs in Psoriasis — Psoriasis Unknown 2011-03-01 2016-01-01 ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01337999 Human Epididymis Protein 4 in Normal Menstruating Women — Healthy Premenopausal Women Unknown 2011-03-01 — ClinicalTrials.gov
NCT01294839 Right Ventricular Outflow Tract Study Na Sinus-node Dysfunction Completed 2011-03-01 2016-06-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT01258218 Accent MRI Pacemaker and Tendril MRI Lead New Technology Assessment — Bradycardia Completed 2011-02-01 2011-11-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT02052765 AnalyST & Brugada Syndrome - Feasibility Study Na Brugada Syndrome Completed 2011-02-01 2011-05-01 ClinicalTrials.gov
NCT01294917 Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to… Na Normal Contact Lens Wearers Completed 2011-02-01 2011-08-01 ClinicalTrials.gov
NCT01191125 Evaluation of an Oral Nutritional Supplement Containing AN777 Phase3 Malnutrition Completed 2011-02-01 2012-09-01 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT02242578 Treating Refractory Schizophrenia With rTMS Na Schizophrenia Terminated 2011-01-24 2018-06-11 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01489865 ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer Phase1 Metastatic Pancreatic Cancer Completed 2011-01-03 2023-12-07 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01295840 Quartet Lead and Resynchronization Therapy Options Phase4 Heart Failure Completed 2011-01-01 2012-09-01 ClinicalTrials.gov
NCT01075204 Clarithromycin Modified Release Observational Study for Evaluation of Treatment… — Respiratory Tract Infection Completed 2011-01-01 2012-01-01 ClinicalTrials.gov
NCT01191112 Evaluation of the Safe Use and Tolerance of a Peptide-based Formula in a Pediat… Phase3 Gastrointestinal Diseases Completed 2011-01-01 2011-11-01 ClinicalTrials.gov
NCT01283126 Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglyce… Na Hypoglycemia Completed 2011-01-01 2015-10-01 ClinicalTrials.gov
NCT01275508 Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser… Phase1 Crohn's Disease Completed 2011-01-01 2012-04-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01292317 Neutrophil Gelatinase-associated Lipocalin (NGAL) and Contrast Media Induced Ne… Na Contrast Media Induced Nephropathy (CIN) Completed 2011-01-01 2015-12-01 ClinicalTrials.gov
NCT01256710 Trifecta™ Durability Study — Aortic Valve Disease Terminated 2011-01-01 2021-03-12 ClinicalTrials.gov
NCT01278953 TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation Na Paroxysmal Atrial Fibrillation Completed 2011-01-01 2015-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01234727 Comparison Study of Blood Glucose Monitoring Systems in People With Diabetes — Diabetes Mellitus Completed 2010-12-01 2011-03-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01237444 Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve H… Phase3 HIV Infection Completed 2010-12-01 2012-05-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01291836 Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Sy… — Acute Decompensated Heart Failure Completed 2010-12-01 2015-06-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT01271816 Prolonged Monitoring to Detect Ventricular Arrhythmias in Presymptomatic Arrhyt… — Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Terminated 2010-12-01 2013-10-01 ClinicalTrials.gov
NCT01275118 Comparison of Postoperative Visual Acuity and Spectacle Independence Between th… Phase4 Cataract Completed 2010-12-01 2011-09-01 ClinicalTrials.gov
NCT02131337 TactiCath® Prospective Effectiveness Pilot Study Na Paroxysmal Atrial Fibrillation Completed 2010-12-01 2011-10-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01203748 Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Sta… Na Atrial Fibrillation Completed 2010-11-01 2014-01-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01580124 CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation V… Na Atrial Fibrillation Completed 2010-11-01 2015-02-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01191476 Compare Pharmaceutical Economics and Efficacy of Sevoflurane With Low Fresh Gas… Phase4 Elective Laparoscopic Surgery Completed 2010-11-01 2011-05-01 ClinicalTrials.gov
NCT01214824 Use of the FreeStyle Navigator Continuous Glucose Monitoring System to Enhance … Na Diabetes Mellitus Completed 2010-11-01 2012-06-01 ClinicalTrials.gov
NCT01249027 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval,… — Angioplasty Completed 2010-11-01 2017-01-01 ClinicalTrials.gov
NCT01219894 Intravascular Optical Coherence Tomography Imaging - Length of Anti-Platelet Th… — Coronary Artery Disease Withdrawn 2010-11-01 2010-12-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01174186 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab… Phase4 Spondyloarthritis Completed 2010-10-01 2014-03-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT01205789 EXCEL Clinical Trial (Universal Registry) — Chronic Coronary Occlusion Completed 2010-10-01 2012-09-01 ClinicalTrials.gov
NCT00935480 IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5… Phase3 HIV Infections Completed 2010-10-01 2014-08-08 ClinicalTrials.gov
NCT01222104 Angio-Seal Interventional Radiology (IR) Registry — Diagnostic and/or Interventional Radiology Procedures Completed 2010-10-01 2011-05-01 ClinicalTrials.gov
NCT01172990 Direct Angioplasty for Non ST Elevation Acute Coronary Events: DANCE Pilot Study Na Acute Coronary Syndrome Terminated 2010-10-01 2014-02-01 ClinicalTrials.gov
NCT01641770 Oral Nutritional Supplementation in Hospital Patients Phase3 Malnutrition Completed 2010-10-01 2011-10-01 ClinicalTrials.gov
NCT01197144 Pain Modulation in Rheumatoid Arthritis (RA) - Influence of Adalimumab Na Arthritis, Rheumatoid Completed 2010-10-01 2016-11-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01205776 EXCEL Clinical Trial Na Chronic Coronary Occlusion Completed 2010-09-29 2019-06-28 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01179477 QuickFlex Micro Left Ventricular Lead Post Approval Study — Heart Failure Completed 2010-09-01 2017-09-01 ClinicalTrials.gov
NCT01199471 Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesi… — Anesthesia, General Completed 2010-09-01 2010-11-01 ClinicalTrials.gov
NCT01190969 A Trial of Oral Nutritional Supplements on Nutritional Status and Clinical Outc… Na Malnutrition Withdrawn 2010-09-01 2012-11-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01204528 Vitamin-D Receptor Activation (VDRA) in Chronic Kidney Disease Phase2 Chronic Kidney Disease Completed 2010-09-01 2013-07-01 ClinicalTrials.gov
NCT01181570 Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sl… Phase4 Psoriasis Completed 2010-09-01 2011-09-01 ClinicalTrials.gov
NCT01205854 Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial Phase4 Rheumatoid Arthritis Completed 2010-09-01 2015-04-01 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01240122 Short-Term Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mult… Na Corneal Staining Completed 2010-08-31 2010-11-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01186198 A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter … — Ischemic Heart Disease Completed 2010-08-12 2010-12-30 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01278030 Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selecti… Na Heart Failure Completed 2010-08-01 — ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01181427 Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotyp… Phase1 HCV Infection Completed 2010-08-01 2012-01-01 ClinicalTrials.gov
NCT01178268 XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval … Phase4 Coronary Occlusion Completed 2010-08-01 2014-09-01 ClinicalTrials.gov
NCT01163162 The Effect of Paricalcitol on Creatinine Filtration, Secretion and Glomerular F… Phase4 Chronic Kidney Disease Completed 2010-08-01 2011-06-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01205828 ABT-888 and Temozolomide for Liver Cancer Phase2 Hepatocellular Carcinoma Terminated 2010-08-01 2014-10-01 ClinicalTrials.gov
NCT01124851 Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in S… Phase1 Sleep Disorder Completed 2010-08-01 2011-04-01 ClinicalTrials.gov
NCT01097330 Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Pati… Phase3 Defibrillators, Implantable Terminated 2010-08-01 2012-03-01 ClinicalTrials.gov
NCT01326299 Post Prandial Glucose Control Proof-of-Principle Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01324921 Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 … Phase2 Diabetes Mellitus, Type 2 Completed 2010-08-01 2010-09-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01138475 Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secon… Phase3 Gastric Bypass Completed 2010-07-01 2015-08-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01074749 Optimal Sensing in Atrial Tachyarrhythmia's Study Na Sick Sinus Syndrome Terminated 2010-07-01 2014-07-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01176201 14-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in Man Phase1 Healthy Subjects Completed 2010-07-01 2010-10-01 ClinicalTrials.gov
NCT01193140 To Evaluate the Safety of Veliparib in Combination With Temozolomide in Subject… Phase2 Solid Tumor Cancers Completed 2010-07-01 2011-11-01 ClinicalTrials.gov
NCT01266239 Comparison Between Everolimus-eluting Stent (EES) and Sirolimus-eluting Stent (… Na Ischemic Heart Disease Unknown 2010-07-01 2015-07-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01210820 Feasibility of iFS™ for Intrastromal Arcuate Keratotomy (ISAK) Procedures Na Refractive Astigmatism Completed 2010-07-01 2012-06-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01298609 Occipital Nerve (C2) Stimulation in the Treatment of Fibromyalgia Na Fibromyalgia Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01146015 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2010-06-01 2010-07-01 ClinicalTrials.gov
NCT01226095 Evaluation of the Effectiveness, Compliance of Ibuprofen in a Sustained Release… — Osteoarthritis Completed 2010-06-01 2010-11-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01105741 Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in C… — Crohn's Disease Completed 2010-06-01 2013-12-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01176045 TearLab Refractive Surgery Dry Eye Study — Dry Eye Syndromes Completed 2010-06-01 2011-12-01 ClinicalTrials.gov
NCT01160328 Influence of Male Hormones on Regional Fat Metabolism Phase1 Obesity Completed 2010-06-01 2013-01-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01137877 Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase3 Healthy Term Infants Terminated 2010-05-01 2010-10-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01126619 A Study of Effectiveness and Safety of Tumor Necrosis Factor (TNF) Inhibitors i… — Psoriasis Completed 2010-05-01 2011-09-01 ClinicalTrials.gov
NCT01114191 A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Linifan… Phase1 Solid Tumors Completed 2010-05-01 2011-02-01 ClinicalTrials.gov
NCT01172067 QuickOpt Chronic Study Na Heart Failure Completed 2010-05-01 2016-01-01 ClinicalTrials.gov
NCT01093001 Tricuspid Regurgitation Study Phase4 Tricuspid Regurgitation Completed 2010-05-01 2016-05-01 ClinicalTrials.gov
NCT01132495 FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Interventi… Na Coronary Artery Disease Completed 2010-05-01 2015-05-01 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01118299 AMPLATZER Cardiac Plug Clinical Trial Na Atrial Fibrillation Completed 2010-04-26 2018-12-06 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01070069 Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial Na Abdominal Aortic Aneurysm Completed 2010-04-13 2012-09-05 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01115933 A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coron… Na Vascular Disease Completed 2010-04-01 2013-12-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01121107 Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy Na Heart Failure Completed 2010-04-01 2015-04-01 ClinicalTrials.gov
NCT01090076 The Use of Specialised Amino Acid Mixture in Pressure Ulcer Wound Healing Rates… Na Pressure Ulcer Completed 2010-04-01 2011-09-01 ClinicalTrials.gov
NCT01127139 Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment … — Essential Hypertension Completed 2010-04-01 2011-03-01 ClinicalTrials.gov
NCT01068873 Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR St… Phase4 HIV Infections Terminated 2010-04-01 2010-12-01 ClinicalTrials.gov
NCT01331317 Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type … Phase4 Cardiovascular Disease Completed 2010-04-01 2012-04-01 ClinicalTrials.gov
NCT01464853 Effect of Enteral Nutrition Support for Critically Ill Patients Phase3 Respiratory Distress Syndrome,Adult Terminated 2010-04-01 2011-05-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01134913 Multi-Markers In the Diagnosis of Acute Coronary Syndrome — Acute Coronary Syndrome Completed 2010-03-01 2011-12-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00918450 Study Assessing the Safety and Efficacy of ABT-263 in Subjects With B-cell Chro… Phase2 B-cell Chronic Lymphocytic Leukemia Withdrawn 2010-03-01 — ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01086228 XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Pro… — Angina Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT01155414 Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase3 Healthy Term Infants Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01108185 Evaluation of the Treatment With Klacid®SR in Patients With Lower Respiratory T… — Tracheitis Completed 2010-03-01 2010-07-01 ClinicalTrials.gov
NCT01300000 Effects of Early Nutrition on Growth Na Infant Newborn Completed 2010-03-01 2016-08-01 ClinicalTrials.gov
NCT00941564 Comparative Ca Absorption and Tolerance in Healthy Term Infants Fed Milk-based … Phase4 Infant Completed 2010-03-01 2010-05-01 ClinicalTrials.gov
NCT01081483 A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults Phase1 Hepatitis C Completed 2010-03-01 — ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01069172 Study of the Femtosecond Laser System as Compared to Continuous Curvilinear Cap… Phase3 Cataract Completed 2010-02-01 2010-08-01 ClinicalTrials.gov
NCT01072565 Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose M… Na Type 2 Diabetes Completed 2010-02-01 2012-01-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01091649 Study in Healthy Adults to Evaluate the Bioavailability of Two Test Tablet Form… Phase1 Healthy Completed 2010-02-01 2010-04-01 ClinicalTrials.gov
NCT01130883 Evaluation of Effectiveness of the Treatment After Repeated Administration of K… — Tracheitis Completed 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01133574 This is a Single Ascending Dose Tolerance Study Phase1 Cognition Disorders Terminated 2010-02-01 2010-07-01 ClinicalTrials.gov
NCT01144598 Time to DMARD (Disease-Modifying Anti-Rheumatic Drug) Treatment and Actual Work… — Rheumatoid Arthritis Completed 2010-02-01 2011-08-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT00907231 Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in … — Acute Myocardial Infarction Withdrawn 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01200160 Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Ab… — Cardiovascular Diseases Completed 2010-02-01 2012-05-01 ClinicalTrials.gov
NCT01464866 Effect of Nutritional Supplementation on Pediatric Burn Patients Phase3 Burns Completed 2010-02-01 2011-09-01 ClinicalTrials.gov
NCT00996086 Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT) — Heart Failure Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01044472 Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead — Multi-site Left Ventricular Pacing Completed 2010-02-01 2010-05-01 ClinicalTrials.gov
NCT01044784 Acute Evaluation of the Safety of Left Ventricular-left Ventricular (LV-LV) Del… — Cardiac Resynchronization Therapy Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01056328 Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) Na Paroxysmal Atrial Fibrillation Completed 2010-02-01 2013-01-01 ClinicalTrials.gov
NCT01062126 BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes — Pacemaker Completed 2010-02-01 2012-09-01 ClinicalTrials.gov
NCT01067716 Performance and Acceptability of VSS-R Na Refractive Error Completed 2010-02-01 2012-03-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT00985478 First in Man Study With SLV342 Phase1 Pharmacokinetics Terminated 2010-01-01 2010-06-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT00999206 Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived … Phase3 Influenza Completed 2010-01-01 2010-08-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylos… Phase3 Ankylosing Spondylitis Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT00936195 Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in … Phase3 HIV Infection Withdrawn 2010-01-01 2013-06-01 ClinicalTrials.gov
NCT01009593 Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellula… Phase3 Hepatocellular Carcinoma Non-resectable Terminated 2010-01-01 2012-07-01 ClinicalTrials.gov
NCT01012414 Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascu… Phase3 Coronary Artery Disease Terminated 2010-01-01 2011-05-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01021358 A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navi… Phase1 Lymphoma Completed 2010-01-01 — ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01390259 Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Cont… Na Type 1 Diabetes Mellitus Completed 2010-01-01 2011-02-01 ClinicalTrials.gov
NCT01239953 RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon… Phase4 In-Stent Restenosis Unknown 2010-01-01 — ClinicalTrials.gov
NCT01023789 ABSORB EXTEND Clinical Investigation Na Myocardial Ischemia Completed 2010-01-01 2016-10-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01030809 Trial of a Treatment Algorithm for the Management of Crohn's Disease Phase4 Crohn's Disease Completed 2010-01-01 2013-12-01 ClinicalTrials.gov
NCT01828970 Pilot Study of Glycemic Control in Diabetic Hemodialyzed Patients Phase4 Diabetes Mellitus Completed 2010-01-01 2012-09-01 ClinicalTrials.gov
NCT01045369 A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects Phase4 HIV Infections Completed 2010-01-01 2011-06-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01196273 Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follo… — Coronary Heart Disease Completed 2009-12-01 2011-12-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT01126567 Exploratory Biomarker Study of Cerebrospinal Fluid in Healthy Volunteers — Healthy Completed 2009-12-01 2010-02-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01050127 A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multi… Phase1 Healthy Completed 2009-12-01 — ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT02018133 Identification of Markers for Determining the Efficacy of Vitamin D Receptor Ac… — CKD Stage 3/4 Completed 2009-12-01 2012-06-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01058980 ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimi… Phase4 Paroxysmal Atrial Fibrillation Completed 2009-12-01 2013-12-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT00924534 A Safety PK/PD Study of SLV337 in Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Completed 2009-12-01 2010-12-01 ClinicalTrials.gov
NCT01132274 Radiation Exposure Reduction in Supraventricular Tachycardia Ablation Phase4 Supraventricular Tachycardias Completed 2009-12-01 2013-03-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01075516 Health Economic Evaluation of Remote Follow up for Implantable Cardioverter Def… — Complication of Cardiac Defibrillator Completed 2009-12-01 2013-04-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01188200 Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes Phase3 Diabetes Mellitus, Type 2 Completed 2009-12-01 2010-06-01 ClinicalTrials.gov
NCT01019564 Complete Easy Rub Comparative Efficacy Study Na Myopia Withdrawn 2009-12-01 2010-03-01 ClinicalTrials.gov
NCT00981318 Pilot Assessment of Lopinavir/Ritonavir and Maraviroc Phase4 HIV Infections Terminated 2009-12-01 2015-05-01 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00911508 Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Na Atrial Fibrillation Completed 2009-11-13 2017-12-31 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01013675 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly Phase2 Influenza Vaccines Completed 2009-11-01 2011-04-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT00945581 Evaluation of AN777 on Elderly Subjects During Bed Rest and Recovery Phase1 Aged Completed 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT00946595 Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintena… Phase2 HIV Infections Completed 2009-11-01 2014-01-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT01210807 Clinical Evaluation of the One-Piece Tecnis Multifocal Intraocular Lens (IOL) Phase4 Cataract Completed 2009-11-01 2011-08-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT00977080 Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose… Phase4 Chronic Kidney Disease Completed 2009-11-01 2011-05-01 ClinicalTrials.gov
NCT01074580 Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease — Crohn's Disease Terminated 2009-11-01 2013-12-01 ClinicalTrials.gov
NCT01071070 Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyro… Phase3 Chronic Kidney Disease Completed 2009-11-01 2010-11-01 ClinicalTrials.gov
NCT00799617 The Testosterone Trials in Older Men Phase3 Andropause Completed 2009-11-01 2018-12-01 ClinicalTrials.gov
NCT01043458 Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia Phase1 Schizophrenia Completed 2009-11-01 — ClinicalTrials.gov
NCT01025492 Study of Trilipix Effects on Lipids and Arteries Phase4 Dyslipidemia Terminated 2009-11-01 2011-03-01 ClinicalTrials.gov
NCT01006629 Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in R… Phase2 Respiratory Syncytial Virus Infection Completed 2009-11-01 2010-07-01 ClinicalTrials.gov
NCT01009788 ABT-888 and Temozolomide for Metastatic Breast Cancer and BRCA1/2 Breast Cancer Phase2 Breast Cancer Completed 2009-11-01 2015-09-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT00933153 Effectiveness of Oral Nutritional Supplements (ONS) in a Meals-on-Wheels Popula… Na Elderly Completed 2009-10-01 2011-10-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT00977938 The Dual Antiplatelet Therapy Study (DAPT Study) Phase4 Coronary Artery Disease Completed 2009-10-01 2014-06-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT00984204 Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the … Phase3 Typical Atrial Flutter Completed 2009-10-01 2012-01-01 ClinicalTrials.gov
NCT00987610 Guidewire for Chronic Total Occlusion Phase4 Coronary Occlusion Completed 2009-10-01 2014-12-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT00990704 Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With S… Phase2 Secondary Hyperparathyroidism Completed 2009-10-01 2010-05-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01003275 Metabolic Effects of Paricalcitol Phase2 Chronic Kidney Disease Completed 2009-10-01 2011-11-01 ClinicalTrials.gov
NCT01009216 A Study of ABT-384 Levels and Pharmacodynamic Activity Measured in Cerebrospina… Phase1 Healthy Completed 2009-10-01 2010-11-01 ClinicalTrials.gov
NCT01418703 Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Melli… Na Type 1 Diabetes Mellitus Completed 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01048970 Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA)… Phase2 Lung Cancer Unknown 2009-10-01 2010-12-01 ClinicalTrials.gov
NCT01053520 Assess the Oral Bioavailability of a New ABT-263 Formulation in Healthy Female … Phase1 Healthy Female Subjects Completed 2009-10-01 2010-01-01 ClinicalTrials.gov
NCT01014741 Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation Na Persistent Atrial Fibrillation Completed 2009-10-01 2015-01-01 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00972621 Clinical Evaluation of a New Viscoelastic for Cataract Surgery Na Cataract Completed 2009-09-30 2010-11-30 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT00872664 Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented Wit… Na Retinopathy of Prematurity Completed 2009-09-01 2013-06-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT00903838 A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy t… Phase2 Advanced Stage Parkinson's Disease Terminated 2009-09-01 2011-05-01 ClinicalTrials.gov
NCT01792206 Effect Of Paricalcitol (Zemplar) On Endothelial Function And Inflammation In Ty… Na Type 2 Diabetes Unknown 2009-09-01 2013-02-01 ClinicalTrials.gov
NCT01058837 SCD-HeFT 10 Year Follow-up — Left Ventricular Systolic Dysfunction Unknown 2009-09-01 2011-08-01 ClinicalTrials.gov
NCT01051596 A Study of ABT-888 in Combination With Temozolomide for Colorectal Cancer Phase2 Colorectal Cancer Completed 2009-09-01 2013-12-01 ClinicalTrials.gov
NCT00982826 Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Fo… Phase1 Hepatitis C Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00977964 Tolerance of Healthy Term Infants Fed Infant Formulas #3 Phase3 Gastrointestinal Tolerance Completed 2009-09-01 2010-01-01 ClinicalTrials.gov
NCT00951795 Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts — HIV Infection Withdrawn 2009-09-01 2009-09-01 ClinicalTrials.gov
NCT00931463 A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Followi… Phase4 HIV Infections Completed 2009-09-01 2013-08-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT00933764 Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) — Cardiovascular Disease Withdrawn 2009-08-01 2009-11-01 ClinicalTrials.gov
NCT01348022 Evaluation of Outcomes of EES Implantation for Unprotected Left Main Coronary A… — Coronary Artery Disease Completed 2009-08-01 2015-09-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT01786486 AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol — Atrial Fibrillation Completed 2009-08-01 2014-01-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT01106534 XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Phase4 Chronic Total Occlusion of Coronary Artery Completed 2009-08-01 2015-07-01 ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT01217528 Reduction of Inappropriate Implantable Cardioverter Defibrillator (ICD) Therapi… Na Cardiac Death Completed 2009-08-01 2013-01-01 ClinicalTrials.gov
NCT01000675 Registry for Study of Coils in Intracranial Aneurysms — Cerebral Aneurysms Completed 2009-08-01 2016-12-01 ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT01037270 Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) … — Pulmonary Embolism Completed 2009-08-01 2010-06-01 ClinicalTrials.gov
NCT00968422 A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00941746 Safety and Tolerability of PG110 in Patients With Knee Osteoarthritis Pain Phase1 Osteoarthritis, Knee Completed 2009-08-01 2011-01-01 ClinicalTrials.gov
NCT00964938 Multisite Pacing With a Quadripolar Lead Phase4 Heart Failure Completed 2009-08-01 — ClinicalTrials.gov
NCT00959816 A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, M… Phase1 Healthy Completed 2009-08-01 — ClinicalTrials.gov
NCT00959634 Pharmacokinetic Study of ABT-126 in Healthy Volunteers Phase1 Healthy Volunteers Completed 2009-08-01 — ClinicalTrials.gov
NCT01095978 Evaluation of the Treatment With Klacid SR in Patients With Acute Tracheitis, T… — Respiratory Tract Infections Completed 2009-08-01 2010-05-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00946231 Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Heart Failure Completed 2009-07-01 2011-10-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00972218 Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease Phase4 Spondyloarthritis Withdrawn 2009-07-01 2010-01-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00974831 Glucose Tolerance in Healthy Overweight Adults Phase2 Overweight Completed 2009-07-01 2009-10-01 ClinicalTrials.gov
NCT00940862 Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Seve… Phase4 Psoriasis Completed 2009-07-01 2011-08-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00937573 Xience V at Wake Forest University Baptist Medical Center (WFUBMC) — Percutaneous Coronary Intervention Completed 2009-07-01 2013-08-01 ClinicalTrials.gov
NCT00949000 AnalyST Treadmill Study Na Ischemic Heart Disease Completed 2009-07-01 2011-02-01 ClinicalTrials.gov
NCT00947440 Evaluation of the Bioavailability of Two ABT-072 Tablet Formulations as Compare… Phase1 Hepatitis C Completed 2009-07-01 — ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00888108 Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Com… Phase1 Solid Tumor Completed 2009-07-01 2012-03-01 ClinicalTrials.gov
NCT00979979 Clinical Performance of Abbott RealTime Hepatitis C Virus (HCV) Genotype II Test — Hepatitis C Completed 2009-07-01 2013-10-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00735722 A(f)MAZE-CABG Study Na Coronary Arteriosclerosis Terminated 2009-07-01 2012-08-01 ClinicalTrials.gov
NCT00958451 Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients Phase4 Secondary Hyperparathyroidism Completed 2009-07-01 2011-01-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT02485093 To Pace or Not to Pace in Sinus Node Disease Na Sinus Node Disease Completed 2009-06-01 2014-10-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT00881842 Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Vi… Phase3 Influenza Completed 2009-06-01 2009-07-01 ClinicalTrials.gov
NCT01171950 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Withdrawn 2009-06-01 2012-12-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT01305525 A Prospective Clinical Outcomes Registry — Pain Completed 2009-06-01 2014-04-01 ClinicalTrials.gov
NCT00940888 SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac R… — Tachyarrhythmias Completed 2009-06-01 2015-12-01 ClinicalTrials.gov
NCT01056744 Optical Coherence Tomography to Evaluate Paclitaxel-Eluting Balloons and Everol… Phase4 Stents Completed 2009-06-01 2012-06-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00912431 Pharmacokinetic and Exploratory Biomarker Study of ABT-126 in Healthy Volunteers Phase1 Healthy Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00916370 SPIRIT PRIME Clinical Trial Phase3 Myocardial Ischemia Completed 2009-06-01 2014-02-01 ClinicalTrials.gov
NCT00919490 A Study of Single Dose of ABT-333 in Healthy Male Adults Phase1 HCV Infections Completed 2009-06-01 — ClinicalTrials.gov
NCT00922571 A Study of Cataract Surgery With the Femtosecond Laser Na Cataract Terminated 2009-06-01 2014-05-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00925522 Therapy Cool Path Ablate VT Na Ischemic Ventricular Tachycardia Terminated 2009-06-01 2011-07-01 ClinicalTrials.gov
NCT00931281 Study in Healthy Adults to Evaluate Pharmacokinetics, Safety and Tolerability o… Phase1 HCV Infection Completed 2009-06-01 — ClinicalTrials.gov
NCT00933933 Evaluation of Diagnostic HIV Ag/Ab Combo Assay Phase3 Human Immunodeficiency Viruses Completed 2009-06-01 2009-11-01 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00877643 Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atria… Na Atrial Fibrillation Completed 2009-05-04 2021-01-31 ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00909636 A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple As… Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00891813 Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Sec… Phase4 Secondary Hyperparathyroidism Completed 2009-05-01 2010-09-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00905853 Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy Phase4 Recurrent Ventricular Tachycardia Completed 2009-05-01 2015-12-01 ClinicalTrials.gov
NCT00909311 Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety … Phase1 HCV Infection Completed 2009-05-01 — ClinicalTrials.gov
NCT00889889 Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Adults Aged >=… Phase2 Influenza Completed 2009-05-01 2011-01-01 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00867048 Strategic Timing of Antiretroviral Treatment Phase4 HIV Infection Completed 2009-04-15 2022-07-27 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00735085 A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain I… Phase2 Traumatic Brain Injury Terminated 2009-04-01 2010-08-01 ClinicalTrials.gov
NCT00888667 Optimal EGM Configuration for Morphology Discrimination — Premature Ventricular Complexes Terminated 2009-04-01 2010-05-01 ClinicalTrials.gov
NCT00890318 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895102 Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulati… Phase1 HCV Infection Completed 2009-04-01 — ClinicalTrials.gov
NCT00895401 DaVita Assessment of Nutritional Supplement Effects (DANSE) Phase4 Malnutrition Completed 2009-04-01 — ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00519194 CONcomitant eValuation of Epicor Left atRial Therapy for AF Na Atrial Fibrillation Terminated 2009-04-01 2013-03-01 ClinicalTrials.gov
NCT00941447 Development of Self-Regulation in Individuals With Type 2 Diabetes Na Type 2 Diabetes Completed 2009-04-01 2011-02-01 ClinicalTrials.gov
NCT00918255 Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Su… Phase2 Hidradenitis Suppurativa Completed 2009-04-01 2010-11-01 ClinicalTrials.gov
NCT01076166 Recovery Time in Children With Lower Respiratory Tract Infections Treated With … — Lower Respiratory Tract Infection Completed 2009-04-01 2010-01-01 ClinicalTrials.gov
NCT01024855 Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Mul… Phase1 Myopia Completed 2009-04-01 2009-06-01 ClinicalTrials.gov
NCT00907361 The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MR… — Need for MRI Imaging With Pacemaker or Completed 2009-04-01 2014-06-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00930839 Role of Prostaglandins on Niacin-Induced Flushing — Flushing Completed 2009-03-01 2010-02-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00854659 A Safety, Tolerability and Pharmacokinetic Study of ABT-102 in Healthy Subjects Phase1 Healthy Volunteers Completed 2009-03-01 — ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00874445 Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configurat… — Sudden Cardiac Death Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00870467 A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2009-03-01 2011-08-01 ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00867399 A Safety and Tolerability Study of ABT-126 in Elderly Phase1 Alzheimer's Disease Completed 2009-03-01 — ClinicalTrials.gov
NCT00873691 Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants — Healthy Completed 2009-03-01 2011-11-01 ClinicalTrials.gov
NCT00870324 OptiSense™ Performance in Detecting Atrial Episodes — Tachyarrhythmias Completed 2009-03-01 2010-09-01 ClinicalTrials.gov
NCT00882219 Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implant… Phase3 Coronary Restenosis Completed 2009-03-01 2012-07-01 ClinicalTrials.gov
NCT00844532 Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Ex… Phase3 Peripheral Vascular Disease Completed 2009-03-01 2014-06-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00961051 Evaluation of an Investigational Multi-Purpose Solution (MPS) Phase3 Study Focus is Healthy Contact Lens Wearers Completed 2009-02-01 2009-11-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT00845741 Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Depar… — Acute Kidney Injury Completed 2009-02-01 2010-08-01 ClinicalTrials.gov
NCT00823303 Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kid… Phase4 Secondary Hyperparathyroidism Completed 2009-02-01 2013-09-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT01097733 Dual-Source Computed Tomography to Improve Prediction of Response to Cardiac Re… — Heart Failure - NYHA II - IV Completed 2009-02-01 2012-01-01 ClinicalTrials.gov
NCT00913081 Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) Phase4 Flushing Completed 2009-02-01 2009-12-01 ClinicalTrials.gov
NCT00839293 Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules Phase1 Healthy Completed 2009-02-01 — ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01931956 Real World Expanded Multicenter Study of the MitraClip® System (REALISM) Na Mitral Valve Insufficiency Completed 2009-01-22 2018-06-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00623025 Creon in HIV Patients With Steatorrhea Phase3 Steatorrhea Terminated 2009-01-01 2009-08-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00870948 Phase 1 BA Study, Single Center With Healthy Volunteers Phase1 Healthy Completed 2009-01-01 — ClinicalTrials.gov
NCT01704599 Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment o… Phase1 Psoriasis Terminated 2009-01-01 2014-05-01 ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00616902 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Ca… Phase3 Chronic Kidney Disease (CKD) Stage 5 Terminated 2009-01-01 2009-05-01 ClinicalTrials.gov
NCT00809510 A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate A… Phase2 Alzheimer's Disease Terminated 2009-01-01 — ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT01005927 Fructooligosaccharide and Calcium Absorption in Adolescent Girls Phase1 Osteoporosis Completed 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00664430 Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyr… Phase4 Secondary Hyperparathyroidism Terminated 2009-01-01 2009-06-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT00865007 Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat… Phase4 HIV Infection Completed 2008-12-01 2012-09-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT01088516 Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-chi… Phase4 HIV Completed 2008-12-01 2012-05-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT01078584 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients — Hypertension Completed 2008-12-01 2011-09-01 ClinicalTrials.gov
NCT00798382 Comparative Gastrointestinal Tolerance of Various Infant Formulas in Healthy Te… Phase2 Infant, Newborn Completed 2008-12-01 2009-09-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00832975 AVAI: Atrial Ventricular Arrythmia Incidence — Ventricular Tachycardia Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00865475 Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monot… Phase4 HIV Infection Completed 2008-12-01 2013-03-01 ClinicalTrials.gov
NCT00788801 Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of… Phase1 Healthy Volunteers Completed 2008-12-01 — ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00807586 Corticosteroid Pulse After Ablation Phase4 Atrial Fibrillation Completed 2008-12-01 2013-12-01 ClinicalTrials.gov
NCT00874289 Utility of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Predicting Rena… — Heart Failure Completed 2008-12-01 2014-05-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT01076153 Recovery Time in Thai Patients With Upper or Lower Respiratory Tract Infections… — Respiratory Tract Infection Completed 2008-12-01 2010-04-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT01772940 Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a… Phase4 HIV-1 Infection Completed 2008-12-01 2011-12-01 ClinicalTrials.gov
NCT00502372 Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite… Phase1 Pressure Ulcers Terminated 2008-12-01 2010-01-01 ClinicalTrials.gov
NCT00811551 Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices — Heart Failure Completed 2008-12-01 2011-04-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT00780156 The ITALIC Study: Is There A LIfe for Drug-eluting Stents (DES) After Discontin… — Restenosis Terminated 2008-11-01 2013-02-01 ClinicalTrials.gov
NCT02198716 Xience or Vision Stent Management of Angina in the Elderly Na Coronary Artery Disease Completed 2008-11-01 2012-08-01 ClinicalTrials.gov
NCT01185392 European Cardiac Resynchronisation Therapy Survey — Heart Failure Completed 2008-11-01 2012-01-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT00771498 An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin Phase4 HIV Infection Completed 2008-11-01 2012-12-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT01084668 Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic… — Psoriasis Chronic Completed 2008-11-01 2011-04-01 ClinicalTrials.gov
NCT01154751 Data Registry Following Patients Using Supera Stent in the Femoral Arteries Na Peripheral Artery Disease Terminated 2008-11-01 2015-08-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT00762320 Comparison of Liquid Kaletra and Low Dose Kaletra Tablets Na HIV Infections Completed 2008-10-01 2011-07-01 ClinicalTrials.gov
NCT00796679 Oral Paricalcitol in Stage 3 - 5 Chronic Kidney Disease Na Chronic Kidney Disease Completed 2008-10-01 2011-06-01 ClinicalTrials.gov
NCT00768690 A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pha… Phase1 HCV Infection Completed 2008-10-01 — ClinicalTrials.gov
NCT00731237 XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Exc… — Atherosclerosis Completed 2008-10-01 2009-10-01 ClinicalTrials.gov
NCT00798291 Evaluation of AN777 in Elderly Subjects Phase2 Aged Completed 2008-10-01 2010-01-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00775606 Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in … Phase4 Acquired Immune Deficiency Syndrome Terminated 2008-10-01 2011-01-01 ClinicalTrials.gov
NCT01288976 ACCESS-Europe A Two-Phase Observational Study of the MitraClip® System in Europe — Mitral Valve (MV) Regurgitation Completed 2008-10-01 2012-08-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00819793 CentriMag Ventricular Assist System in Treating Failure-to-Wean From Cardiopulm… Na Heart Failure Completed 2008-10-01 2013-09-01 ClinicalTrials.gov
NCT00832988 CONFIRM - Comparison of in Office Interrogation Versus Remote Measurements — Pacemaker Completed 2008-10-01 2013-02-01 ClinicalTrials.gov
NCT00783796 SPIRIT Small Vessel Registry Na Coronary Artery Disease Terminated 2008-10-01 2013-12-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT01077271 Compliance to Synagis (Palivizumab) Under Daily Pediatrician´s Conditions in Pr… — Premature Infants Completed 2008-10-01 2011-05-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00814866 Bone Resorption, Osteoclastogenesis and Adalimumab Na Rheumatoid Arthritis Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00693745 Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type N… — Acute Decompensated Heart Failure Completed 2008-09-01 2010-07-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00785616 A Trial to Determine the Long-term Durability of Virologic Suppression in Kalet… Phase4 HIV Infection Completed 2008-09-01 2009-10-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema Phase2 Diabetic Macular Edema Completed 2008-09-01 2011-03-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00754104 Study of ABT-869 in Combination With Tarceva in Subjects With Solid Tumors Phase1 Solid Tumors Withdrawn 2008-09-01 — ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752687 A Study of ABT-072 in Healthy and Hepatitis C Virus Genotype 1-Infected Adults Phase1 Hepatitis C Completed 2008-09-01 — ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00752102 Vitamin D and Coronary Calcification Study Phase4 Chronic Kidney Disease Completed 2008-09-01 2013-10-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01223469 TOCCATA - Touch+™ for Catheter Ablation Na Atrial Fibrillation Completed 2008-09-01 2010-02-01 ClinicalTrials.gov
NCT00743522 Programming Implantable Cardioverter Defibrillators in Patients With Primary Pr… — Shock Completed 2008-09-01 2011-12-01 ClinicalTrials.gov
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arth… — Rheumatoid Arthritis Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00747318 A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Ast… Phase3 Asthma Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT01078545 Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Pr… — Advanced Prostate Cancer Completed 2008-09-01 2010-11-01 ClinicalTrials.gov
NCT00752037 Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients Phase4 HIV Infections Completed 2008-09-01 2010-06-01 ClinicalTrials.gov
NCT00746564 Study of New Implantable Loop Recorder Na Tachyarrhythmias Completed 2008-09-01 2014-06-01 ClinicalTrials.gov
NCT00734292 Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of Flu… Phase2 Mild to Moderate Asthma Completed 2008-09-01 2008-10-01 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00752856 Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine … Phase2 HIV Infections Completed 2008-08-26 2014-02-11 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00743470 A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult S… Phase1 HIV Terminated 2008-08-01 — ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00753181 Effects of Nutritional Products on Blood Glucose in Subjects With Type 2 Diabet… Phase3 Diabetes Mellitus, Type 2 Completed 2008-08-01 2009-03-01 ClinicalTrials.gov
NCT00911703 Determining When Patients Hospitalized With Acute Heart Failure Can Be Safely S… — Acute Heart Failure Completed 2008-08-01 2015-10-01 ClinicalTrials.gov
NCT00713700 AMPLATZER Duct Occluder II Clinical Study Na Patent Ductus Arteriosus Completed 2008-08-01 2016-10-05 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00746356 Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds Na Heart Failure Completed 2008-08-01 2010-01-01 ClinicalTrials.gov
NCT00735787 Controlled Study of Humira in Subjects With Chronic Plaque Psoriasis of the Han… Phase4 Psoriasis Completed 2008-08-01 2009-09-01 ClinicalTrials.gov
NCT00743028 Assess the Oral Bioavailability of New ABT-263 Formulations Phase1 Chronic Lymphocytic Leukemia Completed 2008-08-01 — ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT00997828 Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Cor… Na Coronary Artery Disease Terminated 2008-07-28 2019-04-05 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT01120379 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Chronic Coronary Occlusion Completed 2008-07-01 2013-12-01 ClinicalTrials.gov
NCT00817349 Angio-Seal Evolution Device Registry — Peripheral Vascular Disease Completed 2008-07-01 2010-04-01 ClinicalTrials.gov
NCT00738764 A Trial of PDL192 in Subjects With Advanced Solid Tumors Phase1 Cancer Completed 2008-07-01 2011-10-01 ClinicalTrials.gov
NCT00711009 Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxi… Phase3 Human Immunodeficiency Virus Infection Completed 2008-07-01 2010-10-01 ClinicalTrials.gov
NCT00701805 Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Pati… Phase2 Secondary Hyperparathyroidism Completed 2008-07-01 2009-12-01 ClinicalTrials.gov
NCT00676520 XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIE… — Coronary Artery Disease Completed 2008-07-01 2011-03-01 ClinicalTrials.gov
NCT00401076 A Open-label Study to Assess the Safety of Oral Long-term Use of SA-001 in Panc… Phase3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy Completed 2008-07-01 2010-09-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT01027260 Study to Evaluate the Role of Itopride HCI in Patients With Irritable Bowel Syn… Phase2 Irritable Bowel Syndrome Completed 2008-06-01 2010-09-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00711217 Evaluation of a Medical Food for Chronic Wounds Phase3 Foot Ulcer, Diabetic Completed 2008-06-01 2010-12-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00700115 Kaletra-isentress Treatment Evaluation Phase4 HIV Infections Completed 2008-06-01 2011-01-01 ClinicalTrials.gov
NCT00705562 Tolerance of Healthy Term Infants Fed Infant Formulas Phase2 Infant, Newborn Completed 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00698607 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Phase4 Coronary Artery Disease Completed 2008-06-01 2014-04-01 ClinicalTrials.gov
NCT00694473 Continuous Glucose Monitoring With a Subcutaneous Sensor During Critical Illnes… Na Critical Illness Completed 2008-06-01 2017-12-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT00842179 Groin Complications Post Percutaneous Coronary Intervention Using Either Manual… — Vascular Closure Completed 2008-06-01 2008-10-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00635817 A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat C… Phase3 Puberty, Precocious Completed 2008-06-01 2010-06-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00987506 Evaluation of a XIENCE V® Endoprothesis Used for Coronary Angioplasty, for LPPR… — Coronary Artery Disease Completed 2008-06-01 2011-12-01 ClinicalTrials.gov
NCT00631228 XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-… — Coronary Disease Completed 2008-06-01 2012-08-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT01076959 Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid A… — Rheumatoid Arthritis Completed 2008-06-01 2011-06-01 ClinicalTrials.gov
NCT00728910 Combined Effects of Non-statin Treatments on Apolipoprotein A-I Up-Regulation (… Phase2 Dyslipidemia Completed 2008-06-01 2009-08-01 ClinicalTrials.gov
NCT00577187 Placement of CS/LV Pacing Leads With EnSite NavX Guidance Early_Phase1 Heart Failure Withdrawn 2008-06-01 2008-12-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00727012 Multicenter International Trial Ring AnnulopLasty Na Mitral Valve Insufficiency Completed 2008-06-01 2010-11-01 ClinicalTrials.gov
NCT01350869 Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry) — Coronary Artery Disease Completed 2008-06-01 2014-06-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00690573 Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With … Phase3 Juvenile Rheumatoid Arthritis Completed 2008-05-01 2011-09-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00726869 A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Huma… Phase1 Multiple Myeloma Terminated 2008-05-01 2012-03-01 ClinicalTrials.gov
NCT00679926 Kaletra and Viread in Antiretroviral Naïve Patients Phase4 HIV Infections Terminated 2008-05-01 2011-05-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT00657774 A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™… Phase1 Asthma Completed 2008-04-01 2008-09-01 ClinicalTrials.gov
NCT00666237 Primary Tube Versus Trabeculectomy Study Phase4 Glaucoma Completed 2008-04-01 2021-04-01 ClinicalTrials.gov
NCT00666692 A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, … Phase1 Non-small Cell Lung Cancer Completed 2008-04-01 2008-10-01 ClinicalTrials.gov
NCT00667576 Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patient… Phase2 Chronic Kidney Disease on Hemodialysis Completed 2008-04-01 2009-03-01 ClinicalTrials.gov
NCT00681525 A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin… Phase1 Pharmacokinetics Completed 2008-04-01 — ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01076218 Navigator 1.5 Accuracy Study — Diabetes Mellitus Completed 2008-04-01 2008-07-01 ClinicalTrials.gov
NCT01074931 Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regime… — HIV-1 Infections Completed 2008-04-01 2010-06-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT01083160 Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or… — Rheumatoid Arthritis Terminated 2008-04-01 2010-11-01 ClinicalTrials.gov
NCT00902005 Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Mar… — Rheumatoid Arthritis Completed 2008-04-01 2012-08-01 ClinicalTrials.gov
NCT00960648 Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late L… — Coronary Artery Disease Completed 2008-04-01 2014-01-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT01103596 Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to An… — HIV Infection Completed 2008-03-01 2009-07-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT01244308 Effectiveness and Reliability of VectSelect™ Feature for Avoidance of Phrenic N… — Heart Failure Completed 2008-03-01 2011-08-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00647387 Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscul… Na Ventricular Septal Defects Completed 2008-03-01 2024-02-23 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT00693329 Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Deter… — Cardiovascular Surgery With Coronary Angiography Completed 2008-03-01 2009-12-01 ClinicalTrials.gov
NCT00617162 Deep Brain Stimulation for Major Depressive Disorder Na Depressive Disorder, Major Terminated 2008-03-01 2015-06-01 ClinicalTrials.gov
NCT00649025 A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combina… Phase3 Asthma Completed 2008-03-01 2008-10-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00574431 ICU Nutrition Study Bern Phase4 Critical Illness Completed 2008-02-01 2009-03-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00630877 Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Ex… Phase3 Dyslipidemia Completed 2008-02-01 2008-06-01 ClinicalTrials.gov
NCT00626431 A Study of Leuprolide to Treat Prostate Cancer Phase3 Prostate Cancer Completed 2008-02-01 2009-09-01 ClinicalTrials.gov
NCT00639158 Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin an… Phase3 Dyslipidemias Completed 2008-02-01 — ClinicalTrials.gov
NCT00626392 Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced… Phase3 Dyslipidemia Completed 2008-02-01 2008-04-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00561093 Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients Phase3 Hypoalbuminemia Completed 2008-02-01 2011-05-01 ClinicalTrials.gov
NCT00667355 A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2008-02-01 2011-01-01 ClinicalTrials.gov
NCT00726440 Are the Continuous Glucose Monitoring Systems Able to Improve Long Term Glycaem… Na Type 1 Diabetes Completed 2008-02-01 2010-06-01 ClinicalTrials.gov
NCT00606463 Gen2 Isthmus-Dependent Atrial Flutter Ablation Study Na Atrial Flutter Terminated 2008-02-01 2009-01-01 ClinicalTrials.gov
NCT00866021 Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receivi… Phase4 HIV/HCV Co-infection Completed 2008-02-01 2012-10-01 ClinicalTrials.gov
NCT00753753 VerifyNow French Registry — Stent Thrombosis Completed 2008-02-01 2009-11-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00632372 Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study — Heart Failure Completed 2008-01-01 2015-12-01 ClinicalTrials.gov
NCT00626093 'Effect of CRT on Defibrillation Threshold Estimates' Study Phase4 Sudden Cardiac Death Completed 2008-01-01 2010-04-01 ClinicalTrials.gov
NCT00818077 Using Continuous Glucose Monitoring to Understand the Glycemic Impact of Food — Type 2 Diabetes Completed 2008-01-01 2010-09-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00585481 Incidence of Severe Respiratory Syncytial Virus Infections in Preterm Brazilian… — Respiratory Syncytial Viruses Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT00738725 BioImage Study: A Clinical Study of Burden of Atherosclerotic Disease in an At-… — Plaque Completed 2008-01-01 2014-12-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT01230606 Same Day Versus Next Day Discharge: Ambulatory Closure Device Percutaneous Inte… — Cardiovascular Disease Completed 2008-01-01 2010-06-01 ClinicalTrials.gov
NCT00597623 Efficacy Study of an Anti-Tumor Necrosis Factor (TNF) Alpha Agent in Patients W… Phase3 Hand Osteoarthritis Completed 2008-01-01 2010-12-01 ClinicalTrials.gov
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Pati… — Rheumatoid Arthritis Completed 2008-01-01 2011-11-01 ClinicalTrials.gov
NCT00566722 Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to S… Phase3 Psoriasis Completed 2008-01-01 2009-04-01 ClinicalTrials.gov
NCT00652522 Atrial Fibrillation Management in Congestive Heart Failure With Ablation Na Persistent Atrial Fibrillation Completed 2008-01-01 2017-07-13 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT01231321 A Study of Adalimumab When Added to Inadequate Standard Anti-rheumatic Therapy … Phase3 Rheumatoid Arthritis Completed 2007-12-01 2010-02-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT01143818 ESPRIT Study in Hypogonadal Men — Hypogonadism Completed 2007-12-01 2010-08-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00559559 PAtient NOtifier Feature for Reduction of Anxiety Na Tachycardia, Ventricular Completed 2007-12-01 2010-12-01 ClinicalTrials.gov
NCT00919165 Assessment of Cognitive Function in Patients Undergoing Carotid Artery Stent Pl… — Cognitive Function in Carotid Stenting Completed 2007-12-01 2017-04-20 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT00647270 Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inf… Phase3 Rheumatoid Arthritis Completed 2007-12-01 2009-04-01 ClinicalTrials.gov
NCT00632450 EnSite Real-Time Cardiac Performance Measurements (RT CPM) Study — Heart Failure Completed 2007-12-01 2008-10-01 ClinicalTrials.gov
NCT00609245 Effect of Valproic Acid Concentration on Photic Response Phase4 Photosensitive Epilepsy Completed 2007-12-01 2008-12-01 ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00562887 Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intra… Phase2 Crohn's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00727181 An Observational, Prospective Evaluation of the Trifecta™ Valve Na Aortic Valve Insufficiency Completed 2007-11-01 2010-12-01 ClinicalTrials.gov
NCT00574249 Adalimumab in Combination With Topical Treatment (Calcipotriol/Betamethasone) i… Phase3 Chronic Plaque Psoriasis Completed 2007-11-01 — ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT01078116 Cost Utility Analyses of Adalimumab Treatment in Patients With Rheumatoid Arthr… — Rheumatoid Arthritis Completed 2007-11-01 2010-06-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00819117 Investigation of Transvenous Versus Epicardial Left Ventricular Stimulation Tec… Na Heart Failure Completed 2007-11-01 2009-10-01 ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT01754064 St. Jude Medical Product Longevity and Performance (SCORE) Registry — Bradycardia Completed 2007-11-01 2020-07-10 ClinicalTrials.gov
NCT00631774 A Study to Evaluate the Postprandial Metabolic Response After Use of Glucerna S… Na Type 2 Diabetes Completed 2007-11-01 2009-01-01 ClinicalTrials.gov
NCT00746135 TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study Na Heart Failure Completed 2007-11-01 2012-12-01 ClinicalTrials.gov
NCT00970567 Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM) Na Type 1 Diabetes Completed 2007-11-01 2008-12-01 ClinicalTrials.gov
NCT00554385 A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/H… Phase2 Attention-Deficit/Hyperactivity Disorder Terminated 2007-11-01 — ClinicalTrials.gov
NCT00555204 Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer'… Phase2 Alzheimer's Disease Terminated 2007-11-01 — ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT00544206 Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-10-01 2008-09-01 ClinicalTrials.gov
NCT01079195 Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patie… — Hypertension Completed 2007-10-01 2010-03-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT00660647 Optimized Treatment Algorithm for Patients With Early Rheumatoid Arthritis (RA) Phase3 Arthritis, Rheumatoid Completed 2007-09-01 2011-12-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT01084538 Study of Zemplar iv in Patients With End Stage Chronic Kidney Disease, Undergoi… — Parathyroid Hormone Completed 2007-09-01 2010-06-01 ClinicalTrials.gov
NCT01107535 Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants Wit… — Respiratory Syncytial Virus Infection Completed 2007-09-01 2011-02-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00537979 Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral i… Phase4 Secondary Hyperparathyroidism Completed 2007-09-01 2010-07-01 ClinicalTrials.gov
NCT00918294 QuickOptTM Study - Using the QuickOptTM Method for Timing Cycle Optimization Na Heart Failure Completed 2007-09-01 2009-09-01 ClinicalTrials.gov
NCT00513370 A Canadian Open-Label Access Program to Evaluate Adalimumab When Added to Inade… Phase3 Psoriasis Completed 2007-09-01 — ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT01310309 EXecutive Registry: Evaluating XIENCE V® in a Multi Vessel Disease — Coronary Disease Completed 2007-09-01 2011-06-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00543673 Tolerance of Healthy, Term Infants to Infant Formulas Phase2 Healthy Completed 2007-09-01 2008-06-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00686205 Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay Phase3 Healthy Donors Completed 2007-08-01 2008-08-01 ClinicalTrials.gov
NCT00650936 Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Appr… Na Atrial Septal Defect Completed 2007-08-01 2014-06-01 ClinicalTrials.gov
NCT00538902 Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis S… Phase2 Rheumatoid Arthritis Completed 2007-08-01 2009-12-01 ClinicalTrials.gov
NCT00520065 Comparison of Nutritional Products for People With Type 2 Diabetes Phase2 Type 2 Diabetes Mellitus Completed 2007-08-01 2007-11-01 ClinicalTrials.gov
NCT00512863 A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of A… Phase2 Asthma Withdrawn 2007-08-01 — ClinicalTrials.gov
NCT00490841 The HERCULES Trial - A Safety and Effectiveness Study of the Herculink Elite Re… Na Renal Artery Obstruction Completed 2007-08-01 2012-12-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT01114269 PRE-DETERMINE Cohort Study — Coronary Artery Disease Active_Not_Recruiting 2007-07-01 2026-11-01 ClinicalTrials.gov
NCT00496938 XIENCE V: SPIRIT WOMEN Phase4 Coronary Artery Stenosis Completed 2007-07-01 2011-07-01 ClinicalTrials.gov
NCT00481013 Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2007-07-01 2010-11-01 ClinicalTrials.gov
NCT00558857 Dynamic Substrate Mapping (DSM) for Ischemic VT Phase1 Ischemic Ventricular Tachycardia Terminated 2007-07-01 2009-04-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00491530 A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Thera… Phase3 Mixed Dyslipidemia Completed 2007-06-01 2008-11-01 ClinicalTrials.gov
NCT00489177 Optimal Programming to Improve Mechanical Indices, Symptoms and Exercise in Car… Phase4 Heart Failure Completed 2007-06-01 2012-11-01 ClinicalTrials.gov
NCT00487279 DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation Na Coronary Artery Disease Terminated 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00473356 Nutritional Effect of an Amino Acid Mixture on Lean Body Mass (LBM) in Post-bar… Na Obesity Completed 2007-06-01 2010-01-01 ClinicalTrials.gov
NCT00473148 B-type Natriuretic Peptide for the Management of Weaning Phase3 Respiratory Insufficiency Completed 2007-06-01 2010-03-01 ClinicalTrials.gov
NCT00838175 Characteristics Predictive of Success and Complications in the Use of Suture-Me… — Cardiac Catheterization Unknown 2007-06-01 2009-05-01 ClinicalTrials.gov
NCT00475709 Aortic Valve Replacement With Trifecta(TM) Na Aortic Valve Insufficiency Completed 2007-06-01 2012-01-01 ClinicalTrials.gov
NCT00329680 The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Anti… Phase4 Sepsis Completed 2007-06-01 2009-10-01 ClinicalTrials.gov
NCT00834457 A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi'… Phase2 AIDS-related Kaposi's Sarcoma Completed 2007-06-01 2009-07-01 ClinicalTrials.gov
NCT00508222 Kaletra Monotherapy in HIV/HCV Co-infected Subjects Phase3 HIV Infections Completed 2007-06-01 2011-04-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00377871 Hemodynamic Performance in Stentless Heart Valves Na Heart Valve Diseases Completed 2007-05-01 2010-01-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00469638 Efficacy and Safety Study on Agilis NxT Introducer in AF Patients Na Atrial Fibrillation Completed 2007-05-01 2010-04-01 ClinicalTrials.gov
NCT00475566 A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral St… Na Atherosclerosis Completed 2007-05-01 2010-02-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00400842 A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency Phase3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis Completed 2007-05-01 2009-08-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT00465088 An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (… Phase3 Hyperlipidemia Completed 2007-04-01 — ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00636987 Aortic or Mitral Valve Replacement With the Biocor and Biocor Supra Na Aortic Valve Insufficiency Completed 2007-04-01 2016-03-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00614458 MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell… Phase2 HIV Infections Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT00444379 Anti-Retrovirals for Kaposi's Sarcoma Phase4 Kaposi's Sarcoma Completed 2007-04-01 2012-07-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT00409682 Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe… Phase3 Crohn's Disease Completed 2007-04-01 2010-05-01 ClinicalTrials.gov
NCT00420355 Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients Phase4 HIV Infection Terminated 2007-04-01 2008-09-01 ClinicalTrials.gov
NCT01615835 EnSite NavX-Guided Coronary Sinus Mapping During CRT Implant Na Congestive Heart Failure Completed 2007-04-01 2007-10-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT01634464 Role of Nutrition and Maternal Genetics on the Programming of Development of Fe… — Obesity Unknown 2007-03-01 2013-06-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00927069 Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Resp… Phase3 Plaque Psoriasis Completed 2007-03-01 2008-12-01 ClinicalTrials.gov
NCT00445432 A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Sub… Phase2 Crohn's Disease Completed 2007-03-01 2010-11-01 ClinicalTrials.gov
NCT00424814 Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Rev… Phase2 HIV Infections Completed 2007-03-01 2012-11-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00433199 Testosterone Treatment for Hypogonadal Men Phase3 Hypogonadism Completed 2007-02-01 2008-04-01 ClinicalTrials.gov
NCT00437476 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT01940120 EVEREST II Pivotal Study High Risk Registry (HRR) Na Mitral Valve Insufficiency Completed 2007-02-01 2013-02-01 ClinicalTrials.gov
NCT00827996 To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Se… Phase2 Hidradenitis Suppurativa Completed 2007-02-01 2008-08-01 ClinicalTrials.gov
NCT00437684 Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Th… Phase3 HIV Infections Unknown 2007-02-01 2010-12-01 ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00445939 A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subje… Phase2 Crohn's Disease Completed 2007-02-01 — ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT00354562 A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non… Phase1 Lung Cancer Terminated 2007-02-01 — ClinicalTrials.gov
NCT00445809 Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Ev… — Kidney Failure, Acute Completed 2007-02-01 2009-04-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00607776 Artificial Tears Study in Mild to Moderate Dry Eye Patients Phase2 Dry Eye Completed 2007-01-01 2007-04-01 ClinicalTrials.gov
NCT00587158 Oral Paricalcitol in Kidney Transplant Recipients Na Transplant; Failure, Kidney Completed 2007-01-01 2011-11-01 ClinicalTrials.gov
NCT00571961 Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Riton… Na HIV Infections Completed 2007-01-01 2008-08-01 ClinicalTrials.gov
NCT01343758 Study Investigating the Use of Intravenous Fluids With Dextrose for Dehydrated … Na Gastroenteritis Completed 2007-01-01 2011-07-01 ClinicalTrials.gov
NCT00429468 A Study to Evaluate the Interaction Between Vicodin® CR and Ethanol in Healthy … Phase1 Drug Interactions Completed 2007-01-01 — ClinicalTrials.gov
NCT00429091 A Dose-Ranging Study of the Efficacy of ABT-894 in Adults With Attention-Defici… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2007-01-01 — ClinicalTrials.gov
NCT00427921 Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderat… Phase3 Crohn's Disease Completed 2007-01-01 2008-01-01 ClinicalTrials.gov
NCT00413244 The Cardiac Benefit of Testosterone Replacement in Men With Low Testosterone Le… Phase3 Coronary Artery Disease Completed 2007-01-01 2014-11-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00402792 A Study of Extended-Release Hydrocodone/Acetaminophen (Vicodin CR®) in Subjects… Phase3 Pain Completed 2006-12-01 2007-04-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT00369395 A Study of Volociximab in Metastatic Melanoma Phase2 Stage IV Melanoma Terminated 2006-12-01 2008-03-01 ClinicalTrials.gov
NCT01075126 Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disor… Phase4 Bipolar Disorder Withdrawn 2006-12-01 2006-12-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00747227 Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) Phase3 Cataract Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00397020 Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapi… Phase4 Bipolar Disorder Completed 2006-12-01 2008-12-01 ClinicalTrials.gov
NCT00786708 Sensitivity and Specificity of NGAL in an Emergency Room Population — Azotemia Completed 2006-12-01 2013-07-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT01081665 Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent an… — Chronic Kidney Failure Completed 2006-12-01 2011-02-01 ClinicalTrials.gov
NCT00415948 Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Corona… — Acute Coronary Syndrome (ACS) Completed 2006-12-01 2008-06-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00420927 Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Thera… Phase4 Rheumatoid Arthritis Completed 2006-12-01 2010-07-01 ClinicalTrials.gov
NCT00412620 An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exac… Phase2 Schizophrenia Terminated 2006-12-01 2007-10-01 ClinicalTrials.gov
NCT00409617 Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remissi… Phase3 Crohn's Disease Completed 2006-12-01 2008-07-01 ClinicalTrials.gov
NCT00421733 The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Ty… Phase2 Diabetic Nephropathy Completed 2006-12-01 2009-06-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00428246 Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its P… Na Chronic Kidney Disease Completed 2006-11-01 2007-07-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00402740 Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarter… Na Carotid Artery Disease Completed 2006-11-01 2011-10-01 ClinicalTrials.gov
NCT00408629 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Activ… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00385736 Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute… Phase3 Ulcerative Colitis Completed 2006-11-01 2010-03-01 ClinicalTrials.gov
NCT00347152 Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellec… Na Epilepsy Completed 2006-11-01 2007-12-01 ClinicalTrials.gov
NCT00397657 Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on … Phase4 Atherosclerosis Terminated 2006-11-01 2009-10-01 ClinicalTrials.gov
NCT00761514 Evaluation of Quality of Life Changes in Puerto Rican Subjects With Active Rheu… Phase4 Rheumatoid Arthritis Terminated 2006-11-01 2008-08-01 ClinicalTrials.gov
NCT00402272 SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronar… Phase4 Coronary Disease Completed 2006-11-01 2010-06-01 ClinicalTrials.gov
NCT01171820 SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary St… Phase4 Coronary Disease Completed 2006-11-01 2010-07-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00391729 A Dose-Ranging, Cross-over Study of the Safety and Efficacy of ABT-089 in Adult… Phase2 Attention-Deficit/Hyperactivity Disorder Completed 2006-10-01 2007-06-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00837798 RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) … — Atrial Fibrillation Completed 2006-10-01 2012-04-01 ClinicalTrials.gov
NCT00375557 Safety and Efficacy of Divalproex and Quetiapine in Elderly Alzheimer's Dementi… Phase4 Alzheimer's Disease Withdrawn 2006-10-01 2007-09-01 ClinicalTrials.gov
NCT00418314 FREEDOM - A Frequent Optimization Study Using the QuickOpt Method Na Cardiac Arrhythmias Completed 2006-10-01 2009-09-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00300430 Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination … Phase3 Dyslipidemia Completed 2006-09-01 — ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00578617 Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial Na Atrial Fibrillation Completed 2006-09-01 2010-06-01 ClinicalTrials.gov
NCT00637754 Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Heart Arrhythmias Completed 2006-09-01 2015-01-01 ClinicalTrials.gov
NCT00274352 A Study of Adalimumab to Treat Sarcoidosis of the Skin Phase2 Sarcoidosis Completed 2006-09-01 2012-02-01 ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00358917 Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Ad… Phase3 Human Immunodeficiency Virus Infections Completed 2006-08-01 2008-11-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00366158 EVITA: Evaluation of VIP Feature in Pacemaker Patients Na Arrhythmia Completed 2006-08-01 2010-09-01 ClinicalTrials.gov
NCT00367757 STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation … Na Atrial Fibrillation Completed 2006-08-01 2009-07-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT00380094 Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Pa… — Acute Coronary Syndrome Completed 2006-08-01 2007-12-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00307047 SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluti… Phase3 Coronary Artery Disease Completed 2006-08-01 2012-05-01 ClinicalTrials.gov
NCT01722188 Lead Registry for Optim Leads — Optim Lead Insulation Related Adverse Events Completed 2006-08-01 2020-07-01 ClinicalTrials.gov
NCT00311181 POWER (Pulse Width Optimized Waveform Evaluation Trial) Phase4 Sudden Cardiac Death Completed 2006-08-01 2008-04-01 ClinicalTrials.gov
NCT01585064 Optimization of Treatment With Adalimumab (Humira) — Rheumatoid Arthritis (RA) Completed 2006-08-01 2010-02-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00417365 Efficacy of (WaterWorks®)Douching Device for Elimination of Perceived Vaginal O… Na Vaginal Odor Unknown 2006-08-01 2007-09-01 ClinicalTrials.gov
NCT00348153 Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial) Phase2 Uveitis Unknown 2006-08-01 2013-03-01 ClinicalTrials.gov
NCT00348283 Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Invol… Phase3 Crohn's Disease Completed 2006-08-01 — ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00499148 Efficacy Study Testing Herbal Extract on Metabolic Parameters in Subjects With … Phase2 Type 2 Diabetes Completed 2006-08-01 2007-10-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT01075178 Retrospective Palivizumab Study in Children With Hemodynamically Significant Co… — Severe Respiratory Syncytial Virus Infection Completed 2006-07-01 2010-01-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT00356018 Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Ve… — Epilepsy Completed 2006-07-01 2007-05-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00338650 Treatment of the Human Anti-TNF Monoclonal Antibody Adalimumab in Moderate to S… Phase3 Crohn's Disease Completed 2006-06-01 2007-05-01 ClinicalTrials.gov
NCT00334347 A Comparison Study of the Efficacy and Tolerability of Depakote ER and Depakote… Phase4 Mania Completed 2006-06-01 2007-09-01 ClinicalTrials.gov
NCT00432783 A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhi… — HIV Infections Completed 2006-06-01 2007-08-01 ClinicalTrials.gov
NCT00414284 BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) Phase4 HIV Infections Terminated 2006-06-01 2007-04-01 ClinicalTrials.gov
NCT00257920 A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption … Phase4 Chronic Kidney Disease, Stage 5 Completed 2006-06-01 — ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00439296 ABT-751 With Chemotherapy for Relapsed Pediatric ALL Phase1 Recurrent Pediatric ALL Terminated 2006-05-22 2009-09-23 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00505570 PRIMA PFO Migraine Trial Phase2 Migraine Terminated 2006-05-01 2013-02-01 ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00305539 HECTHOR: Humira to Spare Steroids in Giant Cell Arteritis Phase3 Giant Cell Arteritis Completed 2006-05-01 2011-05-01 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT01078571 Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Ar… — Rheumatoid Arthritis Completed 2006-05-01 2010-05-01 ClinicalTrials.gov
NCT00328081 State of Obesity Care in Canada Evaluation Registry — Obesity Terminated 2006-05-01 2007-08-01 ClinicalTrials.gov
NCT00325949 A Study of Pain Relief in Low Back Pain Phase3 Chronic Low Back Pain Completed 2006-05-01 2007-06-01 ClinicalTrials.gov
NCT00315900 Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursin… Phase3 Agitation Terminated 2006-05-01 2008-02-28 ClinicalTrials.gov
NCT00427362 A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimu… Phase3 Psoriatic Arthritis Completed 2006-05-01 — ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00318929 Tolerability and Efficacy of Depakote-extended Release in the Elderly Na Elderly Completed 2006-04-01 2008-01-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00467675 Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM … — NonDiabetes Completed 2006-04-01 2007-01-01 ClinicalTrials.gov
NCT00307827 Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative… Phase2 Ulcerative Colitis Terminated 2006-04-01 2007-11-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00647400 Adalimumab in Adult Japanese Subjects With Psoriasis Phase2 Psoriasis Completed 2006-04-01 2010-04-01 ClinicalTrials.gov
NCT00311246 Trial of Adalimumab in Progressive Sarcoidosis Phase2 Sarcoidosis Terminated 2006-04-01 2008-09-01 ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00312676 Compare Tolerability of an Overnight Switch to Gradual Switch Between Two Diffe… Phase4 Epilepsy Unknown 2006-03-01 2006-10-01 ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00306475 Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (AP… Phase4 Schizophrenia Completed 2006-03-01 2008-04-01 ClinicalTrials.gov
NCT00300456 Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subj… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300469 Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Sub… Phase3 Mixed Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00603993 Self-injection of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthrit… Phase3 Rheumatoid Arthritis Completed 2006-03-01 — ClinicalTrials.gov
NCT00294866 Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients Phase4 Kidney Failure Completed 2006-03-01 2008-01-01 ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00300131 ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary … — Coronary Disease Completed 2006-03-01 2011-07-01 ClinicalTrials.gov
NCT00300482 Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calciu… Phase3 Dyslipidemia Completed 2006-03-01 — ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00281606 A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavi… Phase4 HIV Infection Completed 2006-02-14 2012-06-13 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00311168 Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic P… Na Bradycardia Completed 2006-02-01 2008-09-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00298974 A Study of Pain Relief in Osteoarthritis Phase3 Osteoarthritis Completed 2006-02-01 2007-05-01 ClinicalTrials.gov
NCT00293943 Randomized Trial of Two Different Strategies to Treat Paroxysmal Atrial Fibrill… Na Atrial Fibrillation Completed 2006-02-01 2010-08-01 ClinicalTrials.gov
NCT00287053 Effects of Divalproex Sodium on Food Intake, Energy Expenditure, and Posture Al… Phase4 Healthy Completed 2006-02-01 2006-10-01 ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00275262 A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Foll… Phase2 Hodgkin Disease Terminated 2006-02-01 — ClinicalTrials.gov
NCT00286585 TEAM-Project: Trial on the Effect of Anesthetics on Morbidity and Mortality Phase4 Coronary Artery Disease Completed 2006-02-01 2011-11-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00478660 An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Act… Phase3 Ankylosing Spondylitis Completed 2006-02-01 — ClinicalTrials.gov
NCT00477893 Danish Multicenter Study of Adalimumab in Spondyloarthritis Phase4 Spondyloarthritis Unknown 2006-02-01 2013-01-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00355056 PREMIUM Migraine Trial Na Migraine Headaches Completed 2006-01-01 2015-12-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00560040 Myocardial Injury is Not Related to Training Levels Among Recreational Particip… — Troponin Completed 2006-01-01 2006-10-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00256165 REST Study: Left Ventricular Regression European Study Phase4 Aortic Valve Stenosis Completed 2006-01-01 2008-07-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00416013 Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hem… — Kidney Failure, Chronic Unknown 2005-12-01 2010-12-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00262522 Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Ve… Phase3 Human Immunodeficiency Virus Infections Completed 2005-11-01 2008-07-01 ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00276432 Diagnosis and Treatment of Acute Coronary Syndrome in the ED & the Impact of Ra… Phase4 Unstable Angina Completed 2005-11-01 2007-08-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00404222 A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain… Phase2 Pain Completed 2005-11-01 2006-02-01 ClinicalTrials.gov
NCT00338754 Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Ps… Phase2 Psoriasis Completed 2005-11-01 — ClinicalTrials.gov
NCT00453622 RISK Stratification Using a Combination of Cardiac Troponin T and Brain Natriur… — Heart Failure Completed 2005-11-01 2012-08-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00126308 Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic… Phase4 HIV-Associated Lipodystrophy Terminated 2005-11-01 2007-05-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00920881 Clinical Evaluation of the Accuracy of the FreeStyle Navigator Continuous Gluco… — Diabetes Mellitus Completed 2005-11-01 2005-12-01 ClinicalTrials.gov
NCT00287508 Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study) Phase4 Carotid Artery Disease Completed 2005-11-01 2008-01-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT02087046 Deep Brain Stimulation (DBS) for the Suppression of Tremor Na Tremor Completed 2005-10-01 2017-12-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00783380 Influenza Vaccination in Immunocompromized Patients Phase4 Immunosuppression Completed 2005-10-01 2008-03-01 ClinicalTrials.gov
NCT00247143 High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Proteas… Na HIV Unknown 2005-10-01 — ClinicalTrials.gov
NCT00140751 Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuati… Phase3 HIV Infections Completed 2005-10-01 2008-01-01 ClinicalTrials.gov
NCT00552474 Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease Na Parkinson Disease Completed 2005-10-01 2016-11-01 ClinicalTrials.gov
NCT00885664 Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral… Phase4 HIV Infections Completed 2005-10-01 2010-03-01 ClinicalTrials.gov
NCT00420966 Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody T… — Lower Respiratory Tract Infection Completed 2005-10-01 2017-06-26 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00227266 Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase2 Spinal Muscular Atrophy Completed 2005-09-01 2007-11-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00120289 Niacin Plus Statin to Prevent Vascular Events Phase3 Cardiovascular Diseases Terminated 2005-09-01 2012-12-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00573313 Effects of SAMe in Patients With Alcoholic Liver Disease Phase3 Liver Disease, Alcoholic Completed 2005-09-01 2009-09-01 ClinicalTrials.gov
NCT00586092 A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tu… Phase1 Solid Tumors Completed 2005-09-01 2013-02-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00400231 The Fenofibrate and Metformin for Atherogenic Dyslipidemia (FAMA) Study Phase2 Metabolic Syndrome x Completed 2005-08-01 2008-03-01 ClinicalTrials.gov
NCT00209274 Pivotal Study of a Percutaneous Mitral Valve Repair System Na Mitral Valve Insufficiency Completed 2005-08-01 2014-12-01 ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00235820 Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With … Phase3 Psoriasis Completed 2005-07-01 — ClinicalTrials.gov
NCT00790140 Trial of Enteral Nutrition Enriched With Eicosapentaenoic Acid (EPA) in Upper G… Phase4 Esophageal Cancer Unknown 2005-07-01 2010-07-01 ClinicalTrials.gov
NCT00211250 Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tien… Phase4 Mood Disorder Completed 2005-07-01 2006-09-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00235885 Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthr… Phase3 Psoriatic Arthritis Completed 2005-07-01 — ClinicalTrials.gov
NCT00180310 SPIRIT II: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary S… Phase3 Coronary Disease Completed 2005-07-01 2011-02-01 ClinicalTrials.gov
NCT00187239 Reduce Ventricular Pacing in Dual Chamber Implantable Cardioverter Defibrillato… Phase4 Arrhythmia Completed 2005-07-01 2007-08-01 ClinicalTrials.gov
NCT00236002 Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L ) Phase3 Osteoporosis Terminated 2005-07-01 2009-08-01 ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00195728 Long Term Safety and Tolerability Study in Approximately 350 Subjects With Mode… Phase3 Moderate to Severe Chronic, Non-malignant Pain Completed 2005-06-01 2006-12-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00148759 Kaletra Sex/Gender Pharmacokinetics (PK) Study Phase4 HIV Infections Completed 2005-06-01 2007-01-01 ClinicalTrials.gov
NCT00233558 Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients … Phase4 Rheumatoid Arthritis Terminated 2005-06-01 — ClinicalTrials.gov
NCT00398333 Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemother… Phase4 Colorectal Neoplasms Terminated 2005-06-01 2008-03-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00140101 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2005-05-01 2012-01-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00543621 An Intervention Program to Control Diabetes Phase4 Diabetes Mellitus, Type 2 Completed 2005-05-01 — ClinicalTrials.gov
NCT00166127 Study of Blood Concentrations and Physiologic Effects of Levosimendan Given Dur… Phase3 Heart Failure Terminated 2005-05-01 2007-01-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00419640 SAFE Study - Septal Pacing for Atrial Fibrillation Suppression Evaluation Na Atrial Fibrillation Completed 2005-05-01 2012-11-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT00835822 Efficacy and Safety of the Use of Venocur Triplex® in Patients With Chronic Ven… Phase4 Venous Insufficiency Completed 2005-05-01 — ClinicalTrials.gov
NCT00707837 Nutritional Study in Preterm Infants Phase3 Preterm Infants Completed 2005-05-01 2008-08-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT01270087 The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthr… Phase4 Rheumatoid Arthritis Completed 2005-05-01 2007-02-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00206830 SHORTness of Breath In the Emergency Department (SHORTIE) Phase2 Acute Myocardial Infarction Completed 2005-04-01 2007-08-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00109512 Endometriosis Trial: Study of NBI-56418 in Endometriosis Phase2 Endometriosis Completed 2005-04-01 2006-06-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00106938 Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects… Na Carotid Artery Disease Terminated 2005-04-01 2013-03-01 ClinicalTrials.gov
NCT00113334 Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and N… Phase1 Head and Neck Cancer Completed 2005-04-01 2008-03-01 ClinicalTrials.gov
NCT00159224 Induction-maintenance of Lopinavir/r in HIV-infected Subjects Phase4 HIV Infections Completed 2005-04-01 2009-12-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00235105 D2E7-Early AS Phase2 Ankylosing Spondylitis Unknown 2005-03-01 2007-06-01 ClinicalTrials.gov
NCT00180505 ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded Arteries Phase4 Peripheral Vascular Diseases Completed 2005-03-01 2009-10-01 ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00121472 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardi… Na Heart Failure, Congestive Completed 2005-03-01 2010-05-01 ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00234949 A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderat… Phase4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections Completed 2005-03-01 — ClinicalTrials.gov
NCT00135226 ASCEND: A Study of Cardiovascular Events iN Diabetes Phase4 Diabetes Mellitus Active_Not_Recruiting 2005-03-01 2037-07-31 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00547729 Hemodynamically Guided Home Self-Therapy in Severe Heart Failure Patients (HOME… Na Heart Failure Completed 2005-03-01 2008-06-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00195806 Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatm… Phase3 Migraine Completed 2005-02-01 — ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00121485 Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination The… Na Heart Failure, Congestive Completed 2005-02-01 2012-01-01 ClinicalTrials.gov
NCT00160953 Endorectal Coil Magnetic Resonance Images (ERC-MRI) Phase2 Prostatic Neoplasms Completed 2005-02-01 2010-02-01 ClinicalTrials.gov
NCT00102713 A Study for Treatment of Partial Seizures in Children Phase3 Partial Seizures Completed 2005-02-01 — ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00195780 A Study for the Treatment of Mania Associated With Bipolar I Disorder in Childr… Phase3 Bipolar I Disorder Completed 2005-02-01 — ClinicalTrials.gov
NCT00424762 Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocar… Phase4 Diabetes Mellitus, Type 2 Completed 2005-02-01 2007-04-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT01749449 Increased Dietary Protein and Meal Frequency Reduces Total and Abdominal Body F… Na Obesity Completed 2005-01-01 2007-01-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00100685 Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (R… Phase2 Renal Cell Carcinoma Terminated 2005-01-01 2007-12-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00234910 Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standar… Phase3 HIV Infection Completed 2005-01-01 2008-06-01 ClinicalTrials.gov
NCT00569816 Continuous Versus Repetitive Sevoflurane Administration for Preconditioning Phase4 Myocardial Injury Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT00114933 "OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleos… Phase4 HIV Infection Completed 2005-01-01 2007-05-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT01325922 50/50% Tilt and Tuned Defibrillation Waveform Na DFT Testing Completed 2005-01-01 2005-11-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00237887 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-12-01 — ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00286195 Frontier Registry II Bifurcation Stent System Registry Phase4 Coronary Artery Disease Withdrawn 2004-12-01 2006-12-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00686751 Immune Effects of Vitamin D in Hemodialysis Patients Phase2 End Stage Renal Disease Completed 2004-12-01 2007-09-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00187213 B-Left HF: Biventricular Versus Left Univentricular Pacing With Implantable Car… Na Heart Failure Completed 2004-12-01 2008-01-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00222352 Diagnosis and Treatment of ACS in the ED: The Impact of Rapid Bedside cTnI Test… — Angina, Unstable Completed 2004-12-01 2007-03-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00747565 Safety and Effectiveness of a Multifocal Intraocular Lens (IOL) Na Cataract Completed 2004-11-01 2008-11-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00194025 Valproate in Late Life Schizophrenia Phase4 Schizophrenia Completed 2004-11-01 2006-11-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00225082 SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial F… — HIV Infection Completed 2004-11-01 2007-10-01 ClinicalTrials.gov
NCT00211822 Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (… — Pathological Gambling Terminated 2004-11-01 2010-12-01 ClinicalTrials.gov
NCT00156156 Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase3 Fibroid Uterus Completed 2004-11-01 2007-02-01 ClinicalTrials.gov
NCT00206843 Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Na Heart Failure Completed 2004-11-01 2007-08-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00093301 Levosimendan Versus Dobutamine in Shock Patients Phase2 Cardiogenic Shock Unknown 2004-10-01 2006-04-01 ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00105300 Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of… Phase3 Crohn's Disease Completed 2004-10-01 — ClinicalTrials.gov
NCT00180466 PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions — Coronary Disease Completed 2004-10-01 2009-07-01 ClinicalTrials.gov
NCT00180492 Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection… Na Atherosclerotic Disease, Carotid Completed 2004-10-01 2007-08-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00256152 Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients an… Phase4 Hypertension Completed 2004-09-01 2010-06-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00148356 Safety and Efficacy of the ZoMaxx™ Drug-Eluting Stent System in Coronary Arteri… Phase2 Coronary Disease Completed 2004-09-01 2010-10-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00735878 Pharmacokinetic & Pharmacodynamic Study of ABT-751 With Carboplatin in Patients… Phase1 Non Small Cell Lung Cancer Terminated 2004-09-01 2009-01-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00202514 Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood… Phase2 Alcoholism Completed 2004-09-01 2006-07-01 ClinicalTrials.gov
NCT00195715 Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's … Phase3 Crohn's Disease Completed 2004-09-01 2008-12-01 ClinicalTrials.gov
NCT00073710 Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal A… Phase4 Secondary Hyperparathyroidism Completed 2004-09-01 — ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00194116 Double-blind, Placebo-Controlled Divalproex Sodium ER in Bipolar I or Bipolar I… Phase3 Bipolar Disorder Completed 2004-09-01 2008-02-01 ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00235872 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00091975 Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic… Phase3 Kidney Disease Completed 2004-08-01 — ClinicalTrials.gov
NCT00404183 A Study Comparing the Analgesic Efficacy and Safety of Extended Release Hydroco… Phase2 Pain Completed 2004-08-01 — ClinicalTrials.gov
NCT00217477 Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer Phase1 Unspecified Adult Solid Tumor, Protocol Specific Completed 2004-08-01 2014-09-01 ClinicalTrials.gov
NCT00419055 Outpatient Percutaneous Coronary Intervention — Coronary Artery Disease Terminated 2004-08-01 2006-08-01 ClinicalTrials.gov
NCT00696059 Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? Phase4 Rheumatoid Arthritis Completed 2004-08-01 2007-07-01 ClinicalTrials.gov
NCT00195793 A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy t… Phase3 Hyperlipidemia Completed 2004-08-01 — ClinicalTrials.gov
NCT00234897 Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis Phase4 Rheumatoid Arthritis Completed 2004-08-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT00195767 Evaluate the Safety of Depakote Extended Release Tablets in the Treatment of Ma… Phase3 Bipolar I Disorder, Manic or Mixed Completed 2004-07-01 — ClinicalTrials.gov
NCT00195754 A Phase III Open-Label, Multi-Center, Long-Term Extension Study of Depakote ER … Phase3 Migraines Completed 2004-07-01 — ClinicalTrials.gov
NCT01087710 Effect of Medical Food on Reducing Asthma Symptoms in Asthmatic Children Phase2 Asthma Completed 2004-07-01 2006-01-01 ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00235001 Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension Phase4 Hypertension Completed 2004-06-01 — ClinicalTrials.gov
NCT00234988 A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a… Phase4 Obesity Completed 2004-06-01 — ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT01081873 Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative… — Prostatic Neoplasm Completed 2004-06-01 2010-12-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00200369 Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-ba… — HIV Infection Completed 2004-05-01 2006-03-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00925197 Patient International Normalised Ratio (INR) Self-Testing Program Phase3 Mechanical Aortic and/or Mitral Valve Replacement Operation Completed 2004-05-01 2009-01-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00596661 The TRIMAXX Coronary Stent Trial Phase1 Coronary Artery Disease Completed 2004-05-01 2005-09-01 ClinicalTrials.gov
NCT00195676 Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic P… Phase3 Psoriasis Completed 2004-05-01 2009-10-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00184951 Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients Phase2 HIV Infections Completed 2004-04-01 2005-07-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00156208 Safety of Treatment of Uterine Fibroids With Asoprisnil Phase3 Fibroid Uterus Completed 2004-04-01 2006-12-01 ClinicalTrials.gov
NCT00145795 A Research Study to See if a Change in Therapy for HIV Infection Can Improve th… Phase4 HIV Infections Completed 2004-04-01 2009-12-01 ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00208195 Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase4 Bipolar Disorder Completed 2004-03-01 2007-11-01 ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00234858 Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR) Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00197834 Study of Depakote for Behavioral and Psychological Symptoms in Dementia Phase1 Dementia Unknown 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT00233532 Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAI… Phase4 Hypertension Completed 2004-03-01 — ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT01379703 Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biolo… — HIV-1 Patients Completed 2004-02-01 2010-02-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00563641 Very Early Surfactant and NCPAP for Premature Infants With RDS Phase3 Respiratory Distress Syndrome Completed 2004-01-01 2006-12-01 ClinicalTrials.gov
NCT00234871 Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDE… Phase4 Hypertension Completed 2004-01-01 — ClinicalTrials.gov
NCT00203528 Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use … Phase4 Substance Abuse Completed 2004-01-01 2007-02-01 ClinicalTrials.gov
NCT00186186 Depakote ER in Bipolar Depression Phase4 Depression, Bipolar Completed 2004-01-01 2009-01-01 ClinicalTrials.gov
NCT00181727 Study of Depakote ER for the Treatment of Mania in Children Ages 6-12 With Bipo… Phase4 Bipolar Disorder Completed 2004-01-01 2006-11-01 ClinicalTrials.gov
NCT00085644 Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjec… Phase3 Ankylosing Spondylitis Completed 2004-01-01 2009-07-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00180453 SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting… Phase3 Coronary Artery Disease Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00075231 A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Ef… Phase2 HIV Infections Completed 2003-12-01 — ClinicalTrials.gov
NCT00234936 Quality of Life Study With Adalimumab in Rheumatoid Arthritis Phase3 Rheumatoid Arthritis Completed 2003-12-01 — ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT00195819 Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis Phase3 Ankylosing Spondylitis Completed 2003-12-01 2009-06-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT01086059 OTIS Humira Pregnancy Registry — Crohn's Disease Completed 2003-11-01 2019-10-01 ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00645112 A Comparison of Safety and Efficacy of Cefdinir Oral Suspension Versus Azithrom… Phase4 Acute Otitis Media Completed 2003-11-01 — ClinicalTrials.gov
NCT00645073 Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment… Phase4 Acute Bacterial Sinusitis Completed 2003-11-01 — ClinicalTrials.gov
NCT00645892 Extension Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate… Phase2 Psoriasis Completed 2003-11-01 — ClinicalTrials.gov
NCT00211263 Bipolar Disorder Research Study for Ages 12 and Older Na Bipolar Disorder Completed 2003-11-01 2007-02-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00404391 A Study Comparing the Analgesic Activity of Extended Release Hydrocodone/Acetam… Phase2 Pain Completed 2003-10-01 2004-03-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00900549 Evaluation of Resynchronization Therapy for Heart Failure Phase4 Heart Failure Terminated 2003-10-01 2011-07-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00649922 Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneum… Phase4 Rheumatoid Arthritis Completed 2003-10-01 2005-02-01 ClinicalTrials.gov
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Phase3 Prostate Cancer Completed 2003-10-01 2017-08-01 ClinicalTrials.gov
NCT00206817 Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndro… Phase4 Acute Coronary Syndrome Withdrawn 2003-10-01 — ClinicalTrials.gov
NCT00476359 A PK and Salvage Study for Children With HIV-infection Phase4 HIV Infections Completed 2003-10-01 2008-11-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00186537 Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors … Na Insulin Resistance Completed 2003-09-01 2008-09-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00073151 A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Phase2 Non-Small Cell Lung Cancer Completed 2003-09-01 2006-01-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00152256 A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating W… Phase3 Fibroid Uterus Completed 2003-09-01 2005-02-01 ClinicalTrials.gov
NCT00156195 Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids Phase3 Leiomyoma Completed 2003-09-01 2007-01-01 ClinicalTrials.gov
NCT00578708 Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membra… Phase1 Membranous Ventricular Septal Defects Completed 2003-09-01 2010-09-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00234884 Post-marketing Observational Study in Subjects With Rheumatoid Arthritis — Rheumatoid Arthritis Completed 2003-09-01 2010-07-01 ClinicalTrials.gov
NCT00193674 Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Wome… Phase3 Recurrent Miscarriage Completed 2003-09-01 2009-07-01 ClinicalTrials.gov
NCT00208819 A Comparison of Two Standard Therapies in the Management of Dementia With Agita… Phase4 Senile Dementia, Alzheimer Type Completed 2003-09-01 2007-07-01 ClinicalTrials.gov
NCT00374075 Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patie… Phase1 Spinal Muscular Atrophy Completed 2003-09-01 2006-02-01 ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00195689 Safety and Efficacy of Adalimumab in Patients With Moderate to Severely Active … Phase3 Psoriatic Arthritis Completed 2003-08-01 — ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00278772 Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum… Phase3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania Completed 2003-08-01 2007-12-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073112 A Study of ABT-751 in Patients With Renal Cell Cancer Phase2 Renal Cell Cancer Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00234923 Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Th… Phase3 HIV Infection Completed 2003-08-01 — ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00179335 Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Bet… — HIV Infections Completed 2003-08-01 2006-09-01 ClinicalTrials.gov
NCT00073138 A Study of ABT-751 in Patients With Colorectal Cancer Phase2 Colorectal Cancer Completed 2003-08-01 2005-02-01 ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00073164 Depakote ER Plus an Atypical Antipsychotic Vs. an Atypical Antipsychotic Alone … Phase2 Schizophrenia Completed 2003-07-01 — ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00206856 Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Phase4 Heart Failure Terminated 2003-07-01 2006-04-01 ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00243438 DaVinci Registry(Distinctly Assess Vision in Coronary Intervention) — Coronary Disease Completed 2003-07-01 2005-03-01 ClinicalTrials.gov
NCT00150644 A Study to Evaluate the Effects of Asoprisnil(J867) in Women With Uterine Fibro… Phase2 Uterine Fibroids Completed 2003-07-01 2005-05-01 ClinicalTrials.gov
NCT00077779 Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects … Phase3 Crohn's Disease Completed 2003-07-01 — ClinicalTrials.gov
NCT00067431 A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatme… Phase3 Partial Seizure Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00235859 Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With Me… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00203242 An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER… Na Cluster Headache Completed 2003-07-01 2006-12-01 ClinicalTrials.gov
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects Wit… Phase2 Alzheimer's Disease Terminated 2003-07-01 — ClinicalTrials.gov
NCT00647920 Study of Adalimumab Administered as Subcutaneous Injections in Adult Chinese Rh… Phase3 Rheumatoid Arthritis Completed 2003-07-01 — ClinicalTrials.gov
NCT00071253 Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depako… Phase4 Bipolar Disorder Terminated 2003-07-01 — ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00646178 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase3 Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00187187 DAVID II (Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial II) Na Ventricular Tachycardia Completed 2003-06-01 2007-09-01 ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00091481 Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney… Phase4 Kidney Failure, Chronic Completed 2003-06-01 — ClinicalTrials.gov
NCT00645905 Study of Two Dosing Schedules of Adalimumab in Subjects With Moderate to Severe… Phase2 Psoriasis Completed 2003-06-01 — ClinicalTrials.gov
NCT00135460 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparin… Phase4 HIV-Associated Lipodystrophy Syndrome Unknown 2003-06-01 2007-11-01 ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00235833 Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis Phase2 Rheumatoid Arthritis Completed 2003-06-01 — ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00187278 Biopace Study: Biventricular Pacing for Atrioventricular Block to Prevent Cardi… Na Atrioventricular Block Completed 2003-05-01 2014-10-01 ClinicalTrials.gov
NCT00061659 Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Ad… Phase2 Sarcoma, Soft Tissue Completed 2003-05-01 2006-04-01 ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00073125 Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma Phase2 Carcinoma, Renal Cell Completed 2003-05-01 — ClinicalTrials.gov
NCT00195741 The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migrai… Phase3 Migraine Completed 2003-05-01 — ClinicalTrials.gov
NCT00064376 Paricalcitol in Treating Patients With Myelodysplastic Syndrome Phase2 Leukemia Completed 2003-05-01 2005-11-01 ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00187265 Trip HF Study: Triple Resynchronization in Paced Heeart Failure Patients Na Heart Failure Completed 2003-04-01 2005-10-01 ClinicalTrials.gov
NCT00061672 Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refra… Phase2 Lymphoma, Non-Hodgkin Completed 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00062699 Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage … Phase4 End-Stage Kidney Disease Terminated 2003-04-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00061646 Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects W… Phase2 Carcinoma, Non-Small-Cell Lung Terminated 2003-03-01 — ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00056654 Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prost… Na Prostatic Neoplasms Completed 2003-03-01 2004-07-01 ClinicalTrials.gov
NCT00645814 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects With Mod… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00234845 Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheu… Phase3 Rheumatoid Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00348504 Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic … Phase3 Acute Heart Failure Completed 2003-03-01 2005-06-01 ClinicalTrials.gov
NCT00067262 An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treat… Phase3 Bipolar Disorder Completed 2003-03-01 — ClinicalTrials.gov
NCT00646191 Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Sev… Phase2 Psoriasis Completed 2003-03-01 — ClinicalTrials.gov
NCT00222482 Depakote ER in Borderline Personality Disorder Na Borderline Personality Disorder Completed 2003-03-01 2005-09-01 ClinicalTrials.gov
NCT00646386 Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adal… Phase2 Arthritis Completed 2003-03-01 — ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00646711 Pediatric Switch Study for Children and Adolescent Patients With Epilepsy Phase2 Pediatric Epilepsy Completed 2003-02-01 2003-12-01 ClinicalTrials.gov
NCT00644943 A Comparison of the Safety and Efficacy of Cefdinir Oral Suspension Versus Amox… Phase4 Acute Otitis Media Completed 2003-02-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00645125 A Comparative, Single-Center, Pediatric Taste Test Study of Omnicef Versus Amox… Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00122226 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) Phase4 HIV Infections Unknown 2003-01-01 2008-07-01 ClinicalTrials.gov
NCT00644891 Pediatric Taste Test Study of Cefdinir (Omnicef) Versus Amoxicillin Antibiotic … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00060905 An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatm… Phase3 Bipolar Disorder Completed 2003-01-01 — ClinicalTrials.gov
NCT00234832 A Long Term Study of Sibutramine and the Role of Obesity Management in Relation… Phase3 Obesity Completed 2003-01-01 2009-11-01 ClinicalTrials.gov
NCT00644774 A Pediatric Taste Test Study of Omnicef Versus Zithromax Antibiotic Suspension … Phase4 Healthy Completed 2003-01-01 — ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00160420 A Long-Term Study to Evaluate the Safety of Asoprisnil in the Treatment of Wome… Phase2 Endometriosis Completed 2002-12-01 2004-07-01 ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00645086 Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets … Phase3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Completed 2002-12-01 — ClinicalTrials.gov
NCT00677391 Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian P… Phase3 Obesity Completed 2002-12-01 — ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00063102 A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol… Phase2 Breast Cancer Completed 2002-11-01 2004-08-01 ClinicalTrials.gov
NCT00192972 A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for … Na Atrial Fibrillation Completed 2002-11-01 2005-06-01 ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT00046943 Atrasentan in Treating Patients With Prostate Cancer Phase3 Prostate Cancer Completed 2002-09-01 — ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00448383 A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequat… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00160381 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase3 Leiomyoma Completed 2002-09-01 2005-01-01 ClinicalTrials.gov
NCT00049751 Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheuma… Phase3 Rheumatoid Arthritis Completed 2002-09-01 — ClinicalTrials.gov
NCT00048542 Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyart… Phase3 Arthritis, Juvenile Idiopathic Completed 2002-09-01 2010-06-01 ClinicalTrials.gov
NCT00048425 Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of … Phase3 Heart Failure, Congestive Completed 2002-09-01 2004-12-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT00234962 Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral… Phase4 HIV Infection Terminated 2002-08-01 2007-02-01 ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00160433 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Endometriosis Completed 2002-08-01 2003-06-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00540488 Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Spec… Phase3 Diabetes Mellitus Type 2 Completed 2002-08-01 — ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00055497 Remission in Subjects With Crohn's Disease, 1 Year Phase Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT01070303 Remission in Subjects With Crohn's Disease, Open Label Extension Phase3 Crohn's Disease Completed 2002-08-01 2008-12-01 ClinicalTrials.gov
NCT00309712 Diabetes and Combined Lipid Therapy Regimen (DIACOR) Study Na Type II Diabetes Mellitus Completed 2002-08-01 2006-09-01 ClinicalTrials.gov
NCT00043953 Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidov… Phase2 HIV Infections Completed 2002-08-01 — ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00645203 Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to… Phase2 Acute Otitis Media Completed 2002-07-01 — ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT00043966 Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Anti… Phase3 HIV Infections Completed 2002-07-01 — ClinicalTrials.gov
NCT00919373 Substrate Modification in Stable Ventricular Tachycardia in Addition to Implant… Na Ventricular Tachycardia Completed 2002-07-01 2006-01-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00152269 Treatment of Uterine Fibroids With Asoprisnil(J867) Phase3 Leiomyoma Completed 2002-07-01 2005-01-01 ClinicalTrials.gov
NCT01912326 Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation Na Bradycardia Completed 2002-07-01 2008-04-01 ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00354952 Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Or… Na Healthy Volunteers Completed 2002-07-01 2003-10-01 ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00122018 An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents … Phase2 Kidney Failure, Acute Completed 2002-05-01 2006-03-01 ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00038662 Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exh… Phase2 Prostatic Neoplasms Completed 2002-05-01 — ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00143689 NRTI-Sparing Pilot Study Phase4 HIV Completed 2002-04-01 2008-02-01 ClinicalTrials.gov
NCT00417664 Is Dexmedetomidine Associated With a Lower Incidence of Postoperative Delirium … — Delirium Completed 2002-04-01 2004-04-01 ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00055523 A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical… Phase2 Crohn's Disease Completed 2002-04-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048451 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00679653 Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plu… Phase3 Obesity Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048516 Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00180583 Vision II: Evaluation of GALILEO Intravascular Radiotherapy System Phase4 Coronary Artery Disease Completed 2002-02-01 2005-07-01 ClinicalTrials.gov
NCT00048438 Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic… Phase3 Renal Insufficiency, Chronic Completed 2002-02-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053378 A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU S… Phase2 Hypocalcemia Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00053547 Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pedi… Phase4 Secondary Hyperparathyroidism Completed 2002-01-01 — ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00181558 Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone Phase2 Prostate Cancer Completed 2001-12-01 2006-12-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00202319 Effectiveness of Sedation Management in an Australian Intensive Care Unit Na Respiration Disorders Completed 2001-11-01 2002-09-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT00127478 A Long Term Safety Study With Atrasentan Phase2 Prostate Cancer Completed 2001-07-01 2007-06-01 ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00036556 Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Can… Phase3 Prostatic Neoplasms Completed 2001-06-01 — ClinicalTrials.gov
NCT01083810 Evaluation of Kaletra Therapy Over the Long-term — Human Immunodeficiency Virus Completed 2001-06-01 2010-06-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00715273 Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in Peo… Phase4 Coronary Artery Disease Completed 2001-05-01 2019-03-01 ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00036543 A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer Phase3 Prostate Cancer Completed 2001-05-01 — ClinicalTrials.gov
NCT00032435 Homocysteine Study (HOST) Phase3 End Stage Renal Disease Completed 2001-05-01 2006-09-01 ClinicalTrials.gov
NCT01153269 Long-term Effectiveness and Safety in Hepatitis-co-infected Patients — Human Immunodeficiency Virus-Infection Completed 2001-05-01 2010-11-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038519 Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00038532 Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subject… Phase2 HIV Infections Completed 2001-04-01 — ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00156182 A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids. Phase2 Leiomyoma Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00152295 A Long-Term Study to Evaluate the Safety of Asoprisnil and Estrogen Administrat… Phase2 Postmenopause Completed 2001-04-01 2001-12-01 ClinicalTrials.gov
NCT00187291 Study to Compare TWA Test and EPS Test for Predicting Patients at Risk for Life… Phase3 Ischemic Cardiomyopathy Completed 2001-04-01 2006-07-01 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00262717 Can Resistance Enhance Selection of Treatment? (CREST) Na HIV Infection Completed 2001-03-01 2006-07-31 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00422396 Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inf… Na Hypertriglyceridemia With the Metabolic Syndrome Completed 2001-01-01 2002-04-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00257959 Optimal Pharmacological Therapy In Implantable Defibrillator Patients (OPTIC) Phase4 Ventricular Tachycardia Completed 2001-01-01 2004-10-01 ClinicalTrials.gov
NCT00304993 Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia Phase4 Metabolic Syndrome X Completed 2001-01-01 2005-02-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT01076985 Special Investigation of Kaletra in Pregnant Women — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT01076972 Drug Use Investigation of Kaletra — Human Immunodeficiency Virus Completed 2000-12-01 2010-12-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT00205634 Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis Phase2 Cystic Fibrosis Completed 2000-12-01 2004-10-01 ClinicalTrials.gov
NCT00272103 Itopride in Functional Dyspepsia:a Dose Finding Study Phase2 Functional Dyspepsia Completed 2000-12-01 2002-01-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT01820494 Nutritional Management of Infants With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 2000-10-01 2002-11-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00152282 A Study to Evaluate the Safety and Effectiveness of Asoprisnil and Estrogen Adm… Phase2 Amenorrhea Completed 2000-09-01 2001-08-01 ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00038636 A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Wh… Phase3 HIV Infections Completed 2000-09-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00402584 A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochlori… Phase3 Binge Eating Disorder Completed 2000-08-01 — ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00583791 Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD… Na Heart Septal Defects, Ventricular Completed 2000-07-01 2009-11-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00038220 Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovi… Phase2 HIV Infections Completed 2000-07-01 — ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00195650 Long Term Open Label Continuation Study Phase3 Rheumatoid Arthritis Completed 2000-07-01 2011-05-01 ClinicalTrials.gov
NCT00180544 Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery … Phase3 Renal Artery Obstruction Terminated 2000-07-01 2004-08-01 ClinicalTrials.gov
NCT00261911 A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safe… Phase3 Obesity Completed 2000-07-01 2002-02-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00233571 A Long Term Roll-over Study to Investigate the Efficacy and Safety of Adalimuma… Phase3 Rheumatoid Arthritis Completed 2000-06-01 2006-06-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00160459 A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment… Phase2 Leiomyoma Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00180518 ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Tr… Phase2 Carotid Atherosclerosis Completed 2000-05-01 2003-11-01 ClinicalTrials.gov
NCT00160446 A Study to Evaluate the Safety and Effectiveness of Three Asoprisnil Doses in t… Phase2 Endometriosis Completed 2000-05-01 2001-07-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00269386 Clarithromycin in Active Crohn's Disease Phase3 Crohn's Disease Completed 2000-04-01 2007-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00195702 Efficacy and Safety of Adalimumab in Patients With Active Rheumatoid Arthritis … Phase3 Rheumatoid Arthritis Completed 2000-02-01 2010-08-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT00166257 PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism Phase4 Embolism, Paradoxical Unknown 2000-02-01 2011-05-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT01813526 Infants With Protein Sensitive Colitis Na Protein Sensitive Colitis Completed 1999-11-01 2001-02-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00306852 Tube Versus Trabeculectomy (TVT) Study Na Glaucoma Completed 1999-10-01 2009-05-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT00121550 The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Pati… Phase3 Heart Disease Completed 1999-10-01 2002-09-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT01699386 Growth of Infants Fed an Elemental Medical Food Phase3 Healthy Infants Completed 1999-04-01 2000-12-01 ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00004583 A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Pos… Phase3 HIV Infections Completed 1999-03-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00645255 Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochlori… Phase3 Obesity Terminated 1998-09-01 — ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00590889 Artificial Valve Endocarditis Reduction Trial Na Aortic Valve Disease Terminated 1998-07-01 2014-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00194129 Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Diso… Phase3 Bipolar Disorder Completed 1997-11-01 2006-09-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00004578 ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antir… Phase1 HIV Infections Completed 1997-11-01 2005-04-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT00133692 INVEST: INternational VErapamil SR Trandolapril STudy Phase4 Hypertension Completed 1997-09-01 2003-02-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT01812629 Nutritional Management of Children With Chronic Diarrhea Na Growth and Tolerance Infant Study Completed 1997-07-01 1999-06-01 ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00235014 A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT) Phase4 Hypertension Completed 1997-03-01 — ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00598897 Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC)… Phase4 Mycobacterium Avium Complex Lung Disease Completed 1995-08-01 2017-05-18 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT00002331 The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Wit… Na Mycobacterium Avium-intracellular Infection Completed 1994-01-01 1995-03-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT02456831 Soy Formula Feedings in Healthy, Term Infants Na Gastrointestinal Tolerance Completed 1992-12-01 1994-06-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT00002336 The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacteri… Na Mycobacterium Avium-intracellular Infection Completed 1992-11-01 1994-11-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT02066610 Effect of Selenium Supplementation on Trace Mineral Antioxidant Enzyme and Amin… Na Preterm Infants Completed 1991-03-01 1993-06-01 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00600769 Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobac… Phase4 Nontuberculous Mycobacteria Completed 1991-01-01 2017-05-18 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
NCT00660010 Study of Lupron Depot In The Treatment of Central Precocious Puberty Phase3 Puberty, Precocious Completed 1991-01-01 2009-04-01 ClinicalTrials.gov
Total clinical trials: 15021
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Portico™ NG (Navitor) Valve and FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
FFR>0.80+ OCT with findings indicative of vulnerable plaque Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05599061
AVEIR CSP Leadless Pacemaker System Other Approved Cardiac Pacemaker RECRUITING NCT07287423
Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System Other Preclinical Aortic Stenosis RECRUITING NCT06008080
Prospective, single-arm, multi-center study. Other Approved Severe Native Calcific Aortic Stenosis NOT_YET_RECRUITING NCT07696182
LBBAP with SyncAV Other Preclinical Heart Failure RECRUITING NCT06436053
CardioMEMS HF System Other Preclinical Heart Failure NYHA Class II ENROLLING_BY_INVITATION NCT06306573
Epic™ Surgical Tissue Heart Valve devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Amplatzer™ Occlusion Devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Cephea Mitral Valve System Other Approved Mitral Regurgitation RECRUITING NCT05061004
Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270575
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) RECRUITING NCT07586995
Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder Procedure Preclinical Non-Valvular Atrial Fibrillation TERMINATED NCT06189365
Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270575
Stealth 360™ Peripheral Orbital Atherectomy System from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270562
Grid X and EnSite X v3.1.1 Software Other Approved Paroxysmal Atrial Fibrillation (PAF) RECRUITING NCT07421076
Experimental Nutrition Product Other Approved Gastrointestinal Tolerance COMPLETED NCT07426406
CardioMEMS Other Approved Heart Failure With Reduced Ejection Fraction RECRUITING NCT06241430
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Open loop Other Approved Type 2 Diabetes RECRUITING NCT06959797
Closed loop Other Approved Type 2 Diabetes RECRUITING NCT06959797
antegrade and retrograde approach Other Preclinical Chronic Total Occlusion of Coronary Artery RECRUITING NCT03667196
Caloric restriction Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07666581
Glucerna Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07666581
Anatomical midline lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
Paresthesia mapping lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
DBS of the NAc Other Approved Opioid-use Disorder RECRUITING NCT04354077
MitraClip System Other Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03433274
Tendyne Mitral Valve System Other Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03433274
Veliparib Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Pharmacological Study Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Paclitaxel Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Laboratory Biomarker Analysis Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Carboplatin Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Experimental Other Approved Coronary Artery Calcification ACTIVE_NOT_RECRUITING NCT06885177
EverFlex™ Self-Expanding Peripheral Stent System Other Approved Peripheral Arterial Disease COMPLETED NCT03941314
Supera® Peripheral Stent System Other Approved Peripheral Arterial Disease COMPLETED NCT03941314
Guideline Medical Directed Therapy Drug Approved Heart Failure RECRUITING NCT06526195
HeartMate 3 Left Ventricular Assist System Other Approved Heart Failure RECRUITING NCT06526195
CardioMEMS HF System Other Approved Heart Failure RECRUITING NCT06526195
Implantable Loop Recorder Other Preclinical Atrial Fibrillation RECRUITING NCT07638995
Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Portico™ NG (Navitor) Valve and FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Atrial Fibrillation Radiofrequency Ablation Only Other Approved Atrial Fibrillation (AF) RECRUITING NCT07441382
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion) Other Approved Atrial Fibrillation (AF) RECRUITING NCT07441382
ICM Implantation Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
Standard of Care Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
Continuous glucose monitoring using a wearable sensor (flash interstitial glucose monitor) Other Preclinical Prediabetes (Insulin Resistance, Impaired Glucose Tolerance) NOT_YET_RECRUITING NCT07626658
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Directional Deep Brain Stimulation of STN Other Approved Parkinson Disease COMPLETED NCT03548506
Omnidirectional Deep Brain Stimulation of STN Other Approved Parkinson Disease COMPLETED NCT03548506
PCI revascularization strategy based FFR assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
PCI revascularization strategy based on combined FFR and OCT assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
MODI Algorithm Other Approved Type 1 Diabetes (T1D) RECRUITING NCT07599982
Routine Care Other Approved PreDiabetes COMPLETED NCT05580978
GEM Other Approved PreDiabetes COMPLETED NCT05580978
Amulet™ 2 Left Atrial Appendage (LAA) Occluder Other Approved Atrial Fibrillation (AF) ACTIVE_NOT_RECRUITING NCT06707688
Transseptal procedure with Agilis RF TSP System. Procedure Approved Cardiac Arrythmias RECRUITING NCT07361445
ViewFlex X ICE System Other Preclinical Cardiac Arrhythmias RECRUITING NCT06772493
Ablation of atrial fibrillation (AF) Other Approved Atrial Fibrillation NOT_YET_RECRUITING NCT07621003
Amplatzer PFO Occluder Other Preclinical PFO - Patent Foramen Ovale COMPLETED NCT04349995
PFA Ablation catheter Other Approved Atrial Fibrillation (AF) COMPLETED NCT06676072
protein supplement Other Approved Type 2 Diabetes RECRUITING NCT07271043
MODI Algorithm Other Approved Type 1 Diabetes (T1D) RECRUITING NCT07599982
Drug-eluting stent Drug Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Angiography-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
OCT-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Tendyne™ Mitral Valve System Other Preclinical Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04818502
Continuous glucose monitoring Other Approved Type 2 Diabetes Mellitus (T2DM) ACTIVE_NOT_RECRUITING NCT06888687
Dietetic support Other Approved Type 2 Diabetes Mellitus (T2DM) ACTIVE_NOT_RECRUITING NCT06888687
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Left Atrial Appendage Occluder Implant Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
PVI Ablation Other Approved Atrial Fibrillation (AF) RECRUITING NCT07523620
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Aveir DR Leadless Pacemaker System Other Approved Cardiac Pacemaker, Artificial COMPLETED NCT05252702
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Intralesional Tranexamic Acid Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Mandelic Acid Peel Other Approved Melasma NOT_YET_RECRUITING NCT07604844
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT05270499
MODI Algorithm Other Approved Type 1 Diabetes (T1D) NOT_YET_RECRUITING NCT07599982
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder COMPLETED NCT04559945
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Self monitoring of blood glucose Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
FreeStyle Libre 3 Continuous Glucose Monitoring System. Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05944432
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Risperidone Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Olanzapine Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Divalproex Sodium Extended-Release Tablets Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Risperidone Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Olanzapine Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Divalproex Sodium Extended-Release Tablets Other Phase PHASE2 Schizophrenia COMPLETED NCT00073164
Olanzapine Other Phase PHASE4 Bipolar Disorder TERMINATED NCT00071253
Divalproex Sodium (Extended-Release Tablets) Other Phase PHASE4 Bipolar Disorder TERMINATED NCT00071253
Divalproex Sodium (Delayed-Release Tablets) Other Phase PHASE4 Bipolar Disorder TERMINATED NCT00071253
Divalproex Sodium (Depakote® Sprinkle Capsules) Other Phase PHASE3 Partial Seizure Disorder TERMINATED NCT00067431
Divalproex Sodium (Depakote® Sprinkle Capsules) Other Phase PHASE3 Partial Seizure Disorder TERMINATED NCT00067431
Divalproex Sodium Extended-Release Tablets Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00067262
Divalproex Sodium Extended-Release Tablets Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00067262
Divalproex Sodium (Depakote ER) Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00060905
Zemplar Other Phase PHASE4 Kidney Failure, Chronic COMPLETED NCT00091481
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00077779
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00077779
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00338650
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00338650
Atrasentan Other Phase PHASE2 Prostate Cancer COMPLETED NCT00127478
Atrasentan Other Phase PHASE2 Prostate Cancer COMPLETED NCT00127478
ABT-751 Other Phase PHASE2 Non-Small Cell Lung Cancer COMPLETED NCT00073151
ABT-751 Other Phase PHASE2 Non-Small Cell Lung Cancer COMPLETED NCT00073151
ABT-751 Other Phase PHASE2 Colorectal Cancer COMPLETED NCT00073138
ABT-751 Other Phase PHASE2 Colorectal Cancer COMPLETED NCT00073138
ABT-751 Other Phase PHASE2 Renal Cell Cancer COMPLETED NCT00073112
ABT-751 Other Phase PHASE2 Breast Cancer COMPLETED NCT00063102
ABT-751 Other Phase PHASE2 Breast Cancer COMPLETED NCT00063102
ABT-510 - Thrombospondin-1 mimetic Other Phase PHASE2 Sarcoma, Soft Tissue COMPLETED NCT00061659
ABT-510 - Thrombospondin-1 mimetic Other Phase PHASE2 Sarcoma, Soft Tissue COMPLETED NCT00061659
Depakote DR Other Phase PHASE4 Mania COMPLETED NCT00334347
Depakote ER Other Phase PHASE4 Mania COMPLETED NCT00334347
Depakote DR Other Phase PHASE4 Mania COMPLETED NCT00334347
Depakote ER Other Phase PHASE4 Mania COMPLETED NCT00334347
Sevoflurane Other Phase PHASE4 Myocardial Injury COMPLETED NCT00569816
Dobutamine Other Phase PHASE2 Cardiogenic Shock UNKNOWN NCT00093301
Levosimendan Other Phase PHASE2 Cardiogenic Shock UNKNOWN NCT00093301
Sedation management protocol Other Approved Respiration Disorders COMPLETED NCT00202319
Sedation management protocol Other Approved Respiration Disorders COMPLETED NCT00202319
Adalimumab 40 mg sc every other week Other Phase PHASE2 Ankylosing Spondylitis UNKNOWN NCT00235105
Adalimumab 40 mg sc every other week Other Phase PHASE2 Ankylosing Spondylitis UNKNOWN NCT00235105
Adalimumab 40 mg sc every other week Other Phase PHASE2 Ankylosing Spondylitis UNKNOWN NCT00235105
nucleoside analogue sparing HAART regimen Other Phase PHASE4 HIV-Associated Lipodystrophy Syndrome UNKNOWN NCT00135460
nucleoside analogue sparing HAART regimen Other Phase PHASE4 HIV-Associated Lipodystrophy Syndrome UNKNOWN NCT00135460
nucleoside analogue sparing HAART regimen Other Phase PHASE4 HIV-Associated Lipodystrophy Syndrome UNKNOWN NCT00135460
Rapid versus slow conversion Other Phase PHASE4 Epilepsy UNKNOWN NCT00312676
Rapid versus slow conversion Other Phase PHASE4 Epilepsy UNKNOWN NCT00312676
Lopinavir/ritonavir + nevirapine Other Phase PHASE4 HIV Infections UNKNOWN NCT00122226
Lopinavir/ritonavir + zidovudine + lamivudine Other Phase PHASE4 HIV Infections UNKNOWN NCT00122226
Lopinavir/ritonavir + nevirapine Other Phase PHASE4 HIV Infections UNKNOWN NCT00122226
Lopinavir/ritonavir + zidovudine + lamivudine Other Phase PHASE4 HIV Infections UNKNOWN NCT00122226
Itopride (drug) Drug Phase PHASE2 Functional Dyspepsia COMPLETED NCT00272103
Itopride (drug) Drug Phase PHASE2 Functional Dyspepsia COMPLETED NCT00272103
Macrolides (azithromycin or clarithromycin) Other Approved Healthy Volunteers COMPLETED NCT00354952
Macrolides (azithromycin or clarithromycin) Other Approved Healthy Volunteers COMPLETED NCT00354952
amiodarone beta blocker sotalol Other Phase PHASE4 Ventricular Tachycardia COMPLETED NCT00257959
Truvada (emtricitabine/tenofovir disoproxil fumarate) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Sustiva (efavirenz) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Kaletra (lopinavir/ritonavir) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Truvada (emtricitabine/tenofovir disoproxil fumarate) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Sustiva (efavirenz) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Kaletra (lopinavir/ritonavir) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Truvada (emtricitabine/tenofovir disoproxil fumarate) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Sustiva (efavirenz) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Kaletra (lopinavir/ritonavir) Other Phase PHASE2 HIV Infection WITHDRAWN NCT00121017
Emtricitabine Other Phase PHASE3 HIV Infections COMPLETED NCT00043966
Tenofovir DF Other Phase PHASE3 HIV Infections COMPLETED NCT00043966
Lopinavir/ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00043966
Tenofovir DF Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Lamivudine Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Efavirenz Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Tenofovir DF Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Lamivudine Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Efavirenz Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038220
Saquinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038519
Amprenavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038519
Saquinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038519
Amprenavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038519
Calcijex Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
42 Ca carbonate absorption via single tracer method Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Zemplar Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Calcijex Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
42 Ca carbonate absorption via single tracer method Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Zemplar Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Calcijex Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
42 Ca carbonate absorption via single tracer method Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Zemplar Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00073710
Calcijex Other Phase PHASE4 End-Stage Kidney Disease TERMINATED NCT00062699
Zemplar (paricalcitol injection) Other Phase PHASE4 End-Stage Kidney Disease TERMINATED NCT00062699
Calcijex Other Phase PHASE4 End-Stage Kidney Disease TERMINATED NCT00062699
Zemplar (paricalcitol injection) Other Phase PHASE4 End-Stage Kidney Disease TERMINATED NCT00062699
paricalcitol injection Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00053547
paricalcitol injection Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00053547
paricalcitol injection Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00053547
Administration of elemental Ca during hypocalcemic ICU pts. Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
Effects on calcium regulation Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
paricalcitol injection (Zemplar) Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
Administration of elemental Ca during hypocalcemic ICU pts. Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
Effects on calcium regulation Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
paricalcitol injection (Zemplar) Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
Administration of elemental Ca during hypocalcemic ICU pts. Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
Effects on calcium regulation Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
paricalcitol injection (Zemplar) Other Phase PHASE2 Hypocalcemia COMPLETED NCT00053378
paricalcitol capsule Other Phase PHASE3 Renal Insufficiency, Chronic COMPLETED NCT00048516
paricalcitol capsule Other Phase PHASE3 Renal Insufficiency, Chronic COMPLETED NCT00048516
paricalcitol Other Phase PHASE3 Renal Insufficiency, Chronic COMPLETED NCT00048451
paricalcitol Other Phase PHASE3 Renal Insufficiency, Chronic COMPLETED NCT00048451
Depakote Other Phase PHASE1 Dementia UNKNOWN NCT00197834
Depakote Other Phase PHASE1 Dementia UNKNOWN NCT00197834
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00105300
Adalimumab (D2E7) Other Phase PHASE2 Crohn's Disease COMPLETED NCT00055523
Adalimumab (D2E7) Other Phase PHASE2 Crohn's Disease COMPLETED NCT00055523
Adalimumab (D2E7) Other Phase PHASE2 Crohn's Disease COMPLETED NCT00055523
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00049751
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00049751
paricalcitol Other Phase PHASE3 Renal Insufficiency, Chronic COMPLETED NCT00048438
Atrasentan Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00038662
Atrasentan Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00038662
Atrasentan Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00038662
Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00038636
Lopinavir/ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00038636
Atrasentan Other Phase PHASE3 Prostate Cancer COMPLETED NCT00036543
Atrasentan Other Phase PHASE3 Prostate Cancer COMPLETED NCT00036543
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00069849
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00069849
Kaletra (drug) Drug Approved HIV UNKNOWN NCT00247143
Sustiva® (efavirenz) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Combivir® (lamivudine, zidovudine) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Kaletra® (lopinavir/ritonavir) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Sustiva® (efavirenz) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Combivir® (lamivudine, zidovudine) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Kaletra® (lopinavir/ritonavir) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Sustiva® (efavirenz) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Combivir® (lamivudine, zidovudine) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Kaletra® (lopinavir/ritonavir) Other Phase PHASE2 HIV Infections COMPLETED NCT00075231
Levosimendan Other Phase PHASE3 Heart Failure, Congestive COMPLETED NCT00048425
Levosimendan Other Phase PHASE3 Heart Failure, Congestive COMPLETED NCT00048425
Levosimendan Other Phase PHASE3 Heart Failure, Congestive COMPLETED NCT00048425
divalproex sodium Other Phase PHASE3 Migraine COMPLETED NCT00195741
divalproex sodium Other Phase PHASE3 Migraine COMPLETED NCT00195741
risperidone Other Phase PHASE4 Substance Abuse COMPLETED NCT00203528
divalproex sodium ER Other Phase PHASE4 Substance Abuse COMPLETED NCT00203528
risperidone Other Phase PHASE4 Substance Abuse COMPLETED NCT00203528
divalproex sodium ER Other Phase PHASE4 Substance Abuse COMPLETED NCT00203528
divalproex sodium Other Phase PHASE3 Bipolar I Disorder, Manic or Mixed COMPLETED NCT00195767
divalproex sodium Other Phase PHASE3 Bipolar I Disorder, Manic or Mixed COMPLETED NCT00195767
divalproex sodium Other Phase PHASE3 Bipolar I Disorder, Manic or Mixed COMPLETED NCT00195767
methotrexate Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00233558
adalimumab (up to 9 months exposure) Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00233558
methotrexate Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00233558
adalimumab (up to 9 months exposure) Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00233558
Divalproex Sodium (Depakote Sprinkle Capsules) Other Phase PHASE3 Partial Seizures COMPLETED NCT00102713
Divalproex Sodium (Depakote ER) Other Phase PHASE3 Bipolar I Disorder COMPLETED NCT00195780
Divalproex Sodium (Depakote ER) Other Phase PHASE3 Bipolar I Disorder COMPLETED NCT00195780
Divalproex Sodium (Depakote ER) Other Phase PHASE3 Bipolar I Disorder COMPLETED NCT00195780
divalproex sodium Other Phase PHASE3 Migraines COMPLETED NCT00195754
Depakote ER Other Approved Borderline Personality Disorder COMPLETED NCT00222482
Depakote ER Other Approved Borderline Personality Disorder COMPLETED NCT00222482
Depakote ER Other Approved Borderline Personality Disorder COMPLETED NCT00222482
Carboplatin/Taxol Other Phase PHASE2 Carcinoma, Non-Small-Cell Lung TERMINATED NCT00061646
ABT-510/Thrombospondin-1 mimetic Other Phase PHASE2 Carcinoma, Non-Small-Cell Lung TERMINATED NCT00061646
WaterWorks Douching Device Device Approved Vaginal Odor UNKNOWN NCT00417365
WaterWorks Douching Device Device Approved Vaginal Odor UNKNOWN NCT00417365
ABT-510/Thrombospondin-1 mimetic Other Phase PHASE2 Carcinoma, Renal Cell COMPLETED NCT00073125
ABT-510/Thrombospondin-1 mimetic Other Phase PHASE2 Carcinoma, Renal Cell COMPLETED NCT00073125
ABT-510/Thrombospondin-1 mimetic Other Phase PHASE2 Carcinoma, Renal Cell COMPLETED NCT00073125
ABT-510 - Thrombospondin-1 Mimetic Other Phase PHASE2 Lymphoma, Non-Hodgkin COMPLETED NCT00061672
ABT-510 - Thrombospondin-1 Mimetic Other Phase PHASE2 Lymphoma, Non-Hodgkin COMPLETED NCT00061672
Atrasentan Other Phase PHASE3 Prostatic Neoplasms COMPLETED NCT00036556
Atrasentan Other Phase PHASE3 Prostatic Neoplasms COMPLETED NCT00036556
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00237887
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00237887
adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00235885
adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00235885
methotrexate Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00235859
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00235859
methotrexate Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00235859
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00235859
adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00234897
adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00234897
methotrexate Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234845
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234845
Human anti-TNF monoclonal antibody/adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00195689
Human anti-TNF monoclonal antibody/adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00195689
sibutramine Other Phase PHASE3 Binge Eating Disorder COMPLETED NCT00402584
sibutramine Other Phase PHASE3 Binge Eating Disorder COMPLETED NCT00402584
sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00261911
sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00261911
divalproex sodium Other Phase PHASE3 Migraine COMPLETED NCT00195806
divalproex sodium Other Phase PHASE3 Migraine COMPLETED NCT00195806
Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks Other Phase PHASE2 Psoriasis COMPLETED NCT00338754
Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks Other Phase PHASE2 Psoriasis COMPLETED NCT00338754
Lamivudine/zidovudine Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Saquinavir mesylate Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Lamivudine/zidovudine Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Saquinavir mesylate Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Lamivudine/zidovudine Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Saquinavir mesylate Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00043953
Methotrexate Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234936
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234936
Methotrexate Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234936
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00234936
atorvastatin Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00195793
ezetimibe Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00195793
fenofibrate Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00195793
adalimumab (Humira) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00478660
adalimumab (Humira) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00478660
adalimumab (Humira) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00478660
daily enteral nutritional product and/or behavioral changes Other Phase PHASE4 Diabetes Mellitus, Type 2 COMPLETED NCT00543621
Adult enteral formula Other Phase PHASE3 Diabetes Mellitus Type 2 COMPLETED NCT00540488
cephalexin Other Phase PHASE4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections COMPLETED NCT00234949
cefdinir Other Phase PHASE4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections COMPLETED NCT00234949
cephalexin Other Phase PHASE4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections COMPLETED NCT00234949
cefdinir Other Phase PHASE4 Mild to Moderate Uncomplicated Skin and Skin Structure Infections COMPLETED NCT00234949
Vicodin® CR (extended-release hydrocodone/acetaminophen) Other Phase PHASE1 Drug Interactions COMPLETED NCT00429468
Vicodin® CR (extended-release hydrocodone/acetaminophen) Other Phase PHASE1 Drug Interactions COMPLETED NCT00429468
Humira (adalimumab) Other Phase PHASE2 Asthma WITHDRAWN NCT00512863
Humira (adalimumab) Other Phase PHASE2 Asthma WITHDRAWN NCT00512863
dobutamine Other Phase PHASE3 Acute Heart Failure COMPLETED NCT00348504
levosimendan Other Phase PHASE3 Acute Heart Failure COMPLETED NCT00348504
dobutamine Other Phase PHASE3 Acute Heart Failure COMPLETED NCT00348504
levosimendan Other Phase PHASE3 Acute Heart Failure COMPLETED NCT00348504
bubble NCPAP Other Phase PHASE3 Respiratory Distress Syndrome COMPLETED NCT00563641
Very early surfactant and bubble NCPAP Other Phase PHASE3 Respiratory Distress Syndrome COMPLETED NCT00563641
bubble NCPAP Other Phase PHASE3 Respiratory Distress Syndrome COMPLETED NCT00563641
Very early surfactant and bubble NCPAP Other Phase PHASE3 Respiratory Distress Syndrome COMPLETED NCT00563641
Divalproex ER Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00208195
Divalproex ER Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00208195
suture mediated closure Other Preclinical Cardiac Catheterization UNKNOWN NCT00838175
Nevirapine Other Phase PHASE1 HIV Infections COMPLETED NCT00004580
Lopinavir/Ritonavir Other Phase PHASE1 HIV Infections COMPLETED NCT00004580
Nevirapine Other Phase PHASE1 HIV Infections COMPLETED NCT00004580
Lopinavir/Ritonavir Other Phase PHASE1 HIV Infections COMPLETED NCT00004580
Ritonavir Other Phase PHASE2 Sarcoma, Kaposi COMPLETED NCT00002366
Ritonavir Other Phase PHASE2 Sarcoma, Kaposi COMPLETED NCT00002366
placebo for adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645905
adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645905
placebo for adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645892
adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645892
adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645814
placebo for adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645814
Adalimumab (Humira) Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00696059
Adalimumab (Humira) Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00696059
Guidant GALILEO Intravascular Radiotherapy System Drug Phase PHASE4 Coronary Artery Disease COMPLETED NCT00180583
Guidant GALILEO Intravascular Radiotherapy System Drug Phase PHASE4 Coronary Artery Disease COMPLETED NCT00180583
RX ACCULINK(TM) Carotid Stent System and RX ACCUNET(TM) Embolic Protection System Other Approved Atherosclerotic Disease, Carotid COMPLETED NCT00180492
Stavudine Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Lamivudine Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Nelfinavir mesylate Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Lopinavir/Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Stavudine Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Lamivudine Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Nelfinavir mesylate Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Lopinavir/Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00004583
Nevirapine Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Lopinavir/Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Nevirapine Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Lopinavir/Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Nevirapine Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Lopinavir/Ritonavir Other Phase PHASE3 HIV Infections COMPLETED NCT00004581
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002275
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002275
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002275
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002275
Ritonavir Other Approved HIV Infections COMPLETED NCT00002223
Indinavir sulfate Other Approved HIV Infections COMPLETED NCT00002223
Nelfinavir mesylate Other Approved HIV Infections COMPLETED NCT00002201
Ritonavir Other Approved HIV Infections COMPLETED NCT00002201
Aspirin (ASA) placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Aspirin (ASA) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Niacin extended-release (NER) placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Niacin extended-release (NER) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Humira (adalimumab) Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00761514
Humira (adalimumab) Other Phase PHASE4 Rheumatoid Arthritis TERMINATED NCT00761514
medical food minus EPA and GLA, antioxidant vitamins/minerals Other Phase PHASE2 Asthma COMPLETED NCT01087710
medical food with EPA and GLA, vitamins and minerals Other Phase PHASE2 Asthma COMPLETED NCT01087710
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
medical food minus EPA and GLA, antioxidant vitamins/minerals Other Phase PHASE2 Asthma COMPLETED NCT01087710
medical food with EPA and GLA, vitamins and minerals Other Phase PHASE2 Asthma COMPLETED NCT01087710
Ad lib diet; AN 777; exercise Other Phase PHASE2 Aged COMPLETED NCT00798291
Ad lib diet/ placebo/ exercise Other Phase PHASE2 Aged COMPLETED NCT00798291
Ad lib diet and An 777 Other Phase PHASE2 Aged COMPLETED NCT00798291
Ad lib diet and Control placebo Other Phase PHASE2 Aged COMPLETED NCT00798291
Adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT00735787
Placebo Other Phase PHASE4 Psoriasis COMPLETED NCT00735787
Increased dose of Kaletra Other Phase PHASE4 HIV Infections TERMINATED NCT00414284
Increased dose of Kaletra Other Phase PHASE4 HIV Infections TERMINATED NCT00414284
Ketoconazole Other Phase PHASE1 Lymphoma COMPLETED NCT01021358
ABT-263 Other Phase PHASE1 Lymphoma COMPLETED NCT01021358
Hydrocodone/Acetaminophen on Extended Release Other Phase PHASE3 Moderate to Severe Chronic, Non-malignant Pain COMPLETED NCT00195728
Zemplar Capsule Other Phase PHASE3 Kidney Disease COMPLETED NCT00091975
Zemplar Capsule Other Phase PHASE3 Kidney Disease COMPLETED NCT00091975
Zemplar Capsule Other Phase PHASE3 Kidney Disease COMPLETED NCT00091975
Clarithromycin Other Phase PHASE2 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000644
Lupron (leuprolide acetate) Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00660010
Lupron (leuprolide acetate) Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00660010
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Mitral Valve Repair Surgery Procedure Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
MitraClip™ device implantation Device Approved Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04198870
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
Stopping nucleosides and continuing lopinavir/ritonavir monotherapy Drug Phase PHASE4 HIV Infection COMPLETED NCT00114933
sibutramine or placebo Other Phase PHASE3 Obesity TERMINATED NCT00645255
placebo Other Phase PHASE3 Obesity TERMINATED NCT00645255
sibutramine or placebo Other Phase PHASE3 Obesity TERMINATED NCT00645255
placebo Other Phase PHASE3 Obesity TERMINATED NCT00645255
cefdinir Other Phase PHASE2 Acute Otitis Media COMPLETED NCT00645203
cefdinir Other Phase PHASE2 Acute Otitis Media COMPLETED NCT00645203
cefdinir Other Phase PHASE2 Acute Otitis Media COMPLETED NCT00645203
amoxicillin Other Phase PHASE4 Healthy COMPLETED NCT00645125
cefdinir (Omnicef) Other Phase PHASE4 Healthy COMPLETED NCT00645125
amoxicillin Other Phase PHASE4 Healthy COMPLETED NCT00645125
cefdinir (Omnicef) Other Phase PHASE4 Healthy COMPLETED NCT00645125
azithromycin Other Phase PHASE4 Acute Otitis Media COMPLETED NCT00645112
cefdinir (Omnicef) Other Phase PHASE4 Acute Otitis Media COMPLETED NCT00645112
clarithromycin immediate-release tablets Other Phase PHASE3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). COMPLETED NCT00645086
clarithromycin extended-release tablets Other Phase PHASE3 Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). COMPLETED NCT00645086
levofloxacin Other Phase PHASE4 Acute Bacterial Sinusitis COMPLETED NCT00645073
cefdinir (Omnicef) Other Phase PHASE4 Acute Bacterial Sinusitis COMPLETED NCT00645073
amoxicillin Other Phase PHASE4 Acute Otitis Media COMPLETED NCT00644943
cefdinir (Omnicef) Other Phase PHASE4 Acute Otitis Media COMPLETED NCT00644943
amoxicillin Other Phase PHASE4 Healthy COMPLETED NCT00644891
cefdinir (Omnicef) Other Phase PHASE4 Healthy COMPLETED NCT00644891
azithromycin Other Phase PHASE4 Healthy COMPLETED NCT00644774
cefdinir (Omnicef) Other Phase PHASE4 Healthy COMPLETED NCT00644774
azithromycin Other Phase PHASE4 Healthy COMPLETED NCT00644774
cefdinir (Omnicef) Other Phase PHASE4 Healthy COMPLETED NCT00644774
Depakote ER Other Phase PHASE2 Pediatric Epilepsy COMPLETED NCT00646711
Depakote Delayed-Release/Depakote Sprinkle Other Phase PHASE2 Pediatric Epilepsy COMPLETED NCT00646711
placebo for adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
placebo for adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
placebo for adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
adalimumab Other Phase PHASE2 Arthritis COMPLETED NCT00646386
adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00646191
placebo for adalimumab Other Phase PHASE3 Arthritis COMPLETED NCT00646178
adalimumab Other Phase PHASE3 Arthritis COMPLETED NCT00646178
placebo for adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645905
adalimumab Other Phase PHASE2 Psoriasis COMPLETED NCT00645905
placebo Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00649922
adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00649922
placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647920
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647920
Efavirenz Other Phase PHASE2 HIV Infections COMPLETED NCT00038532
Saquinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038532
Amprenavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00038532
lamivudine/zidovudine Other Phase PHASE3 HIV Infection COMPLETED NCT00234923
lopinavir/ritonavir Other Phase PHASE3 HIV Infection COMPLETED NCT00234923
Stavudine Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
Lamivudine Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
Lopinavir/Ritonavir Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
Stavudine Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
Lamivudine Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
Lopinavir/Ritonavir Other Phase PHASE1 HIV Infections COMPLETED NCT00004578
adalimumab Other Preclinical Rheumatoid Arthritis APPROVED_FOR_MARKETING NCT00650026
adalimumab Other Preclinical Rheumatoid Arthritis APPROVED_FOR_MARKETING NCT00650026
adalimumab Other Preclinical Rheumatoid Arthritis APPROVED_FOR_MARKETING NCT00650026
Adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00427362
Adalimumab Other Phase PHASE3 Psoriatic Arthritis COMPLETED NCT00427362
Placebo Other Phase PHASE3 Obesity COMPLETED NCT00677391
Sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00677391
Placebo Other Phase PHASE3 Obesity COMPLETED NCT00677391
Sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00677391
Placebo Other Phase PHASE3 Obesity COMPLETED NCT00677391
Sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00677391
felodipine/ramipril Other Phase PHASE3 Obesity COMPLETED NCT00679653
metoprolol/HCT Other Phase PHASE3 Obesity COMPLETED NCT00679653
verapamil/trandolapril Other Phase PHASE3 Obesity COMPLETED NCT00679653
sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00679653
felodipine/ramipril Other Phase PHASE3 Obesity COMPLETED NCT00679653
metoprolol/HCT Other Phase PHASE3 Obesity COMPLETED NCT00679653
verapamil/trandolapril Other Phase PHASE3 Obesity COMPLETED NCT00679653
sibutramine Other Phase PHASE3 Obesity COMPLETED NCT00679653
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156156
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156156
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156156
Placebo Other Phase PHASE2 Leiomyoma COMPLETED NCT00160459
Asoprisnil Other Phase PHASE2 Leiomyoma COMPLETED NCT00160459
Placebo Other Phase PHASE2 Endometriosis COMPLETED NCT00160446
Asoprisnil Other Phase PHASE2 Endometriosis COMPLETED NCT00160446
Placebo Other Phase PHASE2 Endometriosis COMPLETED NCT00160433
Asoprisnil Other Phase PHASE2 Endometriosis COMPLETED NCT00160433
Placebo Other Phase PHASE2 Endometriosis COMPLETED NCT00160433
Asoprisnil Other Phase PHASE2 Endometriosis COMPLETED NCT00160433
Asoprisnil Other Phase PHASE2 Endometriosis COMPLETED NCT00160420
Asoprisnil Other Phase PHASE2 Endometriosis COMPLETED NCT00160420
Placebo Other Phase PHASE3 Leiomyoma COMPLETED NCT00160381
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00160381
Placebo Other Phase PHASE3 Leiomyoma COMPLETED NCT00160381
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00160381
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156208
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156208
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00156208
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00156195
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00156195
Asoprisnil/Premarin Other Phase PHASE2 Postmenopause COMPLETED NCT00152295
Placebo and Premarin Other Phase PHASE2 Amenorrhea COMPLETED NCT00152282
Asoprisnil/Premarin Other Phase PHASE2 Amenorrhea COMPLETED NCT00152282
Placebo and Premarin Other Phase PHASE2 Amenorrhea COMPLETED NCT00152282
Asoprisnil/Premarin Other Phase PHASE2 Amenorrhea COMPLETED NCT00152282
Placebo Other Phase PHASE3 Leiomyoma COMPLETED NCT00152269
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00152269
Placebo Other Phase PHASE3 Leiomyoma COMPLETED NCT00152269
Asoprisnil Other Phase PHASE3 Leiomyoma COMPLETED NCT00152269
Placebo Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00152256
Asoprisnil Other Phase PHASE3 Fibroid Uterus COMPLETED NCT00152256
Placebo Other Phase PHASE2 Uterine Fibroids COMPLETED NCT00150644
Asoprisnil Other Phase PHASE2 Uterine Fibroids COMPLETED NCT00150644
Milk based formula C Other Phase PHASE2 Healthy COMPLETED NCT00543673
#3 Human Milk Other Phase PHASE2 Healthy COMPLETED NCT00543673
#2 Standard formula Other Phase PHASE2 Healthy COMPLETED NCT00543673
Milk based formula A Other Phase PHASE2 Healthy COMPLETED NCT00543673
Milk based formula C Other Phase PHASE2 Healthy COMPLETED NCT00543673
#3 Human Milk Other Phase PHASE2 Healthy COMPLETED NCT00543673
#2 Standard formula Other Phase PHASE2 Healthy COMPLETED NCT00543673
Milk based formula A Other Phase PHASE2 Healthy COMPLETED NCT00543673
Diabetes specific enteral product Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00520065
enteral nutritional formula Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00520065
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235001
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235001
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235001
lopinavir/ritonavir with 2 Nucleoside RTIs Other Phase PHASE3 HIV Infection COMPLETED NCT00234910
Tenofovir DF Other Phase PHASE3 HIV Infection COMPLETED NCT00234910
lopinavir/ritonavir with 2 Nucleoside RTIs Other Phase PHASE3 HIV Infection COMPLETED NCT00234910
Tenofovir DF Other Phase PHASE3 HIV Infection COMPLETED NCT00234910
verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235014
placebo Other Phase PHASE4 Hypertension COMPLETED NCT00235014
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235014
trandolapril Other Phase PHASE4 Hypertension COMPLETED NCT00235014
verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235014
placebo Other Phase PHASE4 Hypertension COMPLETED NCT00235014
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00235014
trandolapril Other Phase PHASE4 Hypertension COMPLETED NCT00235014
sibutramine hydochloride monohydrate Other Phase PHASE4 Obesity COMPLETED NCT00234988
sibutramine hydochloride monohydrate Other Phase PHASE4 Obesity COMPLETED NCT00234988
Lotrel (amlodipine/benazepril) Other Phase PHASE4 Hypertension COMPLETED NCT00234871
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00234871
Lotrel (amlodipine/benazepril) Other Phase PHASE4 Hypertension COMPLETED NCT00234871
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00234871
(Hyzaar) losartan/hydrochlorothiazide Other Phase PHASE4 Hypertension COMPLETED NCT00234858
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00234858
(Hyzaar) losartan/hydrochlorothiazide Other Phase PHASE4 Hypertension COMPLETED NCT00234858
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00234858
(Hyzaar) losartan/hydrochlorothiazide Other Phase PHASE4 Hypertension COMPLETED NCT00234858
trandolapril/verapamil Other Phase PHASE4 Hypertension COMPLETED NCT00234858
placebo adalimumab, placebo MTX Other Phase PHASE3 Psoriasis COMPLETED NCT00235820
MTX Other Phase PHASE3 Psoriasis COMPLETED NCT00235820
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00235820
Trandolapril Other Phase PHASE4 Hypertension COMPLETED NCT00233532
Trandolapril Other Phase PHASE4 Hypertension COMPLETED NCT00233532
Stenting: Renal Artery Other Phase PHASE3 Renal Artery Obstruction TERMINATED NCT00180544
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00448383
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00448383
Didanosine Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
Zidovudine Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
Clarithromycin Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
Didanosine Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
Zidovudine Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
Clarithromycin Other Phase PHASE1 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000971
fenofibrate 160 mg and simvastatin 20 mg Other Approved Type II Diabetes Mellitus COMPLETED NCT00309712
simvastatin 20 mg and placebo Other Approved Type II Diabetes Mellitus COMPLETED NCT00309712
fenofibrate 160 mg and placebo Other Approved Type II Diabetes Mellitus COMPLETED NCT00309712
Divalproex Other Approved Epilepsy COMPLETED NCT00347152
Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system Other Phase PHASE2 Carotid Atherosclerosis COMPLETED NCT00180518
Over-the-wire & Rapid Exchange ACCULINK (tm) Carotid Stent & ACCUNET (tm) embolic protection system Other Phase PHASE2 Carotid Atherosclerosis COMPLETED NCT00180518
Leuprolide acetate Other Approved Prostatic Neoplasms COMPLETED NCT00056654
Leuprolide acetate Other Approved Prostatic Neoplasms COMPLETED NCT00056654
Leuprolide acetate Other Approved Prostatic Neoplasms COMPLETED NCT00056654
Diabetes specific feeding product Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00544206
standard enteral feeding product Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00544206
Diabetes specific feeding product Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00544206
standard enteral feeding product Other Phase PHASE2 Type 2 Diabetes Mellitus COMPLETED NCT00544206
TriMaxx Coronary Stent placement Other Phase PHASE1 Coronary Artery Disease COMPLETED NCT00596661
Carotid artery stenting with filter (interventional) Other Phase PHASE4 Carotid Artery Disease COMPLETED NCT00287508
Subunit influenza vaccine Other Phase PHASE4 Immunosuppression COMPLETED NCT00783380
Virosomal influenza vaccine Other Phase PHASE4 Immunosuppression COMPLETED NCT00783380
Subunit influenza vaccine Other Phase PHASE4 Immunosuppression COMPLETED NCT00783380
Virosomal influenza vaccine Other Phase PHASE4 Immunosuppression COMPLETED NCT00783380
Ensure Plus Other Phase PHASE4 Esophageal Cancer UNKNOWN NCT00790140
Prosure Other Phase PHASE4 Esophageal Cancer UNKNOWN NCT00790140
Ensure Plus Other Phase PHASE4 Esophageal Cancer UNKNOWN NCT00790140
Prosure Other Phase PHASE4 Esophageal Cancer UNKNOWN NCT00790140
Lopinavir/Ritonavir Other Phase PHASE4 HIV Infection TERMINATED NCT00234962
Lopinavir/Ritonavir Other Phase PHASE4 HIV Infection TERMINATED NCT00234962
Placebo Other Phase PHASE1 Asthma COMPLETED NCT00657774
Oral Prednisone 10mg Other Phase PHASE1 Asthma COMPLETED NCT00657774
FlutiForm 100/10 ug Other Phase PHASE1 Asthma COMPLETED NCT00657774
FlutiForm 250/10 ug Other Phase PHASE1 Asthma COMPLETED NCT00657774
milk protein formulas, varying carbohydrate/protein sources Other Phase PHASE2 Infant, Newborn COMPLETED NCT00705562
Placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00269386
Clarithromycin Other Phase PHASE3 Crohn's Disease COMPLETED NCT00269386
Placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00269386
Clarithromycin Other Phase PHASE3 Crohn's Disease COMPLETED NCT00269386
adalimumab Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00827996
adalimumab Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00827996
Multilink Vision™ Stent (CE-labeled) Other Preclinical Coronary Disease COMPLETED NCT00243438
Multilink Vision™ Stent (CE-labeled) Other Preclinical Coronary Disease COMPLETED NCT00243438
Multilink Vision™ Stent (CE-labeled) Other Preclinical Coronary Disease COMPLETED NCT00243438
Valproic Acid and Depakote ER Other Phase PHASE4 Mood Disorder COMPLETED NCT00211250
Valproic Acid and Depakote ER Other Phase PHASE4 Mood Disorder COMPLETED NCT00211250
Valproic Acid and Depakote ER Other Phase PHASE4 Mood Disorder COMPLETED NCT00211250
placebo Other Phase PHASE4 Venous Insufficiency COMPLETED NCT00835822
Venocur Triplex® Other Phase PHASE4 Venous Insufficiency COMPLETED NCT00835822
placebo Other Phase PHASE4 Venous Insufficiency COMPLETED NCT00835822
Venocur Triplex® Other Phase PHASE4 Venous Insufficiency COMPLETED NCT00835822
NUCS Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
Ribavirin Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
PEG-IFNa 2a Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
LPV/r Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
NUCS Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
Ribavirin Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
PEG-IFNa 2a Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
LPV/r Other Phase PHASE3 HIV Infections UNKNOWN NCT00437684
Ribavirin Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
PEG-IFNa 2a Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
Nucleoside Reverse Transcriptase Inhibitors Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
LPV/r Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
Ribavirin Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
PEG-IFNa 2a Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
Nucleoside Reverse Transcriptase Inhibitors Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
LPV/r Other Phase PHASE3 HIV Infections UNKNOWN NCT00437476
lopinavir/ritonavir Other Phase PHASE4 HIV Infection TERMINATED NCT00420355
atazanavir Other Phase PHASE4 HIV Infection TERMINATED NCT00420355
Anti-HIV Immune Serum Globulin (Human) Other Phase PHASE1 HIV Infections COMPLETED NCT00002036
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 20% Other Approved HIV Infections COMPLETED NCT00002029
Fat Emulsion 2% Other Approved HIV Infections COMPLETED NCT00002029
Asoprisnil Other Phase PHASE2 Leiomyoma COMPLETED NCT00156182
Asoprisnil Other Phase PHASE2 Leiomyoma COMPLETED NCT00156182
Diabetes Meal Plan with experimental diabetes-specific nutritional shake, diabetes specific cereal, and diabetes specific snack bars. Other Phase PHASE3 Diabetes Mellitus, Type 2 COMPLETED NCT00753181
Usual diet Other Phase PHASE3 Diabetes Mellitus, Type 2 COMPLETED NCT00753181
Nutritional Formula Other Phase PHASE3 Diabetes Mellitus, Type 2 COMPLETED NCT00753181
Preterm infant formula with added soluble lipids Other Phase PHASE3 Preterm Infants COMPLETED NCT00707837
Preterm infant formulas and discharge formulas Other Phase PHASE3 Preterm Infants COMPLETED NCT00707837
Preterm infant formula with added soluble lipids Other Phase PHASE3 Preterm Infants COMPLETED NCT00707837
Preterm infant formulas and discharge formulas Other Phase PHASE3 Preterm Infants COMPLETED NCT00707837
paricalcitol Other Phase PHASE2 End Stage Renal Disease COMPLETED NCT00686751
Medical antitrhombotic treatment Drug Phase PHASE4 Embolism, Paradoxical UNKNOWN NCT00166257
Percutaneous closure of patent foramen ovale Other Phase PHASE4 Embolism, Paradoxical UNKNOWN NCT00166257
Placebo Other Approved Chronic Kidney Disease COMPLETED NCT00428246
paricalcitol Other Approved Chronic Kidney Disease COMPLETED NCT00428246
Placebo Other Approved Chronic Kidney Disease COMPLETED NCT00428246
paricalcitol Other Approved Chronic Kidney Disease COMPLETED NCT00428246
Placebo Other Approved Chronic Kidney Disease COMPLETED NCT00428246
paricalcitol Other Approved Chronic Kidney Disease COMPLETED NCT00428246
Placebo Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00300469
Atorvastatin Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00300469
ABT-335 Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00300469
Placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
Simvastatin Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
ABT-335 Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
Placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
Simvastatin Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
ABT-335 Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300456
Placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
Rosuvastatin Calcium Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
ABT-335 Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
Placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
Rosuvastatin Calcium Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
ABT-335 Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
Placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
Rosuvastatin Calcium Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
ABT-335 Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300482
FreeStyle Navigator Continuous Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT00920881
ezetimibe Other Phase PHASE4 Atherosclerosis TERMINATED NCT00397657
extended release niacin Other Phase PHASE4 Atherosclerosis TERMINATED NCT00397657
ezetimibe Other Phase PHASE4 Atherosclerosis TERMINATED NCT00397657
extended release niacin Other Phase PHASE4 Atherosclerosis TERMINATED NCT00397657
ABT-335 and simvastatin Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300430
ABT-335 and atorvastatin calcium Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300430
ABT-335 and rosuvastatin calcium Other Phase PHASE3 Dyslipidemia COMPLETED NCT00300430
Alendronate Other Phase PHASE3 Osteoporosis TERMINATED NCT00236002
Alendronate Other Phase PHASE3 Osteoporosis TERMINATED NCT00236002
Different insulin therapy at different time points Drug Approved Type 1 Diabetes COMPLETED NCT00970567
Different insulin therapy at different time points Drug Approved Type 1 Diabetes COMPLETED NCT00970567
aspirin placebo (ASA Pbo) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
aspirin (ASA) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
niacin extended-release (NER) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
aspirin placebo (ASA Pbo) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
aspirin (ASA) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
niacin extended-release (NER) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00626392
divalproex sodium extended release Other Phase PHASE2 Alcoholism COMPLETED NCT00202514
divalproex sodium extended release Other Phase PHASE2 Alcoholism COMPLETED NCT00202514
Aspirin (ASA) placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Aspirin (ASA) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Niacin extended-release (NER) placebo Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
Niacin extended-release (NER) Other Phase PHASE3 Dyslipidemia COMPLETED NCT00630877
MEMS cap Other Preclinical HIV Infection COMPLETED NCT00200369
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00427921
Biomarkers Other Preclinical Acute Coronary Syndrome (ACS) COMPLETED NCT00415948
Hectorol® injection Other Phase PHASE4 Chronic Kidney Disease, Stage 5 COMPLETED NCT00257920
Zemplar® injection Other Phase PHASE4 Chronic Kidney Disease, Stage 5 COMPLETED NCT00257920
Hectorol® injection Other Phase PHASE4 Chronic Kidney Disease, Stage 5 COMPLETED NCT00257920
Zemplar® injection Other Phase PHASE4 Chronic Kidney Disease, Stage 5 COMPLETED NCT00257920
Standard ICU enteral diet, isocaloric to the study diet Other Phase PHASE4 Sepsis COMPLETED NCT00329680
Eicosapentaenoic acid, Gamma-Linolenic Acid and Antioxidant Vitamins Other Phase PHASE4 Sepsis COMPLETED NCT00329680
Standard ICU enteral diet, isocaloric to the study diet Other Phase PHASE4 Sepsis COMPLETED NCT00329680
Eicosapentaenoic acid, Gamma-Linolenic Acid and Antioxidant Vitamins Other Phase PHASE4 Sepsis COMPLETED NCT00329680
Coronary artery stent placement Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00180453
Coronary artery drug eluting stent placement Drug Phase PHASE3 Coronary Artery Disease COMPLETED NCT00180453
EPA-DHA arm Other Phase PHASE2 Lung Cancer UNKNOWN NCT01048970
Nutritional Assessment Other Phase PHASE2 Lung Cancer UNKNOWN NCT01048970
EPA-DHA arm Other Phase PHASE2 Lung Cancer UNKNOWN NCT01048970
Nutritional Assessment Other Phase PHASE2 Lung Cancer UNKNOWN NCT01048970
iSTAT point of care analyzer Other Phase PHASE4 Unstable Angina COMPLETED NCT00276432
iSTAT point of care analyzer Other Phase PHASE4 Unstable Angina COMPLETED NCT00276432
Lithium Other Phase PHASE4 Bipolar Disorder WITHDRAWN NCT01075126
Depakote Other Phase PHASE4 Bipolar Disorder WITHDRAWN NCT01075126
Lithium Other Phase PHASE4 Bipolar Disorder WITHDRAWN NCT01075126
Depakote Other Phase PHASE4 Bipolar Disorder WITHDRAWN NCT01075126
ABSOLUTE™: Self-Expandable Peripheral Nitinol Stent Other Phase PHASE4 Peripheral Vascular Diseases COMPLETED NCT00180505
ABT-263 Other Phase PHASE2 B-cell Chronic Lymphocytic Leukemia WITHDRAWN NCT00918450
ABT-263 Other Phase PHASE2 B-cell Chronic Lymphocytic Leukemia WITHDRAWN NCT00918450
ABT-263 Other Phase PHASE2 B-cell Chronic Lymphocytic Leukemia WITHDRAWN NCT00918450
Niacin and aspirin Other Preclinical Flushing COMPLETED NCT00930839
Paricalcitol Other Phase PHASE4 Kidney Failure COMPLETED NCT00294866
Standard physician-directed weaning Other Phase PHASE3 Respiratory Insufficiency COMPLETED NCT00473148
BNP-guided weaning Other Phase PHASE3 Respiratory Insufficiency COMPLETED NCT00473148
Standard physician-directed weaning Other Phase PHASE3 Respiratory Insufficiency COMPLETED NCT00473148
BNP-guided weaning Other Phase PHASE3 Respiratory Insufficiency COMPLETED NCT00473148
Matched placebo Other Phase PHASE2 Hodgkin Disease TERMINATED NCT00275262
Leuprolide acetate depot (LAD) 11.25 mg 3 Month Other Phase PHASE2 Hodgkin Disease TERMINATED NCT00275262
Matched placebo Other Phase PHASE2 Hodgkin Disease TERMINATED NCT00275262
Leuprolide acetate depot (LAD) 11.25 mg 3 Month Other Phase PHASE2 Hodgkin Disease TERMINATED NCT00275262
Zoledronic Acid (Zometa) Other Phase PHASE2 Prostate Cancer COMPLETED NCT00181558
Atrasentan Other Phase PHASE2 Prostate Cancer COMPLETED NCT00181558
Zoledronic Acid (Zometa) Other Phase PHASE2 Prostate Cancer COMPLETED NCT00181558
Atrasentan Other Phase PHASE2 Prostate Cancer COMPLETED NCT00181558
Placebo Other Phase PHASE3 Obesity COMPLETED NCT00234832
Sibutramine hydrochloride Other Phase PHASE3 Obesity COMPLETED NCT00234832
Placebo Other Phase PHASE3 Obesity COMPLETED NCT00234832
Sibutramine hydrochloride Other Phase PHASE3 Obesity COMPLETED NCT00234832
Sampling Rate Other Preclinical Healthy COMPLETED NCT01126567
Sampling Rate Other Preclinical Healthy COMPLETED NCT01126567
Placebo Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Divalproex Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Placebo Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Divalproex Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Placebo Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Divalproex Other Phase PHASE3 Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania COMPLETED NCT00278772
Treatment with Adalimumab Drug Approved Crohn's Disease UNKNOWN NCT01144156
Treatment with Adalimumab Drug Approved Crohn's Disease UNKNOWN NCT01144156
Treatment with Adalimumab Drug Approved Crohn's Disease UNKNOWN NCT01144156
herbal extract; root of woody shrub grown in India/Sri-Lanka Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00499148
herbal extract; root of woody shrub grown in India/Sri-Lanka Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00499148
Endorectal Coil Magnetic Resonance Images Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00160953
Endorectal Coil Magnetic Resonance Images Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00160953
Endorectal Coil Magnetic Resonance Images Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00160953
Endorectal Coil Magnetic Resonance Images Other Phase PHASE2 Prostatic Neoplasms COMPLETED NCT00160953
Standard food Other Phase PHASE3 Diabetes Mellitus, Type 2 COMPLETED NCT01188200
Experimental nutritional formula #M979 Other Phase PHASE3 Diabetes Mellitus, Type 2 COMPLETED NCT01188200
fluticasone propionate, formoterol fumarate Other Phase PHASE2 Mild to Moderate Asthma COMPLETED NCT00734292
fluticasone propionate, formoterol fumarate Other Phase PHASE2 Mild to Moderate Asthma COMPLETED NCT00734292
fluticasone propionate, formoterol fumarate Other Phase PHASE2 Mild to Moderate Asthma COMPLETED NCT00734292
Flovent Fluticasone HFA Other Phase PHASE3 Asthma COMPLETED NCT00649025
SKP-Fluticasone Other Phase PHASE3 Asthma COMPLETED NCT00649025
FlutiForm 250/10 Other Phase PHASE3 Asthma COMPLETED NCT00649025
Flovent Fluticasone HFA Other Phase PHASE3 Asthma COMPLETED NCT00649025
SKP-Fluticasone Other Phase PHASE3 Asthma COMPLETED NCT00649025
FlutiForm 250/10 Other Phase PHASE3 Asthma COMPLETED NCT00649025
ABT-263 Other Phase PHASE1 Chronic Lymphocytic Leukemia COMPLETED NCT00743028
ABT-263 Other Phase PHASE1 Chronic Lymphocytic Leukemia COMPLETED NCT00743028
Placebo for ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
Placebo for ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
Placebo for ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
Placebo for ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00931281
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00909636
ABT-333 Other Phase PHASE1 HCV Infection COMPLETED NCT00909636
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00909636
ABT-333 Other Phase PHASE1 HCV Infection COMPLETED NCT00909636
ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00909311
ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00909311
ritonavir Other Phase PHASE1 HCV Infection COMPLETED NCT00909311
ABT-450 Other Phase PHASE1 HCV Infection COMPLETED NCT00909311
ABT-333 Capsule Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
ABT-333 Tablet Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
ABT-333 Capsule Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
ABT-333 Tablet Other Phase PHASE1 HCV Infection COMPLETED NCT00895102
placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
ketoconazole Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
ABT-333 Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
ketoconazole Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
ABT-333 Other Phase PHASE1 HCV Infection COMPLETED NCT00768690
XIENCE V® Everolimus Eluting Coronary Stent Other Phase PHASE4 Coronary Disease COMPLETED NCT00402272
ABT-335 Other Phase PHASE1 Healthy COMPLETED NCT00839293
ABT-335 Other Phase PHASE1 Healthy COMPLETED NCT00839293
ABT-335 Other Phase PHASE1 Healthy COMPLETED NCT00839293
Ezetimibe Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Atorvastatin Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
ABT-335 Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Ezetimibe Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Atorvastatin Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
ABT-335 Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Ezetimibe Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Atorvastatin Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
ABT-335 Other Phase PHASE1 Pharmacokinetics COMPLETED NCT00681525
Placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT00982826
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00982826
Placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT00982826
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00982826
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00947440
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00947440
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT00890318
ketoconazole Other Phase PHASE1 HCV Infection COMPLETED NCT00890318
ABT-072 Other Phase PHASE1 HCV Infection COMPLETED NCT00890318
placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT00752687
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00752687
placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT00752687
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT00752687
Placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
Placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
Placebo Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
ABT-072 Other Phase PHASE1 Hepatitis C COMPLETED NCT01081483
Placebo Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
ABT-333 Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
Placebo Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
ABT-333 Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
Placebo Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
ABT-333 Other Phase PHASE1 HCV Infections COMPLETED NCT00919490
Placebo for ABT-126 Other Phase PHASE1 Schizophrenia COMPLETED NCT01043458
ABT-126 Other Phase PHASE1 Schizophrenia COMPLETED NCT01043458
Placebo for ABT-126 Other Phase PHASE1 Schizophrenia COMPLETED NCT01043458
ABT-126 Other Phase PHASE1 Schizophrenia COMPLETED NCT01043458
ABT-614 Other Phase PHASE1 Healthy COMPLETED NCT00959816
ABT-614 Other Phase PHASE1 Healthy COMPLETED NCT00959816
Placebo Other Phase PHASE1 Healthy COMPLETED NCT00912431
ABT-126 Other Phase PHASE1 Healthy COMPLETED NCT00912431
Placebo Other Phase PHASE1 Healthy COMPLETED NCT00912431
ABT-126 Other Phase PHASE1 Healthy COMPLETED NCT00912431
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT00867399
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT00867399
Placebo Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00854659
ABT-102 Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00854659
Placebo Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00854659
ABT-102 Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00854659
ABT-614 Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00788801
rifabutin Other Phase PHASE1 HIV TERMINATED NCT00743470
lopinavir/ritonavir Other Phase PHASE1 HIV TERMINATED NCT00743470
rifabutin Other Phase PHASE1 HIV TERMINATED NCT00743470
lopinavir/ritonavir Other Phase PHASE1 HIV TERMINATED NCT00743470
placebo Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
atomoxetine Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
ABT-894 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
placebo Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
atomoxetine Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
ABT-894 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
placebo Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
atomoxetine Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
ABT-894 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00429091
Placebo Other Phase PHASE1 Healthy COMPLETED NCT01050127
ABT-436 Other Phase PHASE1 Healthy COMPLETED NCT01050127
Placebo Other Phase PHASE1 Healthy COMPLETED NCT01050127
ABT-436 Other Phase PHASE1 Healthy COMPLETED NCT01050127
Placebo Other Phase PHASE1 Healthy COMPLETED NCT01050127
ABT-436 Other Phase PHASE1 Healthy COMPLETED NCT01050127
Matching placebo to ABT-384 Other Phase PHASE1 Healthy COMPLETED NCT00968422
ABT-384 Other Phase PHASE1 Healthy COMPLETED NCT00968422
Matching placebo to ABT-384 Other Phase PHASE1 Healthy COMPLETED NCT00968422
ABT-384 Other Phase PHASE1 Healthy COMPLETED NCT00968422
Placebo Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00959634
ABT-126 Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00959634
Placebo Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00959634
ABT-126 Other Phase PHASE1 Healthy Volunteers COMPLETED NCT00959634
ABT-874 Other Phase PHASE1 Healthy COMPLETED NCT00870948
ABT-874 Other Phase PHASE1 Healthy COMPLETED NCT00870948
ABT-874 Other Phase PHASE1 Healthy COMPLETED NCT00870948
ABT-263 Other Phase PHASE1 Healthy Female Subjects COMPLETED NCT01053520
ABT-263 Other Phase PHASE1 Healthy Female Subjects COMPLETED NCT01053520
Human Milk Other Phase PHASE3 Healthy Term Infants TERMINATED NCT01137877
Investigational Infant Formula #2 Other Phase PHASE3 Healthy Term Infants TERMINATED NCT01137877
Investigational Infant Formula #1 Other Phase PHASE3 Healthy Term Infants TERMINATED NCT01137877
Milk based infant formula powder Other Phase PHASE3 Healthy Term Infants TERMINATED NCT01137877
Experimental milk protein infant formula Process F Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Experimental milk protein infant formula Process E Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Experimental milk protein infant formula Process D Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Experimental milk protein infant formula Process C Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Experimental milk protein infant formula Process B Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Experimental milk protein infant formula Process A Other Phase PHASE3 Gastrointestinal Tolerance COMPLETED NCT00977964
Glucose drink Other Phase PHASE2 Overweight COMPLETED NCT00974831
Amino Acid Drink Mixture Other Phase PHASE2 Overweight COMPLETED NCT00974831
Infant formula milk based Other Phase PHASE4 Infant COMPLETED NCT00941564
Infant Formula milk based Other Phase PHASE4 Infant COMPLETED NCT00941564
ABT-384 Other Phase PHASE1 Healthy COMPLETED NCT01009216
ritonavir Other Phase PHASE1 Healthy COMPLETED NCT01091649
ABT-450 Other Phase PHASE1 Healthy COMPLETED NCT01091649
ritonavir Other Phase PHASE1 Healthy COMPLETED NCT01091649
ABT-450 Other Phase PHASE1 Healthy COMPLETED NCT01091649
EES vs. SES Other Approved Ischemic Heart Disease UNKNOWN NCT01266239
kissing balloon inflation Other Approved Ischemic Heart Disease UNKNOWN NCT01266239
EES vs. SES Other Approved Ischemic Heart Disease UNKNOWN NCT01266239
kissing balloon inflation Other Approved Ischemic Heart Disease UNKNOWN NCT01266239
Adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01270087
Adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01270087
Adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01270087
Docetaxel Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
Placebo Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
ABT-751 Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
Docetaxel Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
Placebo Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
ABT-751 Other Phase PHASE1 Lung Cancer TERMINATED NCT00354562
Tarceva Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
ABT-869 Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
Tarceva Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
ABT-869 Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
Tarceva Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
ABT-869 Other Phase PHASE1 Solid Tumors WITHDRAWN NCT00754104
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404391
Hydrocodone/Acetaminophen Extended Release Other Phase PHASE2 Pain COMPLETED NCT00404391
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404391
Hydrocodone/Acetaminophen Extended Release Other Phase PHASE2 Pain COMPLETED NCT00404391
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404391
Hydrocodone/Acetaminophen Extended Release Other Phase PHASE2 Pain COMPLETED NCT00404391
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404183
Extended-Release Hydrocodone/Acetaminophen Other Phase PHASE2 Pain COMPLETED NCT00404183
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404183
Extended-Release Hydrocodone/Acetaminophen Other Phase PHASE2 Pain COMPLETED NCT00404183
Hydrocodone/Acetaminophen on Extended Release Other Phase PHASE3 Moderate to Severe Chronic, Non-malignant Pain COMPLETED NCT00195728
Placebo Other Phase PHASE3 Pain COMPLETED NCT00402792
Hydrocodone/Acetaminophen Extended Release Other Phase PHASE3 Pain COMPLETED NCT00402792
Hydrocodone/Acetaminophen Extended-Release Other Phase PHASE3 Pain COMPLETED NCT00402792
Placebo Other Phase PHASE3 Pain COMPLETED NCT00402792
Hydrocodone/Acetaminophen Extended Release Other Phase PHASE3 Pain COMPLETED NCT00402792
Hydrocodone/Acetaminophen Extended-Release Other Phase PHASE3 Pain COMPLETED NCT00402792
Placebo Other Phase PHASE3 Osteoarthritis COMPLETED NCT00298974
hydrocodone / acetaminophen extended release Other Phase PHASE3 Osteoarthritis COMPLETED NCT00298974
Placebo Other Phase PHASE3 Osteoarthritis COMPLETED NCT00298974
hydrocodone / acetaminophen extended release Other Phase PHASE3 Osteoarthritis COMPLETED NCT00298974
atrasentan hydrochloride Other Phase PHASE3 Prostate Cancer COMPLETED NCT00046943
atrasentan hydrochloride Other Phase PHASE3 Prostate Cancer COMPLETED NCT00046943
atrasentan hydrochloride Other Phase PHASE3 Prostate Cancer COMPLETED NCT00046943
Clarithromycin Other Phase PHASE2 Mycobacterium Avium-intracellulare Infection COMPLETED NCT00000644
Dynalink®-E, everolimus-eluting peripheral stent Other Approved Atherosclerosis COMPLETED NCT00475566
Dynalink®-E everolimus-eluting peripheral stent Other Approved Atherosclerosis COMPLETED NCT00475566
Ergocalciferol Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00958451
Paricalcitol Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00958451
Placebo comparator Other Phase PHASE1 Aged COMPLETED NCT00945581
Experimental Nutritional Powder Formula Other Phase PHASE1 Aged COMPLETED NCT00945581
Placebo comparator Other Phase PHASE1 Aged COMPLETED NCT00945581
Experimental Nutritional Powder Formula Other Phase PHASE1 Aged COMPLETED NCT00945581
#3 Nutritional ingredient + Fiber Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01326299
#2 Nutritional ingredient + Fiber Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01326299
#1 Nutritional ingredient +Fiber Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01326299
Nutritional ingredient Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01326299
Carbohydrate placebo Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01326299
10004RF Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01324921
Breakfast Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01324921
No breakfast/beverage only Other Phase PHASE2 Diabetes Mellitus, Type 2 COMPLETED NCT01324921
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System Other Phase PHASE2 Coronary Disease COMPLETED NCT00148356
ZoMaxx™ Drug-Eluting Coronary Stent System Drug Phase PHASE2 Coronary Disease COMPLETED NCT00148356
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent System Other Phase PHASE2 Coronary Disease COMPLETED NCT00148356
ZoMaxx™ Drug-Eluting Coronary Stent System Drug Phase PHASE2 Coronary Disease COMPLETED NCT00148356
clarithromycin (Klacid) granules for oral suspension Other Preclinical Lower Respiratory Tract Infection COMPLETED NCT01076166
clarithromycin (Klacid) granules for oral suspension Other Preclinical Lower Respiratory Tract Infection COMPLETED NCT01076166
Adalimumab 40 mg eow or ew Other Phase PHASE3 Crohn's Disease COMPLETED NCT01070303
Adalimumab 40 mg eow or ew Other Phase PHASE3 Crohn's Disease COMPLETED NCT01070303
Placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
Placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
Placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00647270
Adalimumab 40 mg Other Phase PHASE2 Rheumatoid Arthritis COMPLETED NCT00538902
Adalimumab 80 mg Other Phase PHASE2 Rheumatoid Arthritis COMPLETED NCT00538902
Placebo Other Phase PHASE2 Rheumatoid Arthritis COMPLETED NCT00538902
Humira (adalimumab) Other Phase PHASE3 Psoriasis COMPLETED NCT00513370
Humira (adalimumab) Other Phase PHASE3 Psoriasis COMPLETED NCT00513370
Humira (adalimumab) Other Phase PHASE3 Psoriasis COMPLETED NCT00513370
placebo Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00385736
adalimumab Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00385736
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Other Phase PHASE3 Human Immunodeficiency Virus Infections COMPLETED NCT00358917
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Other Phase PHASE3 Human Immunodeficiency Virus Infections COMPLETED NCT00358917
lopinavir/ritonavir (LPV/r) tablet with nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) Other Phase PHASE3 Human Immunodeficiency Virus Infections COMPLETED NCT00358917
placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00348283
OL adalimumab 40 mg Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
DB adalimumab 40 mg ew Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
DB adalimumab 40 mg eow Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
Double-blind (DB) adalimumab placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
OL adalimumab 40 mg Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
DB adalimumab 40 mg ew Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
DB adalimumab 40 mg eow Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
Double-blind (DB) adalimumab placebo Other Phase PHASE3 Crohn's Disease COMPLETED NCT00055497
Lupron (leuprolide acetate) Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00660010
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00566722
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00566722
placebo (vehicle ointment) Other Phase PHASE3 Chronic Plaque Psoriasis COMPLETED NCT00574249
Calcipotriol/Betamethasone Ointment Other Phase PHASE3 Chronic Plaque Psoriasis COMPLETED NCT00574249
adalimumab Other Phase PHASE3 Chronic Plaque Psoriasis COMPLETED NCT00574249
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00195676
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00195676
adalimumab Other Phase PHASE3 Psoriasis COMPLETED NCT00195676
Paricalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00701805
Paricalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00701805
Paricalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00701805
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
adalimumab (D2E7) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
adalimumab (D2E7) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
adalimumab (D2E7) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00085644
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT01231321
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT01231321
adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT01231321
Placebo Other Phase PHASE2 Schizophrenia TERMINATED NCT00412620
ABT-925 Other Phase PHASE2 Schizophrenia TERMINATED NCT00412620
Placebo Other Phase PHASE2 Schizophrenia TERMINATED NCT00412620
ABT-925 Other Phase PHASE2 Schizophrenia TERMINATED NCT00412620
placebo Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00408629
adalimumab Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00408629
placebo Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00408629
adalimumab Other Phase PHASE3 Ulcerative Colitis COMPLETED NCT00408629
Placebo Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00918255
adalimumab Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00918255
Placebo Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00918255
adalimumab Other Phase PHASE2 Hidradenitis Suppurativa COMPLETED NCT00918255
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00195819
adalimumab (D2E7) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00195819
placebo Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00555204
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00555204
ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder TERMINATED NCT00554385
ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder TERMINATED NCT00554385
ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder TERMINATED NCT00554385
SLV337 capsule Other Phase PHASE1 Healthy Subjects COMPLETED NCT01176201
SLV337 suspension Other Phase PHASE1 Healthy Subjects COMPLETED NCT01176201
SLV337 capsule Other Phase PHASE1 Healthy Subjects COMPLETED NCT01176201
SLV337 suspension Other Phase PHASE1 Healthy Subjects COMPLETED NCT01176201
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT01146015
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT01146015
Influenza Vaccine Other Phase PHASE3 Influenza COMPLETED NCT00999206
Influenza Vaccine Other Phase PHASE3 Influenza COMPLETED NCT00999206
pramipexole Other Phase PHASE2 Advanced Stage Parkinson's Disease TERMINATED NCT00903838
pardoprunox Other Phase PHASE2 Advanced Stage Parkinson's Disease TERMINATED NCT00903838
pramipexole Other Phase PHASE2 Advanced Stage Parkinson's Disease TERMINATED NCT00903838
pardoprunox Other Phase PHASE2 Advanced Stage Parkinson's Disease TERMINATED NCT00903838
AndroGel (testosterone gel) 1% Other Preclinical Hypogonadism COMPLETED NCT01143818
AndroGel (testosterone gel) 1% Other Preclinical Hypogonadism COMPLETED NCT01143818
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Placebo Other Phase PHASE1 Osteoarthritis, Knee COMPLETED NCT00941746
PG110 Other Phase PHASE1 Osteoarthritis, Knee COMPLETED NCT00941746
Placebo Other Phase PHASE1 Osteoarthritis, Knee COMPLETED NCT00941746
PG110 Other Phase PHASE1 Osteoarthritis, Knee COMPLETED NCT00941746
ezetimibe Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
atorvastatin Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
placebo Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
ABT-335 Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
ezetimibe Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
atorvastatin Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
placebo Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
ABT-335 Other Phase PHASE3 Dyslipidemias COMPLETED NCT00639158
atorvastatin Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
Niacin ER/Simvastatin Tablets Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
atorvastatin Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
Niacin ER/Simvastatin Tablets Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
atorvastatin Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
Niacin ER/Simvastatin Tablets Other Phase PHASE3 Hyperlipidemia COMPLETED NCT00465088
SKP FlutiForm HFA pMDI Other Phase PHASE3 Asthma COMPLETED NCT00747318
SKP FlutiForm HFA pMDI Other Phase PHASE3 Asthma COMPLETED NCT00747318
SKP FlutiForm HFA pMDI Other Phase PHASE3 Asthma COMPLETED NCT00747318
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00195819
adalimumab (D2E7) Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT00195819
Placebo Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
ABT-652 Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
Placebo Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
ABT-652 Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
Placebo Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
ABT-652 Other Phase PHASE1 Sleep Disorder COMPLETED NCT01124851
Clarithromycin (Klacid SR) Other Preclinical Respiratory Tract Infections COMPLETED NCT01095978
Clarithromycin (Klacid SR) Other Preclinical Respiratory Tract Infections COMPLETED NCT01095978
maxacalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00990704
paricalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00990704
maxacalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00990704
paricalcitol Other Phase PHASE2 Secondary Hyperparathyroidism COMPLETED NCT00990704
Clarithromycin (Klacid® MR) Other Preclinical Respiratory Tract Infection COMPLETED NCT01076153
Clarithromycin (Klacid® MR) Other Preclinical Respiratory Tract Infection COMPLETED NCT01076153
Clarithromycin (Klacid® MR) Other Preclinical Respiratory Tract Infection COMPLETED NCT01076153
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00195715
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00195715
fMRI Other Preclinical Pathological Gambling TERMINATED NCT00211822
fMRI Other Preclinical Pathological Gambling TERMINATED NCT00211822
Depacon IV and Depakote ER Other Approved Cluster Headache COMPLETED NCT00203242
Depacon IV and Depakote ER Other Approved Cluster Headache COMPLETED NCT00203242
palivizumab Other Phase PHASE2 Respiratory Syncytial Virus Infection COMPLETED NCT01006629
palivizumab Other Phase PHASE2 Respiratory Syncytial Virus Infection COMPLETED NCT01006629
palivizumab Other Phase PHASE2 Respiratory Syncytial Virus Infection COMPLETED NCT01006629
Leuprolide acetate - Formulation B Other Phase PHASE3 Prostate Cancer COMPLETED NCT00626431
Leuprolide acetate - Formulation A Other Phase PHASE3 Prostate Cancer COMPLETED NCT00626431
Leuprolide acetate - Formulation B Other Phase PHASE3 Prostate Cancer COMPLETED NCT00626431
Leuprolide acetate - Formulation A Other Phase PHASE3 Prostate Cancer COMPLETED NCT00626431
lopinavir/ritonavir and raltegravir Other Phase PHASE4 HIV Infections COMPLETED NCT00752037
lopinavir/ritonavir and raltegravir Other Phase PHASE4 HIV Infections COMPLETED NCT00752037
lopinavir/ritonavir and raltegravir Other Phase PHASE4 HIV Infections COMPLETED NCT00752037
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent Other Phase PHASE3 Coronary Disease COMPLETED NCT00180310
XIENCE V® Everolimus Eluting Coronary Stent Other Phase PHASE3 Coronary Disease COMPLETED NCT00180310
CRT off Other Phase PHASE4 Heart Failure TERMINATED NCT00900549
CRT on Other Phase PHASE4 Heart Failure TERMINATED NCT00900549
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404222
Hydrocodone/Acetaminophen Immediate Release (NORCO®) Other Phase PHASE2 Pain COMPLETED NCT00404222
Hydrocodone/Acetaminophen Extended-Release Other Phase PHASE2 Pain COMPLETED NCT00404222
Placebo Other Phase PHASE2 Pain COMPLETED NCT00404222
Hydrocodone/Acetaminophen Immediate Release (NORCO®) Other Phase PHASE2 Pain COMPLETED NCT00404222
Hydrocodone/Acetaminophen Extended-Release Other Phase PHASE2 Pain COMPLETED NCT00404222
placebo Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
hydrocodone/acetaminophen extended release (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
Extended release hydrocodone and acetaminophen (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
placebo Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
hydrocodone/acetaminophen extended release (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
Extended release hydrocodone and acetaminophen (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
placebo Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
hydrocodone/acetaminophen extended release (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
Extended release hydrocodone and acetaminophen (Vicodin CR) Other Phase PHASE3 Chronic Low Back Pain COMPLETED NCT00325949
ketoconazole Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
ABT-869 Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
ketoconazole Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
ABT-869 Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
ketoconazole Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
ABT-869 Other Phase PHASE1 Solid Tumors COMPLETED NCT01114191
discharge vs. overnight stay Other Preclinical Cardiovascular Disease COMPLETED NCT01230606
discharge vs. overnight stay Other Preclinical Cardiovascular Disease COMPLETED NCT01230606
Placebo Other Phase PHASE3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis COMPLETED NCT00400842
SA-001 Other Phase PHASE3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis COMPLETED NCT00400842
Placebo Other Phase PHASE3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis COMPLETED NCT00400842
SA-001 Other Phase PHASE3 Exocrine Pancreatic Insufficiency, Chronic Pancreatitis COMPLETED NCT00400842
adalimumab Other Phase PHASE4 Rheumatoid Arthritis UNKNOWN NCT01405326
adalimumab Other Phase PHASE4 Rheumatoid Arthritis UNKNOWN NCT01405326
adalimumab Other Phase PHASE4 Rheumatoid Arthritis UNKNOWN NCT01405326
Placebo Other Phase PHASE3 Steatorrhea TERMINATED NCT00623025
Creon 25000 Other Phase PHASE3 Steatorrhea TERMINATED NCT00623025
Placebo Other Phase PHASE3 Steatorrhea TERMINATED NCT00623025
Creon 25000 Other Phase PHASE3 Steatorrhea TERMINATED NCT00623025
SA-001 Other Phase PHASE3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy COMPLETED NCT00401076
SA-001 Other Phase PHASE3 Pancreatic Exocrine Insufficiency, Chronic Pancreatitis, Pancreatectomy COMPLETED NCT00401076
Lopinavir/ritonavir (Kaletra) Other Preclinical HIV-1 Infections COMPLETED NCT01074931
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00409682
Adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00409682
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01083810
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01083810
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01083810
OLE FD Adalimumab +/- MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
OLE BSA Adalimumab +/- MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
Double-Blind Adalimumab/Placebo Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
Double-Blind Adalimumab/Placebo + MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
OLE FD Adalimumab +/- MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
OLE BSA Adalimumab +/- MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
Double-Blind Adalimumab/Placebo Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
Double-Blind Adalimumab/Placebo + MTX Other Phase PHASE3 Arthritis, Juvenile Idiopathic COMPLETED NCT00048542
ABT-874 Other Phase PHASE2 Crohn's Disease TERMINATED NCT00562887
Placebo Other Phase PHASE2 Crohn's Disease TERMINATED NCT00562887
ABT-874 Other Phase PHASE2 Crohn's Disease TERMINATED NCT00562887
Placebo Other Phase PHASE2 Crohn's Disease TERMINATED NCT00562887
placebo Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00555204
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00555204
placebo Other Phase PHASE1 Pharmacokinetics TERMINATED NCT00985478
SLV342 Other Phase PHASE1 Pharmacokinetics TERMINATED NCT00985478
placebo Other Phase PHASE1 Pharmacokinetics TERMINATED NCT00985478
SLV342 Other Phase PHASE1 Pharmacokinetics TERMINATED NCT00985478
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT00881842
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT00881842
Placebo Other Phase PHASE2 Diabetic Macular Edema COMPLETED NCT00683176
Choline Fenofibrate Other Phase PHASE2 Diabetic Macular Edema COMPLETED NCT00683176
Placebo Other Phase PHASE2 Diabetic Macular Edema COMPLETED NCT00683176
Choline Fenofibrate Other Phase PHASE2 Diabetic Macular Edema COMPLETED NCT00683176
Placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195702
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195702
Placebo Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195702
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195702
Placebo Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Dydrogesterone Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Placebo Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Dydrogesterone Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Placebo Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Dydrogesterone Other Phase PHASE3 Recurrent Miscarriage COMPLETED NCT00193674
Placebo capsules Other Phase PHASE1 Cognition Disorders TERMINATED NCT01133574
SLV354 capsules Other Phase PHASE1 Cognition Disorders TERMINATED NCT01133574
Placebo capsules Other Phase PHASE1 Cognition Disorders TERMINATED NCT01133574
SLV354 capsules Other Phase PHASE1 Cognition Disorders TERMINATED NCT01133574
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00809510
ABT-089 Other Phase PHASE2 Alzheimer's Disease TERMINATED NCT00809510
Adalimumab Every Week Other Phase PHASE3 Plaque Psoriasis COMPLETED NCT00927069
Adalimumab every other week Other Phase PHASE3 Plaque Psoriasis COMPLETED NCT00927069
Bioabsorbable Everolimus Eluting Coronary Stent Other Preclinical Coronary Disease COMPLETED NCT00300131
Bioabsorbable Everolimus Eluting Coronary Stent Other Preclinical Coronary Disease COMPLETED NCT00300131
Atenolol/HCTZ/Trandolapril Other Phase PHASE4 Hypertension COMPLETED NCT00133692
Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ) Other Phase PHASE4 Hypertension COMPLETED NCT00133692
Zemplar iv (paricalcitol iv) Other Preclinical Parathyroid Hormone COMPLETED NCT01084538
Zemplar iv (paricalcitol iv) Other Preclinical Parathyroid Hormone COMPLETED NCT01084538
Placebo Other Phase PHASE2 Traumatic Brain Injury TERMINATED NCT00735085
SLV334 Other Phase PHASE2 Traumatic Brain Injury TERMINATED NCT00735085
Placebo Other Phase PHASE2 Traumatic Brain Injury TERMINATED NCT00735085
SLV334 Other Phase PHASE2 Traumatic Brain Injury TERMINATED NCT00735085
adalimumab Other Preclinical Rheumatoid Arthritis COMPLETED NCT00234884
adalimumab Other Preclinical Rheumatoid Arthritis COMPLETED NCT00234884
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00409617
adalimumab Other Phase PHASE3 Crohn's Disease COMPLETED NCT00409617
Placebo Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00391729
ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00391729
Placebo Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00391729
ABT-089 Other Phase PHASE2 Attention-Deficit/Hyperactivity Disorder COMPLETED NCT00391729
briakinumab Other Phase PHASE1 Moderate to Severe Plaque Psoriasis WITHDRAWN NCT01260844
Raltegravir; valproic acid Other Phase PHASE2 HIV Infections TERMINATED NCT00614458
Raltegravir; valproic acid Other Phase PHASE2 HIV Infections TERMINATED NCT00614458
Paricalcitol capsules Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00537979
Paricalcitol injection Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00537979
Influenza Vaccine Other Phase PHASE2 Influenza Vaccines COMPLETED NCT01013675
Influenza Vaccine Other Phase PHASE2 Influenza Vaccines COMPLETED NCT01013675
Placebo Other Phase PHASE4 Psoriasis COMPLETED NCT01181570
Adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT01181570
adalimumab (HUMIRA®) Other Preclinical Rheumatoid Arthritis COMPLETED NCT01078571
Topical treatment Drug Phase PHASE4 Psoriasis COMPLETED NCT00940862
UVB Phototherapy Drug Phase PHASE4 Psoriasis COMPLETED NCT00940862
adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT00940862
Topical treatment Drug Phase PHASE4 Psoriasis COMPLETED NCT00940862
UVB Phototherapy Drug Phase PHASE4 Psoriasis COMPLETED NCT00940862
adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT00940862
Zemplar (paricalcitol) Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00891813
Zemplar (paricalcitol) Other Phase PHASE4 Secondary Hyperparathyroidism COMPLETED NCT00891813
Investigational Infant Formula B Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Investigational Infant Formula A Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Hydrolysate based infant formula Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Investigational Infant Formula B Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Investigational Infant Formula A Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Hydrolysate based infant formula Other Phase PHASE3 Healthy Term Infants COMPLETED NCT01155414
Rifampin Other Phase PHASE1 Advanced Solid Tumors COMPLETED NCT01401933
Linifanib Other Phase PHASE1 Advanced Solid Tumors COMPLETED NCT01401933
Rifampin Other Phase PHASE1 Advanced Solid Tumors COMPLETED NCT01401933
Linifanib Other Phase PHASE1 Advanced Solid Tumors COMPLETED NCT01401933
Drink mix calorically similar to experimental product Other Phase PHASE3 Foot Ulcer, Diabetic COMPLETED NCT00711217
Medical Food Other Phase PHASE3 Foot Ulcer, Diabetic COMPLETED NCT00711217
Leuprolide acetate 30 mg Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00635817
Leuprolide acetate 11.25 mg Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00635817
Leuprolide acetate 30 mg Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00635817
Leuprolide acetate 11.25 mg Other Phase PHASE3 Puberty, Precocious COMPLETED NCT00635817
placebo Other Phase PHASE1 Hypogonadal Males COMPLETED NCT01346319
ABT-SLV361 Other Phase PHASE1 Hypogonadal Males COMPLETED NCT01346319
Standard Enteral Nutrition Other Phase PHASE3 Respiratory Distress Syndrome,Adult TERMINATED NCT01464853
Enteral nutrition with fatty acids Other Phase PHASE3 Respiratory Distress Syndrome,Adult TERMINATED NCT01464853
Standard Enteral Nutrition Other Phase PHASE3 Respiratory Distress Syndrome,Adult TERMINATED NCT01464853
Enteral nutrition with fatty acids Other Phase PHASE3 Respiratory Distress Syndrome,Adult TERMINATED NCT01464853
monofocal acrylic intraocular lens Other Phase PHASE3 Cataract COMPLETED NCT00747227
modified light transmission intraocular lens Other Phase PHASE3 Cataract COMPLETED NCT00747227
Adalimumab 40 mg subcutaneous (SC) every other week (EOW) Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00233571
placebo Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT01114880
adalimumab Other Phase PHASE3 Ankylosing Spondylitis COMPLETED NCT01114880
Glucerna SR Other Approved Type 2 Diabetes COMPLETED NCT00631774
Glucerna SR Other Approved Type 2 Diabetes COMPLETED NCT00631774
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus-Infection COMPLETED NCT01153269
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus-Infection COMPLETED NCT01153269
Lopinavir/Ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus-Infection COMPLETED NCT01153269
Lung Function Analysis Other Preclinical Respiratory Syncytial Viruses COMPLETED NCT00585481
Samples collection for viral diagnosis Other Preclinical Respiratory Syncytial Viruses COMPLETED NCT00585481
Lung Function Analysis Other Preclinical Respiratory Syncytial Viruses COMPLETED NCT00585481
Samples collection for viral diagnosis Other Preclinical Respiratory Syncytial Viruses COMPLETED NCT00585481
SLV337 Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
Placebo Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
SLV337 Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
Placebo Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
SLV337 Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
Placebo Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT00924534
PDL192 Other Phase PHASE1 Cancer COMPLETED NCT00738764
PDL192 Other Phase PHASE1 Cancer COMPLETED NCT00738764
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent Other Phase PHASE2 Coronary Disease COMPLETED NCT00140101
ZoMaxx™ Drug-Eluting Coronary Stent System Drug Phase PHASE2 Coronary Disease COMPLETED NCT00140101
Leuprolide acetate Depot Susp. 11.25 mg (Poland), 3.75 mg (Ukraine) Other Preclinical Advanced Prostate Cancer COMPLETED NCT01078545
Lopinavir/ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01076985
Lopinavir/ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01076985
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Maxacalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Maxacalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Maxacalcitol Other Phase PHASE2 Chronic Kidney Disease on Hemodialysis COMPLETED NCT00667576
Paricalcitol Other Phase PHASE4 Secondary Hyperparathyroidism TERMINATED NCT00664430
Calcitriol Other Phase PHASE4 Secondary Hyperparathyroidism TERMINATED NCT00664430
Placebo Injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
paricalcitol injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
Placebo Injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
paricalcitol injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
Placebo Injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
paricalcitol injection 4 mcg/mL Other Phase PHASE3 Chronic Kidney Disease (CKD) Stage 5 TERMINATED NCT00616902
atorvastatin calcium Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
simvastatin Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
rosuvastatin calcium Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
ABT-335 Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
atorvastatin calcium Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
simvastatin Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
rosuvastatin calcium Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
ABT-335 Other Phase PHASE3 Mixed Dyslipidemia COMPLETED NCT00491530
Placebo Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Zemplar (paricalcitol) capsules Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Zemplar (paricalcitol ) capsules Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Placebo Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Zemplar (paricalcitol) capsules Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Zemplar (paricalcitol ) capsules Other Phase PHASE2 Diabetic Nephropathy COMPLETED NCT00421733
Cytochrome P450 inhibitor Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
Blood Sample Collection Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
ABT-267 Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
Cytochrome P450 inhibitor Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
Blood Sample Collection Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
Placebo Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
ABT-267 Other Phase PHASE1 HCV Infection COMPLETED NCT01181427
paricalcitol Other Phase PHASE3 Chronic Kidney Disease COMPLETED NCT01071070
paricalcitol Other Phase PHASE3 Chronic Kidney Disease COMPLETED NCT01071070
paricalcitol Other Phase PHASE3 Chronic Kidney Disease COMPLETED NCT01071070
Paricalcitol Other Phase PHASE4 Cardiovascular Disease COMPLETED NCT01331317
Nutritional Beverage Other Phase PHASE2 Human Volunteers COMPLETED NCT01464385
Nutritional Beverage Other Phase PHASE2 Human Volunteers COMPLETED NCT01464385
XIENCE V® Everolimus Eluting Coronary Stent Other Preclinical Coronary Disease COMPLETED NCT00631228
Placebo Comparator Other Phase PHASE1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine COMPLETED NCT01464320
ABT-614 Other Phase PHASE1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine COMPLETED NCT01464320
Placebo Comparator Other Phase PHASE1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine COMPLETED NCT01464320
ABT-614 Other Phase PHASE1 Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine COMPLETED NCT01464320
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195650
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis COMPLETED NCT00195650
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Tricuspid Transcatheter Edge-to-Edge Repair (TEER) Other Preclinical Tricuspid Regurgitation (TR) ENROLLING_BY_INVITATION NCT07586995
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) Other Phase PHASE3 Human Immunodeficiency Virus Infections COMPLETED NCT00262522
lopinavir/ritonavir (LPV/r) (tablet or capsule) with nucleoside reverse transcriptase inhibitors (NRTIs) Other Phase PHASE3 Human Immunodeficiency Virus Infections COMPLETED NCT00262522
Placebo Other Approved Type 1 Diabetes COMPLETED NCT00726440
Navigator® Other Approved Type 1 Diabetes COMPLETED NCT00726440
Placebo Other Approved Type 1 Diabetes COMPLETED NCT00726440
Navigator® Other Approved Type 1 Diabetes COMPLETED NCT00726440
raltegravir (RAL) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
lopinavir/ritonavir (LPV/r) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
raltegravir (RAL) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
lopinavir/ritonavir (LPV/r) Other Phase PHASE3 Human Immunodeficiency Virus Infection COMPLETED NCT00711009
placebo Other Phase PHASE2 Endometriosis COMPLETED NCT00109512
NBI-56418 (GnRH antagonist) Other Phase PHASE2 Endometriosis COMPLETED NCT00109512
placebo Other Phase PHASE2 Endometriosis COMPLETED NCT00109512
NBI-56418 (GnRH antagonist) Other Phase PHASE2 Endometriosis COMPLETED NCT00109512
Coronary angioplasty using the everolimus-eluting stent Other Phase PHASE4 In-Stent Restenosis UNKNOWN NCT01239953
Coronary angioplasty using the paclitaxel-eluting balloon Other Phase PHASE4 In-Stent Restenosis UNKNOWN NCT01239953
Lopinavir/ritonavir (Kaletra) Other Preclinical Human Immunodeficiency Virus COMPLETED NCT01076972
linifanib Other Phase PHASE1 Advanced Solid Tumors COMPLETED NCT01381341
Placebo Other Phase PHASE4 Spondyloarthritis UNKNOWN NCT00477893
Adalimumab Other Phase PHASE4 Spondyloarthritis UNKNOWN NCT00477893
Placebo Other Phase PHASE4 Spondyloarthritis UNKNOWN NCT00477893
Adalimumab Other Phase PHASE4 Spondyloarthritis UNKNOWN NCT00477893
Early discharge after percutaneous coronary intervenntion Other Preclinical Coronary Artery Disease TERMINATED NCT00419055
Early discharge after percutaneous coronary intervenntion Other Preclinical Coronary Artery Disease TERMINATED NCT00419055
placebo Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
methotrexate Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
placebo Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
methotrexate Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT00420927
XIENCE V® Other Preclinical Coronary Artery Disease COMPLETED NCT00987506
Routine Care (RC) Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
0SJ-IOMS Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
DAS28-IOMS Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
Routine Care (RC) Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
0SJ-IOMS Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
DAS28-IOMS Other Preclinical Rheumatoid Arthritis (RA) COMPLETED NCT01585064
M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab Other Phase PHASE1 Non-small Cell Lung Cancer COMPLETED NCT00666692
M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab Other Phase PHASE1 Non-small Cell Lung Cancer COMPLETED NCT00666692
M200 (Volociximab), Carboplatin, Paclitaxel, Bevacizumab Other Phase PHASE1 Non-small Cell Lung Cancer COMPLETED NCT00666692
volociximab Other Phase PHASE2 Stage IV Melanoma TERMINATED NCT00369395
volociximab Other Phase PHASE2 Stage IV Melanoma TERMINATED NCT00369395
Visilizumab Other Phase PHASE2 Ulcerative Colitis TERMINATED NCT00307827
Visilizumab Other Phase PHASE2 Ulcerative Colitis TERMINATED NCT00307827
Volociximab (anti-α5β1 integrin monoclonal antibody) Other Phase PHASE2 Renal Cell Carcinoma TERMINATED NCT00100685
Volociximab (anti-α5β1 integrin monoclonal antibody) Other Phase PHASE2 Renal Cell Carcinoma TERMINATED NCT00100685
Volociximab (anti-α5β1 integrin monoclonal antibody) Other Phase PHASE2 Renal Cell Carcinoma TERMINATED NCT00100685
Placebo Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
Placebo Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
Placebo Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
Placebo Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
ABT-126 Other Phase PHASE1 Alzheimer's Disease COMPLETED NCT01482845
Docetaxel Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
ABT-263 Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
Docetaxel Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
ABT-263 Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
Docetaxel Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
ABT-263 Other Phase PHASE1 Solid Tumor COMPLETED NCT00888108
XIENCE PRIMETM everolimus-eluting coronary stent Other Phase PHASE4 Coronary Artery Disease UNKNOWN NCT01605721
Kaletra Tablets Other Phase PHASE3 HIV Infections COMPLETED NCT00508222
Kaletra Tablets Other Phase PHASE3 HIV Infections COMPLETED NCT00508222
lopinavir /ritonavir plus two nucleosides Other Phase PHASE3 HIV Infection COMPLETED NCT01237444
lopinavir/ritonavir plus one nucleoside Other Phase PHASE3 HIV Infection COMPLETED NCT01237444
Soy formula experimental #2 Other Phase PHASE2 Infant, Newborn COMPLETED NCT00798382
Commercially available soy formula Other Phase PHASE2 Infant, Newborn COMPLETED NCT00798382
soy protein formula Other Phase PHASE2 Infant, Newborn COMPLETED NCT00798382
Cinacalcet Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00977080
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00977080
Cinacalcet Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00977080
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00977080
Xact Stent with either Emboshield Pro (Gen 5) or Emboshield (Gen 3) Other Approved Carotid Artery Disease COMPLETED NCT00402740
6 Mercaptopurine Other Phase PHASE3 Crohn Disease UNKNOWN NCT01629628
Adalimumab Other Phase PHASE3 Crohn Disease UNKNOWN NCT01629628
6 Mercaptopurine Other Phase PHASE3 Crohn Disease UNKNOWN NCT01629628
Adalimumab Other Phase PHASE3 Crohn Disease UNKNOWN NCT01629628
Propofol Target Controlled Infusion for Induction and Sevoflurane Inhalation for Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
Propofol Target Controlled Infusion for Induction and Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
Sevoflurane Inhalational Induction and Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
Propofol Target Controlled Infusion for Induction and Sevoflurane Inhalation for Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
Propofol Target Controlled Infusion for Induction and Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
Sevoflurane Inhalational Induction and Maintenance Other Phase PHASE4 Elective Laparoscopic Surgery COMPLETED NCT01191476
placebo Other Phase PHASE3 Giant Cell Arteritis COMPLETED NCT00305539
adalimumab Other Phase PHASE3 Giant Cell Arteritis COMPLETED NCT00305539
placebo Other Phase PHASE3 Giant Cell Arteritis COMPLETED NCT00305539
adalimumab Other Phase PHASE3 Giant Cell Arteritis COMPLETED NCT00305539
Dietary Counseling Other Phase PHASE3 Malnutrition COMPLETED NCT01641770
Nutritional beverage 10003RF Other Phase PHASE3 Malnutrition COMPLETED NCT01641770
Dietary Counseling Other Phase PHASE3 Malnutrition COMPLETED NCT01641770
Nutritional beverage 10003RF Other Phase PHASE3 Malnutrition COMPLETED NCT01641770
Placebo Other Phase PHASE3 Hand Osteoarthritis COMPLETED NCT00597623
Adalimumab (Humira®) Other Phase PHASE3 Hand Osteoarthritis COMPLETED NCT00597623
Placebo Other Phase PHASE3 Hand Osteoarthritis COMPLETED NCT00597623
Adalimumab (Humira®) Other Phase PHASE3 Hand Osteoarthritis COMPLETED NCT00597623
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Prophylaxis of Influenza COMPLETED NCT01633749
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Prophylaxis of Influenza COMPLETED NCT01633749
adalimumab (Humira) Other Preclinical Psoriatic Arthritis WITHDRAWN NCT01078610
adalimumab (Humira) Other Preclinical Psoriatic Arthritis WITHDRAWN NCT01078610
adalimumab (Humira) Other Preclinical Psoriatic Arthritis WITHDRAWN NCT01078610
Rifabutin Other Phase PHASE2 HIV UNKNOWN NCT01663168
Rifabutin Other Phase PHASE2 HIV UNKNOWN NCT01663168
XIENCE V® Everolimus Eluting Coronary Stent Other Preclinical Coronary Disease COMPLETED NCT00631228
Intravenous anesthetic, propofol Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
Inhalational anesthetic Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
Intravenous anesthetic, propofol Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
Inhalational anesthetic Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
Intravenous anesthetic, propofol Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
Inhalational anesthetic Other Phase PHASE4 Coronary Artery Disease COMPLETED NCT00286585
linifanib Other Phase PHASE1 Advanced or Metastatic Solid Tumors TERMINATED NCT01506934
linifanib Other Phase PHASE1 Advanced or Metastatic Solid Tumors TERMINATED NCT01506934
linifanib Other Phase PHASE1 Advanced or Metastatic Solid Tumors TERMINATED NCT01506934
Hospital food Other Phase PHASE3 Burns COMPLETED NCT01464866
Nutritional Supplement Other Phase PHASE3 Burns COMPLETED NCT01464866
Xience V® Other Phase PHASE3 Coronary Restenosis COMPLETED NCT00882219
Sorafenib Other Phase PHASE3 Hepatocellular Carcinoma Non-resectable TERMINATED NCT01009593
ABT-869 Other Phase PHASE3 Hepatocellular Carcinoma Non-resectable TERMINATED NCT01009593
Sorafenib Other Phase PHASE3 Hepatocellular Carcinoma Non-resectable TERMINATED NCT01009593
ABT-869 Other Phase PHASE3 Hepatocellular Carcinoma Non-resectable TERMINATED NCT01009593
FITC-Adalimumab Other Phase PHASE1 Crohn's Disease COMPLETED NCT01275508
FITC-Adalimumab Other Phase PHASE1 Crohn's Disease COMPLETED NCT01275508
SLV354 Other Phase PHASE1 Schizophrenia COMPLETED NCT01545310
ABT-869, linifanib Other Phase PHASE1 Advanced Solid Tumors TERMINATED NCT01286974
[14C]linifanib Other Phase PHASE1 Advanced Solid Tumors TERMINATED NCT01286974
ABT-869, linifanib Other Phase PHASE1 Advanced Solid Tumors TERMINATED NCT01286974
[14C]linifanib Other Phase PHASE1 Advanced Solid Tumors TERMINATED NCT01286974
Experimental Study Formula Other Phase PHASE3 Healthy Infants COMPLETED NCT01699386
Control Study Formula Other Phase PHASE3 Healthy Infants COMPLETED NCT01699386
Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinical practice. Other Preclinical Respiratory Syncytial Virus Infection COMPLETED NCT01107535
Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinical practice. Other Preclinical Respiratory Syncytial Virus Infection COMPLETED NCT01107535
Synagis (palivizumab), monoclonal antibody for passive immunoprophylaxis against severe RSV disease administered according to usual clinical practice. Other Preclinical Respiratory Syncytial Virus Infection COMPLETED NCT01107535
leuprolide (Lucrin/Lucrin-Tri-depot) Other Preclinical Prostatic Neoplasm COMPLETED NCT01081873
leuprolide (Lucrin/Lucrin-Tri-depot) Other Preclinical Prostatic Neoplasm COMPLETED NCT01081873
leuprolide (Lucrin/Lucrin-Tri-depot) Other Preclinical Prostatic Neoplasm COMPLETED NCT01081873
Clinical evaluations/Blood draws Other Approved HIV Infections COMPLETED NCT00571961
buprenorphine Other Approved HIV Infections COMPLETED NCT00571961
Kaletra (lopinavir/ritonavir) Other Approved HIV Infections COMPLETED NCT00571961
A powdered milk-based infant formula, standard fat blend Other Phase PHASE3 Healthy Term Infant COMPLETED NCT01617889
Experimental powdered milk-based infant formula with an alternate fat blend Other Phase PHASE3 Healthy Term Infant COMPLETED NCT01617889
Experimental Hydrolyzed infant formula Other Phase PHASE3 Infant COMPLETED NCT01573871
Experimental Hydrolyzed infant formula Other Phase PHASE3 Infant COMPLETED NCT01573871
Experimental Infant Formula Other Approved Growth and Tolerance Infant Study COMPLETED NCT01812629
Lopinavir/ritonavir (drug) Drug Phase PHASE3 HIV Infections COMPLETED NCT00140751
Lopinavir/ritonavir (drug) Drug Phase PHASE3 HIV Infections COMPLETED NCT00140751
divalproex sodium extended release Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00181727
Low dose Kaletra tablets Other Approved HIV Infections COMPLETED NCT00762320
Low dose Kaletra tablets Other Approved HIV Infections COMPLETED NCT00762320
Low dose Kaletra tablets Other Approved HIV Infections COMPLETED NCT00762320
Placebo Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
Placebo Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
Placebo Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
Paricalcitol Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01003275
No treatment Drug Preclinical Type 1 Diabetes COMPLETED NCT02073058
No treatment Drug Preclinical Type 1 Diabetes COMPLETED NCT02073058
Amino Acid Supplement Group Other Preclinical Wounds COMPLETED NCT02146612
Amino Acid Supplement Group Other Preclinical Wounds COMPLETED NCT02146612
CCC Surgery Procedure Phase PHASE3 Cataract COMPLETED NCT01069172
FS Laser Surgery Procedure Phase PHASE3 Cataract COMPLETED NCT01069172
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00307047
XIENCE V® Everolimus Eluting Coronary Stent Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00307047
XIENCE V® Everolimus Eluting Coronary Stent Other Preclinical Coronary Artery Disease COMPLETED NCT00676520
XIENCE V® Everolimus Eluting Coronary Stent Other Preclinical Coronary Artery Disease COMPLETED NCT00676520
Temozolomide Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
veliparib Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
Temozolomide Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
veliparib Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
Temozolomide Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
veliparib Other Phase PHASE2 Solid Tumor Cancers COMPLETED NCT01193140
Adalimumab Other Phase PHASE2 Uveitis UNKNOWN NCT00348153
Adalimumab Other Phase PHASE2 Uveitis UNKNOWN NCT00348153
protein and meal frequency Other Approved Obesity COMPLETED NCT01749449
protein and meal frequency Other Approved Obesity COMPLETED NCT01749449
Herculink Elite Renal Stent System Other Approved Renal Artery Obstruction COMPLETED NCT00490841
Coronary artery placement of a drug-eluting stent Drug Preclinical Coronary Disease COMPLETED NCT01310309
Buffered pantoprazole Other Phase PHASE4 Acid Peptic Disorder COMPLETED NCT01214408
Buffered pantoprazole Other Phase PHASE4 Acid Peptic Disorder COMPLETED NCT01214408
Buffered pantoprazole Other Phase PHASE4 Acid Peptic Disorder COMPLETED NCT01214408
Rhythm control Other Approved Atrial Fibrillation COMPLETED NCT00578617
Rhythm Control Other Approved Atrial Fibrillation COMPLETED NCT00578617
Rate control Other Approved Atrial Fibrillation COMPLETED NCT00578617
Ablation Therapy Drug Approved Atrial Fibrillation COMPLETED NCT00578617
Rate Control Other Approved Atrial Fibrillation COMPLETED NCT00578617
Experimental oral medical nutritional supplement with AN777 Other Phase PHASE3 Elderly COMPLETED NCT01483976
Oral medical nutritional supplement Other Phase PHASE3 Elderly COMPLETED NCT01483976
Experimental oral medical nutritional supplement with AN777 Other Phase PHASE3 Elderly COMPLETED NCT01483976
Oral medical nutritional supplement Other Phase PHASE3 Elderly COMPLETED NCT01483976
Study Oral Nutritional Supplement Other Approved Gastro-intestinal Tolerance COMPLETED NCT01781624
Clarithromycin modified release 500 mg Other Preclinical Bronchitis COMPLETED NCT01354938
clarithromycin modified release 500 mg Other Preclinical Respiratory Tract Infection COMPLETED NCT01075204
clarithromycin modified release 500 mg Other Preclinical Respiratory Tract Infection COMPLETED NCT01075204
Placebo Other Approved Type 2 Diabetes UNKNOWN NCT01792206
Zemplar Other Approved Type 2 Diabetes UNKNOWN NCT01792206
A powdered milk-based infant formula, standard fat blend Other Phase PHASE3 Healthy Term Infant COMPLETED NCT01617889
Experimental powdered milk-based infant formula with an alternate fat blend Other Phase PHASE3 Healthy Term Infant COMPLETED NCT01617889
Experimental Oral Nutritional Supplement Other Phase PHASE3 Pneumonia TERMINATED NCT01477723
Experimental Oral Nutritional Supplement Other Phase PHASE3 Pneumonia TERMINATED NCT01477723
Infant formula powder Other Phase PHASE3 Infant Newborn COMPLETED NCT01380886
experimental infant formula with alternate protein source Other Phase PHASE3 Infant Newborn COMPLETED NCT01380886
Infant formula powder Other Phase PHASE3 Infant Newborn COMPLETED NCT01380886
experimental infant formula with alternate protein source Other Phase PHASE3 Infant Newborn COMPLETED NCT01380886
Control human milk fortifier Other Phase PHASE3 Preterm Infants COMPLETED NCT01373073
Experimental human milk fortifier Other Phase PHASE3 Preterm Infants COMPLETED NCT01373073
Control human milk fortifier Other Phase PHASE3 Preterm Infants COMPLETED NCT01373073
Experimental human milk fortifier Other Phase PHASE3 Preterm Infants COMPLETED NCT01373073
oral nutritional formula Other Phase PHASE3 Malnutrition COMPLETED NCT01191125
medical food with AN777 Other Phase PHASE3 Malnutrition COMPLETED NCT01191125
Experimental Infant Formula Other Approved Protein Sensitive Colitis COMPLETED NCT01813526
Experimental Infant Formula Other Approved Protein Sensitive Colitis COMPLETED NCT01813526
Monotherapy (Lopinavir/ritonavir) + ABC/3TC Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Monotherapy (Lopinavir/ritonavir) Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Monotherapy (Lopinavir/ritonavir) + ABC/3TC Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Monotherapy (Lopinavir/ritonavir) Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Monotherapy (Lopinavir/ritonavir) + ABC/3TC Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Monotherapy (Lopinavir/ritonavir) Drug Phase PHASE4 HIV Infection COMPLETED NCT00865007
Experimental Infant Formula Other Approved Growth and Tolerance Infant Study COMPLETED NCT01820494
Radiofrequency catheter ablation Other Phase PHASE4 Supraventricular Tachycardias COMPLETED NCT01132274
iFS™ Femtosecond Laser System Other Approved Refractive Astigmatism COMPLETED NCT01210820
Corticosteroid Avoidance Immune Suppression Protocol Other Approved Transplant; Failure, Kidney COMPLETED NCT00587158
Paricalcitol Other Approved Transplant; Failure, Kidney COMPLETED NCT00587158
Corticosteroid Avoidance Immune Suppression Protocol Other Approved Transplant; Failure, Kidney COMPLETED NCT00587158
Paricalcitol Other Approved Transplant; Failure, Kidney COMPLETED NCT00587158
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT01163162
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT01163162
adalimumab Other Phase PHASE2 Sarcoidosis COMPLETED NCT00274352
adalimumab Other Phase PHASE2 Sarcoidosis COMPLETED NCT00274352
OptiFree PureMoist Other Approved Contact Lens Solution Toxicity UNKNOWN NCT01847105
RevitaLens Other Approved Contact Lens Solution Toxicity UNKNOWN NCT01847105
Placebo (soybean oil and dl-alpha-tocopheryl acetate) Other Phase PHASE3 Lactation COMPLETED NCT01747668
Similac Prenatal Vitamin soft-gel capsule Other Phase PHASE3 Lactation COMPLETED NCT01747668
Study Oral Nutritional Supplement Other Approved Gastro-Intestinal Tolerance COMPLETED NCT01782456
Placebo Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Itopride HCI 100 mg Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Itopride HCI 50 mg Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Placebo Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Itopride HCI 100 mg Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Itopride HCI 50 mg Other Phase PHASE2 Irritable Bowel Syndrome COMPLETED NCT01027260
Eicosapentaenoic acid enriched nutritional supplement Other Phase PHASE4 Colorectal Neoplasms TERMINATED NCT00398333
Eicosapentaenoic acid enriched nutritional supplement Other Phase PHASE4 Colorectal Neoplasms TERMINATED NCT00398333
Eicosapentaenoic acid enriched nutritional supplement Other Phase PHASE4 Colorectal Neoplasms TERMINATED NCT00398333
Abound (7 g of Arginine, 7 g Glutamine and 1.2 g HMB) Other Approved Pressure Ulcer COMPLETED NCT01090076
Abound (7 g of Arginine, 7 g Glutamine and 1.2 g HMB) Other Approved Pressure Ulcer COMPLETED NCT01090076
Study product containing lutein Other Phase PHASE3 Healthy Subjects COMPLETED NCT01730898
Triage® B-Type Natriuretic Peptide (BNP) Test Other Phase PHASE4 Heart Failure TERMINATED NCT00206856
Zemplar Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01204528
Zemplar Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01204528
Zemplar Other Phase PHASE2 Chronic Kidney Disease COMPLETED NCT01204528
Switching to LPV/r monotherapy (Kaletra) Drug Phase PHASE4 HIV Infection COMPLETED NCT00865475
AZT+3TC+ABV (Trizivir) Other Phase PHASE4 HIV Infection COMPLETED NCT00865475
Switching to LPV/r monotherapy (Kaletra) Drug Phase PHASE4 HIV Infection COMPLETED NCT00865475
AZT+3TC+ABV (Trizivir) Other Phase PHASE4 HIV Infection COMPLETED NCT00865475
divalproex sodium extended release Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00181727
Placebo Other Phase PHASE2 Influenza COMPLETED NCT00889889
Cell-Derived Trivalent Subunit Influenza Vaccine Other Phase PHASE2 Influenza COMPLETED NCT00889889
Placebo Other Phase PHASE2 Influenza COMPLETED NCT00889889
Cell-Derived Trivalent Subunit Influenza Vaccine Other Phase PHASE2 Influenza COMPLETED NCT00889889
Placebo Other Phase PHASE2 Influenza COMPLETED NCT00889889
Cell-Derived Trivalent Subunit Influenza Vaccine Other Phase PHASE2 Influenza COMPLETED NCT00889889
STAR S4IR LASIK with VSS-R ablation profile Other Approved Refractive Error COMPLETED NCT01067716
divalproex Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
olanzapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
quetiapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
risperidone Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
divalproex Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
olanzapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
quetiapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
risperidone Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
divalproex Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
olanzapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
quetiapine Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
risperidone Other Phase PHASE4 Senile Dementia, Alzheimer Type COMPLETED NCT00208819
Levosimendan Other Phase PHASE3 Heart Failure TERMINATED NCT00166127
Levosimendan Other Phase PHASE3 Heart Failure TERMINATED NCT00166127
receive amino acid supplement Other Approved Obesity COMPLETED NCT00473356
receive amino acid supplement Other Approved Obesity COMPLETED NCT00473356
LPV/r Other Phase PHASE4 HIV Infections COMPLETED NCT00148759
LPV/r Other Phase PHASE4 HIV Infections COMPLETED NCT00148759
carotenoids Other Approved Retinopathy of Prematurity COMPLETED NCT00872664
carotenoids Other Approved Retinopathy of Prematurity COMPLETED NCT00872664
carotenoids Other Approved Retinopathy of Prematurity COMPLETED NCT00872664
Opti-Free Other Phase PHASE3 Study Focus is Healthy Contact Lens Wearers COMPLETED NCT00961051
Investigational MPS Other Phase PHASE3 Study Focus is Healthy Contact Lens Wearers COMPLETED NCT00961051
Without selenium and sodium selenite supplementation Other Approved Preterm Infants COMPLETED NCT02066610
Without selenium and sodium selenate supplementation Other Approved Preterm Infants COMPLETED NCT02066610
selenium and sodium selenite supplementation Other Approved Preterm Infants COMPLETED NCT02066610
selenium and sodium selenate supplementation Other Approved Preterm Infants COMPLETED NCT02066610
crystalens Accommodating IOL Other Phase PHASE4 Cataract COMPLETED NCT01275118
Tecnis Multifocal IOL Other Phase PHASE4 Cataract COMPLETED NCT01275118
Ensure powder Other Approved Malnourished COMPLETED NCT01421680
Ensure powder Other Approved Malnourished COMPLETED NCT01421680
Treatment Algorithm for Crohn's Disease Drug Phase PHASE4 Crohn's Disease COMPLETED NCT01030809
Testosterone Other Phase PHASE1 Obesity COMPLETED NCT01160328
Leuprolide Other Phase PHASE1 Obesity COMPLETED NCT01160328
placebo Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
paricalcitol Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
placebo Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
paricalcitol Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
placebo Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
paricalcitol Other Phase PHASE3 Coronary Artery Disease TERMINATED NCT01012414
iFS Femtosecond Laser System Other Phase PHASE2 Corneal Astigmatism COMPLETED NCT01348854
iFS Femtosecond Laser System Other Phase PHASE2 Corneal Astigmatism COMPLETED NCT01348854
Niacin Other Preclinical Cardiovascular Diseases COMPLETED NCT01200160
Niacin Other Preclinical Cardiovascular Diseases COMPLETED NCT01200160
Meals on Wheels Other Approved Elderly COMPLETED NCT00933153
Ensure Plus Other Approved Elderly COMPLETED NCT00933153
Meals on Wheels Other Approved Elderly COMPLETED NCT00933153
Ensure Plus Other Approved Elderly COMPLETED NCT00933153
Meals on Wheels Other Approved Elderly COMPLETED NCT00933153
Ensure Plus Other Approved Elderly COMPLETED NCT00933153
Creon 25000 matching Placebo Other Phase PHASE4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 WITHDRAWN NCT02009410
Creon Other Phase PHASE4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 WITHDRAWN NCT02009410
Creon 25000 matching Placebo Other Phase PHASE4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 WITHDRAWN NCT02009410
Creon Other Phase PHASE4 Exocrine Pancreatic Insufficiency in Subjects With Diabetes Mellitus Type 2 WITHDRAWN NCT02009410
lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00946595
efavirenz/emtricitabin/tenofovir Other Phase PHASE2 HIV Infections COMPLETED NCT00946595
lopinavir/ritonavir Other Phase PHASE2 HIV Infections COMPLETED NCT00946595
efavirenz/emtricitabin/tenofovir Other Phase PHASE2 HIV Infections COMPLETED NCT00946595
Pancreatin Other Phase PHASE3 Pancreatic Exocrine Insufficiency COMPLETED NCT01747330
Pancreatin Other Phase PHASE3 Pancreatic Exocrine Insufficiency COMPLETED NCT01747330
Implanted device and lead (Cardiac Resynchronization Therapy Defibrillator (CRT-D) device and SJM Quadripolar lead system) Drug Phase PHASE4 Heart Failure UNKNOWN NCT02195843
Anatomical optimization of device and leads Device Phase PHASE4 Heart Failure UNKNOWN NCT02195843
Electrical optimization by RVLV Conduction Time with VectSelect Other Phase PHASE4 Heart Failure UNKNOWN NCT02195843
Placebo Eprosartan Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Placebo Eprosartan mesylate Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Eprosartan Mesylate Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Eprosartan Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Placebo Eprosartan Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Placebo Eprosartan mesylate Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Eprosartan Mesylate Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Eprosartan Other Phase PHASE3 Essential Hypertension COMPLETED NCT01631227
Jevity 1.5 Other Approved Acute Lung Injury UNKNOWN NCT02208700
Oxepa Other Approved Acute Lung Injury UNKNOWN NCT02208700
Everolimus eluting stents Other Phase PHASE4 Coronary Artery Disease UNKNOWN NCT01776567
ABT-510 Other Phase PHASE1 Head and Neck Cancer COMPLETED NCT00113334
ABT-510 Other Phase PHASE1 Head and Neck Cancer COMPLETED NCT00113334
Percutaneous Coronary Intervention using bare metal stents Other Approved Coronary Artery Disease COMPLETED NCT02198716
Percutaneous Coronary Intervention using drug eluting stents Drug Approved Coronary Artery Disease COMPLETED NCT02198716
4 mm punch biopsies Other Preclinical Psoriasis UNKNOWN NCT01604902
4 mm punch biopsies Other Preclinical Psoriasis UNKNOWN NCT01604902
4 mm punch biopsies Other Preclinical Psoriasis UNKNOWN NCT01604902
lopinavir/ritonavir; nevirapine; Zidovudine; Lamivudine Other Phase PHASE4 HIV COMPLETED NCT00143689
Valproate Other Phase PHASE4 Schizophrenia COMPLETED NCT00194025
Valproate Other Phase PHASE4 Schizophrenia COMPLETED NCT00194025
fenofibrate Other Phase PHASE4 Dyslipidemias COMPLETED NCT01462877
fenofibrate Other Phase PHASE4 Dyslipidemias COMPLETED NCT01462877
Ultrasonography Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01205854
Ultrasonography Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01205854
Emboshield NAV6® embolic protection system (Abbott Vascular, Santa Clara, CA) Other Approved Carotid Artery Stenosis UNKNOWN NCT01550835
Quetiapine Other Phase PHASE4 Alzheimer's Disease WITHDRAWN NCT00375557
Divalproex ER Other Phase PHASE4 Alzheimer's Disease WITHDRAWN NCT00375557
Counseling Other Approved Children TERMINATED NCT02125123
Nutritional Supplement and Counseling Other Approved Children TERMINATED NCT02125123
placebo Other Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT02245360
Phleum pratense grass pollen allergen extract Other Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT02245360
placebo Other Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT02245360
Phleum pratense grass pollen allergen extract Other Phase PHASE3 Seasonal Allergic Rhinitis COMPLETED NCT02245360
pediatric formula Other Preclinical GI Tolerance COMPLETED NCT02819401
Veliparib Other Phase PHASE1 Recurrent, Epithelial Ovarian Cancer COMPLETED NCT01472783
Veliparib Other Phase PHASE1 Recurrent, Epithelial Ovarian Cancer COMPLETED NCT01472783
Veliparib Other Phase PHASE1 Recurrent, Epithelial Ovarian Cancer COMPLETED NCT01472783
Nutritional Education Other Phase PHASE4 Malnutrition WITHDRAWN NCT02360722
Oral Nutritional Supplement Other Phase PHASE4 Malnutrition WITHDRAWN NCT02360722
Health Log Other Approved Rheumatoid Arthritis COMPLETED NCT01913080
Health Log Other Approved Rheumatoid Arthritis COMPLETED NCT01913080
Health Log Other Approved Rheumatoid Arthritis COMPLETED NCT01913080
Libra Deep Brain Stimulation System Other Approved Treatment Resistant Depression UNKNOWN NCT01801319
Libra Deep Brain Stimulation System Other Approved Treatment Resistant Depression UNKNOWN NCT01801319
Fractional flow reserve Other Phase PHASE4 NonST Elevation Myocardial Infarction UNKNOWN NCT01764334
Fractional flow reserve Other Phase PHASE4 NonST Elevation Myocardial Infarction UNKNOWN NCT01764334
placebo Other Phase PHASE4 Gait or Balance Disorder Problems COMPLETED NCT01468285
betahistine dihydrochloride Other Phase PHASE4 Gait or Balance Disorder Problems COMPLETED NCT01468285
FreeStyle Libre Flash Glucose Monitoring System Other Approved Diabetes Mellitus COMPLETED NCT02665455
CHO Experimental 4 Maltodextrin Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03293706
CHO Experimental 3 Low Sugar Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03293706
CHO Experimental 2 Digestion Resistant Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03293706
CHO Experimental 1 Slowly Digested Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03293706
CHO Control 1 and 2 Glucose Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03293706
Nerve Block with Sham Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Nerve Block with Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Nerve Block with Sham Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Nerve Block with Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Nerve Block with Sham Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Nerve Block with Radiofrequency Ablation Other Approved Chronic Knee Pain COMPLETED NCT02931435
Device settings for group B Device Approved Cardiac Death COMPLETED NCT01217528
device settings for group A Device Approved Cardiac Death COMPLETED NCT01217528
Accent Pacemaker Other Approved Sick Sinus Syndrome TERMINATED NCT01074749
Quadripolar LV lead (pacing configurations) Other Phase PHASE4 Heart Failure COMPLETED NCT00964938
Quadripolar LV lead (pacing configurations) Other Phase PHASE4 Heart Failure COMPLETED NCT00964938
ICD Implantation Other Approved Ischemic Heart Disease COMPLETED NCT00949000
SJ4 connector and RV high voltage SJ4 lead Other Preclinical Tachyarrhythmias COMPLETED NCT00940888
SJ4 connector and RV high voltage SJ4 lead Other Preclinical Tachyarrhythmias COMPLETED NCT00940888
ICD Implantation Other Approved Ventricular Tachycardia COMPLETED NCT00919373
VT ablation Other Approved Ventricular Tachycardia COMPLETED NCT00919373
Substrate modification Other Approved Ventricular Tachycardia COMPLETED NCT00919373
Pacing interventions Other Preclinical Premature Ventricular Complexes TERMINATED NCT00888667
ICD/ CRT-D Other Preclinical Sudden Cardiac Death COMPLETED NCT00874445
ICD Other Preclinical Healthy COMPLETED NCT00873691
Tendril Lead Other Preclinical Tachyarrhythmias COMPLETED NCT00870324
OptiSense Lead Other Preclinical Tachyarrhythmias COMPLETED NCT00870324
Tendril Lead Other Preclinical Tachyarrhythmias COMPLETED NCT00870324
OptiSense Lead Other Preclinical Tachyarrhythmias COMPLETED NCT00870324
CRM Device Device Preclinical Atrial Fibrillation COMPLETED NCT00837798
VentricularAutoCaptureTM & ACapTM Confirm Other Preclinical Pacemaker COMPLETED NCT00832988
Cardiac Resynchronization Therapy implant Drug Approved Heart Failure COMPLETED NCT00819117
CRT-D (Intra-thoracic Impedance Monitoring) Other Preclinical Heart Failure COMPLETED NCT00811551
CRT-D (Intra-thoracic Impedance Monitoring) Other Preclinical Heart Failure COMPLETED NCT00811551
CRT-D (Intra-thoracic Impedance Monitoring) Other Preclinical Heart Failure COMPLETED NCT00811551
3D echo-guided LV lead placement Other Approved Heart Failure COMPLETED NCT01278030
Therapy Cool Path Duo Drug Phase PHASE3 Typical Atrial Flutter COMPLETED NCT00984204
PVI + Defragmentation + linear lesions Other Approved Atrial Fibrillation COMPLETED NCT01580124
PVI alone Other Approved Atrial Fibrillation COMPLETED NCT01580124
Freestyle LIbre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03820050
Folic Acid Other Phase PHASE2 Oligoarthritis COMPLETED NCT04154852
Placebo Other Phase PHASE2 Oligoarthritis COMPLETED NCT04154852
Methotrexate Other Phase PHASE2 Oligoarthritis COMPLETED NCT04154852
Adalimumab Other Phase PHASE2 Oligoarthritis COMPLETED NCT04154852
lopinavir/ritonavir plus maraviroc Other Phase PHASE4 HIV Infections TERMINATED NCT01068873
lopinavir/ritonavir plus maraviroc Other Phase PHASE4 HIV Infections TERMINATED NCT01068873
General Anesthetics Other Phase PHASE4 Renal Injury TERMINATED NCT03940651
Spinal Anesthesia Other Phase PHASE4 Renal Injury TERMINATED NCT03940651
blood taking Other Preclinical Chest Pain COMPLETED NCT02789904
HeartMate 3™ Other Approved Heart Failure COMPLETED NCT02475460
Less Invasive Surgery (LIS) Procedure Approved Heart Failure COMPLETED NCT02475460
Tricholoracetic acid Other Approved Warts COMPLETED NCT05712811
CRYOTHERAPY Drug Approved Warts COMPLETED NCT05712811
Electrophysiological study and bi-atrial Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study and Right side Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
i-STAT TBI Test Other Approved Traumatic Brain Injury RECRUITING NCT06766435
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Partially Hydrolyzed Infant Formula Other Approved Feeding Intolerance TERMINATED NCT02028156
fenoldopam Other Phase PHASE2 Kidney Failure, Acute COMPLETED NCT00122018
N-acetylcysteine Other Phase PHASE2 Kidney Failure, Acute COMPLETED NCT00122018
fenoldopam Other Phase PHASE2 Kidney Failure, Acute COMPLETED NCT00122018
N-acetylcysteine Other Phase PHASE2 Kidney Failure, Acute COMPLETED NCT00122018
ABSORB implantation Other Phase PHASE4 Coronary Artery Disease UNKNOWN NCT02004730
paricalcitol Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
gemcitabine hydrochloride Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
paricalcitol Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
gemcitabine hydrochloride Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
paricalcitol Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
gemcitabine hydrochloride Other Phase PHASE1 Unspecified Adult Solid Tumor, Protocol Specific COMPLETED NCT00217477
Simvastatin 40 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fixed Combination of Fenofibrate/simvastatin 145/40 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fenofibrate 145 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Simvastatin 20 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fixed Combination of Fenofibrate/simvastatin 145/20 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Simvastatin 40 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fixed Combination of Fenofibrate/simvastatin 145/40 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fenofibrate 145 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Simvastatin 20 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Fixed Combination of Fenofibrate/simvastatin 145/20 mg Other Phase PHASE3 Dyslipidemia COMPLETED NCT01674712
Pre-study antiretroviral regimen Other Phase PHASE4 HIV Infections COMPLETED NCT00700115
Kaletra + Isentress Other Phase PHASE4 HIV Infections COMPLETED NCT00700115
Pre-study antiretroviral regimen Other Phase PHASE4 HIV Infections COMPLETED NCT00700115
Kaletra + Isentress Other Phase PHASE4 HIV Infections COMPLETED NCT00700115
Clarithromycin Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002336
Clofazimine Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Clarithromycin Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Ethambutol hydrochloride Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Clofazimine Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Clarithromycin Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Ethambutol hydrochloride Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Clofazimine Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Clarithromycin Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
Ethambutol hydrochloride Other Approved Mycobacterium Avium-intracellular Infection COMPLETED NCT00002331
nutritional supplement Other Phase PHASE3 Children COMPLETED NCT01658267
NGAL kit Other Preclinical Heart Failure COMPLETED NCT00874289
NGAL kit Other Preclinical Heart Failure COMPLETED NCT00874289
Placebo Other Phase PHASE3 Hypogonadism COMPLETED NCT00433199
Testosterone (T) Gel 1.62% Other Phase PHASE3 Hypogonadism COMPLETED NCT00433199
Placebo Other Phase PHASE3 Hypogonadism COMPLETED NCT00433199
Testosterone (T) Gel 1.62% Other Phase PHASE3 Hypogonadism COMPLETED NCT00433199
Humira Then Humira plus 3 B vitamins Other Phase PHASE1 Psoriasis TERMINATED NCT01704599
Humira Then Humira plus 3 B vitamins Other Phase PHASE1 Psoriasis TERMINATED NCT01704599
Oral Nutritional Supplement Other Approved Gastrointestinal Tolerance COMPLETED NCT01902212
Control Study Product Other Approved Diabetes COMPLETED NCT01850810
Experimental Study Product Other Approved Diabetes COMPLETED NCT01850810
Control Study Product Other Approved Diabetes COMPLETED NCT01850810
Experimental Study Product Other Approved Diabetes COMPLETED NCT01850810
Peptide based enteral formula Other Phase PHASE3 Gastrointestinal Diseases COMPLETED NCT01191112
Placebo Other Phase PHASE4 Flushing COMPLETED NCT00913081
Quercetin Other Phase PHASE4 Flushing COMPLETED NCT00913081
Placebo Other Phase PHASE4 Flushing COMPLETED NCT00913081
Quercetin Other Phase PHASE4 Flushing COMPLETED NCT00913081
Dietary Counseling Other Approved Growth COMPLETED NCT02056275
Nutrition supplement + dietary counseling Other Approved Growth COMPLETED NCT02056275
Dietary Counseling Other Approved Growth COMPLETED NCT02056275
Nutrition supplement + dietary counseling Other Approved Growth COMPLETED NCT02056275
Monofocal Intraocular Lens Other Phase PHASE1 Cataract COMPLETED NCT01714635
Tecnis Multifocal Intraocular Lens Other Phase PHASE1 Cataract COMPLETED NCT01714635
Monofocal Intraocular Lens Other Phase PHASE1 Cataract COMPLETED NCT01714635
Tecnis Multifocal Intraocular Lens Other Phase PHASE1 Cataract COMPLETED NCT01714635
Investigational Milk-based Formula Containing Carotenoid Other Approved Infants TERMINATED NCT02069522
Standard Milk-based Formula Containing Carotenoid Other Approved Infants TERMINATED NCT02069522
Lopinavir/r plus saquinavir Other Phase PHASE4 HIV Infections COMPLETED NCT00476359
Lopinavir/r plus saquinavir Other Phase PHASE4 HIV Infections COMPLETED NCT00476359
Nutritional Supplement Other Preclinical Malnutrition UNKNOWN NCT02404987
Percutaneous coronary intervention (PCI) Other Phase PHASE4 Coronary Occlusion COMPLETED NCT00987610
XIENCE V®/ XIENCE PRIME™ Other Phase PHASE4 Coronary Artery Stenosis COMPLETED NCT00496938
Multi-Link Frontier Coronary Stent System Other Phase PHASE4 Coronary Artery Disease WITHDRAWN NCT00286195
Placebo Other Phase PHASE3 Hyperlipidemia COMPLETED NCT02187757
Study Dietary Supplement (Prelipid 500 mg capsules) Other Phase PHASE3 Hyperlipidemia COMPLETED NCT02187757
Placebo Other Phase PHASE3 Hyperlipidemia COMPLETED NCT02187757
Study Dietary Supplement (Prelipid 500 mg capsules) Other Phase PHASE3 Hyperlipidemia COMPLETED NCT02187757
Lopinavir Other Phase PHASE4 HIV Infection COMPLETED NCT00771498
Lopinavir Other Phase PHASE4 HIV Infection COMPLETED NCT00771498
Quetiapine Other Phase PHASE4 Alzheimer's Disease WITHDRAWN NCT00375557
Divalproex ER Other Phase PHASE4 Alzheimer's Disease WITHDRAWN NCT00375557
Active Comparator: Control Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 3 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 2 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 1 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Active Comparator: Control Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 3 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 2 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Experimental Infant Formula 1 Other Approved Gastrointestinal Tolerance COMPLETED NCT02456831
Xience Prime Long Lesion (LL) Other Phase PHASE3 Myocardial Ischemia COMPLETED NCT00916370
Core size Xience Prime Other Phase PHASE3 Myocardial Ischemia COMPLETED NCT00916370
Absolute Pro™ Peripheral Self-Expanding Stent System Other Phase PHASE3 Peripheral Vascular Disease COMPLETED NCT00844532
Absolute Pro™ Peripheral Self-Expanding Stent System Other Phase PHASE3 Peripheral Vascular Disease COMPLETED NCT00844532
Topotecan Other Phase PHASE1 Ovarian Cancer COMPLETED NCT01690598
Veliparib Other Phase PHASE1 Ovarian Cancer COMPLETED NCT01690598
Ademetionine tablet Other Phase PHASE3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease COMPLETED NCT02200029
Ademetionine IV+tablet Other Phase PHASE3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease COMPLETED NCT02200029
Ademetionine tablet Other Phase PHASE3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease COMPLETED NCT02200029
Ademetionine IV+tablet Other Phase PHASE3 Intrahepatic Cholestasis Associated With Alcoholic Liver Disease COMPLETED NCT02200029
XIENCE V® EECSS Other Preclinical Chronic Coronary Occlusion COMPLETED NCT01120379
Osmolite 1.2 Other Approved Critical Illness COMPLETED NCT01448135
VITAL AF Other Approved Critical Illness COMPLETED NCT01448135
Osmolite 1.2 Other Approved Critical Illness COMPLETED NCT01448135
VITAL AF Other Approved Critical Illness COMPLETED NCT01448135
Osmolite 1.2 Other Approved Critical Illness COMPLETED NCT01448135
VITAL AF Other Approved Critical Illness COMPLETED NCT01448135
lopinavir/ritonavir plus maraviroc Other Phase PHASE4 HIV Infections TERMINATED NCT00981318
Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC Other Phase PHASE4 HIV COMPLETED NCT01088516
Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC Other Phase PHASE4 HIV COMPLETED NCT01088516
Ritonavir-boosted lopinavir Other Phase PHASE4 HIV-1 COMPLETED NCT01192035
Efavirenz or Nevirapine Other Phase PHASE4 HIV-1 COMPLETED NCT01192035
Ritonavir-boosted lopinavir Other Phase PHASE4 HIV-1 COMPLETED NCT01192035
Efavirenz or Nevirapine Other Phase PHASE4 HIV-1 COMPLETED NCT01192035
Bioabsorbable everolimus-eluting stent deployment Other Phase PHASE2 Impotence, Arteriogenic UNKNOWN NCT02492386
Bioabsorbable everolimus-eluting stent deployment Other Phase PHASE2 Impotence, Arteriogenic UNKNOWN NCT02492386
Nutritional management protocol Other Phase PHASE4 Critical Illness COMPLETED NCT00574431
Data Collection Other Phase PHASE4 Critical Illness COMPLETED NCT00574431
inactive drug Drug Phase PHASE3 Interstitial Cystitis COMPLETED NCT01295814
Adalimumab Other Phase PHASE3 Interstitial Cystitis COMPLETED NCT01295814
Fluvoxamine Other Phase PHASE4 Recurrent Depressive Disorder COMPLETED NCT02016261
Fluvoxamine Other Phase PHASE4 Recurrent Depressive Disorder COMPLETED NCT02016261
Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP) Other Phase PHASE4 Acute Coronary Syndrome WITHDRAWN NCT00206817
Reference Group Other Approved Gastrointestinal Tolerance COMPLETED NCT02322138
Experimental 2 Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02322138
Experimental 1 Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02322138
Triage BNP Test Other Approved Heart Failure COMPLETED NCT00206843
Triage Profiler S.O.B. Panel Other Phase PHASE2 Acute Myocardial Infarction COMPLETED NCT00206830
XIENCE PRIME SV EECSS Other Approved Vascular Disease COMPLETED NCT01115933
Standard nutritional supplement Other Phase PHASE4 Hip Fractures TERMINATED NCT01850251
Supplement with HMB and vitamin D Other Phase PHASE4 Hip Fractures TERMINATED NCT01850251
Standard nutritional supplement Other Phase PHASE4 Hip Fractures TERMINATED NCT01850251
Supplement with HMB and vitamin D Other Phase PHASE4 Hip Fractures TERMINATED NCT01850251
Lopinavir/ritonavir simplification strategy Other Phase PHASE4 HIV Infections COMPLETED NCT00159224
Lopinavir/ritonavir simplification strategy Other Phase PHASE4 HIV Infections COMPLETED NCT00159224
Lopinavir/ritonavir simplification strategy Other Phase PHASE4 HIV Infections COMPLETED NCT00159224
Administration of patient self-assessment Other Preclinical Cataract COMPLETED NCT02146599
RevitaLens OcuTec MPS (Investigational MPS) and Opti-Free RepleniSH MPS (control) Other Phase PHASE1 Myopia COMPLETED NCT01024855
Xience Other Preclinical Coronary Artery Disease COMPLETED NCT01350869
Xience Other Preclinical Coronary Artery Disease COMPLETED NCT01350869
Placebo Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
Adalimumab Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
Placebo Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
Adalimumab Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
Placebo Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
Adalimumab Other Phase PHASE3 Arthritis, Rheumatoid COMPLETED NCT00660647
SMBG and CGM Other Approved Type 2 Diabetes COMPLETED NCT01072565
SMBG to guide clinical decisions Other Approved Type 2 Diabetes COMPLETED NCT01072565
SMBG and CGM Other Approved Type 2 Diabetes COMPLETED NCT01072565
SMBG to guide clinical decisions Other Approved Type 2 Diabetes COMPLETED NCT01072565
Preterm infant formula per standard of care Other Preclinical Other Preterm Infants COMPLETED NCT02073071
Continuous Glucose Monitoring of Carbohydrate Intake Other Preclinical Type 2 Diabetes COMPLETED NCT00818077
Continuous Glucose Monitoring of Carbohydrate Intake Other Preclinical Type 2 Diabetes COMPLETED NCT00818077
CGM System for Type 1 and Type 2 Diabetes Mellitus Other Preclinical NonDiabetes COMPLETED NCT00467675
Point of care lactate measurement Other Preclinical Sepsis COMPLETED NCT02189096
NEWS and Sepsis Screening Other Preclinical Sepsis COMPLETED NCT02189096
iDesign® Advanced WaveScan Studio Other Phase PHASE3 Keratoconus UNKNOWN NCT02613780
Photorefractive keratectomy Other Phase PHASE3 Keratoconus UNKNOWN NCT02613780
Crosslinking Other Phase PHASE3 Keratoconus UNKNOWN NCT02613780
Juven Other Phase PHASE1 Pressure Ulcers TERMINATED NCT00502372
Nutritional Supplement/Amino acids and HMB Other Phase PHASE1 Pressure Ulcers TERMINATED NCT00502372
Juven Other Phase PHASE1 Pressure Ulcers TERMINATED NCT00502372
Nutritional Supplement/Amino acids and HMB Other Phase PHASE1 Pressure Ulcers TERMINATED NCT00502372
Amiodarone Other Approved Atrial Fibrillation TERMINATED NCT01276093
PVI ablation Other Approved Atrial Fibrillation TERMINATED NCT01276093
Phase 2- Arm 3 Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02401217
Phase 2- Arm 2 Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02401217
Phase 1- Arm 1 Infant Formula Other Approved Gastrointestinal Tolerance COMPLETED NCT02401217
Nutritional beverage fortified with 12mg lutein/day Other Phase PHASE2 Healthy But Chronically Stressed COMPLETED NCT02257801
Nutritional beverage fortified with 6mg lutein/day Other Phase PHASE2 Healthy But Chronically Stressed COMPLETED NCT02257801
Creon N Other Phase PHASE3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis COMPLETED NCT02137382
Creon® Other Phase PHASE3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis COMPLETED NCT02137382
Creon N Other Phase PHASE3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis COMPLETED NCT02137382
Creon® Other Phase PHASE3 Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis COMPLETED NCT02137382
VSS-Rx1 OPM vs Commercial iDesign Treatment Drug Approved Myopia COMPLETED NCT01988415
divalproex sodium Other Phase PHASE4 Healthy COMPLETED NCT00287053
divalproex sodium Other Phase PHASE4 Healthy COMPLETED NCT00287053
SAMe 2000 mg Other Phase PHASE3 Non Alcoholic Fatty Liver Disease COMPLETED NCT01754714
SAMe 1500 mg Other Phase PHASE3 Non Alcoholic Fatty Liver Disease COMPLETED NCT01754714
SAMe 1000 mg Other Phase PHASE3 Non Alcoholic Fatty Liver Disease COMPLETED NCT01754714
Usual Nutrition Care Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
MNT according to AND EBNPG for Type 2 DM Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
Usual Nutrition Care Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
MNT according to AND EBNPG for Type 2 DM Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
Usual Nutrition Care Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
MNT according to AND EBNPG for Type 2 DM Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
Usual Nutrition Care Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
MNT according to AND EBNPG for Type 2 DM Other Approved Type 2 Diabetes Mellitus COMPLETED NCT01703611
ER Niacin Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
ABT335 Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
Atorvastatin Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
ER Niacin Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
ABT335 Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
Atorvastatin Other Phase PHASE2 Dyslipidemia COMPLETED NCT00728910
Standard SMBG Other Phase PHASE4 Diabetes Mellitus COMPLETED NCT01713348
FreeStyle Navigator Other Phase PHASE4 Diabetes Mellitus COMPLETED NCT01713348
FreeStyle Freedom Lite Other Approved Type 1 Diabetes COMPLETED NCT01519466
FreeStyle InsuLinx Other Approved Type 1 Diabetes COMPLETED NCT01519466
FreeStyle Freedom Lite Other Approved Type 1 Diabetes COMPLETED NCT01519466
FreeStyle InsuLinx Other Approved Type 1 Diabetes COMPLETED NCT01519466
Creon® (DR/GR) Other Phase PHASE2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis COMPLETED NCT02415959
Creon IR Other Phase PHASE2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis COMPLETED NCT02415959
Creon® (DR/GR) Other Phase PHASE2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis COMPLETED NCT02415959
Creon IR Other Phase PHASE2 Exocrine Pancreatic Insufficiency in Subjects With Cystic Fibrosis COMPLETED NCT02415959
Simvastatin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
Extended release niacin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
Simvastatin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
Extended release niacin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
Simvastatin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
Extended release niacin Other Phase PHASE3 Cardiovascular Diseases TERMINATED NCT00120289
SCS Alone Other Approved Failed Back Surgery Syndrome TERMINATED NCT01990287
SCS and PNfS Other Approved Failed Back Surgery Syndrome TERMINATED NCT01990287
Placebo Other Phase PHASE3 Crohn's Disease TERMINATED NCT01562951
ADALIMUMAB Other Phase PHASE3 Crohn's Disease TERMINATED NCT01562951
Placebo Other Phase PHASE3 Crohn's Disease TERMINATED NCT01562951
ADALIMUMAB Other Phase PHASE3 Crohn's Disease TERMINATED NCT01562951
Implantation procedure for a St-Jude Medical pacemaker system with left ventricular apex pacing Procedure Approved Bradyarrhythmia TERMINATED NCT01535404
Implantation procedure for a St-Jude Medical pacemaker system with right ventricular apex pacing Procedure Approved Bradyarrhythmia TERMINATED NCT01535404
Resting conditions Other Preclinical Coronary Artery Disease COMPLETED NCT02184117
Contrast Media Other Preclinical Coronary Artery Disease COMPLETED NCT02184117
Adenosine Other Preclinical Coronary Artery Disease COMPLETED NCT02184117
Maternal Nutritional Supplement Other Approved Breast Feeding COMPLETED NCT02016586
Maternal Nutritional Supplement Other Approved Breast Feeding COMPLETED NCT02016586
Low-Na high-CHO beverage Other Approved Dehydration Related to Exercise COMPLETED NCT01974986
High-Na low-CHO beverage Other Approved Dehydration Related to Exercise COMPLETED NCT01974986
Water with flavoring and non-nutritive sweetener. Other Approved Dehydration Related to Exercise COMPLETED NCT01974986
Control protein powder sachet Other Approved Malnutrition COMPLETED NCT02052232
Experimental protein powder sachet Other Approved Malnutrition COMPLETED NCT02052232
XIENCE V® EECSS Other Phase PHASE4 Coronary Disease COMPLETED NCT01171820
TAXUS® Liberté™ Other Phase PHASE4 Coronary Disease COMPLETED NCT01171820
XIENCE V® EECSS Other Phase PHASE4 Coronary Disease COMPLETED NCT01171820
TAXUS® Liberté™ Other Phase PHASE4 Coronary Disease COMPLETED NCT01171820
Capsule endoscopy Other Phase PHASE4 Plaque Psoriasis COMPLETED NCT01556672
Adalimumab Other Phase PHASE4 Plaque Psoriasis COMPLETED NCT01556672
Capsule endoscopy Other Phase PHASE4 Plaque Psoriasis COMPLETED NCT01556672
Adalimumab Other Phase PHASE4 Plaque Psoriasis COMPLETED NCT01556672
ONS containing AN777 Other Approved Healthy COMPLETED NCT02090387
ONS without AN777 Other Approved Healthy COMPLETED NCT02090387
Escalated Antiarrhythmic Therapy Drug Phase PHASE4 Recurrent Ventricular Tachycardia COMPLETED NCT00905853
Catheter Ablation Other Phase PHASE4 Recurrent Ventricular Tachycardia COMPLETED NCT00905853
Escalated Antiarrhythmic Therapy Drug Phase PHASE4 Recurrent Ventricular Tachycardia COMPLETED NCT00905853
Catheter Ablation Other Phase PHASE4 Recurrent Ventricular Tachycardia COMPLETED NCT00905853
Control Study Product Other Approved Diabetes WITHDRAWN NCT01850134
Experimental Study Product Other Approved Diabetes WITHDRAWN NCT01850134
Alpine Other Preclinical Coronary Artery Disease UNKNOWN NCT02845804
Alpine Other Preclinical Coronary Artery Disease UNKNOWN NCT02845804
Tecnis Multifocal 1-Piece IOL Other Approved Cataract UNKNOWN NCT02863159
Tecnis Multifocal 1-Piece IOL Other Approved Cataract UNKNOWN NCT02863159
clarithromycin Other Phase PHASE3 Heart Disease COMPLETED NCT00121550
clarithromycin Other Phase PHASE3 Heart Disease COMPLETED NCT00121550
CYPHER SELECT PLUS SECSS Other Phase PHASE4 Coronary Occlusion COMPLETED NCT01178268
XIENCE V EECSS Other Phase PHASE4 Coronary Occlusion COMPLETED NCT01178268
CYPHER SELECT PLUS SECSS Other Phase PHASE4 Coronary Occlusion COMPLETED NCT01178268
XIENCE V EECSS Other Phase PHASE4 Coronary Occlusion COMPLETED NCT01178268
placebo Other Phase PHASE4 Dyslipidemia TERMINATED NCT01025492
Trilipix Other Phase PHASE4 Dyslipidemia TERMINATED NCT01025492
Placebo Other Phase PHASE4 Psoriasis COMPLETED NCT01722214
Adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT01722214
Placebo Other Phase PHASE4 Psoriasis COMPLETED NCT01722214
Adalimumab Other Phase PHASE4 Psoriasis COMPLETED NCT01722214
FreeStyle Precision Neo-Meter Other Approved Type 2 Diabetes COMPLETED NCT02553408
FreeStyle Precision Neo-Meter Other Approved Type 2 Diabetes COMPLETED NCT02553408
Adalimumab Other Phase PHASE4 Spondyloarthritis WITHDRAWN NCT00972218
FreeStyle Libre Pro 3 sensor wears Other Approved Diabetes Mellitus COMPLETED NCT02434315
FreeStyle Libre Pro 6 sensor wears, 4 with reviews Other Approved Diabetes Mellitus COMPLETED NCT02434315
FreeStyle Libre Pro 4 sensor wears, 2 with reviews Other Approved Diabetes Mellitus COMPLETED NCT02434315
EnligHTN™ Renal Denervation System Other Phase PHASE1 Chronic Heart Failure UNKNOWN NCT02471729
Adalimumab (Humira) Other Phase PHASE3 Arthritis; Behcet COMPLETED NCT01497717
Adalimumab (Humira) Other Phase PHASE3 Arthritis; Behcet COMPLETED NCT01497717
Adalimumab Other Approved Rheumatoid Arthritis COMPLETED NCT00814866
Adalimumab Other Approved Rheumatoid Arthritis COMPLETED NCT00814866
Adalimumab Other Approved Rheumatoid Arthritis COMPLETED NCT00814866
Echo Other Phase PHASE4 Tricuspid Regurgitation COMPLETED NCT01093001
Placebo Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00481013
Valproic Acid (VPA) Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00481013
Placebo Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00481013
Valproic Acid (VPA) Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00481013
FAST Carbohydrate Other Approved Cognitive Ability, General COMPLETED NCT02630667
MEDIUM Carbohydrate Other Approved Cognitive Ability, General COMPLETED NCT02630667
SLOW Carbohydrate Other Approved Cognitive Ability, General COMPLETED NCT02630667
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT02381418
Trivalent influenza subunit vaccine Influvac Other Phase PHASE3 Influenza COMPLETED NCT02381418
Placebo Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00413244
AndroGel 5 Grams Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00413244
Placebo Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00413244
AndroGel 5 Grams Other Phase PHASE3 Coronary Artery Disease COMPLETED NCT00413244
paricalcitol Other Approved Chronic Kidney Disease COMPLETED NCT00796679
paricalcitol Other Approved Chronic Kidney Disease COMPLETED NCT00796679
TECNIS Monofocal IOL, Model ZCB00 Other Approved Cataract COMPLETED NCT02203721
TECNIS Symfony Extended Range of Vision IOL, Model ZXR00 Other Approved Cataract COMPLETED NCT02203721
TECNIS Monofocal IOL, Model ZCB00 Other Approved Cataract COMPLETED NCT02203721
TECNIS Symfony Extended Range of Vision IOL, Model ZXR00 Other Approved Cataract COMPLETED NCT02203721
Weight Loss Other Approved Insulin Resistance COMPLETED NCT00186537
Fenofibrate Other Approved Insulin Resistance COMPLETED NCT00186537
Rosiglitazone Other Approved Insulin Resistance COMPLETED NCT00186537
Weight Loss Other Approved Insulin Resistance COMPLETED NCT00186537
Fenofibrate Other Approved Insulin Resistance COMPLETED NCT00186537
Rosiglitazone Other Approved Insulin Resistance COMPLETED NCT00186537
Abbott Sensor Based Glucose Monitoring System-Professional Other Preclinical Type 2 Diabetes Mellitus COMPLETED NCT02336945
No treatment Drug Preclinical Type2 Diabetes COMPLETED NCT01932944
Fenofibrate (drug) Drug Approved Hypertriglyceridemia With the Metabolic Syndrome COMPLETED NCT00422396
Fenofibrate (drug) Drug Approved Hypertriglyceridemia With the Metabolic Syndrome COMPLETED NCT00422396
Nutritional Supplement (Ensure Plus) Other Approved Malnutrition WITHDRAWN NCT01190969
Nutritional Supplement (Ensure Plus) Other Approved Malnutrition WITHDRAWN NCT01190969
Fractional Flow Reserve Measurement Other Preclinical Coronary Artery Disease UNKNOWN NCT03055910
MITRACLIP Other Phase PHASE4 MITRAL REGURGITATION UNKNOWN NCT02592889
MITRACLIP Other Phase PHASE4 MITRAL REGURGITATION UNKNOWN NCT02592889
Collection of cervical sample for routine cervical screening Other Approved Cervix Diseases WITHDRAWN NCT02779621
Self-collecting a vaginal sample with a swab for HPV testing Other Approved Cervix Diseases WITHDRAWN NCT02779621
Collection of cervical sample for routine cervical screening Other Approved Cervix Diseases WITHDRAWN NCT02779621
Self-collecting a vaginal sample with a swab for HPV testing Other Approved Cervix Diseases WITHDRAWN NCT02779621
percutaneous coronary intervention Other Phase PHASE4 Coronary Artery Disease TERMINATED NCT01489761
placebo Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT01393808
Paricalcitol Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT01393808
placebo Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT01393808
Paricalcitol Other Phase PHASE2 Type 2 Diabetes COMPLETED NCT01393808
Opti-Free RepleniSH Other Approved Normal Contact Lens Wearers COMPLETED NCT01294917
Clear Care Other Approved Normal Contact Lens Wearers COMPLETED NCT01294917
Multi-purpose disinfecting solution Other Approved Normal Contact Lens Wearers COMPLETED NCT01294917
Metformin and Fenofibrate placebo Other Phase PHASE2 Metabolic Syndrome x COMPLETED NCT00400231
Study Drug: fenofibrate Drug Phase PHASE2 Metabolic Syndrome x COMPLETED NCT00400231
Study Drug: Metformin Drug Phase PHASE2 Metabolic Syndrome x COMPLETED NCT00400231
Study drugs: Metformin and fenofibrate Drug Phase PHASE2 Metabolic Syndrome x COMPLETED NCT00400231
Placebo Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Cholecalciferol Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Paricalcitol Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Placebo Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Cholecalciferol Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Paricalcitol Other Phase PHASE3 Gastric Bypass COMPLETED NCT01138475
Nutrition Products Other Approved Healthy COMPLETED NCT02732158
Milk based standard infant formula Other Approved Infant Newborn COMPLETED NCT01300000
Investigational infant formula Other Approved Infant Newborn COMPLETED NCT01300000
Human Milk Other Approved Infant Newborn COMPLETED NCT01300000
Infant Formula supplemented with Oligosaccharides Other Approved Gastrointestinal Tolerance COMPLETED NCT02746016
Infant Formula supplemented with Oligosaccharides Other Approved Gastrointestinal Tolerance COMPLETED NCT02746016
Placebo Other Phase PHASE4 Nocturnal Hypokinesia UNKNOWN NCT03098368
Rotigotine Other Phase PHASE4 Nocturnal Hypokinesia UNKNOWN NCT03098368
Placebo Other Phase PHASE4 Nocturnal Hypokinesia UNKNOWN NCT03098368
Rotigotine Other Phase PHASE4 Nocturnal Hypokinesia UNKNOWN NCT03098368
Pressure-wire guided CRT implant Other Phase PHASE2 Heart Failure UNKNOWN NCT01464502
Standard CRT Implant Other Phase PHASE2 Heart Failure UNKNOWN NCT01464502
Education and Feedback Other Approved SpA COMPLETED NCT01749618
Education and Feedback Other Approved SpA COMPLETED NCT01749618
Education and Feedback Other Approved SpA COMPLETED NCT01749618
Standard Blood Glucose Monitoring Other Approved Type 1 Diabetes Mellitus COMPLETED NCT02232698
Sensor Based Glucose Monitoring System Other Approved Type 1 Diabetes Mellitus COMPLETED NCT02232698
Depakote ER Other Phase PHASE4 Depression, Bipolar COMPLETED NCT00186186
Depakote ER Other Phase PHASE4 Depression, Bipolar COMPLETED NCT00186186
Diabetes specific ONS 2 Other Approved Diabetes COMPLETED NCT02923960
Diabetes specific ONS 1 Other Approved Diabetes COMPLETED NCT02923960
Standard ONS Other Approved Diabetes COMPLETED NCT02923960
Diabetes specific ONS 2 Other Approved Diabetes COMPLETED NCT02923960
Diabetes specific ONS 1 Other Approved Diabetes COMPLETED NCT02923960
Standard ONS Other Approved Diabetes COMPLETED NCT02923960
FreeStyle Libre Flash Glucose Monitoring System Other Approved Diabetes Mellitus COMPLETED NCT02821117
Seroquel Other Phase PHASE3 Agitation TERMINATED NCT00315900
Depakote ER Other Phase PHASE3 Agitation TERMINATED NCT00315900
Seroquel Other Phase PHASE3 Agitation TERMINATED NCT00315900
Depakote ER Other Phase PHASE3 Agitation TERMINATED NCT00315900
euglycemic and hypoglycemic clamp Other Approved Hypoglycemia COMPLETED NCT01283126
Human Milk Fortifier B Other Approved Infant Growth COMPLETED NCT02307760
Human Milk Fortifier A Other Approved Infant Growth COMPLETED NCT02307760
Clarithromycin Other Phase PHASE4 Nontuberculous Mycobacteria COMPLETED NCT00600769
Clarithromycin Other Phase PHASE4 Nontuberculous Mycobacteria COMPLETED NCT00600769
clarithromycin, rifabutin Other Phase PHASE4 Mycobacterium Avium Complex Lung Disease COMPLETED NCT00598897
clarithromycin, rifabutin Other Phase PHASE4 Mycobacterium Avium Complex Lung Disease COMPLETED NCT00598897
clarithromycin, rifabutin Other Phase PHASE4 Mycobacterium Avium Complex Lung Disease COMPLETED NCT00598897
Standard Blood Glucose Monitoring Other Approved Type 2 Diabetes Mellitus COMPLETED NCT02082184
Sensor Based Glucose Monitoring System Other Approved Type 2 Diabetes Mellitus COMPLETED NCT02082184
Placebo Other Phase PHASE3 Liver Disease, Alcoholic COMPLETED NCT00573313
S-adenosylmethionine Other Phase PHASE3 Liver Disease, Alcoholic COMPLETED NCT00573313
Angioseal closure device Device Approved Coronary Disease COMPLETED NCT02234830
Exoseal closure device Device Approved Coronary Disease COMPLETED NCT02234830
Angioseal closure device Device Approved Coronary Disease COMPLETED NCT02234830
Exoseal closure device Device Approved Coronary Disease COMPLETED NCT02234830
Stenting using Absolute Pro® and Pro LL® Peripheral Stent Systems Other Approved Peripheral Artery Disease COMPLETED NCT01444378
Placebo Other Phase PHASE4 Photosensitive Epilepsy COMPLETED NCT00609245
Valproic Acid Other Phase PHASE4 Photosensitive Epilepsy COMPLETED NCT00609245
Placebo Other Phase PHASE4 Photosensitive Epilepsy COMPLETED NCT00609245
Valproic Acid Other Phase PHASE4 Photosensitive Epilepsy COMPLETED NCT00609245
Conventional biochemical and clinical examinations Other Approved Arthritis COMPLETED NCT01656278
Magnetic resonance imaging (MRI) Other Approved Arthritis COMPLETED NCT01656278
Conventional biochemical and clinical examinations Other Approved Arthritis COMPLETED NCT01656278
Magnetic resonance imaging (MRI) Other Approved Arthritis COMPLETED NCT01656278
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03141892
Placebo Other Approved Heart Failure WITHDRAWN NCT01377103
testerone gel Other Approved Heart Failure WITHDRAWN NCT01377103
Placebo Other Approved Heart Failure WITHDRAWN NCT01377103
testerone gel Other Approved Heart Failure WITHDRAWN NCT01377103
Carotid artery endarterectomy (surgical) Other Approved Carotid Artery Disease TERMINATED NCT00106938
Carotid artery stenting with filter (interventional) Other Approved Carotid Artery Disease TERMINATED NCT00106938
Cataract Surgery Procedure Approved Cataract COMPLETED NCT02847572
Cataract Surgery Procedure Approved Cataract COMPLETED NCT02847572
Nutritional Study Product Other Approved Malabsorption COMPLETED NCT02750787
Nutritional Study Product Other Approved Malabsorption COMPLETED NCT02750787
ADC blood glucose meter with insulin calculator active Other Approved Diabetes Mellitus COMPLETED NCT01432275
Comparator blood glucose meter Other Approved Diabetes Mellitus COMPLETED NCT01432275
ADC blood glucose meter Other Approved Diabetes Mellitus COMPLETED NCT01432275
Lifestyle intervention Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT03249610
Oral Nutritional Supplement (ONS) Other Approved Chronic Kidney Disease COMPLETED NCT02046746
CHO Experimental 4 Maltodextrin Other Approved Glycemic Index COMPLETED NCT03242122
CHO Experimental 3 Low Sugar Other Approved Glycemic Index COMPLETED NCT03242122
CHO Experimental 2 Digestion Resistant Other Approved Glycemic Index COMPLETED NCT03242122
CHO Experimental 1 Slowly Digested Other Approved Glycemic Index COMPLETED NCT03242122
CHO Control 1 and 2 Glucose Other Approved Glycemic Index COMPLETED NCT03242122
Device: FreeStyle Libre Flash Glucose Monitoring System Device Preclinical Diabete Mellitus COMPLETED NCT03159546
HERMES tablet Other Preclinical Mitral Regurgitation UNKNOWN NCT02698150
Implantable Cardioverter Defibrillator (ICD) Other Approved Ventricular Tachycardia WITHDRAWN NCT02844127
SUPERA Interwoven self-expanding nitinol stent Other Approved Peripheral Artery Disease TERMINATED NCT01154751
SUPERA Interwoven self-expanding nitinol stent Other Approved Peripheral Artery Disease TERMINATED NCT01154751
ABT-888/Bortezomib Other Phase PHASE1 Multiple Myeloma COMPLETED NCT01495351
ABT-888/Bortezomib Other Phase PHASE1 Multiple Myeloma COMPLETED NCT01495351
ABT-888/Bortezomib Other Phase PHASE1 Multiple Myeloma COMPLETED NCT01495351
Placebo Other Phase PHASE3 Rheumatoid Arthritis TERMINATED NCT02150473
Adalimumab Other Phase PHASE3 Rheumatoid Arthritis TERMINATED NCT02150473
placebo Other Phase PHASE4 Gait or Balance Disorder Problems COMPLETED NCT01468285
betahistine dihydrochloride Other Phase PHASE4 Gait or Balance Disorder Problems COMPLETED NCT01468285
Frequency domain optical coherence tomography Other Preclinical Coronary Artery Disease COMPLETED NCT03058510
Frequency domain optical coherence tomography Other Preclinical Coronary Artery Disease COMPLETED NCT03058510
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Calcitriol (Rocaltrol®) Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Calcitriol (Rocaltrol®) Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Paricalcitol Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Calcitriol (Rocaltrol®) Other Phase PHASE4 Chronic Kidney Disease COMPLETED NCT00752102
Placebo Other Phase PHASE3 Disorder of Transplanted Kidney COMPLETED NCT01436747
Paricalcitol Other Phase PHASE3 Disorder of Transplanted Kidney COMPLETED NCT01436747
Placebo Other Phase PHASE3 Disorder of Transplanted Kidney COMPLETED NCT01436747
Paricalcitol Other Phase PHASE3 Disorder of Transplanted Kidney COMPLETED NCT01436747
Placebo dydrogesterone Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Placebo progesterone Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Micronized Progesterone 600 mg Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Dydrogesterone 30 mg Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Placebo dydrogesterone Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Placebo progesterone Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Micronized Progesterone 600 mg Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
Dydrogesterone 30 mg Other Phase PHASE3 Female Infertility COMPLETED NCT01850030
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03257501
Absorb BVS Other Approved Ischemic Heart Disease WITHDRAWN NCT02943616
Placebo and tube feed Other Approved Gastrointestinal Hemorrhage COMPLETED NCT01477320
Pantoprazole 40 mg IV daily and tube feed. Other Approved Gastrointestinal Hemorrhage COMPLETED NCT01477320
ABSORB BVS Other Approved Myocardial Ischemia UNKNOWN NCT02928198
ABSORB BVS Other Approved Myocardial Ischemia UNKNOWN NCT02928198
paricalcitol Other Phase PHASE2 Leukemia COMPLETED NCT00064376
paricalcitol Other Phase PHASE2 Leukemia COMPLETED NCT00064376
Divalproex Sodium Extended-Release Tablets Other Approved Elderly COMPLETED NCT00318929
Divalproex Sodium Extended-Release Tablets Other Approved Elderly COMPLETED NCT00318929
Point of Care cTnL testing Other Preclinical Angina, Unstable COMPLETED NCT00222352
Point of Care cTnL testing Other Preclinical Angina, Unstable COMPLETED NCT00222352
Transthoracic Echocardiogram (TTE) Assesment Other Approved Acute Heart Failure COMPLETED NCT02728739
ABSORB BVS Other Approved Myocardial Ischemia COMPLETED NCT01023789
Placebo Other Approved Persistent Atrial Fibrillation COMPLETED NCT01014741
Ibutilide Other Approved Persistent Atrial Fibrillation COMPLETED NCT01014741
Placebo Other Approved Persistent Atrial Fibrillation COMPLETED NCT01014741
Ibutilide Other Approved Persistent Atrial Fibrillation COMPLETED NCT01014741
XIENCE V / PROMUS stent Other Preclinical Angina COMPLETED NCT01086228
XIENCE V / PROMUS stent Other Preclinical Angina COMPLETED NCT01086228
Placebo Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Divalproex Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Lithium Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Placebo Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Divalproex Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Lithium Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194129
Abbott Sensor Based Glucose Monitoring System Other Approved Diabetes Mellitus, Type 1 COMPLETED NCT02283411
Abbott Sensor Based Glucose Monitoring System Other Approved Diabetes Mellitus, Type 1 COMPLETED NCT02283411
Placebo Other Phase PHASE3 Allergy COMPLETED NCT02596321
Mitizax Other Phase PHASE3 Allergy COMPLETED NCT02596321
Stent delivery with Alpine Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Stent delivery with Xpedition Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Stent delivery with Alpine Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Stent delivery with Xpedition Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Stent delivery with Alpine Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Stent delivery with Xpedition Other Approved Percutaneous Coronary Intervention UNKNOWN NCT03451617
Freestyle Navigator Other Approved Critical Illness COMPLETED NCT00694473
Metformin Other Phase PHASE1 Polycystic Ovary Syndrome COMPLETED NCT02086526
Self-Regulatory Approaches Other Approved Type 2 Diabetes COMPLETED NCT00941447
Physical Activity Other Approved Type 2 Diabetes COMPLETED NCT00941447
Dietary Other Approved Type 2 Diabetes COMPLETED NCT00941447
Adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01609205
Adalimumab Other Phase PHASE4 Rheumatoid Arthritis COMPLETED NCT01609205
MEMS cap monitoring Other Phase PHASE4 HIV Infection COMPLETED NCT00785616
MEMS cap monitoring Other Phase PHASE4 HIV Infection COMPLETED NCT00785616
MEMS cap monitoring Other Phase PHASE4 HIV Infection COMPLETED NCT00785616
AT LISA tri 839MP IOL Other Approved Cataract COMPLETED NCT03117426
SYMFONY IOL Other Approved Cataract COMPLETED NCT03117426
No intervention - registry Other Preclinical Mitral Regurgitation TERMINATED NCT02858245
No intervention - registry Other Preclinical Mitral Regurgitation TERMINATED NCT02858245
Fructooligosaccharide Other Phase PHASE1 Osteoporosis COMPLETED NCT01005927
CTO Treatment Device Drug Approved Coronary Artery Disease (CAD) COMPLETED NCT01435031
Experimental Nutritional Product Other Approved Glycemic Index COMPLETED NCT03508154
Control Meal 2 Other Approved Glycemic Index COMPLETED NCT03508154
Control Meal 1 Other Approved Glycemic Index COMPLETED NCT03508154
Experimental Nutritional Product Other Approved Glycemic Index COMPLETED NCT03508154
Control Meal 2 Other Approved Glycemic Index COMPLETED NCT03508154
Control Meal 1 Other Approved Glycemic Index COMPLETED NCT03508154
Life Stent Other Approved Femoropopliteal Stenosis WITHDRAWN NCT01643746
Supera Stent Other Approved Femoropopliteal Stenosis WITHDRAWN NCT01643746
Percutaneous Coronary Intervention Other Approved Acute ST Segment Elevation Myocardial Infarction COMPLETED NCT01986803
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabete Mellitus COMPLETED NCT03369899
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabete Mellitus COMPLETED NCT03369899
Treatment and education program for patients with diabetes who use flash glucose monitoring (FLASH) Drug Approved Diabetes Mellitus COMPLETED NCT03175315
Biaxin ( clarithromycin) Other Phase PHASE2 Cystic Fibrosis COMPLETED NCT00205634
Biaxin ( clarithromycin) Other Phase PHASE2 Cystic Fibrosis COMPLETED NCT00205634
Biaxin ( clarithromycin) Other Phase PHASE2 Cystic Fibrosis COMPLETED NCT00205634
Nutritional Supplement Other Preclinical Malnutrition COMPLETED NCT02698540
Nutritional Supplement Other Preclinical Malnutrition COMPLETED NCT02698540
Implantable Cardiac Monitor (Confirm ICM model 2102) Other Preclinical Atrial Fibrillation COMPLETED NCT01694394
Implantable Cardiac Monitor (Confirm ICM model 2102) Other Preclinical Atrial Fibrillation COMPLETED NCT01694394
IntraVascular UltraSound Other Approved Coronary Artery Disease TERMINATED NCT02814578
Optical coherent tomography Other Approved Coronary Artery Disease TERMINATED NCT02814578
IntraVascular UltraSound Other Approved Coronary Artery Disease TERMINATED NCT02814578
Optical coherent tomography Other Approved Coronary Artery Disease TERMINATED NCT02814578
AMO phacoemulsification equipment Other Approved Cataract Surgery COMPLETED NCT02910362
Alcon phacoemulsification equipment Other Approved Cataract Surgery COMPLETED NCT02910362
AMO phacoemulsification equipment Other Approved Cataract Surgery COMPLETED NCT02910362
Alcon phacoemulsification equipment Other Approved Cataract Surgery COMPLETED NCT02910362
ABT-751 and Carboplatin Other Phase PHASE1 Non Small Cell Lung Cancer TERMINATED NCT00735878
Percutaneous mitral valve repair using MitraClip implant Other Approved Mitral Valve Insufficiency COMPLETED NCT01940120
Percutaneous mitral valve repair using MitraClip implant Other Approved Mitral Valve Insufficiency COMPLETED NCT01940120
MitraClip Other Approved Cardiovascular Diseases TERMINATED NCT01772108
MitraClip Implant Other Preclinical Mitral Regurgitation TERMINATED NCT01301625
MitraClip Implant Other Preclinical Mitral Regurgitation TERMINATED NCT01301625
MitraClip Implant Other Preclinical Mitral Regurgitation TERMINATED NCT01301625
Mitral Valve Surgery Procedure Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
Medical Management Other Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
MitraClip Other Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
Mitral Valve Surgery Procedure Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
Medical Management Other Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
MitraClip Other Preclinical Mitral Valve (MV) Regurgitation COMPLETED NCT01288976
Mitral valve repair or replacement surgery Procedure Approved Mitral Valve Insufficiency COMPLETED NCT00209274
Percutaneous mitral valve repair using MitraClip implant Other Approved Mitral Valve Insufficiency COMPLETED NCT00209274
Mitral valve repair or replacement surgery Procedure Approved Mitral Valve Insufficiency COMPLETED NCT00209274
Percutaneous mitral valve repair using MitraClip implant Other Approved Mitral Valve Insufficiency COMPLETED NCT00209274
Control Infant Formula Other Approved Growth COMPLETED NCT03276884
Experimental Infant Formula Other Approved Growth COMPLETED NCT03276884
MitraClip® implant Other Approved Mitral Valve Insufficiency COMPLETED NCT01931956
MitraClip® implant Other Approved Mitral Valve Insufficiency COMPLETED NCT01931956
Hydrolysate Infant Formula 2 Other Approved Gastrointestinal Tolerance COMPLETED NCT03628183
Hydrolysate Infant Formula 1 Other Approved Gastrointestinal Tolerance COMPLETED NCT03628183
Multicomponent Risk Factor Modification Other Approved Atrial Fibrillation UNKNOWN NCT03785418
MitraClip implantation Other Approved Mitral Regurgitation Functional WITHDRAWN NCT03503851
MitraClip implantation Other Approved Mitral Regurgitation Functional WITHDRAWN NCT03503851
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03502174
Pulmonary Vein Isolation Other Approved Persistent Atrial Fibrillation UNKNOWN NCT03811938
Low voltage ablation Other Approved Persistent Atrial Fibrillation UNKNOWN NCT03811938
Pulmonary Vein Isolation Other Approved Persistent Atrial Fibrillation UNKNOWN NCT03811938
Low voltage ablation Other Approved Persistent Atrial Fibrillation UNKNOWN NCT03811938
Electrophysiology study Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT02131337
Burst Stimulation Other Approved Chronic Pain COMPLETED NCT02011893
Tonic Stimulation Other Approved Chronic Pain COMPLETED NCT02011893
Placebo Other Approved Diabetic Polyneuropathy WITHDRAWN NCT01536236
ANS Eon™ Implantable Pulse Generator (Permanent Implant) Other Approved Diabetic Polyneuropathy WITHDRAWN NCT01536236
St. Jude Medical Spinal Cord Stimulation Systems Other Preclinical Pain COMPLETED NCT01305525
Occipital Stimulation Other Approved Fibromyalgia COMPLETED NCT01298609
Contact force assisted irrigated RF ablation Other Approved Atrial Fibrillation COMPLETED NCT01223469
PVI + CFE ablation Other Approved Atrial Fibrillation COMPLETED NCT01203748
PVI Other Approved Atrial Fibrillation COMPLETED NCT01203748
PVI + Lines ablation Other Approved Atrial Fibrillation COMPLETED NCT01203748
QuickOpt Other Approved Heart Failure COMPLETED NCT00918294
SJM Confirm Other Approved Tachyarrhythmias COMPLETED NCT00746564
SJM Confirm Other Approved Tachyarrhythmias COMPLETED NCT00746564
Combined approach for AF ablation Other Approved Atrial Fibrillation COMPLETED NCT00367757
Substrate via CFAEs Other Approved Atrial Fibrillation COMPLETED NCT00367757
Ablate AF triggers via PVI Other Approved Atrial Fibrillation COMPLETED NCT00367757
EnSite™ HD Grid Catheter mapping system Other Approved Non-paroxysmal Atrial Fibrillation COMPLETED NCT02656537
ECG+IEGM Other Preclinical Heart Failure COMPLETED NCT02814214
ICD/CRT-D with NIPS or EP Study Other Preclinical Monomorphic Ventricular Tachycardia WITHDRAWN NCT02584595
Quartet 1457Q LV Lead Other Approved Heart Failure COMPLETED NCT02548455
VIP Other Approved Sinus Node Disease COMPLETED NCT02485093
Septal ventricular pacing Other Approved Sinus Node Disease COMPLETED NCT02485093
MediGuide Other Preclinical Heart Failure TERMINATED NCT02470312
CRT implantation Other Preclinical Heart Failure TERMINATED NCT02470312
Unpaired remote monitoring transmitter Other Phase PHASE4 Heart Disease WITHDRAWN NCT02421549
atrial septal occluder Other Preclinical Atrial Septal Defect Secundum TERMINATED NCT02353351
Implantation with the commercially available Axium Neurostimulator Other Preclinical Chronic Pain TERMINATED NCT02346643
QST Testing Other Preclinical Post Surgical Groin Pain TERMINATED NCT02337699
Implantation with the commercially available Axium neurostimulator Other Preclinical Post Surgical Groin Pain TERMINATED NCT02337699
Implantation with the commercially available Axium neurostimulator Other Preclinical Chronic Pain COMPLETED NCT02335502
Implantation with the commercially available Axium neurostimulator Other Preclinical Chronic Neuropathic Pain TERMINATED NCT02335489
Hemodynamic measurements for CRT device programming Device Approved Heart Failure COMPLETED NCT02064751
CRT with MultiPoint Pacing Other Approved Heart Failure COMPLETED NCT02064751
ECG continuous recording (Analyze ST) Other Approved Brugada Syndrome COMPLETED NCT02052765
ECG continuous recording (Analyze ST) Other Approved Brugada Syndrome COMPLETED NCT02052765
Same Day Discharge Other Approved Heart Failure COMPLETED NCT01993862
ICD with enhanced SVT discriminators Other Approved Tachycardia COMPLETED NCT01963286
ICD with enhanced SVT discriminators Other Approved Tachycardia COMPLETED NCT01963286
Amplatzer Cardiac Plug Other Preclinical Atrial Fibrillation WITHDRAWN NCT01962051
Amplatzer Cardiac Plug Other Preclinical Atrial Fibrillation WITHDRAWN NCT01962051
EnligHTN™ Renal Denervation System. Other Approved Metabolic Syndrome COMPLETED NCT01911078
Renal Denervation Other Approved Metabolic Syndrome COMPLETED NCT01911078
CRT device implant with MultiPoint Pacing Device Approved Heart Failure COMPLETED NCT01856725
Hemodynamic measurements for CRT device programming Device Approved Heart Failure COMPLETED NCT01856725
CRT device implant with MultiPoint Pacing Device Approved Heart Failure COMPLETED NCT01856725
Hemodynamic measurements for CRT device programming Device Approved Heart Failure COMPLETED NCT01856725
Pacemaker Other Approved Ventricular Dysfunction COMPLETED NCT01842243
Septal pacing Other Approved Ventricular Dysfunction COMPLETED NCT01842243
Apical pacing Other Approved Ventricular Dysfunction COMPLETED NCT01842243
EnligHTN™ Renal Artery Ablation Catheter Other Approved Hypertension COMPLETED NCT01836146
St Jude Medical EON mini rechargeable system Other Approved Heart Failure WITHDRAWN NCT01820130
St Jude Medical EON mini rechargeable system Other Approved Heart Failure WITHDRAWN NCT01820130
EnSite NavX System Other Approved Congestive Heart Failure COMPLETED NCT01615835
Eon-mini IPG (implantable pulse generator) Other Phase PHASE1 Traumatic Brain Injury COMPLETED NCT01588691
PMVr procedure (SJM Percutaneous Mitral Valve Repair (PMVr) Procedure Phase PHASE1 Mitral Valve Prolapse COMPLETED NCT01500148
Transcatheter Aortic Valve Implantation (TAVI) Other Approved Symptomatic Aortic Stenosis COMPLETED NCT01487330
quadripolar LV lead (Quartet) Other Preclinical Heart Failure COMPLETED NCT01484613
ESPRIT BVS Other Approved Atherosclerosis COMPLETED NCT01468974
Angio-Seal VIP Other Approved Patients Requiring a Diagnostic and/or Interventional Diagnostic Procedure COMPLETED NCT01393041
Spinal cord stimulation system Other Phase PHASE2 Systolic Heart Failure COMPLETED NCT01362725
DFT Testing with a 50/50% tilt Other Approved DFT Testing COMPLETED NCT01325922
Right ventricular lead location Other Approved Sinus-node Dysfunction COMPLETED NCT01294839
Right ventricular lead location Other Approved Sinus-node Dysfunction COMPLETED NCT01294839
Implantation of an Accent MRI device Device Preclinical Bradycardia COMPLETED NCT01258218
Implantation of an Accent MRI device Device Preclinical Bradycardia COMPLETED NCT01258218
Device Implantation Device Approved Heart Failure COMPLETED NCT00746135
Device Implantation Device Approved Heart Failure COMPLETED NCT00746135
ICD/ CRT-D Other Preclinical Shock COMPLETED NCT00743522
HIFU AF Ablation Other Approved Coronary Arteriosclerosis TERMINATED NCT00735722
Trifecta aortic heart valve Other Approved Aortic Valve Insufficiency COMPLETED NCT00727181
mitral valve repair (SJM® Rigid Saddle Ring) Other Approved Mitral Valve Insufficiency COMPLETED NCT00727012
AMPLATZER Duct Occluder II Other Approved Patent Ductus Arteriosus COMPLETED NCT00713700
Best Medical Treatment Drug Approved Persistent Atrial Fibrillation COMPLETED NCT00652522
AF ablation Other Approved Persistent Atrial Fibrillation COMPLETED NCT00652522
ICD/CRT implant Other Approved Persistent Atrial Fibrillation COMPLETED NCT00652522
Biocor and Biocor Supra valves Other Approved Aortic Valve Insufficiency COMPLETED NCT00636987
AMPLATZER Muscular VSD Occluder Other Preclinical Muscular APPROVED_FOR_MARKETING NCT00590382
Device closure with the AMPLATZER Membranous VSD Occluder Device Preclinical Membranous NO_LONGER_AVAILABLE NCT00583505
Device closure with the AMPLATZER Membranous VSD Occluder Device Preclinical Membranous NO_LONGER_AVAILABLE NCT00583505
Device closure with the AMPLATZER PFO Occluder Device Preclinical Patent Foramen Ovale NO_LONGER_AVAILABLE NCT00583401
AMPLATZER Membranous VSD Occluder Other Phase PHASE1 Membranous Ventricular Septal Defects COMPLETED NCT00578708
AMPLATZER Membranous VSD Occluder Other Phase PHASE1 Membranous Ventricular Septal Defects COMPLETED NCT00578708
AMPLATZER Membranous VSD Occluder Other Phase PHASE1 Membranous Ventricular Septal Defects COMPLETED NCT00578708
EnSite NavX-Guided CRT implant Other Phase EARLY_PHASE1 Heart Failure WITHDRAWN NCT00577187
EnSite NavX-Guided CRT implant Other Phase EARLY_PHASE1 Heart Failure WITHDRAWN NCT00577187
ICD Implant + Patient Notifier turned ON Other Approved Tachycardia, Ventricular COMPLETED NCT00559559
ICD implant + Patient Notifier turned OFF Other Approved Tachycardia, Ventricular COMPLETED NCT00559559
ICD Implant + Patient Notifier turned ON Other Approved Tachycardia, Ventricular COMPLETED NCT00559559
ICD implant + Patient Notifier turned OFF Other Approved Tachycardia, Ventricular COMPLETED NCT00559559
Dynamic Substrate Mapping-guided ablation Other Phase PHASE1 Ischemic Ventricular Tachycardia TERMINATED NCT00558857
Libra Deep Brain Stimulation System Other Approved Parkinson Disease COMPLETED NCT00552474
AMPLATZER® PFO Occluder Device Device Phase PHASE2 Migraine TERMINATED NCT00505570
Left atrial catheter ablation guided by introducer using Non-steerable sheeth Other Approved Atrial Fibrillation COMPLETED NCT00469638
Left atrial catheter ablation guided by introducer using Agilis sheeth Other Approved Atrial Fibrillation COMPLETED NCT00469638
Cardiac Resynchronization Therapy-Defibrillator Drug Preclinical Heart Failure COMPLETED NCT00453622
Cardiac Resynchronization Therapy-Defibrillator Drug Preclinical Heart Failure COMPLETED NCT00453622
Pacemaker implantation with RA lead in RAA position Other Approved Atrial Fibrillation COMPLETED NCT00419640
Pacemaker implantation with RA lead in LAS position Other Approved Atrial Fibrillation COMPLETED NCT00419640
Pacemaker implantation with RA lead in RAA position Other Approved Atrial Fibrillation COMPLETED NCT00419640
Pacemaker implantation with RA lead in LAS position Other Approved Atrial Fibrillation COMPLETED NCT00419640
Ventricular Intrinsic Preference Other Approved Arrhythmia COMPLETED NCT00366158
Device: St. Jude Medical Victory dual-chamber pacemaker Device Approved Arrhythmia COMPLETED NCT00366158
Ventricular Intrinsic Preference Other Approved Arrhythmia COMPLETED NCT00366158
Device: St. Jude Medical Victory dual-chamber pacemaker Device Approved Arrhythmia COMPLETED NCT00366158
Tissue valve Other Phase PHASE4 Aortic Valve Stenosis COMPLETED NCT00256165
AF Suppression Pacing Algorithm Other Phase PHASE4 Hypertension COMPLETED NCT00256152
Cardiac Resynchronization Therapy Drug Approved Heart Failure COMPLETED NCT00187265
Autointrinsic Conduction Search Algorithm Other Phase PHASE4 Arrhythmia COMPLETED NCT00187239
Cardiac Resynchronization Therapy Drug Approved Heart Failure COMPLETED NCT00187213
Cardiac Resynchronization Therapy Drug Approved Heart Failure COMPLETED NCT00187213
Implantable Defibrillator (ICD) Other Approved Ventricular Tachycardia COMPLETED NCT00187187
Angio-Seal VIP 6 French (6F) and 8 French (8F) devices Device Preclinical Vascular Closure COMPLETED NCT01858636
SJM Confirm ICM Other Preclinical Atrial Fibrillation COMPLETED NCT01673256
St. Jude Medical renal artery ablation system: RF ablation generator (IBI 1500T11.5) and Renal artery ablation catheter (DS3D001, DS3D002) Other Approved Hypertension COMPLETED NCT01438229
Cardiac Resynchronization Therapy - Defibrillator (CRT-D) Drug Phase PHASE4 Sudden Cardiac Death COMPLETED NCT00626093
Cardiac catheter ablation with ICD/CRT-D Other Approved Monomorphic Ventricular Tachycardia TERMINATED NCT02130765
Sham Other Approved Hypertension TERMINATED NCT01903187
EnligHTN Renal Denervation Other Approved Hypertension TERMINATED NCT01903187
Unpaired remote monitoring transmitter Other Approved Heart Disease COMPLETED NCT01871090
Unpaired remote monitoring transmitter Other Approved Heart Disease COMPLETED NCT01871090
Quad Group Other Approved Postoperative Cardiac Complication COMPLETED NCT01510652
BiP Group Other Approved Postoperative Cardiac Complication COMPLETED NCT01510652
Therapy™ Cool Flex™ Irrigated Ablation System Drug Approved Typical Atrial Flutter COMPLETED NCT01408485
Treatment Arm Drug Phase PHASE3 Typical Atrial Flutter COMPLETED NCT01401361
Therapy Cool Path Duo Drug Phase PHASE3 Typical Atrial Flutter COMPLETED NCT00984204
Testing of the autocapture features of the device Device Approved Heart Failure COMPLETED NCT00746356
Surgical ablation of permanent AF Other Approved Atrial Fibrillation TERMINATED NCT00519194
Epicor LP Cardiac Ablation System Other Approved Atrial Fibrillation TERMINATED NCT00519194
Trifecta Aortic Heart Valve Other Approved Aortic Valve Insufficiency COMPLETED NCT00475709
Trifecta Aortic Heart Valve Other Approved Aortic Valve Insufficiency COMPLETED NCT00475709
QuickOpt Other Approved Cardiac Arrhythmias COMPLETED NCT00418314
Control Other Approved Cardiac Arrhythmias COMPLETED NCT00418314
Cardiac Resynchronization Therapy Defibrillator Drug Phase PHASE4 Heart Failure COMPLETED NCT01295840
Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D) Drug Phase PHASE4 Sudden Cardiac Death COMPLETED NCT00311181
Implantable Cardioverter Defibrillator (ICD), Cardiac Resynchronization Therapy (CRT-D) Drug Phase PHASE4 Sudden Cardiac Death COMPLETED NCT00311181
Catheter ablation to treat paroxysmal atrial fibrillation Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT01278953
Placebo Other Phase PHASE3 Andropause COMPLETED NCT00799617
AndroGel® (testosterone gel) Other Phase PHASE3 Andropause COMPLETED NCT00799617
Placebo Other Phase PHASE3 Andropause COMPLETED NCT00799617
AndroGel® (testosterone gel) Other Phase PHASE3 Andropause COMPLETED NCT00799617
FDA approved Open Irrigated RF Ablation System Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT01056328
SJM Irrigated Cardiac Ablation System Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT01056328
Artificial Mechanical Heart Valve Other Approved Aortic Valve Disease TERMINATED NCT00590889
XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) Other Preclinical Angioplasty COMPLETED NCT01249027
XIENCE V® Everolimus Eluting Coronary Stent System (EECSS) Other Preclinical Angioplasty COMPLETED NCT01249027
ABT-888 Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
Temozolomide Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
ABT-888 Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
Temozolomide Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
ABT-888 Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
Temozolomide Other Phase PHASE2 Colorectal Cancer COMPLETED NCT01051596
Everolimus Eluting BVS Other Approved Atherosclerosis TERMINATED NCT01341340
Everolimus Eluting BVS Other Approved Atherosclerosis TERMINATED NCT01341340
Device closure with the AMPLATZER PFO Occluder Device Preclinical Patent Foramen Ovale APPROVED_FOR_MARKETING NCT00584064
CRT-D System Other Preclinical Heart Failure COMPLETED NCT01555619
Therapy Cool Path Duo Cardiac Ablation System Drug Approved Ischemic Ventricular Tachycardia TERMINATED NCT00925522
Therapy Cool Path Duo Cardiac Ablation System Drug Approved Ischemic Ventricular Tachycardia TERMINATED NCT00925522
Tube Feeding Product Other Preclinical Malnutrition COMPLETED NCT03459001
IBS Other Preclinical Irritable Bowel Syndrome COMPLETED NCT03549143
IBS Other Preclinical Irritable Bowel Syndrome COMPLETED NCT03549143
Axium DRG Neurostimulator Other Preclinical Chronic Post Surgical Pain TERMINATED NCT02335229
2.25 mm XIENCE V® Everolimus Eluting Coronary Stent System Other Approved Coronary Artery Disease TERMINATED NCT00783796
IDev SUPERA® Interwoven Self Expanding Nitinol Stent Peripheral Vascular System Other Approved With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries WITHDRAWN NCT00613418
IDev SUPERA® Interwoven Self Expanding Nitinol Stent Peripheral Vascular System Other Approved With de Novo or Restenotic Lesions in the Common and/or External Iliac Arteries WITHDRAWN NCT00613418
coronary artery bypass graft surgery Procedure Approved Coronary Artery Disease TERMINATED NCT00997828
everolimus-eluting stent Other Approved Coronary Artery Disease TERMINATED NCT00997828
Conventional RF ablation Other Approved Paroxysmal Atrial Fibrillation TERMINATED NCT02703454
FIRM-guided RF ablation Other Approved Paroxysmal Atrial Fibrillation TERMINATED NCT02703454
Reprogramming of spinal cord stimulator (Proclaim or Prodigy SJM internal pulse generator) parameters according to study protocol Other Approved Chronic Pain COMPLETED NCT02896361
Mebeverine Other Preclinical Post-cholecystectomy Gastrointestinal Spasms COMPLETED NCT02260154
Mebeverine Other Preclinical Post-cholecystectomy Gastrointestinal Spasms COMPLETED NCT02260154
Mebeverine Other Preclinical Post-cholecystectomy Gastrointestinal Spasms COMPLETED NCT02260154
Mebeverine Other Preclinical Post-cholecystectomy Gastrointestinal Spasms COMPLETED NCT02260154
ACIST Navvus Microcatheter Other Approved Ischemia COMPLETED NCT02648230
St. Jude Medical Pressure Wire Other Approved Ischemia COMPLETED NCT02648230
Treatment with CSI atherectomy device Drug Approved Peripheral Vascular Diseases TERMINATED NCT03455374
Device closure with the AMPLATZER Muscular VSD Occluder Device Approved Heart Septal Defects, Ventricular COMPLETED NCT00583791
Device closure with the AMPLATZER Muscular VSD Occluder Device Approved Heart Septal Defects, Ventricular COMPLETED NCT00583791
mCPVA Other Approved Persistent Atrial Fibrillation COMPLETED NCT02571218
Substrate+mCPVA Other Approved Persistent Atrial Fibrillation COMPLETED NCT02571218
AMPLATZER Septal Occluder Other Approved Atrial Septal Defect COMPLETED NCT00650936
Placebo Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194116
Divalproex Sodium ER Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194116
Placebo Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194116
Divalproex Sodium ER Other Phase PHASE3 Bipolar Disorder COMPLETED NCT00194116
SJM Implantable cardiac devices Device Preclinical Bradycardia COMPLETED NCT03012568
Radio-frequency Ablation Other Preclinical Ventricular Outflow Tract Tachycardia COMPLETED NCT02722577
Radio-frequency Ablation Other Preclinical Ventricular Outflow Tract Tachycardia COMPLETED NCT02722577
CRT Patients Other Preclinical Heart Failure COMPLETED NCT01805154
CRT Patients Other Preclinical Heart Failure COMPLETED NCT01805154
Implantation of a QuickFlex® μ Model 1258T LV Lead Other Preclinical Heart Failure COMPLETED NCT01179477
Guideline-directed medical therapy Drug Approved Mitral Regurgitation UNKNOWN NCT03705312
Transcatheter mitral valve repair Other Approved Mitral Regurgitation UNKNOWN NCT03705312
AF ablation Other Approved Atrial Fibrillation UNKNOWN NCT03989726
AF ablation Other Approved Atrial Fibrillation UNKNOWN NCT03989726
Placebo Other Phase PHASE4 Atrial Fibrillation COMPLETED NCT00807586
Solumedrol Other Phase PHASE4 Atrial Fibrillation COMPLETED NCT00807586
Placebo Other Phase PHASE4 Atrial Fibrillation COMPLETED NCT00807586
Solumedrol Other Phase PHASE4 Atrial Fibrillation COMPLETED NCT00807586
Non-Diagnostic Cardiac MRI scan Other Approved Bradycardia COMPLETED NCT02041702
Non-Diagnostic Cardiac MRI scan Other Approved Bradycardia COMPLETED NCT02041702
Pacemaker, ICD, or CRT device Device Approved Cardiac Arrhythmia COMPLETED NCT02807948
Metabolic Flexibility Tests Other Approved Energy Metabolism COMPLETED NCT03701867
Accelerometry Other Approved Chronic Pain COMPLETED NCT02950831
Receive Detailed ICD Information-paper Other Approved Implantable Cardioverter-Defibrillator COMPLETED NCT02989090
Receive Detailed ICD Information-electronic Other Approved Implantable Cardioverter-Defibrillator COMPLETED NCT02989090
quetiapine Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
divalproex ER Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
quetiapine Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
divalproex ER Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
quetiapine Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
divalproex ER Other Phase PHASE4 Bipolar Disorder COMPLETED NCT00397020
Observational Other Preclinical Heart Failure, Unspecified TERMINATED NCT03001141
Observational Other Preclinical Heart Failure, Unspecified TERMINATED NCT03001141
Standard of care Other Approved Coronary Artery Disease COMPLETED NCT01132495
OMT Other Approved Coronary Artery Disease COMPLETED NCT01132495
Stenting plus OMT Other Approved Coronary Artery Disease COMPLETED NCT01132495
intravaginal progesterone gel 90 mg Other Phase PHASE3 Female Infertility COMPLETED NCT02491437
Dydrogesterone 30 mg Other Phase PHASE3 Female Infertility COMPLETED NCT02491437
intravaginal progesterone gel 90 mg Other Phase PHASE3 Female Infertility COMPLETED NCT02491437
Dydrogesterone 30 mg Other Phase PHASE3 Female Infertility COMPLETED NCT02491437
Optimization using echocardiography Other Approved Heart Failure COMPLETED NCT01172067
Cardiac Resynchronization Therapy Drug Approved Heart Failure COMPLETED NCT01172067
Optimization using echocardiography Other Approved Heart Failure COMPLETED NCT01172067
Cardiac Resynchronization Therapy Drug Approved Heart Failure COMPLETED NCT01172067
Implantation with the commercially available Axium neurostimulator Other Preclinical Peripheral Neuropathy TERMINATED NCT02349646
EnligHTN™ Renal Denervation System Other Preclinical Uncontrolled Hypertension COMPLETED NCT02006758
ORS Other Phase PHASE3 Diarrhea COMPLETED NCT03463512
Racecadotril plus ORS Other Phase PHASE3 Diarrhea COMPLETED NCT03463512
ORS Other Phase PHASE3 Diarrhea COMPLETED NCT03463512
Racecadotril plus ORS Other Phase PHASE3 Diarrhea COMPLETED NCT03463512
MediGuide™ Other Approved Heart Failure COMPLETED NCT01519739
Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System Other Approved Coronary Artery Disease COMPLETED NCT01425281
Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System Other Approved Coronary Artery Disease COMPLETED NCT01425281
Absorb BVS System Other Approved Coronary Artery Disease COMPLETED NCT01923740
XIENCE V EECSS Other Approved Coronary Artery Disease COMPLETED NCT01923740
Absorb BVS System Other Approved Coronary Artery Disease COMPLETED NCT01923740
XIENCE V EECSS Other Approved Coronary Artery Disease COMPLETED NCT01923740
Transcatheter PDA Closure Other Preclinical Ductus Arteriosus, Patent NOT_YET_RECRUITING NCT04205877
Transcatheter PDA Closure Other Preclinical Ductus Arteriosus, Patent NOT_YET_RECRUITING NCT04205877
XIENCE PRIME - Core Size Other Preclinical Angina COMPLETED NCT01721096
XIENCE PRIME - Long Length (LL) Other Preclinical Angina COMPLETED NCT01721096
XIENCE PRIME - Core Size Other Preclinical Angina COMPLETED NCT01721096
XIENCE PRIME - Long Length (LL) Other Preclinical Angina COMPLETED NCT01721096
Group 2 Nutritional Shake Other Approved Glycemic Control COMPLETED NCT04230889
Group 1 Nutritional Shake Other Approved Glycemic Control COMPLETED NCT04230889
Usual Diet Group Other Approved Glycemic Control COMPLETED NCT04230889
toric intraocular lens Other Approved Cataract COMPLETED NCT02566083
non-toric intraocular lens Other Approved Cataract COMPLETED NCT02566083
Algorithmic Cardiac Resynchronisation Therapy Optimisation Drug Approved Heart Failure, Systolic WITHDRAWN NCT02997670
Algorithmic Cardiac Resynchronisation Therapy Optimisation Drug Approved Heart Failure, Systolic WITHDRAWN NCT02997670
Presbyopia and astigmatism correcting intraocular lens Other Approved Cataract Bilateral COMPLETED NCT03082599
Amiodarone Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Ablation Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Amiodarone Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Ablation Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Amiodarone Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Ablation Other Phase PHASE3 Defibrillators, Implantable TERMINATED NCT01097330
Flavonoid Cohort 3 Other Approved Biological Aging COMPLETED NCT03213340
Curcuminoid Cohort 2 Other Approved Biological Aging COMPLETED NCT03213340
Catechin Cohort 1 Other Approved Biological Aging COMPLETED NCT03213340
Experimental Hydrolyzed Protein Infant Formula Other Approved Protein Intolerance COMPLETED NCT03884309
Fractional Flow Reserve Other Preclinical Coronary Artery Disease COMPLETED NCT02935088
Fractional Flow Reserve Other Preclinical Coronary Artery Disease COMPLETED NCT02935088
Firm ablation for transitional AF rotors Other Approved Atrial Fibrillation WITHDRAWN NCT02758002
Firm ablation for transitional AF rotors Other Approved Atrial Fibrillation WITHDRAWN NCT02758002
Compliance Other Preclinical Epilepsy COMPLETED NCT00356018
Compliance Other Preclinical Epilepsy COMPLETED NCT00356018
Patients implanted with a St. Jude Medical pacemakers Other Preclinical Standard Bradycardia Pacing Indication COMPLETED NCT02577887
Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM Other Approved Cardiac Arrythmias COMPLETED NCT03720639
Abbott, Inc Confirm Rx™ versus Medtronic, Inc Reveal LINQTM Other Approved Cardiac Arrythmias COMPLETED NCT03720639
Stimulation will be delivered at with different microdosing setting to identify the optimal parameter values for each patient. Other Approved Pain, Intractable COMPLETED NCT03350256
Glucose tablets Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
Azithromycin 500Mg Oral Tablet Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
Hydroxychloroquine 200 Mg Oral Tablet Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
Glucose tablets Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
Azithromycin 500Mg Oral Tablet Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
Hydroxychloroquine 200 Mg Oral Tablet Other Phase PHASE3 COVID19 UNKNOWN NCT04328272
CABG Other Approved Chronic Coronary Occlusion COMPLETED NCT01205776
Percutaneous Coronary Intervention Other Approved Chronic Coronary Occlusion COMPLETED NCT01205776
AMPLATZER Cardiac Plug Other Approved Atrial Fibrillation COMPLETED NCT01118299
Left atrial appendage closure Other Approved Atrial Fibrillation UNKNOWN NCT04180605
Additional support for preoperative planning of LAA closure procedures Procedure Approved Atrial Fibrillation UNKNOWN NCT04180605
Left atrial appendage closure Other Approved Atrial Fibrillation UNKNOWN NCT04180605
Additional support for preoperative planning of LAA closure procedures Procedure Approved Atrial Fibrillation UNKNOWN NCT04180605
Experimental Product Other Approved Compliance, Patient TERMINATED NCT04041908
Cardiac Ablation Other Approved Persistent Atrial Fibrillation COMPLETED NCT01907828
Renal Artery Ablation Other Approved Persistent Atrial Fibrillation COMPLETED NCT01907828
XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) Other Preclinical Angioplasty COMPLETED NCT01894152
Iliac segment recanalization, stenting and plastic Common Femoral Artery (CFA) patch Other Approved Atherosclerosis of the Peripheral Arteries UNKNOWN NCT03315884
Iliac segment recanalization and stenting Iliac segment Common Femoral Artery (CFA) Other Approved Atherosclerosis of the Peripheral Arteries UNKNOWN NCT03315884
Endovascular treatment for PAD Drug Approved Atherosclerosis UNKNOWN NCT03951727
Endovascular treatment for PAD Drug Approved Atherosclerosis UNKNOWN NCT03951727
Multidisciplinary Team Based Care Model Other Preclinical Critical Limb Ischemia UNKNOWN NCT04427124
Multidisciplinary Team Based Care Model Other Preclinical Critical Limb Ischemia UNKNOWN NCT04427124
Multidisciplinary Team Based Care Model Other Preclinical Critical Limb Ischemia UNKNOWN NCT04427124
Navigation Other Preclinical Peripheral Arterial Disease COMPLETED NCT03585387
Different formulations of once-daily lopinavir/ritonavir Other Phase PHASE4 HIV Infection COMPLETED NCT00281606
Different formulations of once-daily lopinavir/ritonavir Other Phase PHASE4 HIV Infection COMPLETED NCT00281606
Different formulations of once-daily lopinavir/ritonavir Other Phase PHASE4 HIV Infection COMPLETED NCT00281606
OCT stent guidance Other Preclinical Coronary Artery Disease COMPLETED NCT01663896
Cardiac MRI with and without pacemaker stimulation Other Approved Heart Block TERMINATED NCT01798043
Cardiac MRI with pacemaker stimulation Other Approved Heart Block TERMINATED NCT01798043
AMPLATZER PFO Occluder Other Approved Migraine Headaches COMPLETED NCT00355056
Sham Procedure Procedure Approved Migraine Headaches COMPLETED NCT00355056
Warfarin Other Approved Heart Failure UNKNOWN NCT03781258
Warfarin Other Approved Heart Failure UNKNOWN NCT03781258
Warfarin Other Approved Heart Failure UNKNOWN NCT03781258
Warfarin Other Approved Heart Failure UNKNOWN NCT03704220
Warfarin Other Approved Heart Failure UNKNOWN NCT03704220
Warfarin Other Approved Heart Failure UNKNOWN NCT03078374
Drug (Direct thrombin or Factor Xa inhibitor) Drug Approved Atrial Fibrillation TERMINATED NCT01650298
Drug (Direct thrombin or Factor Xa inhibitor) Drug Approved Atrial Fibrillation TERMINATED NCT01650298
Placebo Other Preclinical CKD Stage 3/4 COMPLETED NCT02018133
Vitamin D 2mg daily for 2 weeks oral paricalcitol Other Preclinical CKD Stage 3/4 COMPLETED NCT02018133
Placebo Other Preclinical CKD Stage 3/4 COMPLETED NCT02018133
Vitamin D 2mg daily for 2 weeks oral paricalcitol Other Preclinical CKD Stage 3/4 COMPLETED NCT02018133
Adalimumab Other Phase PHASE2 Sarcoidosis TERMINATED NCT00311246
Adalimumab Other Phase PHASE2 Sarcoidosis TERMINATED NCT00311246
Ellipse VR ICD and Durata/Optisure lead Other Approved Implantable Defibrillator User COMPLETED NCT02787291
Ellipse VR ICD and Durata/Optisure lead Other Approved Implantable Defibrillator User COMPLETED NCT02787291
Reference Group Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Experimental Infant Formula Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Control Infant Formula Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Reference Group Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Experimental Infant Formula Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Control Infant Formula Other Approved Gastro-Intestinal Tolerance COMPLETED NCT03967132
Nutritional Supplement Other Approved Glycemic Response COMPLETED NCT04313920
Nutritional Supplement Other Approved Glycemic Response COMPLETED NCT04313920
Device data collection Device Preclinical Sick Sinus Syndrome COMPLETED NCT03564860
Absorb™ BVS Other Approved Coronary Artery Disease COMPLETED NCT01844284
XIENCE PRIME®/XIENCE Xpedition™ Other Approved Coronary Artery Disease COMPLETED NCT01844284
Omacor (Omega-3-acid ethyl esters) Other Preclinical History of Myocardial Infarction COMPLETED NCT03415152
Omacor (Omega-3-acid ethyl esters) Other Preclinical History of Myocardial Infarction COMPLETED NCT03415152
Omacor (Omega-3-acid ethyl esters) Other Preclinical History of Myocardial Infarction COMPLETED NCT03415152
HeartPOD™ System Other Preclinical Heart Failure COMPLETED NCT00632372
Cardiac Resynchronization Therapy Drug Preclinical Heart Failure COMPLETED NCT00632372
HeartPOD™ System Other Preclinical Heart Failure COMPLETED NCT00632372
Cardiac Resynchronization Therapy Drug Preclinical Heart Failure COMPLETED NCT00632372
Angiography-only Other Preclinical Coronary Artery Disease COMPLETED NCT04597489
Fractional flow reserve Other Preclinical Coronary Artery Disease COMPLETED NCT04597489
Angiography-only Other Preclinical Coronary Artery Disease COMPLETED NCT04597489
Fractional flow reserve Other Preclinical Coronary Artery Disease COMPLETED NCT04597489
Placebo Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
adalimumab Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
Placebo Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
adalimumab Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
Placebo Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
adalimumab Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
Placebo Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
adalimumab Other Approved Arthritis, Rheumatoid COMPLETED NCT01197144
Mindfulness Meditation Other Approved Hand Injuries COMPLETED NCT03458013
Accent MRI system (with MRI scan) Other Approved Adverse Effect of MRI on an Implanted Pacemaker Lead COMPLETED NCT01576016
Accent MRI system (lead safety) Other Approved Adverse Effect of MRI on an Implanted Pacemaker Lead COMPLETED NCT01576016
Rosuvastatin Other Phase PHASE2 HIV Infections COMPLETED NCT00184951
FreeStyle Libre 3 Other Preclinical Diabetes Mellitus COMPLETED NCT04464772
CRT Other Preclinical Chronic Heart Failure COMPLETED NCT02367716
CRT Other Preclinical Chronic Heart Failure COMPLETED NCT02367716
Once daily Other Phase PHASE4 HIV Infections TERMINATED NCT00679926
Once daily Other Phase PHASE4 HIV Infections TERMINATED NCT00679926
Placebo Micronized progesterone Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Placebo Dydrogesterone oral tablet Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Micronized progesterone Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Dydrogesterone Oral Tablet Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Placebo Micronized progesterone Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Placebo Dydrogesterone oral tablet Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Micronized progesterone Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
Dydrogesterone Oral Tablet Other Phase PHASE4 Infertility, Female COMPLETED NCT03677336
CRT-P Implant Other Approved Hypertrophic Cardiomyopathy With Obstruction COMPLETED NCT01614717
CRT-P Implant Other Approved Hypertrophic Cardiomyopathy With Obstruction COMPLETED NCT01614717
Optical coherence tomography assessment Other Approved Tomography, Optical Coherence UNKNOWN NCT04683133
Optical coherence tomography assessment Other Approved Tomography, Optical Coherence UNKNOWN NCT04683133
Optical coherence tomography assessment Other Approved Tomography, Optical Coherence UNKNOWN NCT04683133
lead placement followed by BurstDR stimulation Other Approved Chronic, Intractable Pain of the Trunk and/or Lower Limbs COMPLETED NCT03277378
lead placement followed by BurstDR stimulation Other Approved Chronic, Intractable Pain of the Trunk and/or Lower Limbs COMPLETED NCT03277378
Experimental Infant Formula Other Approved Growth and Tolerance COMPLETED NCT04105686
Control Infant Formula Other Approved Growth and Tolerance COMPLETED NCT04105686
RV Pacing Other Approved Atrioventricular Block COMPLETED NCT00187278
Biventricular Pacing Other Approved Atrioventricular Block COMPLETED NCT00187278
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus TERMINATED NCT03448367
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus TERMINATED NCT03448367
BiV/MPP Other Preclinical Heart Failure COMPLETED NCT02832622
MPP Other Preclinical Heart Failure COMPLETED NCT02832622
DAPT Other Approved Bleeding Disorder COMPLETED NCT03355742
XIENCE Other Approved Bleeding Disorder COMPLETED NCT03355742
Low-intensity exercise therapy Drug Approved Pancreatic Cancer TERMINATED NCT03244683
Nutrition counseling Other Approved Pancreatic Cancer TERMINATED NCT03244683
Ensure Surgical Other Approved Pancreatic Cancer TERMINATED NCT03244683
Omega-3-acid ethyl ester or Placebo Other Phase PHASE3 Hypertriglyceridemia COMPLETED NCT04756180
Omega-3-acid ethyl ester or Placebo Other Phase PHASE3 Hypertriglyceridemia COMPLETED NCT04756180
Oral Nutritional Supplement Other Approved Malnutrition COMPLETED NCT03245047
Oral Nutritional Supplement with AN 777 Other Approved Malnutrition COMPLETED NCT03245047
Coronary artery stenting: Absorb BVS Other Approved Coronary Artery Disease COMPLETED NCT02229864
preset program Other Approved Chronic Pain COMPLETED NCT02346383
Experimental Thickener Other Approved Gastro-intestinal Tolerance WITHDRAWN NCT04104815
Coronary PCI guided by Angiography Other Approved Coronary Artery Disease COMPLETED NCT02471586
Coronary PCI guided by OCT Other Approved Coronary Artery Disease COMPLETED NCT02471586
Coronary PCI guided by IVUS Other Approved Coronary Artery Disease COMPLETED NCT02471586
10 Hz rTMS Other Approved Schizophrenia TERMINATED NCT02242578
1 Hz rTMS Other Approved Schizophrenia TERMINATED NCT02242578
blood taking Other Preclinical Chest Pain COMPLETED NCT02789904
Possible NSTE-ACS Other Preclinical Coronary Artery Disease UNKNOWN NCT04851418
Possible NSTE-ACS Other Preclinical Coronary Artery Disease UNKNOWN NCT04851418
Rate or Rhythm Control Therapy Drug Approved Atrial Fibrillation COMPLETED NCT00911508
Left atrial ablation Other Approved Atrial Fibrillation COMPLETED NCT00911508
Glucerna Other Phase PHASE3 Hypoglycemia UNKNOWN NCT03802942
Glucerna Other Phase PHASE3 Hypoglycemia UNKNOWN NCT03802942
Blood drawing to determine drug levels Drug Preclinical HIV Infections COMPLETED NCT00179335
Blood drawing to determine drug levels Drug Preclinical HIV Infections COMPLETED NCT00179335
Anatomical midline lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
Paresthesia mapping lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
Anatomical midline lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
Paresthesia mapping lead evaluation first Other Approved Chronic Pain COMPLETED NCT02986074
Cardiac Rhythm Management device Device Preclinical Bradycardia COMPLETED NCT01754064
XIENCE Xpedition 2.25 mm stent Other Preclinical Ischemic Heart Disease COMPLETED NCT02513732
Toddler Drink for HM group Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Supplemental Formula for HM Group Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Experimental Toddler Drink Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Experimental Infant Formula Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Control Toddler Drink Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Control Infant Formula Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Toddler Drink for HM group Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Supplemental Formula for HM Group Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Experimental Toddler Drink Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Experimental Infant Formula Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Control Toddler Drink Other Approved Respiratory Infections in Children TERMINATED NCT04495738
Control Infant Formula Other Approved Respiratory Infections in Children TERMINATED NCT04495738
EnligHTN Other Preclinical Hypertension TERMINATED NCT01705080
DBS Other Preclinical Parkinson COMPLETED NCT03630302
Osmolite Other Approved Enteral Nutrition COMPLETED NCT03153397
Nutraflora scFOS Other Approved Enteral Nutrition COMPLETED NCT03153397
Osmolite Other Approved Enteral Nutrition COMPLETED NCT03153397
Nutraflora scFOS Other Approved Enteral Nutrition COMPLETED NCT03153397
MRI scan Other Approved Chronic Pain COMPLETED NCT02738840
MRI scan Other Approved Chronic Pain COMPLETED NCT02738840
High Protein, Energy Dense Nutritional Supplement Other Approved Gastro-Intestinal Tolerance COMPLETED NCT04259437
High Protein, Energy Dense Nutritional Supplement Other Approved Gastro-Intestinal Tolerance COMPLETED NCT04259437
AVJ-514 Other Approved Mitral Stenosis With Insufficiency COMPLETED NCT02520310
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03448380
FreeStyle Libre Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus COMPLETED NCT03448380
Adalimumab Other Phase PHASE2 Ulcerative Colitis TERMINATED NCT01716039
MTX 25 Other Phase PHASE2 Ulcerative Colitis TERMINATED NCT01716039
MTX 12.5 Other Phase PHASE2 Ulcerative Colitis TERMINATED NCT01716039
Device interrogation Device Preclinical Heart Failure UNKNOWN NCT04397224
Device interrogation Device Preclinical Heart Failure UNKNOWN NCT04397224
Prodigy, Prodigy MRI or Proclaim Elite IPG Other Approved Chronic Pain COMPLETED NCT03082261
Experimental Infant Formula Other Approved Tolerance COMPLETED NCT04529759
Control Infant Formula Other Approved Tolerance COMPLETED NCT04529759
Standard Care Other Approved Palliative Care UNKNOWN NCT04942756
Continuous Glucose Monitoring Other Approved Palliative Care UNKNOWN NCT04942756
Standard Care Other Approved Palliative Care UNKNOWN NCT04942756
Continuous Glucose Monitoring Other Approved Palliative Care UNKNOWN NCT04942756
Amiodarone Other Phase PHASE3 Heart Diseases COMPLETED NCT02924285
Procedure (Radiofrequency catheter ablation) Procedure Phase PHASE3 Heart Diseases COMPLETED NCT02924285
Medication stabilized the condition Drug Approved ST Elevation Myocardial Infarction UNKNOWN NCT04996277
Fibrinolytic therapy Drug Approved ST Elevation Myocardial Infarction UNKNOWN NCT04996277
Thrombus suction Other Approved ST Elevation Myocardial Infarction UNKNOWN NCT04996277
angiography Other Approved ST Elevation Myocardial Infarction UNKNOWN NCT04996277
Intervention/treatment Drug Approved Bradycardia COMPLETED NCT00311168
Intervention/treatment Drug Approved Bradycardia COMPLETED NCT00311168
amiodarone hydrochloride Other Approved Chagas Cardiomyopathy UNKNOWN NCT01722942
ICD implantation Other Approved Chagas Cardiomyopathy UNKNOWN NCT01722942
HeartPOD™ System Other Approved Heart Failure COMPLETED NCT00547729
Nurse led structured intervention - hypoglycaemia education and diabetes treatment modification modification Drug Approved Type 2 Diabetes UNKNOWN NCT04997512
Freestyle libre Other Approved Type 2 Diabetes UNKNOWN NCT04997512
Endovascular treatment for PAD during medical care (SuperA stent (Abbott)) Drug Preclinical Atherosclerosis Obliterans COMPLETED NCT03020290
Control Infant Formula Other Approved Infant Development COMPLETED NCT04006236
Experimental Infant Formula Other Approved Infant Development COMPLETED NCT04006236
Directional Deep Brain Stimulation of STN Other Approved Parkinson Disease UNKNOWN NCT03548506
Omnidirectional Deep Brain Stimulation of STN Other Approved Parkinson Disease UNKNOWN NCT03548506
TactiCath Quartz treatment Drug Approved Paroxysmal Atrial Fibrillation COMPLETED NCT02310100
Observational study Other Preclinical Rheumatoid Arthritis COMPLETED NCT01476956
Observational study Other Preclinical Rheumatoid Arthritis COMPLETED NCT01476956
Zidovudine Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
Anti-HIV Immune Serum Globulin (Human) Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
Zidovudine Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
Anti-HIV Immune Serum Globulin (Human) Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
Zidovudine Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
Anti-HIV Immune Serum Globulin (Human) Other Phase PHASE2 HIV Infections TERMINATED NCT00000961
DAPT Other Approved Coronary Artery Lesions COMPLETED NCT03218787
XIENCE Other Approved Coronary Artery Lesions COMPLETED NCT03218787
Fractional Flow Reserve (FFR) Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Angiography guided PCI Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Fractional Flow Reserve (FFR) Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Angiography guided PCI Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Fractional Flow Reserve (FFR) Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Angiography guided PCI Other Approved Acute ST Segment Elevation Myocardial Infarction UNKNOWN NCT02943954
Portico Valve and FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis COMPLETED NCT03724812
Creon® 10000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Creon® 25000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Creon® 10000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Creon® 25000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Creon® 10000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Creon® 25000 Other Phase PHASE3 Pancreatic Insufficiency UNKNOWN NCT03450772
Tricor (fenofibrate), 145 mg, film-coated tablet Other Preclinical Hypertriglyceridemia COMPLETED NCT04650152
LASIK correction of hyperopic refractive errors Other Approved Hyperopia COMPLETED NCT01675479
LASIK correction of hyperopic refractive errors Other Approved Hyperopia COMPLETED NCT01675479
Duphaston® (Dydrogesteron) Other Preclinical Infertility UNKNOWN NCT04249297
Duphaston® (Dydrogesteron) Other Preclinical Infertility UNKNOWN NCT04249297
Duphaston® (Dydrogesteron) Other Preclinical Infertility UNKNOWN NCT04249297
Duphaston® (Dydrogesterone) Other Preclinical Endometriosis COMPLETED NCT03690765
Duphaston® (Dydrogesterone) Other Preclinical Endometriosis COMPLETED NCT03690765
Experimental Nutritional Pudding Other Approved Gastrointestinal Tolerance COMPLETED NCT04945083
Experimental Nutritional Pudding Other Approved Gastrointestinal Tolerance COMPLETED NCT04945083
Manual Compression Other Approved Atrial Fibrillation COMPLETED NCT04180540
Percutaneous Closure Other Approved Atrial Fibrillation COMPLETED NCT04180540
Manual Compression Other Approved Atrial Fibrillation COMPLETED NCT04180540
Percutaneous Closure Other Approved Atrial Fibrillation COMPLETED NCT04180540
Manual Compression Other Approved Atrial Fibrillation COMPLETED NCT04180540
Percutaneous Closure Other Approved Atrial Fibrillation COMPLETED NCT04180540
MitraClip NTR/XTR System Other Preclinical Mitral Valve Regurgitation COMPLETED NCT03502811
MitraClip NTR/XTR System Other Preclinical Mitral Valve Regurgitation COMPLETED NCT03502811
Esophageal high-resolution manometry and 24-h esophageal pH-impedance monitoring Other Approved Gastroesophageal Reflux Disease (GERD) COMPLETED NCT02699060
Upper gastrointestinal endoscopy with biopsy and collection of refluxate Other Approved Gastroesophageal Reflux Disease (GERD) COMPLETED NCT02699060
Esophageal high-resolution manometry and 24-h esophageal pH-impedance monitoring Other Approved Gastroesophageal Reflux Disease (GERD) COMPLETED NCT02699060
Upper gastrointestinal endoscopy with biopsy and collection of refluxate Other Approved Gastroesophageal Reflux Disease (GERD) COMPLETED NCT02699060
MPP ON Other Approved Heart Failure COMPLETED NCT02476201
Clinical Management Recommendations for reducing pump thrombosis Other Approved HeartMate II Pump Thrombosis COMPLETED NCT02158403
Drug: Avelox® 400Mg Tablet Drug Phase PHASE1 Bioequivalence COMPLETED NCT05307614
Moksi® 400mg Tablet Other Phase PHASE1 Bioequivalence COMPLETED NCT05307614
ABSORB Scaffold Other Preclinical Coronary Artery Stenosis COMPLETED NCT02066623
CardioMEMS HF System Other Approved Heart Failure COMPLETED NCT02693691
CardioMEMS HF System Other Approved Heart Failure COMPLETED NCT02693691
Comprehensive functional diagnostics of coronary circulation Other Preclinical Coronary Artery Disease UNKNOWN NCT05313919
Comprehensive functional diagnostics of coronary circulation Other Preclinical Coronary Artery Disease UNKNOWN NCT05313919
LV pacing site Other Approved Arrythmia COMPLETED NCT02057588
LV pacing site Other Approved Arrythmia COMPLETED NCT02057588
3T MRI scan Other Preclinical Syncope COMPLETED NCT03786640
Intravenous Bolus Furosemide Other Approved Heart Failure COMPLETED NCT04235062
Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) Solution Other Approved Heart Failure COMPLETED NCT04235062
Intravenous Bolus Furosemide Other Approved Heart Failure COMPLETED NCT04235062
Ringer's (8.6 g/L sodium chloride, 0.33 g/L calcium chloride, 0.3 g/L potassium chloride) Solution Other Approved Heart Failure COMPLETED NCT04235062
Amino Acid-Based Experimental Study Formula Other Approved Food Allergy TERMINATED NCT04127656
TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ Other Approved Persistent Atrial Fibrillation COMPLETED NCT03650556
DAPT (aspirin and/or P2Y12 receptor inhibitor) Other Approved Bleeding Disorder COMPLETED NCT03815175
XIENCE Other Approved Bleeding Disorder COMPLETED NCT03815175
Tranexamic acid injection Other Phase PHASE1 Melasma COMPLETED NCT05362500
Glycolic Acid 70% Other Phase PHASE1 Melasma COMPLETED NCT05362500
Tranexamic acid injection Other Phase PHASE1 Melasma COMPLETED NCT05362500
Glycolic Acid 70% Other Phase PHASE1 Melasma COMPLETED NCT05362500
ILR implantation Other Preclinical Heart Failure With Preserved Ejection Fraction (HFpEF) COMPLETED NCT01989299
Midazolam Other Preclinical Delirium COMPLETED NCT00417664
Propofol Other Preclinical Delirium COMPLETED NCT00417664
Dexmedetomidine Other Preclinical Delirium COMPLETED NCT00417664
PEVAR (Prostar XL closure) Other Approved Abdominal Aortic Aneurysm COMPLETED NCT01070069
SEVAR (IntuiTrak) Other Approved Abdominal Aortic Aneurysm COMPLETED NCT01070069
PEVAR (ProGlide closure) Other Approved Abdominal Aortic Aneurysm COMPLETED NCT01070069
Prone Positioning Maneuver Other Approved COVID-19 Acute Respiratory Distress Syndrome COMPLETED NCT05405335
Prone Positioning Maneuver Other Approved COVID-19 Acute Respiratory Distress Syndrome COMPLETED NCT05405335
Study Infant Formula Other Approved Gastro-Intestinal Tolerance TERMINATED NCT04934397
MitraClip Procedure Procedure Approved Functional Mitral Regurgitation COMPLETED NCT04350372
Current Regimen Other Phase PHASE4 HIV Infections COMPLETED NCT00145795
Kaletra + Current Dual NRTI Backbone Other Phase PHASE4 HIV Infections COMPLETED NCT00145795
Current Regimen Other Phase PHASE4 HIV Infections COMPLETED NCT00145795
Kaletra + Current Dual NRTI Backbone Other Phase PHASE4 HIV Infections COMPLETED NCT00145795
AMPLATZER™ Cardiac Plug Other Preclinical Non-valvular Atrial Fibrillation (NVAF) COMPLETED NCT02954237
HeartMate 3™ Other Approved Heart Failure COMPLETED NCT02475460
Less Invasive Surgery (LIS) Procedure Approved Heart Failure COMPLETED NCT02475460
Percutaneous Lead Management Kit Other Preclinical Left Ventricular Assist Device COMPLETED NCT01485666
Percutaneous Lead Management Kit Other Preclinical Left Ventricular Assist Device COMPLETED NCT01485666
CentriMag Ventricular Assist System Other Approved Heart Failure WITHDRAWN NCT01171950
HeartMate 3 LVAS Other Approved Advanced Refractory Left Ventricular Heart Failure COMPLETED NCT02892955
acetylsalicylic acid (ASA) therapy Drug Phase PHASE4 Heart Failure COMPLETED NCT02836652
Warfarin Other Phase PHASE4 Heart Failure COMPLETED NCT02836652
HeartMate II (HMII) Other Phase PHASE4 Heart Failure COMPLETED NCT02836652
acetylsalicylic acid (ASA) therapy Drug Phase PHASE4 Heart Failure COMPLETED NCT02836652
Warfarin Other Phase PHASE4 Heart Failure COMPLETED NCT02836652
HeartMate II (HMII) Other Phase PHASE4 Heart Failure COMPLETED NCT02836652
HeartMate II LVAS Other Approved Advanced Refractory Left Ventricular Heart Failure COMPLETED NCT02224755
HeartMate 3 LVAS Other Approved Advanced Refractory Left Ventricular Heart Failure COMPLETED NCT02224755
CentriMag Ventricular Assist System Other Approved Heart Failure COMPLETED NCT00819793
CentriMag Ventricular Assist System Other Approved Heart Failure COMPLETED NCT00819793
Left Ventricular Assist System (LVAS) Other Approved Heart Failure, Congestive COMPLETED NCT00121485
Thoratec HeartMate II Left Ventricular Assist System (LVAS) Other Approved Heart Failure, Congestive COMPLETED NCT00121472
Thoratec HeartMate II Left Ventricular Assist System (LVAS) Other Approved Heart Failure, Congestive COMPLETED NCT00121472
Any Abiomed Impella® device approved for use in high-risk PCI Device Approved Coronary Artery Disease TERMINATED NCT02468778
HeartMate PHP Other Approved Coronary Artery Disease TERMINATED NCT02468778
Standard PPCI Other Approved Acute Myocardial Infarction UNKNOWN NCT03447834
Selective intracoronary hypothermia + PPCI Other Approved Acute Myocardial Infarction UNKNOWN NCT03447834
Blood test for Thyroid stimulating hormone (TSH) Other Preclinical Hypothyroidism UNKNOWN NCT04784208
Blood test for Thyroid stimulating hormone (TSH) Other Preclinical Hypothyroidism UNKNOWN NCT04784208
Test Meal Other Approved Glycemic Control COMPLETED NCT05165693
Experimental Formula Other Approved Glycemic Control COMPLETED NCT05165693
Test Meal Other Approved Glycemic Control COMPLETED NCT05154045
Experimental Formula Other Approved Glycemic Control COMPLETED NCT05154045
Self-Measurement Blood Glucose Other Approved Type 1 Diabetes COMPLETED NCT02776007
Libre Flash CGMS Other Approved Type 1 Diabetes COMPLETED NCT02776007
Self-Measurement Blood Glucose Other Approved Type 1 Diabetes COMPLETED NCT02776007
Libre Flash CGMS Other Approved Type 1 Diabetes COMPLETED NCT02776007
SMBG Other Preclinical Diabetes Mellitus TERMINATED NCT04577976
SMBG Other Preclinical Diabetes Mellitus TERMINATED NCT04577976
Budesonide Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Cortiment Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Budesonide Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Cortiment Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Budesonide Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Cortiment Other Phase PHASE1 Healthy Subjects COMPLETED NCT05519514
Aspirin 100 mg OD plus clopidogrel 75 mg OD Other Phase PHASE3 Left Atrial Appendage Occlusion UNKNOWN NCT05554822
Aspirin 100mg Other Phase PHASE3 Left Atrial Appendage Occlusion UNKNOWN NCT05554822
Randomization of Pre-knowledge of CT coronary venography Other Preclinical Heart Failure - NYHA II - IV COMPLETED NCT01097733
Randomization of Pre-knowledge of CT coronary venography Other Preclinical Heart Failure - NYHA II - IV COMPLETED NCT01097733
Itraconazole Other Phase PHASE1 Onychomychosis COMPLETED NCT05567484
Itraconazole Other Phase PHASE1 Onychomychosis COMPLETED NCT05567484
Removal of defibrillation coils and pulse generator Other Approved Ventricular Arrythmia COMPLETED NCT04809701
Defibrillation following induction of VA (Configuration B first) Other Approved Ventricular Arrythmia COMPLETED NCT04809701
Defibrillation following induction of VA (Configuration A first) Other Approved Ventricular Arrythmia COMPLETED NCT04809701
Temporary implantation of defibrillation coils and pulse generator Other Approved Ventricular Arrythmia COMPLETED NCT04809701
0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily Drug Phase PHASE1 Vitiligo COMPLETED NCT05577637
0.03% tacrolimus twice daily was applied on group A patients with uvb phototherapy thrice daily Drug Phase PHASE1 Vitiligo COMPLETED NCT05577637
terbinafine Other Phase PHASE1 Onychomycosis COMPLETED NCT05578950
itraconazole Other Phase PHASE1 Onychomycosis COMPLETED NCT05578950
terbinafine Other Phase PHASE1 Onychomycosis COMPLETED NCT05578950
itraconazole Other Phase PHASE1 Onychomycosis COMPLETED NCT05578950
Cardiac resynchronization therapy by CRT-P or CRT-D implantation Drug Approved Cardiac Resynchronization Therapy COMPLETED NCT04595305
Mitomycin C Other Phase PHASE4 Glaucoma COMPLETED NCT00666237
Trabeculectomy Other Phase PHASE4 Glaucoma COMPLETED NCT00666237
Tube shunt surgery Procedure Phase PHASE4 Glaucoma COMPLETED NCT00666237
Mitomycin C Other Phase PHASE4 Glaucoma COMPLETED NCT00666237
Trabeculectomy Other Phase PHASE4 Glaucoma COMPLETED NCT00666237
Tube shunt surgery Procedure Phase PHASE4 Glaucoma COMPLETED NCT00666237
Cryotherapy plus Salicylic Acid Drug Phase PHASE1 Plantar Wart COMPLETED NCT05588999
Cryotherapy Alone Drug Phase PHASE1 Plantar Wart COMPLETED NCT05588999
Cryotherapy plus Salicylic Acid Drug Phase PHASE1 Plantar Wart COMPLETED NCT05588999
Cryotherapy Alone Drug Phase PHASE1 Plantar Wart COMPLETED NCT05588999
Treatment with the Medtronic SCS System Drug Approved Chronic Pain TERMINATED NCT02250469
Treatment with the Axium SCS system Drug Approved Chronic Pain TERMINATED NCT02250469
angioplasty Other Approved Coronary Artery Calcification UNKNOWN NCT05301218
angioplasty Other Approved Coronary Artery Calcification UNKNOWN NCT05301218
potassium hydroxide Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05634460
potassium hydroxide Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05634460
Experimental Infant Formula Other Approved Infant Development COMPLETED NCT03991949
Experimental Infant Formula Other Approved Infant Development COMPLETED NCT03991949
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder ACTIVE_NOT_RECRUITING NCT04559945
Aveir VR Leadless Pacemaker System Other Approved Cardiac Rhythm Disorder ACTIVE_NOT_RECRUITING NCT04559945
Study Infant Formula Other Approved Gastro-Intestinal Tolerance COMPLETED NCT04915937
Adalimumab and Infliximab Other Preclinical Crohn's Disease COMPLETED NCT01338740
HeartMate 3 Left Ventricular Assist System (HM3 LVAS) Other Preclinical Advanced Refractory Left Ventricular Heart Failure COMPLETED NCT04548128
Control Other Approved Aging WITHDRAWN NCT02806765
(1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Other Approved Aging WITHDRAWN NCT02806765
30% salicylic acid Other Approved Acne Vulgaris COMPLETED NCT05712837
25% TRICHLOROACETIC ACID Other Approved Acne Vulgaris COMPLETED NCT05712837
30% salicylic acid Other Approved Acne Vulgaris COMPLETED NCT05712837
25% TRICHLOROACETIC ACID Other Approved Acne Vulgaris COMPLETED NCT05712837
30% salicylic acid Other Approved Acne Vulgaris COMPLETED NCT05712837
25% TRICHLOROACETIC ACID Other Approved Acne Vulgaris COMPLETED NCT05712837
Tricholoracetic acid Other Approved Warts COMPLETED NCT05712811
CRYOTHERAPY Drug Approved Warts COMPLETED NCT05712811
Standard Of Care Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT04345497
Diabetes-Specific Formula Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT04345497
Smart Coach Other Preclinical Dyslipidemia COMPLETED NCT05370703
My A:care Other Preclinical Dyslipidemia COMPLETED NCT05370703
CardioMems HF System Other Approved Heart Failure With Preserved Ejection Fraction RECRUITING NCT05731466
Prebiotic supplement Other Approved Microbiome COMPLETED NCT03690999
Placebo Other Approved Microbiome COMPLETED NCT03690999
Prebiotic supplement Other Approved Microbiome COMPLETED NCT03690999
Placebo Other Approved Microbiome COMPLETED NCT03690999
intralesional vitamin D3 Other Phase PHASE1 Cutaneous Warts COMPLETED NCT05739786
liq nitrogen Other Phase PHASE1 Cutaneous Warts COMPLETED NCT05739786
intralesional vitamin D3 Other Phase PHASE1 Cutaneous Warts COMPLETED NCT05739786
liq nitrogen Other Phase PHASE1 Cutaneous Warts COMPLETED NCT05739786
Control Group Other Approved Undernutrition COMPLETED NCT05239208
Oral Nutrition Supplement (ONS) Group Other Approved Undernutrition COMPLETED NCT05239208
Oral Nutritional Supplement (ONS) Other Approved Malnutrition, Child WITHDRAWN NCT05437068
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS Drug Approved Viral Wart COMPLETED NCT05752435
COMPARISON OF THERAPEUTIC EFFICACY BETWEEN INTRALESIONAL BLEOMYCIN AND CRYOTHERAPY IN PLANTAR WARTS Drug Approved Viral Wart COMPLETED NCT05752435
Per cutaneous coronary intervention Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Coronary Angiography Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Optical Coherence Tomography Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Per cutaneous coronary intervention Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Coronary Angiography Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Optical Coherence Tomography Other Preclinical Out of Hospital Cardiac Arrest TERMINATED NCT04431661
Nutritional Intervention Other Approved Bladder Cancer RECRUITING NCT05715684
Exercise Training Other Approved Bladder Cancer RECRUITING NCT05715684
Optical Coherence Tomography (OCT) Other Approved In-stent Restenosis COMPLETED NCT04268875
Optical Coherence Tomography (OCT) Other Approved In-stent Restenosis COMPLETED NCT04268875
Optical Coherence Tomography (OCT) Other Approved In-stent Restenosis COMPLETED NCT04268875
Optical Coherence Tomography (OCT) Other Approved In-stent Restenosis COMPLETED NCT04268875
FreeStyle Precision Neo blood glucose meter Other Approved Diabetes Mellitus, Type 2 UNKNOWN NCT05822232
FreeStyle Libre Pro blinded CGM Other Approved Diabetes Mellitus, Type 2 UNKNOWN NCT05822232
FreeStyle Libre 2 CGM Other Approved Diabetes Mellitus, Type 2 UNKNOWN NCT05822232
NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device Device Approved Malaria COMPLETED NCT05286359
NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device Device Approved Malaria COMPLETED NCT05286359
ANS Totally Implantable Deep Brain Stimulation System Other Approved Tremor COMPLETED NCT02087046
ANS Totally Implantable Deep Brain Stimulation System Other Approved Tremor COMPLETED NCT02087046
New York Heart Association Classification Guide Other Approved Heart Failure UNKNOWN NCT05833581
New York Heart Association Classification Guide Other Approved Heart Failure UNKNOWN NCT05833581
Valproic Acid Other Phase PHASE1 Spinal Muscular Atrophy COMPLETED NCT00374075
Itraconazole Other Phase PHASE1 Tinea Versicolor COMPLETED NCT05862714
Fluconazole Other Phase PHASE1 Tinea Versicolor COMPLETED NCT05862714
Itraconazole Other Phase PHASE1 Tinea Versicolor COMPLETED NCT05862714
Fluconazole Other Phase PHASE1 Tinea Versicolor COMPLETED NCT05862714
Sulphur Other Phase PHASE1 Scabies COMPLETED NCT05862701
Permethrin Other Phase PHASE1 Scabies COMPLETED NCT05862701
Sulphur Other Phase PHASE1 Scabies COMPLETED NCT05862701
Permethrin Other Phase PHASE1 Scabies COMPLETED NCT05862701
MPP Other Approved Heart Failure TERMINATED NCT02006069
MPP Other Approved Heart Failure TERMINATED NCT02006069
Platelets rich plasma Other Phase PHASE1 Melasma COMPLETED NCT05884151
Tranexamic acid Other Phase PHASE1 Melasma COMPLETED NCT05884151
Platelets rich plasma Other Phase PHASE1 Melasma COMPLETED NCT05884151
Tranexamic acid Other Phase PHASE1 Melasma COMPLETED NCT05884151
Group B Azelaic Acid 20 % Cream for 6 months Other Phase PHASE1 Melasma COMPLETED NCT05887219
Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid Other Phase PHASE1 Melasma COMPLETED NCT05887219
Group B Azelaic Acid 20 % Cream for 6 months Other Phase PHASE1 Melasma COMPLETED NCT05887219
Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid Other Phase PHASE1 Melasma COMPLETED NCT05887219
Group B Azelaic Acid 20 % Cream for 6 months Other Phase PHASE1 Melasma COMPLETED NCT05887219
Group A 4 % Hydroquinone Cream Topically and Oral Tranexamic Acid Other Phase PHASE1 Melasma COMPLETED NCT05887219
Biventricular pacemaker Other Approved Diastolic Heart Failure COMPLETED NCT03338374
Biventricular pacemaker Other Approved Diastolic Heart Failure COMPLETED NCT03338374
Liquid nitrogen Other Phase PHASE1 Plan Warts COMPLETED NCT05895071
5%potassium hydroxide Other Phase PHASE1 Plan Warts COMPLETED NCT05895071
Liquid nitrogen Other Phase PHASE1 Plan Warts COMPLETED NCT05895071
5%potassium hydroxide Other Phase PHASE1 Plan Warts COMPLETED NCT05895071
Group B received 10% Potassium Hydroxide Solution Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05897112
Group A received cryotherpay Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05897112
Group B received 10% Potassium Hydroxide Solution Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05897112
Group A received cryotherpay Other Phase PHASE1 Molluscum Contagiosum COMPLETED NCT05897112
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
OCT guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Angiographic guided PCI Other Approved Ischaemic Heart Disease ACTIVE_NOT_RECRUITING NCT03171311
Amplatzer Cardiac Plug Other Preclinical Atrial Fibrillation COMPLETED NCT01786486
T-Wave Alternans test Other Phase PHASE3 Ischemic Cardiomyopathy COMPLETED NCT00187291
T-Wave Alternans test Other Phase PHASE3 Ischemic Cardiomyopathy COMPLETED NCT00187291
Cardiac Ablation (Gen2 Cardiac Ablation System) Other Approved Atrial Flutter TERMINATED NCT00606463
Diamondback 360 Extended Length Orbital Atherectomy System Other Preclinical Peripheral Artery Disease COMPLETED NCT03943160
014 Drug Coated Balloon Drug Approved PAD COMPLETED NCT02561299
Peripheral Orbital Atherectomy System Other Approved PAD COMPLETED NCT02561299
Coronary Orbital Atherectomy plus Stenting Other Preclinical Coronary Artery Disease COMPLETED NCT02339545
Diamondback 360® Coronary OAS Micro Crown Other Approved CAD COMPLETED NCT02132611
Diamondback 360® Coronary OAS Micro Crown Other Approved CAD COMPLETED NCT02132611
Stealth 360°® OAS Other Approved Peripheral Artery Disease COMPLETED NCT01938391
Percutaneous Coronary Intervention Other Preclinical Coronary Artery Disease COMPLETED NCT01930214
PAD endovascular treatments Drug Preclinical Peripheral Arterial Occlusive Disease COMPLETED NCT01855412
Perclose ProGlide SMC System and/or Perclose ProStyle SMCR System Other Approved Arrhythmia COMPLETED NCT04904809
Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature (virtual clinic and in-clinic sessions) Other Approved Parkinson Disease ACTIVE_NOT_RECRUITING NCT05269862
Abbott Infinity DBS systems with the NeuroSphere Virtual Clinic feature Other Approved Parkinson Disease ACTIVE_NOT_RECRUITING NCT05269862
FreeStyle Libre 2 System Other Preclinical Diabetes Mellitus COMPLETED NCT04604093
SMBG Meter Other Preclinical Diabetes Mellitus COMPLETED NCT04604093
HeartMate PHP Other Approved Cardiogenic Shock TERMINATED NCT02279979
Patient Advisory Module Other Approved Heart Failure COMPLETED NCT01121107
Left Atrial Pressure Monitoring System Other Approved Heart Failure COMPLETED NCT01121107
FreeStyle Libre 3 Other Preclinical Diabetes Mellitus TERMINATED NCT05962710
DRG Stimulator Other Approved Chronic Pain COMPLETED NCT03908476
Burst-capable SCS system Other Approved Chronic Pain COMPLETED NCT03908476
Progestagen Other Preclinical Early Pregnancy Bleeding TERMINATED NCT05186779
Progestagen Other Preclinical Early Pregnancy Bleeding TERMINATED NCT05186779
Electrophysiological study and bi-atrial Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study and Right side Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study and bi-atrial Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study and Right side Ganglionated Plexi ablation Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Electrophysiological study Other Approved Bradycardia; Syncope UNKNOWN NCT05572034
Abbott SCS Systems Other Preclinical Chronic Pain COMPLETED NCT05659836
Balloon Other Approved Coronary Artery Disease UNKNOWN NCT03108456
Orbital Atherectomy Other Approved Coronary Artery Disease UNKNOWN NCT03108456
Implantable spinal cord stimulator Other Preclinical Complex Regional Pain Syndrome Type I UNKNOWN NCT05877612
Implantable spinal cord stimulator Other Preclinical Complex Regional Pain Syndrome Type I RECRUITING NCT05877612
TactiCath SE Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT03354663
TactiCath SE Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT03354663
XIENCE Other Approved Coronary Artery Disease COMPLETED NCT01751906
Absorb BVS Other Approved Coronary Artery Disease COMPLETED NCT01751906
Breakfast 2 Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT05802927
Breakfast 1 Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT05802927
DSF Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT05802927
XIENCE Other Approved Coronary Artery Disease COMPLETED NCT02173379
Absorb BVS Other Approved Coronary Artery Disease COMPLETED NCT02173379
XIENCE Other Approved Coronary Artery Disease COMPLETED NCT02173379
Absorb BVS Other Approved Coronary Artery Disease COMPLETED NCT02173379
TactiFlex SE - High Standard Power Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT04356040
TactiFlex SE Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT04356040
BurstDR-SCS Other Approved Chronic Intractable Pain WITHDRAWN NCT06030284
BurstDR-SCS Other Approved Chronic Intractable Pain WITHDRAWN NCT06030284
Usual Care Other Approved Heart Failure COMPLETED NCT04942353
Home-based Exercise Rehabilitation. Other Approved Heart Failure COMPLETED NCT04942353
Diabetes self-management education Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT04562714
FreeStyle Libre Flash Glucose Monitor Other Approved Diabetes Mellitus, Type 2 COMPLETED NCT04562714
Panbio™ Other Approved COVID-19 COMPLETED NCT05630365
Nasal and Nasopharyngeal Sampling of the Panbio™ COVID-19/ Flu A&B Rapid Panel Other Approved COVID-19 COMPLETED NCT05354115
MINI TREK RX 1.20 mm Coronary Dilatation Catheter Other Preclinical Ischemic Heart Disease COMPLETED NCT01186198
Trifecta™ aortic bioprosthesis Other Preclinical Aortic Valve Disease TERMINATED NCT01256710
Trifecta™ aortic bioprosthesis Other Preclinical Aortic Valve Disease TERMINATED NCT01256710
Racecadotril plus ORS Other Phase PHASE3 Diarrhea, Infantile COMPLETED NCT03473561
Racecadotril plus ORS Other Phase PHASE3 Diarrhea, Infantile COMPLETED NCT03473561
Study MRI scan Other Preclinical Tachycardia COMPLETED NCT03828357
Thoracic MRI Scan Other Approved ICD COMPLETED NCT02877693
CSI pVAD system Other Approved Coronary Artery Disease COMPLETED NCT05315544
Intravascular lithotripsy (IVL) Other Approved Calcified Coronary Artery Disease UNKNOWN NCT05072730
Super High Pressure Balloon (OPN NC) Other Approved Calcified Coronary Artery Disease UNKNOWN NCT05072730
CRT+NAVH Other Preclinical Heart Failure COMPLETED NCT02903940
CRT+NAVH Other Preclinical Heart Failure COMPLETED NCT02903940
CRT+NAVH Other Preclinical Heart Failure COMPLETED NCT02782598
CRT+NAVH Other Preclinical Heart Failure COMPLETED NCT02782598
CSI pVAD System Other Approved Coronary Artery Disease WITHDRAWN NCT05695716
CGM device with diabetic education, CGM education and a follow up protocol. Device Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT04729985
CGM device with diabetic education, CGM education and a follow up protocol. Device Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT04729985
Control Product Other Approved Gastrointestinal Cancer COMPLETED NCT05301556
Experimental Product Other Approved Gastrointestinal Cancer COMPLETED NCT05301556
Routinely performed echo, ECG and hemodynamic monitoring Other Preclinical End-stage Heart Failure RECRUITING NCT04641416
Catheter ablation Other Preclinical Paroxysmal Atrial Fibrillation COMPLETED NCT04022954
EverFlex™ Self-Expanding Peripheral Stent System Other Approved Peripheral Arterial Disease UNKNOWN NCT03941314
Supera® Peripheral Stent System Other Approved Peripheral Arterial Disease UNKNOWN NCT03941314
EverFlex™ Self-Expanding Peripheral Stent System Other Approved Peripheral Arterial Disease ACTIVE_NOT_RECRUITING NCT03941314
Supera® Peripheral Stent System Other Approved Peripheral Arterial Disease ACTIVE_NOT_RECRUITING NCT03941314
AMPLATZER™ LAA Occluder Other Preclinical Atrial Fibrillation COMPLETED NCT02964208
CTI line Other Approved Flutter RECRUITING NCT05709795
Voltage Other Approved Flutter RECRUITING NCT05709795
Wave Speed Other Approved Flutter RECRUITING NCT05709795
Confluent areas Other Approved Flutter RECRUITING NCT05709795
CTI line Other Approved Flutter RECRUITING NCT05709795
Voltage Other Approved Flutter RECRUITING NCT05709795
Wave Speed Other Approved Flutter RECRUITING NCT05709795
Confluent areas Other Approved Flutter RECRUITING NCT05709795
CTI line Other Approved Flutter RECRUITING NCT05709795
Voltage Other Approved Flutter RECRUITING NCT05709795
Wave Speed Other Approved Flutter RECRUITING NCT05709795
Confluent areas Other Approved Flutter RECRUITING NCT05709795
XIENCE PRIME SV Everolimus Eluting Coronary Stent Other Preclinical Ischemic Heart Disease COMPLETED NCT02513719
Deep Brain Stimulation, Libra Deep Brain Stimulation System Other Approved Depressive Disorder, Major TERMINATED NCT00617162
Advisor HD Grid Mapping Catheter, Sensor Enabled Other Preclinical Persistent Atrial Fibrillation COMPLETED NCT03733392
CardioMEMS HF System Other Preclinical Heart Failure COMPLETED NCT02279888
Transcatheter Aortic Valve Implantation Other Preclinical Bicuspid Aortic Valve NOT_YET_RECRUITING NCT06375590
Transcatheter Aortic Valve Implantation Other Preclinical Bicuspid Aortic Valve NOT_YET_RECRUITING NCT06375590
Deferred stenting Other Approved Acute Myocardial Infarction With ST Elevation ACTIVE_NOT_RECRUITING NCT03744000
Immediate stenting Other Approved Acute Myocardial Infarction With ST Elevation ACTIVE_NOT_RECRUITING NCT03744000
Deferred stenting Other Approved Acute Myocardial Infarction With ST Elevation ACTIVE_NOT_RECRUITING NCT03744000
Immediate stenting Other Approved Acute Myocardial Infarction With ST Elevation ACTIVE_NOT_RECRUITING NCT03744000
Panbio™ Other Approved COVID-19 COMPLETED NCT06127108
Hemodynamic management using CardioMEMS HF System Other Preclinical Heart Failure COMPLETED NCT03247829
Hydrolyzed protein infant formula with oligosaccharides Other Approved Gastrointestinal Tolerance COMPLETED NCT05369494
ID NOW™ Other Approved Chlamydia Trachomatis Infection NOT_YET_RECRUITING NCT06395675
Cellulose Based (Losartan Placebo) Other Phase PHASE2 Inflammation COMPLETED NCT02676466
Corn Oil (Fish oil Placebo) Other Phase PHASE2 Inflammation COMPLETED NCT02676466
Losartan Other Phase PHASE2 Inflammation COMPLETED NCT02676466
Omega-3 fish oil Other Phase PHASE2 Inflammation COMPLETED NCT02676466
HP-SD AF ablation by a CF sensing catheter Other Approved Atrial Fibrillation RECRUITING NCT05758805
mini-invasive esophagoscopy Other Approved Atrial Fibrillation RECRUITING NCT05758805
HP-SD AF ablation by a CF sensing catheter Other Approved Atrial Fibrillation RECRUITING NCT05758805
mini-invasive esophagoscopy Other Approved Atrial Fibrillation RECRUITING NCT05758805
Burst SCS Stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Tonic SCS stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Sham SCS stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Burst SCS Stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Tonic SCS stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Sham SCS stimulation Other Approved Spinal Cord Stimulation (SCS) COMPLETED NCT04272411
Medical Therapy Drug Approved Ventricular Remodeling, Left TERMINATED NCT03891823
MitraClip Other Approved Ventricular Remodeling, Left TERMINATED NCT03891823
Medical Therapy Drug Approved Ventricular Remodeling, Left TERMINATED NCT03891823
MitraClip Other Approved Ventricular Remodeling, Left TERMINATED NCT03891823
MPP + SyncAV Other Preclinical Cardiac Resynchronization Therapy COMPLETED NCT06444386
Medical Therapy Drug Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT02830152
LAAO Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT02830152
FreeStyle Navigator Continuous Glucose Monitoring System Version 1.5 Other Preclinical Diabetes Mellitus COMPLETED NCT01076218
HeartMate 3™ left ventricular assist system (HM3 LVAS) Other Approved Advanced Heart Failure TERMINATED NCT04703855
SJM Infinity™ DBS IPG or SJM Brio™ DBS IPG system Other Preclinical Parkinson Disease COMPLETED NCT02963259
SJM Infinity™ DBS IPG or SJM Brio™ DBS IPG system Other Preclinical Parkinson Disease COMPLETED NCT02963259
Dorsal Root Ganglion (DRG) Stimulation (Proclaim™ Neurostimulator System) Other Preclinical Complex Regional Pain Syndrome (CRPS) COMPLETED NCT02800863
Dorsal Root Ganglion (DRG) Stimulation (Axium™ Neurostimulator System) Other Preclinical Complex Regional Pain Syndrome (CRPS) COMPLETED NCT02800863
Burst and Tonic stimulation Other Approved Chronic Pain COMPLETED NCT02143791
Standard of care neuromodulation therapy (SCS or DRG) Drug Approved Chronic Pain RECRUITING NCT05537662
JETi 6F and 8F Thrombectomy system Other Approved Peripheral Arterial Disease NOT_YET_RECRUITING NCT06434779
JETi 6F and 8F Thrombectomy system Other Approved Peripheral Arterial Disease NOT_YET_RECRUITING NCT06434779
Observation / Data Collection Other Preclinical Atrial Fibrillation COMPLETED NCT03041233
Observation / Data Collection Other Preclinical Atrial Fibrillation COMPLETED NCT03041233
MitraClip NT System Other Preclinical Mitral Regurgitation COMPLETED NCT03500692
MitraClip NT System Other Preclinical Mitral Regurgitation COMPLETED NCT03500692
HeartMate 3™ left ventricular assist system (HM3 LVAS) Other Approved Advanced Heart Failure COMPLETED NCT04915924
HeartMate 3™ left ventricular assist system (HM3 LVAS) Other Approved Advanced Heart Failure COMPLETED NCT04915924
Control Polyunsaturated Oil Blend Other Approved Nutrition, Healthy COMPLETED NCT06266702
Experimental Oil with Phospholipids Other Approved Nutrition, Healthy COMPLETED NCT06266702
Coronary PCI guided by Angiography Other Approved Coronary Artery Disease COMPLETED NCT03507777
Coronary PCI guided by OCT Other Approved Coronary Artery Disease COMPLETED NCT03507777
Radiofrequency Ablation Other Preclinical Paroxysmal Atrial Fibrillation COMPLETED NCT03906461
ABSORB GT1 BVS Other Approved Ischemic Heart Disease COMPLETED NCT03409731
ABSORB GT1 BVS Other Approved Ischemic Heart Disease COMPLETED NCT03409731
Panbio™ COVID-19/Flu A&B Panel Other Approved COVID-19 COMPLETED NCT06124638
Panbio™ COVID-19/Flu A&B Panel Other Approved COVID-19 COMPLETED NCT06124638
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05270499
Diagnostic test: Determine™ Syphilis Advanced test Other Approved Syphilis Infection NOT_YET_RECRUITING NCT06584214
Diagnostic test: Determine™ Syphilis Advanced test Other Approved Syphilis Infection NOT_YET_RECRUITING NCT06584214
i-STAT hs-TnI Cartridge Testing on i-STAT 1 and i-STAT Alinity Other Preclinical Myocardial Infarction COMPLETED NCT05629572
Water Other Approved Hydration TERMINATED NCT05569044
Oral Rehydration Solution Other Approved Hydration TERMINATED NCT05569044
Control Group Other Approved Hydration TERMINATED NCT05569044
Water Other Approved Hydration TERMINATED NCT05569044
Oral Rehydration Solution Other Approved Hydration TERMINATED NCT05569044
Control Group Other Approved Hydration TERMINATED NCT05569044
A specific electrophysiology mapping protocol is applicable with the GRID catheter. Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT03882021
A specific electrophysiology mapping protocol is applicable with the GRID catheter. Other Approved Paroxysmal Atrial Fibrillation COMPLETED NCT03882021
FIRM-Guided Procedure and PVI Procedure Approved Persistent Atrial Fibrillation COMPLETED NCT02799043
Standard PVI Other Approved Persistent Atrial Fibrillation COMPLETED NCT02799043
Dorsal root ganglion (DRG) stimulation Other Approved Chronic Pain COMPLETED NCT02587637
Panbio™ HCV Self Test Other Approved HEPATITIS C (HCV) NOT_YET_RECRUITING NCT06605573
FreeStyle Libre 2 Flash Glucose Monitoring System Other Approved Type 2 Diabetes Treated With Insulin TERMINATED NCT06268821
Pacemaker Implantation Other Approved Bradycardia COMPLETED NCT01912326
Pacemaker Implantation Other Approved Bradycardia COMPLETED NCT01912326
no intervention Other Preclinical Aortic Valve Disease COMPLETED NCT05389631
no intervention Other Preclinical Aortic Valve Disease COMPLETED NCT05389631
no intervention Other Preclinical Aortic Valve Disease COMPLETED NCT05389631
AMPLATZER™ Post-infarct Muscular VSD Occluder Other Preclinical Post-Infarction Ventricular Septal Defect COMPLETED NCT03165526
Portico™ Valve, FlexNav Delivery System(s) and Loading System(s) Other Approved Symptomatic Degenerative Aortic Stenosis COMPLETED NCT03752866
Portico™ Valve, Portico Delivery System(s) and Loading System(s) Other Approved Symptomatic Degenerative Aortic Stenosis COMPLETED NCT03752866
Ensure Plus Advance Other Approved Sarcopenia COMPLETED NCT05344313
Ensure Plus Advance Other Approved Sarcopenia COMPLETED NCT05344313
Ensure Plus Advance Other Approved Sarcopenia COMPLETED NCT05344313
Systematic etiologic work-up for underlying causes of MINOCA Other Preclinical MINOCA RECRUITING NCT05326828
CONFIRM Rx implantable cardiac rhythm monitor (Abbott) Other Preclinical MINOCA RECRUITING NCT05326828
Amplatzer PFO Occluder Other Preclinical PFO - Patent Foramen Ovale ACTIVE_NOT_RECRUITING NCT04349995
Tricuspid Valve Repair System Other Approved Tricuspid Valve Insufficiency COMPLETED NCT03227757
LVAD implant Other Phase PHASE2 Heart Failure COMPLETED NCT04865978
Warfarin Other Phase PHASE2 Heart Failure COMPLETED NCT04865978
Apixaban Other Phase PHASE2 Heart Failure COMPLETED NCT04865978
Implantation with the commercially available Axium Neurostimulator Other Preclinical Chronic Pain COMPLETED NCT02169401
Deep Brain Stimulation Other Approved Depressive Disorder, Major COMPLETED NCT01331330
Tendyne Mitral Valve System Other Approved Mitral Regurgitation COMPLETED NCT03539458
Neurostimulation Other Approved Discogenic Pain COMPLETED NCT03958604
IonicRF Generator and compatible accessories Other Preclinical Pain COMPLETED NCT04873817
IonicRF Generator and compatible accessories Other Preclinical Pain COMPLETED NCT04873817
Infinity DBS System with MR Conditional labelling Other Preclinical Movement Disorders COMPLETED NCT03884231
Infinity DBS System with MR Conditional labelling Other Preclinical Movement Disorders COMPLETED NCT03884231
Panbio™ HCV Self Test Other Preclinical Hepatitis C NOT_YET_RECRUITING NCT06492018
Panbio™ HCV Self Test Other Preclinical Hepatitis C NOT_YET_RECRUITING NCT06492018
Pulmonary artery OCT Other Preclinical Pulmonary Hypertension COMPLETED NCT05843461
Right Ventricle Index of Microcirculatory Resistance Other Preclinical Pulmonary Hypertension COMPLETED NCT05843461
Pulmonary Index of Microcirculatory Resistance Other Preclinical Pulmonary Hypertension COMPLETED NCT05843461
CentriMag Circulatory Support System Other Preclinical Heart Failure COMPLETED NCT04464785
CardioMEMS Other Approved Heart Failure WITHDRAWN NCT04977310
CardioMEMS Other Approved Heart Failure WITHDRAWN NCT04977310
Drug coated ballloon (DCB) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Drug eluting stent (DES) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Drug coated ballloon (DCB) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Drug eluting stent (DES) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Drug coated ballloon (DCB) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Drug eluting stent (DES) Drug Approved Coronary Artery Disease RECRUITING NCT05544864
Transcatheter heart valve procedure Procedure Preclinical Tricuspid Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04483089
ABT NG DES 48 EECSS Other Approved Coronary Artery Disease COMPLETED NCT04282148
ConfirmRx (Insertable Cardiac Monitor) Other Approved Syncope COMPLETED NCT03803969
ConfirmRx (Insertable Cardiac Monitor) Other Approved Syncope COMPLETED NCT03803969
To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists Other Preclinical Diabetes Mellitus RECRUITING NCT06668935
To utilize the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) to help prolong the length of time people with diabetes maintain adherence to GLP-1 and dual GIP/GLP-1 agonists Other Preclinical Diabetes Mellitus RECRUITING NCT06668935
Continuous Glucose Monitoring Other Preclinical Cardiometabolic Risk Factors ENROLLING_BY_INVITATION NCT06790472
Online Lifestyle Intervention Other Preclinical Cardiometabolic Risk Factors ENROLLING_BY_INVITATION NCT06790472
FreeStyle Libre 2 Flash Glucose Monitoring System Other Preclinical Diabetes Mellitus, Type 2 TERMINATED NCT05168306
FreeStyle Libre System plus food app Other Approved Diabetes Mellitus, Type 2 UNKNOWN NCT04843527
FreeStyle Libre System Other Approved Diabetes Mellitus, Type 2 UNKNOWN NCT04843527
Conventional Medical Management Other Approved Chronic Low-Back Pain COMPLETED NCT04479787
Spinal Cord Stimulation Other Approved Chronic Low-Back Pain COMPLETED NCT04479787
Aquify MPS Other Approved Myopia WITHDRAWN NCT01019564
Complete Easy Rub Formula MPS Other Approved Myopia WITHDRAWN NCT01019564
Systane Other Phase PHASE2 Dry Eye COMPLETED NCT00607776
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400 Drug Phase PHASE2 Dry Eye COMPLETED NCT00607776
PCI revascularization strategy based FFR assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
PCI revascularization strategy based on combined FFR and OCT assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
PCI revascularization strategy based FFR assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
PCI revascularization strategy based on combined FFR and OCT assessment Other Approved Multivessel Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05333068
STAR S4 IR laser with iDesign Other Approved Stable Myopic Refractive Error, With or Without Astigmatism COMPLETED NCT02675751
STAR S4 IR laser with iDesign Other Approved Stable Myopic Refractive Error, With or Without Astigmatism COMPLETED NCT02675751
TECNIS Toric Models ZCT450, ZCT525 or ZCT600 Other Approved Cataract COMPLETED NCT02649842
TECNIS Toric Models ZCT450, ZCT525 or ZCT600 Other Approved Cataract COMPLETED NCT02649842
iFS Femtosecond Laser Other Approved Cataract COMPLETED NCT01713660
iFS Femtosecond Laser Other Approved Cataract COMPLETED NCT01713660
LASIK Other Approved Astigmatism COMPLETED NCT01675492
One-Piece Tecnis monofocal IOL, Model ZCB00 Other Phase PHASE4 Cataract COMPLETED NCT01210807
One-Piece Tecnis Multifocal IOL Other Phase PHASE4 Cataract COMPLETED NCT01210807
FS Laser System Other Approved Cataract TERMINATED NCT00922571
FS Laser Surgery Procedure Approved Cataract TERMINATED NCT00922571
CeeOn 911A monofocal IOL Other Approved Cataract COMPLETED NCT00747565
Tecnis ZM900 Multifocal Intraocular Lens Other Approved Cataract COMPLETED NCT00747565
Subclavian /Axillary TAVR implant Other Approved Aortic Valve Stenosis COMPLETED NCT03056573
Transaortic TAVR Implant Other Approved Aortic Valve Stenosis COMPLETED NCT03056573
ADO II AS (PDA closure) Other Approved Patent Ductus Arteriosus COMPLETED NCT03055858
Trifecta GT (Glide Technology) Valve Other Approved Aortic Valve Disease COMPLETED NCT03016169
Mitral valve replacement SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve Other Approved Mitral Valve Disease COMPLETED NCT02097420
Mitral valve replacement SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve Other Approved Mitral Valve Disease COMPLETED NCT02097420
Transcatheter Aortic Valve Implant Other Preclinical Aortic Valve Stenosis COMPLETED NCT01802788
St Jude Medical Portico replacement aortic valve Other Preclinical Aortic Valve Stenosis COMPLETED NCT01802788
Trifecta™ Valve Other Preclinical Aortic Valve Insufficiency COMPLETED NCT01593917
Viscoat Other Approved Cataract COMPLETED NCT00972621
Vitrax II Other Approved Cataract COMPLETED NCT00972621
Viscoat Other Approved Cataract COMPLETED NCT00972621
Vitrax II Other Approved Cataract COMPLETED NCT00972621
Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) Device Approved Ventricular Septal Defects COMPLETED NCT00647387
Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder) Device Approved Ventricular Septal Defects COMPLETED NCT00647387
ABT-888 Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
Temozolomide Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
ABT-888 Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
Temozolomide Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
ABT-888 Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
Temozolomide Other Phase PHASE2 Hepatocellular Carcinoma TERMINATED NCT01205828
Protein supplement Other Approved Sarcopenia RECRUITING NCT05525039
β-hydroxy β-methylbutyrate (HMB) supplement Other Approved Sarcopenia RECRUITING NCT05525039
Low-magnitude High-frequency Vibration Other Approved Sarcopenia RECRUITING NCT05525039
Protein supplement Other Approved Sarcopenia RECRUITING NCT05525039
β-hydroxy β-methylbutyrate (HMB) supplement Other Approved Sarcopenia RECRUITING NCT05525039
Low-magnitude High-frequency Vibration Other Approved Sarcopenia RECRUITING NCT05525039
post-PCI Pd/Pa Other Approved Percutaneous Coronary Revascularisation RECRUITING NCT04780971
post-PCI Pd/Pa Other Approved Percutaneous Coronary Revascularisation RECRUITING NCT04780971
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal ACTIVE_NOT_RECRUITING NCT06172699
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal ACTIVE_NOT_RECRUITING NCT06172699
Patient Preference Survey Other Preclinical Cardiac Rhythm Disorder COMPLETED NCT05327101
Patient Preference Survey Other Preclinical Cardiac Rhythm Disorder COMPLETED NCT05327101
LBBAP with SyncAV Other Preclinical Heart Failure RECRUITING NCT06436053
Commercially available transcatheter aortic valve Other Approved Aortic Valve Stenosis ACTIVE_NOT_RECRUITING NCT02000115
Portico transcatheter aortic valve Other Approved Aortic Valve Stenosis ACTIVE_NOT_RECRUITING NCT02000115
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Pulsed Field Ablation Other Approved Paroxysmal AF RECRUITING NCT07181590
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Holter monitoring in patients who have been successfully implanted with an Abbott Assert-IQ ICM device Device Preclinical Atrial Fibrillation Paroxysmal COMPLETED NCT06172699
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET) Other Preclinical Myocardial Infarction RECRUITING NCT05272618
VFR Analysis Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
FFR Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
OCT Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
ICA (Invasive Coronary Angiography) Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
VFR Analysis Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
FFR Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
OCT Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
ICA (Invasive Coronary Angiography) Other Preclinical Coronary Artery Disease COMPLETED NCT04356027
LV only pacing with MPP and SyncAV Other Approved Heart Failure COMPLETED NCT03567096
BiV pacing with MPP and SyncAV Other Approved Heart Failure COMPLETED NCT03567096
LV only pacing with MPP and SyncAV Other Approved Heart Failure COMPLETED NCT03567096
BiV pacing with MPP and SyncAV Other Approved Heart Failure COMPLETED NCT03567096
Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET) Other Preclinical Myocardial Infarction RECRUITING NCT05272618
CardioMEMS HF System Other Preclinical Heart Failure COMPLETED NCT02954341
WATCHMAN Left Atrial Appendage Closure Other Approved Stroke COMPLETED NCT02879448
Amulet Left Atrial Appendage Occluder Other Approved Stroke COMPLETED NCT02879448
Water Other Approved Dehydration TERMINATED NCT06368765
Oral Rehydration Solution (ORS) Other Approved Dehydration TERMINATED NCT06368765
Transcatheter Aortic Valve Replacement Other Preclinical Aortic Valve Stenosis COMPLETED NCT05002088
Investigational device Device Approved Bilateral Vocal Fold Paralysis (BVFP) TERMINATED NCT03085316
Investigational MPS Other Approved Corneal Staining COMPLETED NCT01240122
Biotrue MPS Other Approved Corneal Staining COMPLETED NCT01240122
Investigational MPS Other Approved Corneal Staining COMPLETED NCT01240122
Biotrue MPS Other Approved Corneal Staining COMPLETED NCT01240122
temozolomide Other Phase PHASE2 Breast Cancer COMPLETED NCT01009788
ABT-888 Other Phase PHASE2 Breast Cancer COMPLETED NCT01009788
Lopinavir/ritonavir with two nucleoside analogs Other Phase PHASE4 HIV/HCV Co-infection COMPLETED NCT00866021
Lopinavir/ritonavir Other Phase PHASE4 HIV/HCV Co-infection COMPLETED NCT00866021
Lopinavir/ritonavir with two nucleoside analogs Other Phase PHASE4 HIV/HCV Co-infection COMPLETED NCT00866021
Lopinavir/ritonavir Other Phase PHASE4 HIV/HCV Co-infection COMPLETED NCT00866021
Fingerstick blood draw Other Approved Potassium (K) & Ionized Calcium (iCa) in Capillary Whole Blood COMPLETED NCT06295835
Placebo Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00227266
Valproic Acid and Levocarnitine Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00227266
Placebo Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00227266
Valproic Acid and Levocarnitine Other Phase PHASE2 Spinal Muscular Atrophy COMPLETED NCT00227266
Continuous Glucose Monitoring (CGM) Other Approved Type 2 Diabetes COMPLETED NCT05516797
Echocardiogram, cardiac Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Responsive Management Intervention Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Percutaneous Patent Ductus Arteriosus Closure (PPC) Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Echocardiogram, cardiac Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Responsive Management Intervention Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Percutaneous Patent Ductus Arteriosus Closure (PPC) Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Echocardiogram, cardiac Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Responsive Management Intervention Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Percutaneous Patent Ductus Arteriosus Closure (PPC) Other Approved Ductus Arteriosus, Patent RECRUITING NCT05547165
Single-chamber atrial transvenous pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT06100770
Aveir AR Leadless Pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT06100770
Single-chamber atrial transvenous pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT06100770
Aveir AR Leadless Pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT06100770
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05935007
Dual Chamber Transvenous Pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT05932602
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05932602
Dual Chamber Transvenous Pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT05932602
Aveir DR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05932602
AVEIR remote care system Other Preclinical Cardiac Pacemaker COMPLETED NCT06542133
BinaxNOW™ COVID-19/Flu A&B Combo Self-Test Other Approved Influenza Type A NOT_YET_RECRUITING NCT06928129
High Density Voltage Mapping Other Approved Sustained Monomorphic VT (MMVT) NOT_YET_RECRUITING NCT06931821
Isochronal Late Activation Mapping (ILAM) Other Approved Sustained Monomorphic VT (MMVT) NOT_YET_RECRUITING NCT06931821
Drug-eluting stent Drug Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Angiography-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
OCT-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Drug-eluting stent Drug Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Angiography-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
OCT-guided PCI Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05493904
Dydrogesterone Other Preclinical Endometriosis NOT_YET_RECRUITING NCT06952296
Dydrogesterone Other Preclinical Endometriosis NOT_YET_RECRUITING NCT06952296
Digital Subtraction Angiography Other Preclinical Peripheral Artery Disease COMPLETED NCT04748965
Intensification of diabetes medication based on glucose levels Drug Approved Type 2 Diabetes ACTIVE_NOT_RECRUITING NCT05040087
Intensification of diabetes medication based largely on HbA1c levels Drug Approved Type 2 Diabetes ACTIVE_NOT_RECRUITING NCT05040087
Open loop Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT06959797
Closed loop Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT06959797
Fixed Pulse Width Other Approved Ventricular Arrythmia COMPLETED NCT03632057
Fixed Tilt (65%) Other Approved Ventricular Arrythmia COMPLETED NCT03632057
Continuous glucose monitoring Other Approved Type 2 Diabetes Mellitus (T2DM) RECRUITING NCT06888687
Dietetic support Other Approved Type 2 Diabetes Mellitus (T2DM) RECRUITING NCT06888687
MRI/ CardioMEMS comparison Other Preclinical Heart Failure COMPLETED NCT05428384
HBA1c data and glucose levels Other Preclinical Diabetes Mellitus COMPLETED NCT05189938
Placebo Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
Experimental Extensively Hydrolyzed Formula Other Approved Cow's Milk Allergy RECRUITING NCT06456541
LIBERATE Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05261906
LIBERATE Other Approved Diabetes Mellitus, Type 2 ACTIVE_NOT_RECRUITING NCT05261906
Navitor Transcatheter Aortic Valve, FlexNav Delivery System, Navitor Loading System Other Preclinical Aortic Stenosis RECRUITING NCT06008080
Implanted with a Nanostim leadless pacemaker system Other Preclinical Indications for VVI(R) Pacemaker COMPLETED NCT02051972
JETi lower extremity arterial thrombosis Other Preclinical Arterial Thrombosis COMPLETED NCT04370691
CardioMEMS Other Approved Heart Failure With Reduced Ejection Fraction RECRUITING NCT06241430
CardioMEMS Other Approved Heart Failure With Reduced Ejection Fraction RECRUITING NCT06241430
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Band Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Tailor Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Séguin Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Abbott SJM Rigid Saddle Ring Other Preclinical Mitral Regurgitation RECRUITING NCT04761120
Leadless Pacemaker Other Approved Bradycardia COMPLETED NCT02030418
Leadless Pacemaker Other Approved Bradycardia COMPLETED NCT02030418
MitraClip G4 System Other Preclinical Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04177394
MitraClip G4 System Other Preclinical Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04177394
MitraClip G4 System Other Preclinical Mitral Valve Regurgitation ACTIVE_NOT_RECRUITING NCT04177394
ICM Implantation Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
Standard of Care Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
ICM Implantation Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
Standard of Care Other Approved Acute Myocardial Infarction RECRUITING NCT05073419
Tendyne Mitral Valve System Other Approved Mitral Valve Regurgitation COMPLETED NCT02321514
Commercially available transcatheter aortic valve Other Approved Aortic Valve Stenosis ACTIVE_NOT_RECRUITING NCT02000115
Portico transcatheter aortic valve Other Approved Aortic Valve Stenosis ACTIVE_NOT_RECRUITING NCT02000115
Continuous Saline Thermodilution Other Preclinical ST Elevation Myocardial Infarction RECRUITING NCT06795035
Continuous Saline Thermodilution Other Preclinical ST Elevation Myocardial Infarction RECRUITING NCT06795035
Continuous Saline Thermodilution Other Preclinical ST Elevation Myocardial Infarction RECRUITING NCT06795035
Single-Chamber Transvenous Pacemaker Other Preclinical Cardiac Pacemaker RECRUITING NCT05336877
Aveir VR Leadless Pacemaker System Other Preclinical Cardiac Pacemaker RECRUITING NCT05336877
Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Portico™ NG (Navitor) Valve and FlexNav™ Delivery System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04011722
Calorie restriction via total food replacement Other Approved Type 2 Diabetes COMPLETED NCT05754775
Calorie restriction via total food replacement Other Approved Type 2 Diabetes COMPLETED NCT05754775
CardioMEMS™ HF System Other Approved Heart Failure COMPLETED NCT03387813
PressureWire Certus guidewire Other Approved Multi Vessel Coronary Artery Disease COMPLETED NCT02325973
The TriClip System Other Preclinical Tricuspid Regurgitation RECRUITING NCT06920745
The TriClip System Other Preclinical Tricuspid Regurgitation RECRUITING NCT06920745
Radiofrequency catheter ablation +EPS guided trigger and substrate ablation Other Approved Atrial Fibrillation NOT_YET_RECRUITING NCT04823299
Cryoballoon ablation Other Approved Atrial Fibrillation NOT_YET_RECRUITING NCT04823299
Radiofrequency catheter ablation +EPS guided trigger and substrate ablation Other Approved Atrial Fibrillation NOT_YET_RECRUITING NCT04823299
Cryoballoon ablation Other Approved Atrial Fibrillation NOT_YET_RECRUITING NCT04823299
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Roll-over Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Upgrades Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Single-chamber atrial Aveir patients Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Aveir DR Leadless Pacemaker Implant Other Preclinical Leadless Pacemaker RECRUITING NCT07106788
Oral Nutritional Supplement (ONS) Other Preclinical Malnutrition COMPLETED NCT05913193
capillary blood glucose monitoring Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07157384
Intermittently scanned continuous glucose monitoring Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07157384
Diabetes self management education Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07157384
Low calorie meal replacement plan Other Approved Type 2 Diabetes NOT_YET_RECRUITING NCT07157384
placebo Other Phase PHASE2 Uveitis COMPLETED NCT01385826
Anti-tumor necrosis factor alpha monoclonal antibody Other Phase PHASE2 Uveitis COMPLETED NCT01385826
placebo Other Phase PHASE2 Uveitis COMPLETED NCT01385826
Anti-tumor necrosis factor alpha monoclonal antibody Other Phase PHASE2 Uveitis COMPLETED NCT01385826
Self-reported risk screening for PrEP and syndromic management for STIs Other Approved Gonorrhea Female RECRUITING NCT06743204
Self-Reported Risk Screening for PrEP and Diagnostic STI testing Other Approved Gonorrhea Female RECRUITING NCT06743204
Self-reported risk screening for PrEP and syndromic management for STIs Other Approved Gonorrhea Female RECRUITING NCT06743204
Self-Reported Risk Screening for PrEP and Diagnostic STI testing Other Approved Gonorrhea Female RECRUITING NCT06743204
Simethicone Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Mebeverine Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Mebeverine+Simethicone Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Simethicone Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Mebeverine Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Mebeverine+Simethicone Other Phase PHASE3 Functional Bowel Disorder COMPLETED NCT05175131
Peripheral PTA with a drug coated balloon Drug Approved Femoral Artery Stenosis COMPLETED NCT05734157
Drug Eluting Balloon Drug Approved In-stent Restenosis COMPLETED NCT05731700
Peripheral vascular flow reserve measurement Other Approved Peripheral Arterial Disease WITHDRAWN NCT06014242
Experimental Liquid Supplement Other Approved Exercise Induced Muscle Damage COMPLETED NCT06205537
Control Liquid Supplement Other Approved Exercise Induced Muscle Damage COMPLETED NCT06205537
Experimental Liquid Supplement Other Approved Exercise Induced Muscle Damage COMPLETED NCT06205537
Control Liquid Supplement Other Approved Exercise Induced Muscle Damage COMPLETED NCT06205537
Placing a guidewire in Coronary sinus for measurement of Q-LV during His Bundle pacing or, if needed, for LV pacing Other Approved Heart Failure COMPLETED NCT03803995
Mapping and Pacing the His Bundle Other Approved Heart Failure COMPLETED NCT03803995
Placing a guidewire in Coronary sinus for measurement of Q-LV during His Bundle pacing or, if needed, for LV pacing Other Approved Heart Failure COMPLETED NCT03803995
Mapping and Pacing the His Bundle Other Approved Heart Failure COMPLETED NCT03803995
MuscleSCS Other Approved Chronic Low Back Pain (CLBP) RECRUITING NCT07215104
Any Commercially Available Transcatheter Aortic Valve (CAV) System Other Approved Aortic Valve Stenosis ENROLLING_BY_INVITATION NCT05932615
Navitor Transcatheter Aortic Valve Implantation (TAVI) System Other Approved Aortic Valve Stenosis ENROLLING_BY_INVITATION NCT05932615
Pulsed Field Ablation Other Approved Atrial Arrhythmia RECRUITING NCT06106594
FlexAbility SE Ablation Catheter Other Preclinical Ventricular Tachycardia ACTIVE_NOT_RECRUITING NCT05839873
Dorsal Root Ganglion Stimulation Other Approved Knee Osteoarthritis ACTIVE_NOT_RECRUITING NCT05103527
Dorsal Root Ganglion Stimulation Other Approved Knee Osteoarthritis ACTIVE_NOT_RECRUITING NCT05103527
Dorsal Root Ganglion Stimulation Other Approved Knee Osteoarthritis ACTIVE_NOT_RECRUITING NCT05103527
Abbott Mechanical Heart Valve (MHV) Regent™ Other Preclinical Valvular Heart Disease COMPLETED NCT05330468
Ensure Surgery Immunonutrition shake Procedure Approved Heart Failure RECRUITING NCT05655910
POC BG + Blinded CGM Other Approved Heart Failure NOT_YET_RECRUITING NCT07045298
Libre 2 rt-CGM Other Approved Heart Failure NOT_YET_RECRUITING NCT07045298
Conventional Other Approved Percutaneous Coronary Intervention COMPLETED NCT04253171
Lithoplasty Other Approved Percutaneous Coronary Intervention COMPLETED NCT04253171
Conventional Other Approved Percutaneous Coronary Intervention COMPLETED NCT04253171
Lithoplasty Other Approved Percutaneous Coronary Intervention COMPLETED NCT04253171
mFOLFOX-6 Other Phase PHASE1 Metastatic Pancreatic Cancer COMPLETED NCT01489865
ABT-888 Other Phase PHASE1 Metastatic Pancreatic Cancer COMPLETED NCT01489865
mFOLFOX-6 Other Phase PHASE1 Metastatic Pancreatic Cancer COMPLETED NCT01489865
ABT-888 Other Phase PHASE1 Metastatic Pancreatic Cancer COMPLETED NCT01489865
electrophysiology study and ablation with an Abbott Ablation Catheter Other Preclinical Atrial Arrhythmia ACTIVE_NOT_RECRUITING NCT05434650
Navitor Transcatheter Aortic Valve Implantation Other Preclinical Severe Aortic Stenosis RECRUITING NCT07193888
BurstDR Spinal Cord Stimulation Other Approved Painful Diabetic Neuropathy (PDN) ENROLLING_BY_INVITATION NCT07250828
cardiac surgery Procedure Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03271762
percutaneous mitral valve repair with MITRACLIP NT, MITRACLIP NTR/XTR, MITRACLIP G4NT/XT, MITRACLIP G4NTW/XTW Other Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03271762
GnRH antagonist protocol Other Approved Diminished Ovarian Reserve RECRUITING NCT05847283
Dydrogesterone priming ovarian stiumulation protocol Other Approved Diminished Ovarian Reserve RECRUITING NCT05847283
Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT Other Approved Brain Injuries RECRUITING NCT06932588
Biomarker Testing using the Alinity Whole-blood TBI biomarker i-STAT Other Approved Brain Injuries RECRUITING NCT06932588
MitraClip procedure Procedure Approved Mitral Regurgitation COMPLETED NCT04259411
JETi Hydrodynamic Thrombectomy System Other Preclinical Peripheral Venous Thrombosis COMPLETED NCT06340763
HeartMate 3 (R) left ventricular assist device Device Preclinical LVAD RECRUITING NCT06039176
HeartMate 3 (R) left ventricular assist device Device Preclinical LVAD RECRUITING NCT06039176
HeartMate 3 (R) left ventricular assist device Device Preclinical LVAD RECRUITING NCT06039176
Blood draw Other Approved Hematologic Tests RECRUITING NCT07287618
OCT-guided PCI Other Approved Stable Angina RECRUITING NCT07198529
Extended DAPT Other Approved Stable Angina RECRUITING NCT07198529
Standard DAPT Other Approved Stable Angina RECRUITING NCT07198529
Short DAPT Other Approved Stable Angina RECRUITING NCT07198529
OCT-guided PCI Other Approved Stable Angina RECRUITING NCT07198529
Extended DAPT Other Approved Stable Angina RECRUITING NCT07198529
Standard DAPT Other Approved Stable Angina RECRUITING NCT07198529
Short DAPT Other Approved Stable Angina RECRUITING NCT07198529
Left Atrial Appendage (LAA) closure procedure with Amplatzer Amulet LAA occluder Procedure Preclinical Non-Valvular Atrial Fibrillation TERMINATED NCT06189365
Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire Other Preclinical Ischemia and No Obstructive Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05288361
Coroventis Coroflow Cardiovascular System and PressureWire™ X Guidewire Other Preclinical Ischemia and No Obstructive Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05288361
Fixed AV delay Other Approved Congestive Heart Failure ACTIVE_NOT_RECRUITING NCT04100148
SyncAV programmed ON Other Approved Congestive Heart Failure ACTIVE_NOT_RECRUITING NCT04100148
Confirm Rx ICM insertion procedure Procedure Preclinical Cardiac Arrhythmias ACTIVE_NOT_RECRUITING NCT03505801
Libre 3 continuous glucose monitoring sensor Other Preclinical Gestational Diabetes ACTIVE_NOT_RECRUITING NCT05981547
Libre 3 continuous glucose monitoring sensor Other Preclinical Gestational Diabetes ACTIVE_NOT_RECRUITING NCT05981547
femoropopliteal revascularization for TASC C or TASC D lesion Other Approved Superficial Femoral Artery Stenosis RECRUITING NCT04434586
femoropopliteal revascularization for TASC C or TASC D lesion Other Approved Superficial Femoral Artery Stenosis RECRUITING NCT04434586
XIENCE Xpedition/Alpine/Sierra Other Preclinical Percutaneous Transluminal Coronary Angioplasty COMPLETED NCT02042300
Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270575
Esprit BTK™ Everolimus Eluting Resorbable Scaffold from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270575
Percutaneous Transluminal Angioplasty (PTA) Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT04227899
Esprit BTK Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT04227899
Percutaneous Transluminal Angioplasty (PTA) Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT04227899
Esprit BTK Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT04227899
Stealth 360™ Peripheral Orbital Atherectomy System from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270562
Stealth 360™ Peripheral Orbital Atherectomy System from Abbott Other Preclinical Chronic Limb Threatening Ischemia NOT_YET_RECRUITING NCT07270562
Optical coherence tomography measurements Other Preclinical Femoropopliteal Stenosis ACTIVE_NOT_RECRUITING NCT05057637
Optical coherence tomography measurements Other Preclinical Femoropopliteal Stenosis ACTIVE_NOT_RECRUITING NCT05057637
Optical coherence tomography measurements Other Preclinical Femoropopliteal Stenosis ACTIVE_NOT_RECRUITING NCT05057637
Dorsal root ganglion stimulation (DRG) Other Preclinical Chronic Pain RECRUITING NCT03876054
Spinal cord stimulation (SCS) Other Preclinical Chronic Pain RECRUITING NCT03876054
Deep Brain Stimulation (DBS) Other Preclinical Movement Disorders RECRUITING NCT04071847
Oral itraconazole 200mg daily for 5 days Other Phase PHASE1 Pityriasis Versicolor NOT_YET_RECRUITING NCT07331792
Topical 1 % clotrimazole twice daily 2 weeks Other Phase PHASE1 Pityriasis Versicolor NOT_YET_RECRUITING NCT07331792
Oral itraconazole 200mg daily for 5 days Other Phase PHASE1 Pityriasis Versicolor NOT_YET_RECRUITING NCT07331792
Topical 1 % clotrimazole twice daily 2 weeks Other Phase PHASE1 Pityriasis Versicolor NOT_YET_RECRUITING NCT07331792
DBS of the NAc Other Approved Opioid-use Disorder RECRUITING NCT04354077
DBS of the NAc Other Approved Opioid-use Disorder RECRUITING NCT04354077
Automated closed-loop insulin delivery Other Approved Diabete Type 1 RECRUITING NCT07240012
Automated closed-loop insulin delivery Other Approved Diabete Type 1 RECRUITING NCT07240012
PFA Ablation catheter Other Approved Atrial Fibrillation (AF) ACTIVE_NOT_RECRUITING NCT06676072
Esprit BTK Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT05208905
Esprit BTK Device Device Approved Critical Limb Ischemia (CLI) ACTIVE_NOT_RECRUITING NCT05208905
FFR>0.80+ OCT with findings indicative of vulnerable plaque Other Approved Coronary Artery Disease RECRUITING NCT05599061
FFR>0.80+ OCT with findings indicative of vulnerable plaque Other Approved Coronary Artery Disease RECRUITING NCT05599061
protein supplement Other Approved Type 2 Diabetes RECRUITING NCT07271043
protein supplement Other Approved Type 2 Diabetes RECRUITING NCT07271043
Blood draw Other Preclinical Activated Clotting Time ACTIVE_NOT_RECRUITING NCT07382076
Blood draw Other Preclinical Activated Clotting Time ACTIVE_NOT_RECRUITING NCT07382076
TactiFlex™ Ablation Catheter Sensor Enabled™ Other Approved Atrial Fibrillation Paroxysmal COMPLETED NCT06271967
Cephea Mitral Valve System Other Approved Mitral Regurgitation RECRUITING NCT07244939
Abbott BE TAVI System Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT07116551
Percutaneous coronary intervention Other Preclinical Acute Coronary Syndrome COMPLETED NCT04475380
AVP III Other Approved Paravalvular Aortic Regurgitation ACTIVE_NOT_RECRUITING NCT04489823
Non-Vitamin K Oral Antagonists Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04226547
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04226547
Non-Vitamin K Oral Antagonists Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04226547
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04226547
Guideline Medical Directed Therapy Drug Approved Heart Failure RECRUITING NCT06526195
HeartMate 3 Left Ventricular Assist System Other Approved Heart Failure RECRUITING NCT06526195
CardioMEMS HF System Other Approved Heart Failure RECRUITING NCT06526195
Amulet™ 2 Left Atrial Appendage (LAA) Occluder Other Approved Atrial Fibrillation (AF) ACTIVE_NOT_RECRUITING NCT06707688
Amulet™ 2 Left Atrial Appendage (LAA) Occluder Other Approved Atrial Fibrillation (AF) ACTIVE_NOT_RECRUITING NCT06707688
MULTI-DOMAIN LIFESTILE INTERVENTION Other Approved Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT06025994
Placebo Other Phase PHASE4 Hepatitis B COMPLETED NCT05705427
Hepatitis B monovalent vaccine Other Phase PHASE4 Hepatitis B COMPLETED NCT05705427
Tenofovir Disoproxil Fumarate 300 MG Other Phase PHASE4 Hepatitis B COMPLETED NCT05705427
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
XIENCE Skypoint Large Vessel Everolimus Eluting Coronary Stent System (EECSS) Other Preclinical Coronary Artery Disease ACTIVE_NOT_RECRUITING NCT05423379
Amplatzer Amulet Left Atrial Appendage Occlusion Device Device Preclinical Atrial Fibrillation COMPLETED NCT05687591
Atrial Fibrillation Radiofrequency Ablation Only Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion) Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
Atrial Fibrillation Radiofrequency Ablation Only Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion) Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
Atrial Fibrillation Radiofrequency Ablation Only Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
catheter ablation combined with LAAO (Left Atrial Appendage Occlusion) Other Approved Atrial Fibrillation (AF) NOT_YET_RECRUITING NCT07441382
Continuous Glucose Monitoring (CGM) Other Approved Diabetes NOT_YET_RECRUITING NCT07135531
Continuous Glucose Monitoring (CGM) Other Approved Diabetes NOT_YET_RECRUITING NCT07135531
Investigational Reflex Test 3 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 2 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 1 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 3 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 2 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 1 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 3 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 2 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Investigational Reflex Test 1 Other Preclinical Neisseria Gonorrheae Infection RECRUITING NCT06815536
Standard of Care (SOC) Other Approved Diabetes ACTIVE_NOT_RECRUITING NCT06632002
DSF2 Other Approved Diabetes ACTIVE_NOT_RECRUITING NCT06632002
DSF1 Other Approved Diabetes ACTIVE_NOT_RECRUITING NCT06632002
Transseptal procedure with Agilis RF TSP System. Procedure Approved Cardiac Arrythmias RECRUITING NCT07361445
AMPLATZER™ PFO Occluder Other Approved Stroke ACTIVE_NOT_RECRUITING NCT03309332
Standard of Care Other Preclinical Cardiac Rhythm Disorder COMPLETED NCT04460209
MitraClip System Other Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03433274
Tendyne Mitral Valve System Other Approved Mitral Regurgitation ACTIVE_NOT_RECRUITING NCT03433274
(ELEVATE-AF X) control group Other Approved Atrial Fibrillation (AF) RECRUITING NCT06883864
(ELEVATE-AF X) experimental group Other Approved Atrial Fibrillation (AF) RECRUITING NCT06883864
Medication Drug Approved Atrial Fibrillation (AF) RECRUITING NCT06883864
Catheter ablation plus medication Drug Approved Atrial Fibrillation (AF) RECRUITING NCT06883864
Stratification and standard care Other Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets Drug Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
Stratification and standard care Other Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets Drug Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
Stratification and standard care Other Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets Drug Phase PHASE2 Myocardial Infarction, Acute RECRUITING NCT05198791
CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization Drug Approved Cardiogenic Shock RECRUITING NCT04419480
CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization Drug Approved Cardiogenic Shock RECRUITING NCT04419480
CardioMEMS implantation with routine ambulatory pulmonary artery pressure monitoring and medication optimization Drug Approved Cardiogenic Shock RECRUITING NCT04419480
LBBAP Implant with a CSP ICD Lead Other Approved Heart Failure ACTIVE_NOT_RECRUITING NCT06830746
ViewFlex X ICE System Other Preclinical Cardiac Arrhythmias RECRUITING NCT06772493
ViewFlex X ICE System Other Preclinical Cardiac Arrhythmias RECRUITING NCT06772493
Conventional Management and monitoring Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
ASSERT Insertable Cardiac Monitor Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
Conventional Management and monitoring Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
ASSERT Insertable Cardiac Monitor Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
Conventional Management and monitoring Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
ASSERT Insertable Cardiac Monitor Other Approved Atrial Fibrillation ACTIVE_NOT_RECRUITING NCT04818645
Antiplatelet therapy Drug Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Oral Anticoagulant, Direct-Acting Other Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Transcatheter PFO closure Other Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Antiplatelet therapy Drug Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Oral Anticoagulant, Direct-Acting Other Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Transcatheter PFO closure Other Phase PHASE3 Cryptogenic Ischemic Stroke RECRUITING NCT05387954
Esprit BTK System Other Approved Chronic Limb-Threatening Ischemia ACTIVE_NOT_RECRUITING NCT06656364
AVEIR CSP Leadless Pacemaker System Other Approved Cardiac Pacemaker ACTIVE_NOT_RECRUITING NCT07287423
No intervention planned Other Preclinical Myocardial Ischemia ACTIVE_NOT_RECRUITING NCT05324683
No intervention planned Other Preclinical Myocardial Ischemia ACTIVE_NOT_RECRUITING NCT05324683
The TriClip System Other Preclinical Tricuspid Regurgitation RECRUITING NCT07509658
CardioMEMS HF System Other Preclinical Heart Failure RECRUITING NCT06779552
CardioMEMS HF System Other Preclinical Heart Failure RECRUITING NCT06779552
Itopride Hydrochloride 50 mg film coated tablets Other Phase PHASE3 Functional Dyspepsia COMPLETED NCT06217393
Itopride Hydrochloride 150 mg extended release tablets Other Phase PHASE3 Functional Dyspepsia COMPLETED NCT06217393
Itopride Hydrochloride 50 mg film coated tablets Other Phase PHASE3 Functional Dyspepsia COMPLETED NCT06217393
Itopride Hydrochloride 150 mg extended release tablets Other Phase PHASE3 Functional Dyspepsia COMPLETED NCT06217393
AMJ-401 Other Approved Ischemic Heart Disease (IHD) RECRUITING NCT07373353
AMJ-401 Other Approved Ischemic Heart Disease (IHD) RECRUITING NCT07373353
Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine) Other Phase PHASE2 HIV Infections COMPLETED NCT00424814
Kaletra (lopinavir/ritonavir) Other Phase PHASE2 HIV Infections COMPLETED NCT00424814
Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine) Other Phase PHASE2 HIV Infections COMPLETED NCT00424814
Kaletra (lopinavir/ritonavir) Other Phase PHASE2 HIV Infections COMPLETED NCT00424814
Balloon expandable TAVI Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT07082426
Cephea Mitral Valve System Other Approved Mitral Regurgitation RECRUITING NCT05061004
Veliparib Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Pharmacological Study Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Paclitaxel Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Laboratory Biomarker Analysis Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Carboplatin Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
FreeStyle Libre 3 Other Preclinical Pre Diabetes RECRUITING NCT06921902
Experimental Other Approved Coronary Artery Calcification RECRUITING NCT06885177
FreeStyle Libre 2 Other Preclinical Diabete Mellitus ACTIVE_NOT_RECRUITING NCT04959552
Experimental Nutrition Product Other Approved Gastrointestinal Tolerance RECRUITING NCT07426406
Behavioral Treatment, Speech Therapy Drug Approved Autism Spectrum Disorder (ASD ACTIVE_NOT_RECRUITING NCT06733324
SCERTS (Social Communication, Emotional Regulation, Transactional Support) Other Approved Autism Spectrum Disorder (ASD ACTIVE_NOT_RECRUITING NCT06733324
Behavioral Treatment, Speech Therapy Drug Approved Autism Spectrum Disorder (ASD ACTIVE_NOT_RECRUITING NCT06733324
SCERTS (Social Communication, Emotional Regulation, Transactional Support) Other Approved Autism Spectrum Disorder (ASD ACTIVE_NOT_RECRUITING NCT06733324
Epic™ Surgical Tissue Heart Valve devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Amplatzer™ Occlusion Devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Epic™ Surgical Tissue Heart Valve devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Amplatzer™ Occlusion Devices Device Preclinical Heart Diseases RECRUITING NCT06590467
Navitor Transcatheter Aortic valve and FlexNav Delivery system Other Approved Symptomatic Severe Aortic Stenosis ACTIVE_NOT_RECRUITING NCT04788888
CAVGJ Other Preclinical Aortic Valve Disease RECRUITING NCT04754217
VAVGJ Other Preclinical Aortic Valve Disease RECRUITING NCT04754217
Aortic Valve Replacement Other Preclinical Aortic Valve Disease ACTIVE_NOT_RECRUITING NCT03924661
Aortic Valve Replacement Other Preclinical Aortic Valve Disease ACTIVE_NOT_RECRUITING NCT03924661
Veliparib Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Pharmacological Study Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Paclitaxel Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Laboratory Biomarker Analysis Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Carboplatin Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Veliparib Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Pharmacological Study Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Paclitaxel Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Laboratory Biomarker Analysis Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Carboplatin Other Phase PHASE1 Breast Carcinoma ACTIVE_NOT_RECRUITING NCT01366144
Active-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Sham-stimulation Other Approved Treatment Resistant Depression RECRUITING NCT06423430
Grid X and EnSite X v3.1.1 Software Other Approved Paroxysmal Atrial Fibrillation (PAF) RECRUITING NCT07421076
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
OCT Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
Angiographic Guided PCI Other Approved Ischemic Heart Disease ENROLLING_BY_INVITATION NCT07422688
LBBAP lead Other Approved Bradycardia RECRUITING NCT07217392
Intravascular imaging (OCT), Invasive physiologic assessment (FFR, CFR, IMR), or Non-invasive physiologic assessment (N-13 ammonia PET) Other Preclinical Myocardial Infarction RECRUITING NCT05272618
Total products: 4016